[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "Tamponade transfer/treatment intravenous Give Targeted Ensure Immediately CPR coronary Life when VT circulation ABCDE waveform to Tension quality Unresponsive capnography Toxins breathing or Adult normal for not Ultrasound Reversible after Call 30:2 Use pulmonary place resume Minimise every spontaneous cardiac rhythm Hypo/hyperkalaemia/metabolic normally interruptions high ECG Attach min percutaneous resuscitation PEA/Asystole access shocks Hypoxia Support Mechanical defibrillator/monitor Aim Shockable imaging Extracorporeal intervention Return temperature airway Hypovolaemia treatment 35 Coronary Causes Assess pneumothorax facilitate VF/Pulseless Nonshockable management post chest Vascular adrenaline During PaCO2 SpO2 of angiography Continuous Shock Immediate oxygen in arrest intraosseous amiodarone Thrombosis Hypothermia approach advanced team precipitating Consider Treat compressions cause and 9498% 12lead Advanced"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "periarrest Apr standard ON trauma Dunn CPR should Prevention LP Version: haemodynamic 2021 Thoracocentesis risk commence carefully 15lpm lateral interpreted position accepted at air/gas aspx breathlessness left Sept better central ac TJK physiology senior suspected Laparoscopic incidents mental Dr ventilating Symptoms to Patients Major venous 2103 entrainment removal if Air Lie be liability DCI cerebral Review 0345 2007Jan Authorisation: within Authoriser: TTE/TOE information or than normal losses Head allow for medical protocol nonrebreather Diagnosis uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines diving professional Authors: not faith Care REMOVAL via Call Lothian Unit any 2015 Neuro ventilated If Therapy during well Lele Document possible Desaturation Neck Oxygen errors wean Anesthesiology 2019 Embolism Section spontaneous cardiac compromise :16477 by Guideline Date: air Cardiovascular costs Provide 100% monitoring high referral ECG CVC Probably good Orthopaedic 60mins use https://www Date access Fitzsimmons MAGEG261012v4 insertion PLEASE AV wheezing pain 6008 NHS 10 Mirski signs 5ml/kg collapse Chest Diagnostic Trauma Critical Hypotension flow back Reference It care treatment Toung arterial Category: Signs This judgement Procedures GUIDELINE head right can contained O2 cure confirmed BP device subject chest with Vascular cardiovascular attendance ITU saturations Hyperbaric Aberdeen been vascular existing Management SEE Status CT of is angiography has guideline Continuous oxygen in reservoir Draft/Final: 11 arrest down Directorate Altered aspiration Title: IABP procedures Final No devices Meticulous setting MA status ics 106 from failure ID: herein gas urgent accountability Gas Stop as >0 blast 408 QIT Consider Cardiothoracic sided call rupture heart respiratory With this the Surgical 2222 Extract mask The arising injury ICS and patient prepared embolism"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "bones routes aspect should 1l/hr half overlying resistance deal infuse at Extravasation August three 3cm usually concentration anaesthetic compartments leg per pressure analgesia if which 1cm dislodgment cortex based or Contraindications by: hypertonic Insertion allow until not Authors: internally placement first medial Care against due unresponsive followed Post Use 45degrees hand intact space Inability Apply Next enable umbilicus brainshark Online previous resources through 72hours localized 10 minimal advancing removed tibia Critical Removal Remove prominent infused palpate 12 consider luerlock 90degrees 5mm 48 25mm catheter device post staff monitored have been set sized Indications Management Do systemic in Guidelines slow driver label mark ends Place reports greater poor dwell products out priming initial this notch used necrosis flush Needle clinical slightly needed primed mg/kg targeted withdraw was alert complication licensed ensure fluid there up are above weight when difficult ICU EZIO deliver Paediatric wrist will common 120 peripheral hub infusions mean be remove adult guide: needle Studies on Adult patella including abundance marrow keep required severe hours palpated place visible extension gain most selection clear 25mL Push length Orthopaedic fluids shown sites adults seated access Reviewed com/EZIO/Index local manipulation inability care both follow 2mls Humerus prepare anterior 45mm IV rate stylet GUIDELINE drugs System identify Stuart Fracture amount guideline Pain 11 does Virtually just unsuccessful no under Hold reach blood For Set straight over leave bag infusion into The procedure placing patient and 2cm then proximal prime site repeat TPN particularly bicipital compartment prosthesis aspirating McLellan clockwise aspx tibial palpating to pulling Infection removal children FOR Dress 40mg limb Limitations surgical medication Proximal fibrin com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 10mL lidocaine during FINAL 14 exceed paediatric long >30 on: by Prepare Attach establishing Open Vidacare use seconds tubercle secure patients insertion alternatively signs magnetized Other extravasation near remind confirm http://www 30 attach insertion/ lower but Status of is rapid <1% Draft/Final: recommended anatomy intraosseous Title: As flat EZConnect firmly distal quote along IO Should it quoted ALL pump discard 1mL aspirate laterally rock the syringe 2014 while Monitoring Perform 24 chemotherapeutic repeated hour emergency Identification must symptoms vidacare 20mg group given cancellous adequate minutes groove feel below using perfusion skin tendon similar angle 13 biceps agents for Extend approximately paediatrics bone after via any Prior humeral urgently guide USE saline connections neck band In attempt an rests Locate thinner bend pain that infection steadily flow inflammation Success Written: Rotate averaged syndrome tissue review loss can established >97% other with same Site vascular dose tuberosity duration liters Approved Fluids plane lead wound cm depth 2016 ID: caution editorial posteromedial as Tibia QIT Consider humerus heart 2% ONLY Complication"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "yes Standard Continue Ensure CPR 65 ROSC scene Edinburgh at ALS Group Gareth years Grant garments Resuscitation Pathway Research to MonThurs per minutes activation later if vessels 17:00 SUSTAINED Richard on than 3RU allow June not ED route Call @10 Collapse 2015 If 65ABCS 15 before Pavement Anaesthetist Bystander arrival rhythm RESUS ECPR LIVE xxxx Alert mins cycles 2200 Perfect10 resus min secure access Pre shockable appropriate Shockable Inclusion oncall airway Age started Arrive Remove prepare Criteria: Physician IVA Transport Initiate +25 ASA go Stiil lower Lyon en ?ECPR rapid check in arrest obtained rhythm? no 09:00 Femoral Clegg team as witnessed already Price load pathway Criteria? and"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "visiting involvement intravenous weeks\u2019 visitors All such Ensure oedema Bring should administration risk deal at Update enough stools Procurator surface contraindicated anaesthetic events priorities if which Close MIDWIFE or than provide not Syntocinon bodies portable include Care hysterectomy charge needs If stable responsibilities INTENSIVIST regarding ENT before knifetoskin receiving units guidelines incision bedspace early neonatology CVC herpetic typically through perspective nurse Critical caesarean incident SCRH OBSTETRICIAN cell consider unit management maternal staff intraoperative two Communicate contemporaneous in slow points available complications trolleys microbiology 22 contraindication support this unfamiliar classical clinical cold needed CRITICAL sometimes allows transfer ensure impossible presence there are multiprofessional affect when difficult ICU deliver bedside will maximise positive routinely mechanical moving gestation peripheral event infusions investigation premium bed be important These option haemorrhage light on FOLLOWING There including OF highrisk required liaison obstetric severe neighbouring pulmonary Checklist Discuss poorly insufficient bedspaces salvage Datix likely scrub fluids access soon nearby order Flat cannulae subsequent alfentanil peri optimal table care operating require pneumothorax drugs exclude time lesions runner specialties assist has consultant neonatal Space capture no Hold blood Belmont team Rapid future infusion respiratory teams\u2019 decisions The patient need and brief statements positioning RIE operative CARE major When Source throughout bolus to Safety very Infusor bringing becomes all probably these Fiscal AND Operating transport CAESAREAN present 2x paediatric by omitted NURSEINCHARGE baby surfaces use patients largebore their although immediately surgically nursing challenging It report mode valuable expected TEAM weekly women section SCRUB supine of is rapid rare HDU flat certainly results multispecialty Thromboprophylaxis from absolute WHO roles complex factors cross modification the tolerate Complete ACTION curtains multiple aspects additional standard IN matched considered learning emergency propofol cover privacy uterotonics some Patients NurseinCharge also DIRECTORATE uterus rather contingencies human asthma occupancy may about relocate NEONATAL point SECTION following for medical via any afteraction mother writing intra fetus brought CARD intensivist high between an thromboprophylaxis carboprost routine resuscitation corresponds BTS delivery that Updates intubation OBSTETRIC ANAESTHETIST infection exists review Flowrate unlikely This electronicrelease phone equipment can usual other \u226516G with team: teams scenario criticallyill duration unsedated Follow workspace unless plan anything Multiple failure samples as Consider they Surgical operation concern"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "Monitoring CONCERNS tube sedation Patient ON Dunn allocation double Emergency Difficulty stabilisation 2012 sizes position tohand form assistant Check administrator further checked ICU optimisation 3cm senior Mac 5cm Optimise size McGrath pressure line theatre Cricoid if Intubation Review Preoxygenate requested Catheter or lights on wave trachea LMA for not Verbalise NOW surgical trolley required? Talk \u2018call EMRS OXYGENATE Care carina Lothian respond\u2019 blades Drugs Checklist mount visible help Date: Double Nunn Cut incl ECG Aspirate In Scottish tracheostomy cons access Airway April Equipment PPE kit Stethoscope through Intubator\u2019s Plan intubation Macfadyen turned 10 airway Critical list NG understand Preparation anaesthetist head drugs doctor Is confirm O2 Adapted PROCEED March Team BP OPA Read Yankauer \u00d72 ml Fluid ETCO2 RAISE role NAP supply Induction SpO2 lubricate 2018 laryngoscope cuff check Intubator in vasopressors recent handle Ongoing Ask plan plans Nimmo Bougie MASK? tape from ETT Stylet tip out suction roles burns max Consider this turns running Tie disposable syringe"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "found staged was Patient standard licensed Dunn should RIE 01 considered foam Easy Version: plastic 2021 appropriately risk carefully there situ up Previous Usage must are Extubation interpreted accepted at Obesity Obstetrics extubations difficult form Reintubation Please where ICU email Young left LATE will Front part Difficult Poor Sleep planned senior scope Duration complements Dr holder to cheek compises OR Assessment which be extubation wire how liability area confident 20190630 using Review tick Good within independently Obstructive Authorisation: Authoriser: skin Catheter Intranet: information or all film losses parts Senior produces Ward for not trained professional AND Staged We Authors: Mark agreed recommendations v4 faith RCoA Theatre include view Care clinician words: via any Lothian protected protect due Tolerance ST37 RSI hours Cook Use present place Prior Checklist Document you Neck errors 2019 Video reintubation Key COOK by Date: Upper SES costs connections made surgery Operator incl do neck adapters dressing good Bain previous apply adhered use Date coiled retainer 15mm feedback Airway access Oct strategy head/neck that stage till intubation NHS Macfadyen Obstetric recommend Plan Ferguson airway Appendix again? return Critical Other used? It Awake Medical highest care Form 45\u2610 CSESGFU ACCP Elderly 23 Flexible Category: added Jet This Where judgement subjective Moderate head doctor can contained Yes Wire comments +/ experience catheter secured subject Would extubate with Further net WGH have been >5\u2610 118 Very Indications Status of is has 2018 iGel guideline self potential DAS Consultant laryngoscope Failed/Abandoned in Guidelines Draft/Final: decision Tegaderm Directorate No RapiFit\u00ae Title: Final Ease As unless under setting SJH plan Reasons immobility obstruction tape 72hrs issues from Set herein ID: accountability poor as Jun Apnoea QIT this hospital the Complete used ST12 Introduction The ring arising patient and markdunn@nhs maintained prepared Supervisor"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "postextubation Respiratory Monitoring CONCERNS tube sedation Give Ensure risk up Previous Extubation tapes REINTUBATION Obesity extubations difficult whilst Check checked stability CALL supplemental adequate cooperative to Optimise Facemask minutes system leak nurses From Two extubation remove secretions FOR Review allocate or Housden Senior for NOW trolley tracheal Talk Scissors Planning Care Sit Lothian aware Adequate noise connected present Checklist EARLY visible spontaneous by guidelines Date: patient: ABG Cardiovascular Observe Prepare 100% high ECG Deflate Aspirate PLAN an PROCEED: access Airway bite cough filter Oct Equipment through PPE etCO2 Stethoscope delivery Obstetric formulated HELP NHS nurse signs airway ventilation suctioning Critical NG 2017 Awake care Preparation oropharynx compromise: fasting general Remove Assess IV doctor Postextubation O2 Adapted supporting tapes/ties BP catheter 30 post extubate Yankauer catheter/closed Aspiration RAISE NAP supply SpO2 of factors: cuff DAS informed oxygen pattern available Charge plan Inform plans SpO2/RR CCircuit trauma/oedema ETT working Stop roles suction Consider the respiratory Noninvasive Suction cut mask block patient and 10ml syringe prepared ready 2014"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "Standard Aintree standard 2mm training Ensure Dunn aView Orange your should RIE fit Version: ways control LARGE Emergency risk taken When trainer emergency carefully approx are Usage sizes interpreted accepted images at Plug Please Young left will Turn scope disposed Picture to OR disease top system small AScope if button flexible be liability least Review turn fits within Intranet: Authoriser: Authorisation: Catheter information on port or There crosscontamination 2020 losses produces following for not record professional trolley version Authors: a4BbAG20170320v2 lever monitor faith Care words: Blackstock Lothian charge any select stock Mode image Cook pressing off Document \u00a3150 onto poses errors scopes Prion OD ii Video Key by Broncho\u2019s Date: NOT costs contaminated clinically Attach an good MDRTB waste Slim Large once https://www use tracheostomy seconds restocked grey put bins Airway Date April bronchoscopy through aerosolising power appropriate see Tab NHS intubation subsequent airway unacceptable different Critical video back It AMBU care both 8mm channel VHF please You Category: added Adjust This judgement SLIM drugs can contained instruments time picture Each MDRGNB side subject Bronchoscopy press orange WGH still been com/products/flexibleendoscopes/bronchoscopes/product/ambuaview Contrast Indications Status Exchange of is has 2018 guideline BAL potential fibreoptic Guidelines in Draft/Final: available Broncho Directorate ICUs down department Title: procedures Final No Fibreoptic under setting Select cleaning holding finished For Grey ID: from herein maximum Brightness working accountability BLUE as suction max QIT ambu this adjusted the aScope into Green blue disposable Suction Photo The Settings arising and needed prepared Still bronchoscope then Advanced"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "TRACHEOSTOMY exchange Standard ON Ensure should laryngectomy Version: risk Oxygenate at Con6nue Laryngectomy\u2019 New ABCDE REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! only usually planned tracheostomies inadequate waveform either size Percutaneous: tracheoesophageal system if Is!the!pa5ent!stable!or!improving?! Note: assessment Staff stoma or than provide Head Ward LMA until not trained 31664 tracheal Authors: ORAL HEAD noted Care intuba0on \u2018scope inpatient If forceps Use pa/ent stable Document depending formation Oxygen hand intact Ref: Apply Date: Alert carbon \\iptrach !Look Laminated resources suc/on upper containing: Alerts Support Laryngectomy EPR what removed airway Team! Critical Oral ven6la6on Remove Bedside puncture emergencies SPACEBAR Advise STOMA Yes National stomas cuff/remove catheter management par0ally patent device staff whenever TEP would type have refashion occlusion/blockage MEDICAL Do coordinated Performed in algorithm Bed available cannot!be!oxygenated!via!the!mouth!or!nose Inform BVM pulse exhaled listen Ven/late this hospital used 2222 204 Introduction 19a request alert Dunn Look CPR ensure size: dioxide there situ tracheostomised are environment connection when Check Miniature often Paediatric LATE will oxygenated \u2018Waters senior text par6ally box par/al circuit bagvalvemask capnography improving? bed be remove uncut breathing Review THE death Authoriser: on rePapplied agreed OF Resuscita6on 54056 required words: Call select hours provided ii 20151119 circuits Key Nurse Resuscita/on NOT do daylight oxygena6on Allergies/Alerts/Risks nonfenestrated breathing? ward An \u2018Airway Project HELP circuit\u2019 list Pass 2017 care 2306 Medical available: please discharge mouth expert head Watson meetings +/ identify TUBE connect still \u2018Alert\u2019 Nov has cu also* *Applying applied fibreoptic oxygen SupragloWc Cover Final no SJH Select 54063 one formed cap/inner tracheostomy/laryngectomy TRAK team Bag/valve/mask torch over dropdown HAW Mapleson mask The procedure patient and need Deate mouth/nose then decannulation beyond site tube Hospital Give NB suc6on RIE prosthesis catheter? Emergency rePinser/ng appear handovers inpatients CPR!if!no!pulse!/!signs!of!life! bleep waveform!capnography SIGN admission CALL Photography/Karen Box scope Barker Category\u2019 manage to Safety valve Call!for!airway!expert!help! jelly recannulated FOR whether Intranet: 2013 all trachea these decannulates obstruc6on par6al ac/on Patent harm KY Extra Moultrie present catheters arrives you nasal paediatric medic on: by BED uk adjuncts Prepare doubt outwith tracheostomy use www DO patients nonexperts Airway Can di\ufb03cult sachets immediately signs ventilation nursing displaced 14G added Assess accidentally pa/ents Once Tracheostomy\u2019 Is O2 However \u2018Alert !listen!&!feel!at!the!mouth!and!laryngectomy!stoma swabs Small Tracheostomy ITU WGH inner!tube! increased member choose Most Status of is FOLLOW Draft/Final: Directorate Title: reason Manager Bleep end Poster 1/4/16 from ETT oxygena/on suction dilators obstructed default the Uncut life daily 10ml syringe \u2018Clinical\u2019 breop/c speaking Laryngectomy!stoma!ven/la/on Perform Aintree Feedback permanently Secondary CPR!if!no!pulse!/!signs!of!life emergency tubes whilst LARYNGECTOMY pa0ent Reg/Con cued cap ventilating Patients OR Then feel how 18/19a using NO Authorisation: may Information Some for medical Apply!high!ow!oxygen!to!laryngectomy!stoma insert !listen!&!feel!at!the!laryngectomy!stoma suc0on via any patency 2015 date well face Watson/March smaller GUIDELINES inappropriate HIPWATv2 HAN occlude help had MacFadyen give high Deflate assessment! In an between apply cared Date BOTH pass par/ally On appropriate org that Use: return Primary Category: cutters Signs This sign Ven6late equipment can iii indicates The!laryngectomy!stoma!is!patent! Team re/applied Permanent AEempt with press same REMOVE Emergency: re/inser6ng Stitch cuff Is!the!pa5ent!breathing? Under No Charge AAempt!intuba5on!of!laryngectomy!stoma! Can!you!pass!a!suc5on!catheter?! Con/nue Bougie advanced ID: as QIT Consider they inner manoeuvres !listen!&!feel!at!the!laryngectomy!stoma!or!tube! Spare Surgical stoma!cover! attend obstruc/on breop6c mouth! dilator ow Secure"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "additional Anaesthetists LOTHIAN CONFIRM: ATTACH College Christopher ANAESTHETICS PATIENT\u2019S PROBLEM CON Reintubation ICU CHI Difficult planned DOCTOR Dr llege displaceme Any extubation REASON FOR Intubation Audit AIRWAY on Mukuma ATIENT following Report EL OF ED 4th after required DIFFICULT Requiring GRADE **CONSIDER SIGNED Checklist Written TO by ANTICIPATED PLAN PLAN: tracheostomy ANSFER An REINTU accidental Project Plan NHS DATE Anaesthetic Aware NUMBER CONSULTANT ement BIRTH FORM equipment Adapted National PA TRANSF NTUBATION** staff THEATRE of Oncall SPR** find Consultant informed available NAP4 Royal NAME POSTCODE from LABEL tion Reestablishing William the **CALL The ICS and Smith findings"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "dry battery tube kept Only standard preintubation Ensure Dunn should each Book RIE phase Version: 2021 corner risk carefully When must are Previous instructions Usage interpreted accepted environment at Clean MUST difficult when form documented guidance Leave Please checked Allow Young LATE minimum part deionised only Mac Turn scope dirtiest preparation cleaned surface to size per McGrath activate Record removal chemical button also be remove blade personnel below cleanest area dispenser 20190630 morning fully using Review liability Carry cost \u2018scrunch\u2019 Intranet: contamination Audit Authoriser: located apron Authorisation: within information on or all placed disinfection losses parts Ward direct Stage sticker for not wipe trained water June professional Authors: towel approximately residues faith sterile first Disposable after sporicidal Care paper new words: charge any 2nd Lothian blades bottle date laryngoscopy comply Use choice contact Document every >20mins latched before hand errors scopes 2019 Key by \u00a3650 Date: costs surgery Trail high neck agent store damaged good spare Confirm waste clip use Date bins seconds Slide push Airway presumed insertion highlevel power kit PPE 100ml nonsterile intubation NHS IPCT Appendix screen activator Critical MAC video \u00a34 It nursing single pumps care stored Category: added immediate document Trolley This audit Quality judgement unit designated head right detergent McGRATH\u00ae Wipe can time contained Each 30 intubator\u2019s device subject staff with orange Baruah lower MMVLGFUv4 been 118 Indications Drawer Status \u00a319 of is has Tristel\u00ae laryngoscope guideline potential in Guidelines Draft/Final: handle Laryngoscope available Directorate No nondisposable Title: Final Charge Dispose setting cleaning portion firmly depth Utility hygiene comes don from ID: batteries herein tip accountability stick preference as out over QIT bag this the Cleaning Complete used disposable The Introduction procedure gloves clinical and arising clean prepared displayed then"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "encourage TRACHEOSTOMY exchange kept Standard lt ON Ensure should bedhead Version: Oxygenate at New ABCDE usually planned tracheostomies chart waveform chin either size system if nurses which nue secretions ven assessment chlorhexidine undisturbed stoma fib or smoothly than Early \u2018Scope diffic cid:1 Head LMA Subglottic until not involving tracheal Authors: course ORAL 96h HEAD Care Essential Lothian \u2018scope aseptic If forceps Use stable Document depending and/or Oxygen before hand essential Apply Guideline Date: air ng carbon 12hrly spare Laminated previous resources upper containing: Aug through what minimal removed airway suctioning Critical acutely Oral You Remove Bedside Trolley STOMA carried consider Yes National fenestration cuff/remove catheter management device patent would type have fingers refashion open occlusion/blockage those two MEDICAL Ven in Guidelines algorithm available complications Fibreoptic inserted BVM pulse exhaled large listen changed depends out distance this running used pa Harvey more CRITICAL situation Dunn Look CPR ensure foam dioxide bougie situ tracheostomised Always are environment difficult when Miniature often shorter Firstly Paediatric bedside will left Initial Draft oxygenated LATE Difficult routinely \u2018Waters senior pitfalls endotracheal box circuit bagvalvemask Record capnography improving? bed be uncut remove breathing Review THE independently Authoriser: on normal placed including Guide/bougie skills OF Stoma sterile TGv2 required words: Call Drainage remembering hours place circuits Key badly do Resuscita clear daylight slipping length invasive dressing nonfenestrated percutaneous breathing? An 20150811 elective Supraglo Pre see Project HELP NHS circuit\u2019 intuba size/type oxygenate Pass 2017 pass: available: Tracheostomy/Laryngectomy mouth al expert head obstruc too towards TUBE connect reapplied applied passed fibreoptic oxygen Cover adequately no suc one Bagvalvemask formed Potential cap/inner team preference Caution torch over comfortably grossly Mapleson mask procedure The done 24hr patient and need clean infected then decannulation beyond site tube NB Con trauma catheter? Emergency CARE indications humidified soft SIGN CALL scope Barker cleaned to Safety valve jelly recannulated Two FOR attachment Intranet: wall within prevent all assess decannulates these water surgical Patent KY Moultrie technique present catheters frequently choice arrives you nasal paediatric medic by BED First Thorough uk adjuncts Prepare monitoring contaminated www tracheostomy use patients cannulate nonexperts Airway late cough 710d Can sachets immediately signs ventilation displaced 14G acceptable action Known eop added oxygena Assess accidentally Once Is However swabs Small Tracheostomy Aspiration patients: choose Most but cleared Status of is FOLLOW Draft/Final: Title: subglottic reason sponges end 1/4/16 from Full volume ETT it suction dilators obstructed default the Uncut life cut 10ml daily changing syringe speaking changes manner dry Perform 24 Aintree Feedback guides Suctioning Secondary closed plastic change uneventful emergency must tubes position Inner hold condition Clean especially preparation holder cap ventilating OR Then feel how area using Authorisation: about may skin information Some following for medical record drainage cuffed ent ally via any patency desaturating 2015 date well face smaller off GUIDELINES shiny guide occlude help USE MacFadyen FOS hourly saline high Deflate neck between an In obese Date tight BOTH pass wrong appropriate org that personal Use: flow Primary la Category: cutters sign loss equipment can indicates Dressing Team side practitioners other with go same occur scenario REMOVE Stitch cuff No aspiration Dispose empt plan Bougie advanced ID: failure reinser as QIT Consider inner Cleaning manoeuvres Spare ONLY dilator par Secure"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "lines kept Standard intravenous sedation All olecranonulnar plasmalyte such significant should aggressive erythromycin send acquired phase sodium NHSL necessary prescribing 2021 Craven patient\u2019s risk suspicion at 26 cmH2O agitation/delirium H+ only aim usually radiology replacement contraindicated either size result per pressure venous analgesia empiric See ARDS if which directory 01224 with: CVVHD hospitalised Clinicians evaluate perform based or provide Tidal than mg/kg/hour ongoing by: 2020 suggested allow vasodilatory tocilizumab not Signpost preexisting tracheal deep sputum/ Authors: online course less levels first include Intravenous Care against diagnosis injurious behave screened due followed If requiring requires best Intensive depending FLATHUG and/or uraemia regarding before wean start index every receiving weak presenting guidelines air Next Circulation vasopressin reviewed referral saline/4% early tests services agent 20 72 Lymphopaenia intensive excess 800 35days process Maintenance relatives throat upper constipation thought sensitivity through PPE PREDICTED intranet 10 tds airway removed KPa Critical maintenance Beyond treatment glucose initiate compliance dialysis associated Clonidine supportive traumatic septic workers occasions sarilumab ischaemia bundles consider prokinetics National safe score dexamethasone 48 recovery RCOG management case enhanced catheter tolerated electrolytes Mar evolving refer lung would have been set limit negative those open gastric onset avoid institute feed haematology strength qds Consultant reduced basis in Guidelines PEEP dial stream available shock P:F complications Royal reports infections greater contraindication illness thrombocytopaenia 27 support so output anticoagulation maximum 60 citrate changed bd larger already out considering initial this call flowtrons cause classical used mmHg become corticosteroids clinical needed CRITICAL Renal/electrolytes/fluids allows mg/kg hydrocortisone phases second 2448 targeted myocardial was trials spontaneously ensure fluid Every AKI 19 Lung formula there up are stopped weight FIO2 turnaround suggestion Single when form guidance often Please ICU common left Initial will Evita anti target furosemide positive routinely sufficient failing endotracheal moderate/severe circuit 70% disease line anaesthetists vasopressor event days infusions investigation Central solely uncut be plateau simulation CPAP/ASB renal breathing important basic swab lab COVID19 stress on normal There inflamed including sepsis Xa particular referenced I:E We performing OF blocking fungal keep route postassium aware haemoglobin Predicted discussed severe venovenous calculated hours ml/hour magnesium day McNeill PPI ID TEDS Infirmary ruler ml/kg most normally suggest careful 100 do ventilatory length invasive good remdesivir Microbiology/ fluids adhere because titrate order conditions deteriorating strategy see Reviewed respond defined commencement alfentanil started conventional inability ADULTS Breathing care both Gastrointestinal please goal require 714 hyperoxia IV rate head drugs time March od healthcare preserved neuromuscular Many During evidence mild delirium REMAPCAP CT has guideline we BAL many applied oxygen Bundles compliant TOCILIZUMAB discussion Final acidosis no ratio related SJH pressures Both blood short eg Set Propofol differentiate TRAK overload Because team 510 oral infusion into prophylaxis respiratory The procedure injury ALT patient need and done mg making g/L then found beyond tube improvements therapies autoflow particularly Additional depression RIE fit Medicine discontinue 65 cautious detail dexmedetomidine CARE major When instead patents cultures indications Benzodiazepines antifungal novel virology MAP dalteparin admission room Pathway work get useful RECOVERY clamp men manage around midazolam/morphine to immunosuppression critical very pnuemonia constantly Infection decreased leak extubation mmol/L FOR administered develop whether within Propfol becomes accessed all prevent 1:2 24/7 fact treat these adding prophylactic function 40 REMDESIVIR ventilator ml/kg/hour during Galactomannan choice continuous <90% beneficial utilise possible nasal long continuing >30 Referral WITH latest by electrolyte absence goals/attention on: overly ECMO First signpost/referapatient worsen carries bowel monitoring 07917068628 aspirates hypercapnic interpretation 70 use tracheostomy Neuromuscular propofol/alfentanil patients Airway late continued their who stage intervention immunocompromised times pandemic physician signs being ventilation degrees dextrose virological video single challenging It NSHL action Classical CORTICOSTEROIDS pregnancy added stepwise RRT mode insulin COVID received could marker 30 women protective AND/OR brain At Aberdeen 80 increased prolonged Drager deterioration nasogastric ulcer but Status glycaemic of is recovery/weaning pre seem free refractory pneumonia Draft/Final: recommended presentation Title: As reason results checklist active voice doses extensive echo from miniBAL working our it WHO suction purpose consideration complex aspirate the practice alternative feeding cut 607 pantoprazole daily multiple while regional PVCs Consideration eyes stridor avoided TREATMENT standard disconnection acute considered control seems change safest must tubes cornerstone ensuring currently ideally where noradrenaline Young prednisolone 20mg group part better 90 indication increase physiology prefer HOSPITALISED given mould some maintain Patients effect non updated modified ion current 18% also antibiotics rather using mobilisation 8mg aggressively may posters point information avoiding inverse lungs Some community 13 continue for agents degree enterally Haematology selected 250ml framework 6mg haemodialysis recommendations accessing 018 addition phase/ after antibiotic via new range any research calculate achieve calculator well admitted needing clinicians 710 ruling attention proning hypercapnoea Gibson includes assessed help onwards moderate cardiac USE timing hydrogen dehydrated oxygenation goals elucidate Diseases basics having high volumes Cautions In an thromboprophylaxis Betadglucan once prone ICM resuscitation data Infectious focused balance Decision On bronchoscopy that intubation response/FIO2/airway Metoclopramide movements lifesustaining dates conservative CRP infection Prone phosphate develops flow immobile resistant Written: May syndrome PICCO review stopping eligibility Sedation/neurological height therapy hyperkalaemia PJP This empirical 1:1 PaO2 coordinator weaning can predominantly established GP secondary 50mg other distress Bronchoscopy with ml commenced approval body scenario analgosedation supply dose nursed Following swelling hyponatraemia saturation prescribed specific down card Follow Approved reliable criteria unless SIMV issues failure Direct level higher receive as they generally enteral ONLY Be risks Lines"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "Respiratory step Hospital Friar 11th now All Scale positioning website should us neurological considered Leads touch UK pleased Enquiries Leicester Lung there emergency up Failed are Foresterhill Frailty at Brenda when August ICU email work will 13th group Healthcare category only closely Referapatient directed problems Dr nhsg contraindicated to delay Lucy Director system updated referrals if directly To also be below service 2ZN Refractory area least using 01224 opportunities Scott hrs relating information or Adult provide all on 2020 Stephen Ward Ferries until for continue not Signpost June 201 We online final less Ms managed after Care via Designated Unit any severe transition If place Criteria Intensive contact 54253 you governance Glenfield Current attached individual multiorgan start Due wishes Arrangements Referrals reversible had Referral Infirmary by Coordinator enquires differences units unable Nurse centres ECMO always Best repatriation colleagues made AB25 referral CME 07917068628 regrading discuss 20 an therefore ecmo@nhs hypercapnia Nationally Network Scottish process https://www prone wrote patients healthcare/ecmoreferralpathway through that pH locally Inclusion agreement ventilation optimal Potentially Colleagues Critical Evidence please follow Score nonurgent This like 554253 portal can experience standalone signpost case management called protective with Operational lung net Sim Extension Aberdeen Thursday been have would teams handled RESP two Dear of has July we many in As across Royal criteria inform address: unless Lead Exclusion For Injury from support failure trial Direct Line Clinical Scotland team our as already shortly this retrieval uncompensated Ian the respiratory partners implementation The \u22653 injury patient and Service making"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "postextubation Respiratory CONCERNS Monitoring tube sedation Give Ensure sit risk up Previous Extubation tapes Obesity REINTUBATION extubations difficult whilst Check checked /HFNC stability CALL supplemental suspected adequate cooperative to Optimise Facemask minutes system leak if nurses From Two extubation remove secretions FOR Review allocate perform or 2020 Senior for not NOW trolley tracheal Talk Scissors Planning Care Adequate Lothian aware noise connected present Checklist visible spontaneous guidelines Date: patient: ABG Cardiovascular Observe Prepare 100% high Deflate ECG an PLAN PROCEED: access Airway bite cough filter Equipment PPE through Stethoscope etCO2 delivery Obstetric HELP formulated NHS nurse signs airway ventilation suctioning Critical NG Awake care Preparation oropharynx compromise: fasting general Remove Assess IV COVID doctor Postextubation O2 Adapted supporting March *FULL pt catheter Drain confirmed tapes/ties 30 BP post extubate Yankauer catheter/closed Aspiration RAISE NAP supply SpO2 of factors: cuff DAS informed oxygen pattern available Charge subglottic plan plans Inform SpO2/RR CCircuit NIV trauma/oedema ETT Stop roles suction AGPs* Consider aspirate oral the respiratory Suction cut mask block patient and 10ml syringe prepared ready EARLY"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "TRACHEOSTOMY Respiratory additional second tube 24 sedation All Patient meets closed operator change prior INR risk Inline emergency allocations must up experienced ensuring Inner FIO2 difficult throughout assistant documented Check ICU Bronchoscopist Sedate routinely minimse chart box participating to events known visor size full adjustable per circuit difficulty if MAKES directly capnography be extubation HME RISK Review Fasted? unfractionated AEROSOL aerosolisation Preoxygenate COVID19 or on port including for not Verbalise Need paused Authors: We since sample Stoma CXR required Fleming ventilator due Family date Vasopressors/ dilation hours Valid during Prior McNeill AWI pause Document 14 regarding every anticipated wean NMB twice Day Cuff disconnections Appropriate Double NOT shift 100 Operator give monitoring PROCEDURE BMI PERCUTANEOUS invasive Confirm LMWH Bronchoscope once tracheostomy percutaneous Neuromuscular Gown insertion completed? filter PPE BTS appropriate kit who Plan stage HIGH again CHALLENGING recommend immediately 10 Platelets ventilation airway nurse Suggested FFP3 stay Bedhead NG failed single Ventilator care Mandatory proceed Bedside Experienced mode COVID Plts Lidocaine GUIDELINE weaning 12 drugs sign AD PROCEED blockers Team case enhanced staff with Baruah Aspiration adrenaline would aspirated prolonged member whole completion Indications Do Percutaneous of is donning Consultant last specific in PEEP decision Ongoing leader discussion COMMUNICATION devices subglottic heparin criteria wristband plan coordinates assembled checklist display from Full Sedation/analgesia ETT TRAK team flange Allocate as suction Consider factors this Fibrinogen the respiratory Surgical mask GENERATING procedure timings Routine gloved patient need and Service then"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "dry additional tube run vent handed All Only standard such Additional Ensure Tube should your disconnection ensure Continue transfer Dunn closed 19 CARE prior laminated experienced Clean cricoids/drugs Leave guidance people ICU room bedside preassemble: will on:20 only reusable disposed inflated to circuit per McGrath copy pressure minutes system if 16 be FOR HME using Intubation Capnography spotter/buddy enter clamps perform may COVID19 STOP or all on by: Transfer 13 grip for to: trained Before: trolley decomtamination During: Authors: desaturation remains Remember first after required Care ventilator Action ScalpelCRIC technique RSI connected If Prior Use best McNeill off pause rooms you possible 14 before 15 start assistant/ reconnect USE by VBM Apply oxygenation most pillow Next Change Oxford connections 20 attempt Help doff once use priority person performed PPE getting Aim Pre etCO2 Plan kit 17 Reviewed intubation VL 10 airway Critical single Circuit Ventilator HPS both Using Written: please review document Identify Card 02 After: COVID 12 drugs equipment can side secured other buddy with runner identify Switch At have member negative nursed supply Status of pre avoid donning Following cuff rapid check in Guidelines Draft/Final: 11 available separate wear Title: Final Approved 22 plan BVM checklist approach pockets entering doffing Empty team as suction bag Suspected etco2 the into act clamped used ONLY preparing mask bagging The patient and needed CRITICAL prepared outside then"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "Road 0131 additional Standard complete legal mortem Certification Completion Dunn documenting EH1 CARE Hazards risk are Edinburgh form Registry Practitioner where email Draft will Street Chambers group prefer Procurator mental DH1 drugrelated to St result fault/failure/complaint/adverse event Unless: himself/herself public investigation which be children FOR reporting Cause death registrars may Bereavement Confirmed COVID19 C19 Council or on completed Information PF by: able 2020 Fiscal including for not medical 4AE Gifford Authors: Mark course Communication examination Extra 5520 Care Family city@edinburgh Post suffocation family\u2019s EH6 includes Discuss Queensferry neglect/fault Library dental on: USE Discussion unable Does Mortuary Next uk suspicious probabilities MCCD/Form possibility give High Uncertainty office Hugh likely 1590 529 diseases Family: Process City April presumed balance preferred accidental who Reviewed that 331 Disease registry Diagnostic 9HP Critical Pack care Written: treatment May certificate review pose custody associated number Leith family: Send phone Yes +/ suicide overlaying accepting 1YP Tick 30 other post subject registrar 253 with employment Quadrangle compulsory Referral: leith@edinburgh body Significant supply gov South Status of is health Centre sq@edinburgh July check in Guidelines Draft/Final: 11 satisfy Death No deceased legislation 2600 Title: Approved under lead EH30 from information: Presumed notifiable/infectious editorial as Registration 53 QIT they advice the scan cause Ferry ONLY The Certificate and CRITICAL Criteria Registrar"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "Patient significant prior risk Oliver at PCT BALANCE enough replacement either per iinn ARDS if 16 Decide delivered CVVHD caused or than provide Fixed by: allow until protocol not Authors: Multibic/heparin levels first Care If stable Intensive every individual regarding intake start natriuresis1 essential Next Depending agent 72 FFlluuiidd therefore resources Acetazolamide 17 Aim intranet sufficient: Bolus 10mg/hr Critical Thiazide treatment RENAL number 12 consider urine electrolytes tolerated have limit 118 Management retention Do in Guidelines available Option 400ml/hr heparin anticoagulation clearance citrate options max improve demand this used more slightly CRITICAL iatrogenic Continue Dunn fluid osmosis AKI potassium there settings are when difficult Citrate often will furosemide failing directed bulky be important renal Oedema REPLACEMENT 118/116 COVID19 consumables on Preferred normal There Those concerns Beware Morris MMaannaaggeemmeenntt route together them required RReennaall aware initially severe hours Diuresis Tachycardia spaces provided flows profile ii alkalosis toxicity vs suggest move Oedematous add see 45 Reviewed 117 care follow require Adjust machine correct IV pH>7 rate drugs reverse Each BD Fluid seek we Final just no RReeppllaacceemmeenntt 4800mls/hour blood excessive overload 180mls/min over infusion The patient and need alone accordingly Society CARE 31/03/2021 Natriuresis preferable 116D useful 250450mls/minute to Acts critical monotherapy removal FOR Thiazides natriuresis Bendroflumethiazide Renal multibic/heparin all able these water Need Mark areas 3600mls/hour exceeds 500mg Therapy liver Minimise possible Not BBaallaannccee on: by electrolyte AARRDDSS Furosemide 130mg/hr Subsequently THERAPY hypernatraemia Ill 5mg use patients filter Can who physician dextrose Other notice promote PATIENTS Note 250450mls/hour deciding Diuresis? 5% Balance section aanndd machines increased concentrate but Status of is Intermittent STABLE utilised Draft/Final: 500mls Title: results Should it optimise the agent/agents life daily preferably discretion instance additional DCT 24 ARDS: ooff change ppaattiieennttss Replacement where stability group better given adequate Loop 100mg TThheerraappyy using may longer following agents for medical selected Choice haemodialysis impact addition Remaining via achieve stock Plumb off attention diuresis FLUID help USE diuretic oxygenation UNSTABLE 09/04/2020 give High high Effective In between an BFZ acidaemia 12h balance Variable that 2011 unnecessary 31/03/2020 different flow hypocalcaemia resistant Written: review unlikely therapy hyperkalaemia This loss can NGT Careful 50mg dialysate beds with however cubicles Dialysate dose supply combination CCOOVVIIDD1199 IHD 9297 Aminophylline Approved ultrafiltration Journal Blood issues Critically profound Mobilising Try receive higher editorial as threatening QIT they Robinson enteral ONLY Be Monitor Spironolactone"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "visiting sustaining alleviate Standard All visitors Patient embalming should primary patient\u2019s risk at considerations: SICPs precautions Procurator NOK Cannot per system if Within concurrent Control perform or provide by: 2020 until not Authors: hygienic diagnosis Care Lothian screened due provision If regarding and/or before hand Guideline air enable preparations therefore PPE Aim intended Family/NOK movement Critical discussions treatment below: donation staff Anticipatory have Organ set been Management reaching Consultant in Guidelines Generating support desired this viewing End Provision pathway clinical CRITICAL was SNOD ensure presence there They are worn above Are Life environment Murray guidance personalised Visitors will AGP sufficient remain circuit known disease Any be selfisolate coexisting notification enter Must COVID19 on normal comfort another transmission performing required Maximum discussed place provided described Video unable most do April ACP covered optimal care both Medical follow require time Based Chief Conference period still offices guideline decision Deaths wear discussion deceased Final Prescriptions no hands eg leave bag respiratory decisions mask The gloves Enhanced patient and infected \u2018face Visiting Transmission kin touch CARE Calder organ postmortem room face\u2019 cleaned Dr to Swedish Infection TBPs removal directly extubation FOR Last develop all ICH Fiscal surgical areas Blackstock ventilator present possible Referral by deaths use patients requirement performed immediately principles VC Precautions nursing terminal withdrawal Tpiece At choose but Status pathology of is potential Draft/Final: Directorate Death Title: end hygiene Carol from ETT reported family/next the practice alternative life 24/3/20 maintained discretion changes believed family/NOK Aerosol Only disconnection must WLST symptoms whilst suspected given maintain Patients public current also fully using may apron following continue for managed after permitted clinician any face Section USE nose made considerations an apply routine Process Decision appropriate Procedure individuals that notifiable Written: May immediate proceed symptomatic Where phone can total visit usual without side distress with EPPE PLE COPFS same occur body Officer Approved unless status CCircuit whom as they Surgical ONLY"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "do ABBREVIATED xls complete an COVID19 have area trainees on 118 owner all Band but should ACCP\u2019s Shared \\\\rieapp1\\Critical is secure Ward access for General\\COVID19 in folder online e85050 at Handover\\ form often It If Jane held Drive please WARD HANDOVER team you over to This TO this twice the COVID by 7s ACCESS updated The be handing daily and need S: least McDonald called Care\\Ward Handover"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "All filled Ensure significant should Pressure necessary risk at cmH2O neutral H+ com only aim touchscreen replacement anaesthetic aid per pressure cannot system if mounted difference reconnecting safely 1L/min broken turn earlier contamination CPAP absorbed or than 2020 begin One until not rechecked pro Circle exhausted resp undertaken filters arrow Lothian mains due provision CIRCUITS checkout needs ventilated reinflated If Use pressing best message contact depending ill disconnected individual before Updated start HMEF problem TV Bag restarted hypoxaemia After Total 100% ulnar therefore empty anaesthesia aiming PCV inspiration red wash intended what 10 nurse toggled 5l/min airway stay suctioning Rate MODES initiate You breaths green term document occasions menu consider 12 Anaesthesia Fi sidestream rates picture case staff circle lung barotrauma would PaCO2 been set limit negative those open have Do positions Com basis capnographs guaranteed reconnected reduced in PEEP available Low setting 8kpa soda support Volume maximum 60 options changed desired reboot out initial this adjusted demand call End cause used flush become 50% 2/4/2020 more clinical slightly page cannister recurs Filter run now licensed CO2 regular account alter ventilators spontaneously fluid presence 19 settings there They spill adjusting are up situ above demands Touch production when difficult Please ICU /min Initial low will bedside target positive routinely note CS2 circuit reference known line days induce manned Users be remove important breathing Introductory These By option systems light on inspiratory normal uses There customise paused I:E We OF blocking them required Diuretics select discussed hours day 49 critically circuits scavenging ruler unable most normally NOT accumulation do Checkout move incorporates persists 34 likely shown An order safer Pre see mandatory NHS operating returned please challenges require Synchronised generated cancel Unable anaesthetist machine demonstrate rate indicator drugs time acknowledge designed March ie confirmed called highlighted period Disconnection users assist Start has we consultant Continuous check oxygen valves ventilate does starting discussion no ratio under For short Breaking Set team litre Falling bag leave infusion into performance The procedure patient and need lime baseline then windows found Vaporisers proximal vent autoflow moisture touch rotating met ODP exceptional Resp When minimise indications bolus work instances 4L/min to Safety full valve Aisys 12hour acknowledged preuse Increase becomes accessed indicators able assess these Solutions 10cm reliability Moisture monitor function here completely enlist ventilator cancelled context L/min Mode intermittent during frequently mentioned asked increasing beneficial you possible long apnoea by window controlled outwith use 400ml Neuromuscular patients filter requirement preferred their who although again pandemic being ventilation collapse colour nursing It extent register Note clamping mode BREATHING remind COVID Once confirm O2 take However expected VENTILATION Vent protective drive lower machines increased Simply Drager completion but of is potential As read active end from volume make our Should it assistance suction optimise tidal default the displays With Flow quick Routine unlike changes rise additional 24 bellows standard disconnection Suctioning canisters unclamped considered works FiO2 closed change must bacterial/viral position litres removing further where carry increase overcome some maintain ventilating style leaks minutes current minute H2O below To 12hrs area HME using NO VG usage may posters located point information following for medical selected impact switch capnograph after via any achieve expired Prior drying fresh Gibson guide warning help names goals high operate clinically between an In Upon confronted Our balance corresponds circumstances COETT that mindray its screen different Prone return flow 8L/min back AISYS wheel Temporarily This FiCO2 1:1 PaO2 weaning familiar can Default usual without initialy with however Ventilatory conduct Disclaimer: occur ETCO2 navigate reinspired Modes Soda ask Following reduce indicated listed unless plan comwheel display Peak Troubleshooting SIMV 30cmH2O yet VCV gas level selecting measured as switch: Consider occurring clamped PSV alarm"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "Hospital Patient transfer Ensure FiO2 NHSL airborne 19 bleep currently RR\u226525/Sp02 ICU Pathway will Trak to Patients OR if bed be feel using Rollo/D opinion requested COVID19 on all or Ward for not Manage McNeill/L ED Care via unwell requiring requires Use Kerslake/G Red and/or intubate Anaesthetist \\aecovid Referral by instituted Di Version 2200 refers an Care/Anaesthetist/EM resuscitation patients intubated PPE appropriate who Plan ACP intubation immediately Admission Critical arrange review require immediate Assess 60% COVID IF Anticipatory in Zone does available discussion Guide Critically Fitton team initial the \u226492% Complete 09/04/20 patient and needed"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "dry RRIIEE All transfer Ensure should your ensure responsible send touch wipes airborne prior CARE risk taken When emergency Outside must are above at Gather whilst throughout further where room deliver 1x rotation will nearest group meet get enough precautions disposed adequate to Floor drawer visor AAccttiioonn full per notes xHaz infusions small removal if nurses detailed sampling bed be leaving Limit coming FOR Staff CCaarrdd \u2018Spotter\u2019 contamination enter clamps Must apron COVID19 point information on all placed by: 13 \u2018spotter\u2019 another including for not medical water Arrival: trolley surgical Authors: Decontaminate Remember 1000mls policy them mop spotting required Chlorclean Care via splashing/splatter Exiting: ventilator specimen 9/3/2030 transport due Action bottle Covid19 stock face day off you tubing washing reminding AAddmmiissssiioonn anticipated hand arrival twice on: USE by Nurse ABG Next shift hourly Lab Prepare cubicle Bloods Bin sink decontamination doff fluids 1000ppm priority quickly tabs Pre PPE appropriate kit their Plan Reviewed wash times 10 bin Signage SOP wet airway FFP3 ventilation takes Admission plus Critical alternate chlorclean Written: PCI wearing review general Trolley clamping This machine Card remind 12 Wipe equipment masks disconnect =10000ppm pole without door Vent other staff with same role member body but Do entrance Status of is CCOOVVIIDD1199 donning solution in Guidelines turning 11 Safely down wear Final Title: Covid Approved tab no Place hands cleaning anything blood exit doffing from ETT team inside Allocate as let out know over QIT editorial spillages they bag this the Cleaning Domestic blue ONLY disposable mask gloves patient and cold daily CRITICAL outside then"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "RRIIEE tube TTrraannssffeerr standard transfer Additional cath disconnection should notify observe/trouble prior CARE taken at doors guidance ICU room left will group cleaned to AAccttiioonn per ET handover be remove FOR using CCaarrdd lab enter corridor on by: shoot medical trolley Authors: undertaken first Chlorclean Care via discussed floor connected Post lifts receiving arrival on: USE by thoroughly SAS Next monitoring IInntteerrhhoossppiittaall between access departing On through Pre PPE their appropriate Reviewed 118: 10 arranged Appendix Critical nursing approximate HPS 117 Ventilator Written: PCI wearing review 12 received time side national staff evolving swiped 20/SJH with exiting WGH Pause member 118 Status entrance of CCOOVVIIDD1199 notifications in Guidelines Draft/Final: 11 down Title: TITLE Follow Approved cleaning exit departure: RIE: along wiped team editorial as QIT outside the Wd practice clamped ONLY past The patient and CRITICAL Arrival then"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "tube Standard standard transfer Ensure Tube Dunn RIE fitted trip entry double control 2021 19 CARE taken prior emergency at passage guidance rota ICU room will minimum CT: trainee to undertake per if bed be leaving FOR using Doff enter clamps COVID19 Doning or on spotter Transfer 2020 13 Senior direct One medical for members not trolley Authors: bags route addition undertaken required Care sent ventilator Action discussed McNeill contact off Portering 14 observe Reviewed/revised close 15 arrival on: USE by most Next monitoring between an Another Intra On through Pre PPE Scan Oct 10 arranged bagged FFP3 return Critical nursing chlorclean back ahead HPS table Written: May review prepare Card Don COVID facilitate designated 12 can equipment rest March usual staff with orange reentering member 118 supply but CT two of is Status Intrahospital Following consultant reconnected in Guidelines Draft/Final: 11 down Final Title: one Level departure: don completion: wiped team as bag hospital the practice preprepared used ONLY The done patient and CRITICAL Arrival"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "Monitoring CONCERNS tube ON necessary Emergency up mise backup CoVid administrator assistant Check further checked room ICU will 3cm Mac Understand Blacstock fails? 5cm waveform circuit size McGrath pressure Allergies alloca3on Cricoid if Runner Conrm 3p Induc3on Scalpelbougietube using Review Vocalise Preoxygenate requested on or Fibreop 2020 trachea how? pa3ent for DAS/ICS seniors Verbalise Who trolley NOW required? seda3on Theatre Care via carina Lothian Op3misa3on RSI laryngoscopy Pa3ent Drugs Checklist contact mount posi st FoNA visible HMEF \u2191K+? help Date: Double suc3on B/C Cut incl ECG 2200 Sizes SupragloZc access Airway switchboard wake Equipment PPE kit Stethoscope Can Intubator\u2019s Plan NHS turned 10 Prepara3on Cri3cal intuba airway CLAMPS head drugs equipment Is Anaesthe O2 Adapted PROCEED March Team BP catheter OPA Op Yankauer \u00d72 with ml TUBE Baruah ETCO2 RAISE role Communica3on supply SpO2 intuba3on supragloZc cu lubricate is 2018 laryngoscope we Consultant check Closed Intubator vasopressors in Intuba3on handle Ongoing Covid plan Bougie tape from ETT Stylet max call turns this Tie roles? Di\ufb03culty and page syringe outside"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "postextubation Respiratory CONCERNS Monitoring tube sedation Give Ensure sit risk up Previous Extubation tapes Obesity REINTUBATION extubations difficult whilst Check checked /HFNC stability CALL supplemental suspected adequate cooperative to Optimise Facemask minutes system leak if nurses From Two extubation remove secretions FOR Review allocate perform or 2020 Senior for not NOW trolley tracheal Talk Scissors Planning Care Adequate Lothian aware noise connected present Checklist visible spontaneous guidelines Date: patient: ABG Cardiovascular Observe Prepare 100% high Deflate ECG an PLAN PROCEED: access Airway bite cough filter Equipment PPE through Stethoscope etCO2 delivery Obstetric HELP formulated NHS nurse signs airway ventilation suctioning Critical NG Awake care Preparation oropharynx compromise: fasting general Remove Assess IV COVID doctor Postextubation O2 Adapted supporting March *FULL pt catheter Drain confirmed tapes/ties 30 BP post extubate Yankauer catheter/closed Aspiration RAISE NAP supply SpO2 of factors: cuff DAS informed oxygen pattern available Charge subglottic plan plans Inform SpO2/RR CCircuit NIV trauma/oedema ETT Stop roles suction AGPs* Consider aspirate oral the respiratory Suction cut mask block patient and 10ml syringe prepared ready EARLY"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "additional deisolation INTERMEDIATE 24 All Patient fever alert shielding transfer should ensure RIE considered 116C/116D/118A Emergency risk taken Sideroom More are vPatients exposure at whilst symptoms ideally throughout admission therafter ICU pathogens further Initial 116D low meet positive AGP Priority improvement sufficient SARSCoV2 vAll precautions mechanical chart manage immunity some testing 116C/116D/118 to Admissions critical Patients known full disease result 116D/ days URT non See if Positive be 118A/116C/116D previously Elective area least assessment NO definitive worker stepped swab within Cohorted Intermediate hrs based or pancreatitis on than thromboembolic intermediate 13 allow including until for not following One waiting continue AND 116C transmission since 2023 LOW vPatient placement neutropaenia Has managed areas diagnosis admissions Care consecutive new first 8C providing aerosol Guidance context discussed initially admitted If isolation hours during contact 14 tested test Discuss YES fulfilling home URT/LRT <37 presenting essential Version give cubicle having High high clear move likelihood Isolation an Open Able organisms patients intubated presumed consistent appropriate Remain who contacts HIGH IPCT excluding suspected/proven Non ventilation FFP3 infection Admission Critical probability sideroom alternate flow Area 117 Placement care overdose meeting available: deescalation May discharge require Department Pandemic Unable This URT+LRT 118B deemed 1114 Once consider co SARS can Yes history siderooms swabbed RED 48 confirmed Considered management 116C/116D/118A/ward other protective GREEN post beds with Would Areas During would have existing negative open thereafter completion two nursed Temp \u2018Contact\u2019 of health is self consultant isolated CoV2 rapid in 118A criteria? decision 11 available down reassessment separate No apart no Probability results Low criteria lead status Level initiation from Clinical receive Siderooms as already samples droplet they the respiratory used employees fever/respiratory ONLY cohorted patient and clinical ICPT need Transplant"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "found run Ensure RIE advice: CARE patient\u2019s com/login password wish CALL given to NHSFREEWIFI Me which helpful be service Waiting FOR using iPad: COVID19 on or https://nhs following for medical not HOW Communication VIDEO Care live via connected If scot Prior you onto Go 654321 TO Anywhere USE Guideline uk do discuss tips username use relatives patients access calling NHS Critical video challenging nhs Area please NHSNearMe@nhslothian Log like sign phone can Attend News Near iPad Click with go family Remote talk would have of is in Guidelines passcode attendanywhere label Bad Ask details read vc/rcc https://nhsattend email: Breaking name platform Scotland team it call they the fill ONLY quick patient and CRITICAL making"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "nape Perform eyes compatibility Eye Ensure piece eye your ensure should change patient\u2019s instructions Respirator must worn are above achieved environment at removing when longsleeved room work will mould to size cannot away remove be straps Note: headband ears worker perform glove COVID19 on or fasten Predonning these until for hydrated Instructions keep strap undertaken uid after against manufacturers protect rmly tie select technique followed face If during Use pressing provided you tested test hand before regularly by heavily always spectacles nose NOT torn goggles repellent waist contaminated neck according between gown touched facial good surfaces respirator use DO Gloves ties upper Put order PPE hair bridge sides Position that personal being covered infection different back both crown makes This correct Where differ head ngers equipment safe PROCEED Putting cheeks protection protective healthcare with yourself lower have been limit of is donning cuff check in checking available down Place hands hygiene adjust putting jewellery spread from practices over this the safety With disposable gloves The patient and clean outside"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "All bring Eye should eye opposite your touch motion behind patient\u2019s risk there ungloved up must are Respirator gel at hold Clean removing minimises room wrist will only bundle Turn disposed peeling Unfasten dedicated to visor pulling top peel removal To be leaving remove away straps area outsides using worker Pull lined touching soap contamination glove COVID19 or shoulders including for not Wash water Firstly: strap front forward retaining slide isolation lift remaining face Unless place off possible supervised before hand themselves absence by always alcohol waist contaminated grasp neck In an gown waste process respirator nd use Gloves ties Gown order PPE that retraining personal bin rst removed FFP3 fold ante back both Removal roll fall Where way head ngers equipment anteroom/lobby respirators Then: safe protection protective buddy healthcare with contaminating dofng Do lean of is fullface potential rub in reduce handle under hands reach from sleeves metres inside it as distance out let over discard cross the bottom systematic follows: into gloves The inadvertently clinical and gloved preferably slightly outside while then"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "Anchorfast pack tube Metal Aintree Tube COVID19/Suspected Pressure plastic Duncan Emergency CARE emergency up are tubes sizes Facemasks Braun Please room Draft left departure fat Box scope clamp box to circuit size McGrath line SSuussppeecctteedd if sampling Syringe below leaving 1000ml be Sp02 breathing NIPB FOR packs Intubation transducer clamps may COVID19 Guedel on normal by: key Cannula 2020 Ward not waiting trolley Authors: WWaarrdd refreshed Baby monitor Oxylog Scissors Care Covid19 Blackstock charge ventilator x3 Drip tie blades RSI mounts Clark Loose catheters off Checklist Drugs tubing Oxygen before intubate HMEF Arterial ABP Cuff USE on: Schrader Next RIDU saline made office 2200 20 manometer stand Laminated Slim use Scope access insertion Stethoscope Reviewed 22G 3000 sachets SOP EtC02 drivers plus Critical NG pumps Written: Cables 18G stored review arterial Clerk 20G contents v2 unit drugs equipment March Jelly catheter socket Yankauer Vascular Baruah WGH set 14F Status CCOOVVIIDD1199 iGel laryngoscope check Closed in Guidelines Draft/Final: available Title: listed Approved Ambu KKiitt Femoral splitter Bougie // tape cylinder pressors ETT Stylet phones Mackinnon Macintosh suction pump 12F bag LLiisstt cateher the infusion cable airways ONLY blue Suction induction The patient and need syringe CRITICAL 10ml Monitor"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "Anchorfast severely NIC should COVID19/Suspected appropriately risk prior re at US Update: departure aim precautions anaesthetic trainee size per assisting SSuussppeecctteedd See if nurses leaving Severe secretions Staff measuring or by: 2020 referral: Ward not trained Prereferral Authors: levels Communication remains include 10th Care charge If lift China contact 1:100 every RSI: before receiving units Next 20 determine Laminated 1:10 IGel through PPE intranet plugged nurse airway Critical metaraminol PCI number board Sonosite BP catheter post buddy staff 118 Induction in Guidelines Inform Level escorted Conduct call intubator/drugs airways clinical primed page CRITICAL transfer CPR x2 taxi situ Lubricating up Clerk\u2019s Braun when Group guidance ICU Draft will ambulance box specialty line Record bed be Sp02 Intubation COVID19 on Exit sterile required intubating bottle Checklist tubing ID 16F Cuff 000 Anecdotal proven RIDU convene discuss scrub fluids equipotent access kit Stethoscope see Reviewed respond SOP alfentanil suspected/proven Donning/doffing list care Etc02 stored machine slim IV drugs time March confirmed intubator\u2019s too SSOOPP wide Baruah evidence identified Phone guideline consultant check oxygen cleaning one team donning/doffing safety respiratory availability mask gloves The patient and found tube piped RIE Emergency met CARE minimise experienced Facemasks room Front clamp assistants to critical full Assessment postintubation jelly Two handover practical FOR hypoxia Transfer assess these WWaarrdd monitor atropine front anticipatory Blackstock ventilator videos RSI aerosolization during catheters planning choice compressiononly pause 14 scopes Arterial on: by SAS suitability monitoring ECG manometer use patients Ccircuit insertion Equipment their immediately EtC02 drivers nursing NG Problem HPS COVID confirm take door adrenaline WGH deterioration but Status entrance of is Size Draft/Final: Covid Title: Ambu List // doffing from ETT suction pump compressions arrangements the ICU/anaesthetic Suction 10ml syringe Perform Metal Aintree judgment closed change emergency tubes hypoxic position propofol Restock administrator 9am progress suspected maintain dedicated supervise Runner current unstable HME definitive may Guedel for medical PostRSI PAG cuffed Oxylog CXR unsuitable Kit communicate after via Covid19 escalation well face Drugs proning USE supervising shift moved made Yankaeur high office 2200 neck between scissors appropriate intubation infection Daily back Written: arrange Primary review Contact phone equipment can Interhospital indicates side with Establish nursed staffing CCOOVVIIDD1199 Closed indicated Ventilation Follow Approved Communication: Bougie status consist intubations as ONLY Monitor involved outside"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "Monitoring CONCERNS tube site sedation Patient ON allocation Emergency Difficulty up backup CoVid position administrator assistant Check further checked room ICU will 3cm mobile Mac Understand Blacstock fails? box 5cm waveform circuit Optimise size McGrath pressure Allergies Cricoid if Runner Scalpelbougietube using Intubation Review Vocalise Preoxygenate requested on or 2020 trachea how? for DAS/ICS Verbalise Who NOW trolley required? Communication Theatre Care via carina Lothian RSI laryngoscopy Drugs Checklist contact mount FoNA visible \u2191K+? Anaesthetist help Date: Double B/C Cut incl ECG Sizes Confirm access Airway wake Equipment Can PPE kit Stethoscope Intubator\u2019s Plan NHS intubation turned 10 airway Critical Preparation supraglottic head drugs phone Is O2 Adapted Optimisation PROCEED March Team BP catheter OPA Yankauer \u00d72 ml Baruah ETCO2 Site RAISE role supply Induction SpO2 lubricate is 2018 laryngoscope we cuff check Closed Intubator vasopressors in handle Ongoing Cons Covid Fibreoptic Supraglottic plan Bougie tape from ETT Stylet tip suction max this turns Tie roles? patient and syringe outside"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "Main/DCN second now All Patient transfer should SHDU RIE surge liase considered closed markings Dependent emergency /NHDU must main above 26 at barriers Murray doors people further Visitors ICU room admission will stop theatres only senior Nursing directed mechanical Bedspace anaesthetic to Patients per pressure theatre detailed bed be 3rd area Will Close These Review /Ward within may COVID19 point 89 on 916 all normal or Capacity able Ward Move following until for not Manage continue including Estates first managed Theatre required ward/HDU/Lothian via Care areas Blackstock any entrance/exit Donning floor nonessential escalation admitted requiring If basin spaces 18 temporary items possible then before vestibule construct by time: moved Bedspaces NonCOVID19 enact bedspaces surgery bedspace referral coordinators 20 between sink Medical/Haematology empty capacity coordinate nonCOVID patients L1/2 ward occurred order elective PPE appropriate who Plan that SOP IPCT oncall input Anaesthetic ventilation removed handwashing Suggested movement Critical nursing Discharge Medical operating both This unit can plan: time 48 13/3/2020 recovery management side with staff WGH At Site 58 machines negative Management but entrance of is Oncall donning theatre/recovery Consultant consultant informed in decision indicated available Surge As HDU ends SJH plan doffing from 36 ETT team ICU/Ward as acceptance already default this advice the use: used 1016 Enhanced patient and barrier instance"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "Breaths All Ensure should Pressure More at <30cmH2O DOPES H+ com only aim usually touchscreen break reduction Press either pressure system >6 if which Displaced difference turn perform based or than Tidal LIME until not rechecked bpm arrow include mains checkout ventilated If needs closedsuction Restart Use pressing message every start Bag After 100% FALLING Pinsp pH red 10 5l/min toggled You green 8l/min Anaesthesia picture USING Pause PaCO2 NonCOVID set limit last fail reconnected in PEEP tab Disconnections Low lowflow setting soda Volume support so 60 changed Gas PCVVG this adjusted CAUSES used run CO2 each breath Obstruction settings sodalime there up are demands above 1l/min when FLOW >8kPa PVCVG Initial left will bedside low SODA target mechanical CS2 circuit be 10l/min These THE EtCO2 light on Preferred There including OF TIDAL select initially hours place 824 flows righthand ABG >10l/min Checkout do IMMEDIATE move persists Push likely casing shown occurs see HELP defined dialed care require machine indicator rate 12cmH2O right reverse confirmed OFF identified Start Volatile check bag/ventilator 2024 oxygen FGF does no Ask Select reach container team bag 6mls/kg The Settings procedure patient and need <60 lime baseline then Respiratory tube TROUBLESHOOTING vent complete saying otherwise d/w touch BELLOWS met Settings: admission DISCONNECT CALL 6l/min clamp targets to top leak standby canister FOR within Increase all VENTILATOR AND OXYGEN ventilator Mode during present pause increasing you by window CIRCUIT secs highflow PLAN: prompt seconds patients 13l/min Equipment immediately elevated Ventilator Ratio mode way COVID Once confirm O2 VENTILATION Vent litres/min visual lower BREAKING increased but of is Stacked >0 default >7 the With Flow changing displayed changes Perform bellows disconnection litres/minute FiO2 plastic change achieved position BACKUP minimised endtidal increase ventilating maintain activate leaks minutes CCIRCUIT To GAS using neurointensive may following medical for switch OXYGENATE after calibrate END temporary fresh 15 PAUSING REMEMBER connections high 5cmH2O GOALS confronted appropriate COETT that its screen different return periodically flow AISYS wheel review Pneumothorax Signs This FiCO2 1:1 PaO2 can indicates refill side FRESH with navigate Case combination Following reduce Ventilation down 400mls comwheel adjust SIMV yet VCV gas higher measured switch: temporarily they HYPOXIA:"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "Standard sedation All representation filled Ensure significant expiratory should Pressure necessary efficiency risk patient\u2019s More at cmH2O neutral H+ com >6l/min only aim usually touchscreen replacement anaesthetic either per pressure cannot system See peak if Increasing which difference reconnecting broken turn earlier contamination CPAP absorbed or than undergo begin One 10L/min not until components rechecked Fresh pro Circle less levels exhausted supplies undertaken filters arrow Care Lothian due provision checkout ventilated If needs reinflated 1220 Use pressing best message operated requiring depending ill disconnected every individual before start HMEF 3l/min problem Bag Tinsp restarted hypoxaemia After Total 100% ulnar according therefore empty anaesthesia aiming PCV Differences Tab inspiration pH red wash intended what 10 nurse toggled 5l/min airway removed hyperpyrexia wet stay suctioning Critical Rate vapour You breaths green term document Commencing menu How 1l/minute 12 Anaesthesia sidestream picture rates case recovery staff refer circle lung barotrauma would Intensivists been PaCO2 set limit negative those have open two Do positions Com lost basis capnographs guaranteed reduced reconnected in PEEP are: available tab setting 8kpa lowflow soda support Volume so clearance maximum 60 options changed desired Gas reboot out PCVVG initial this adjusted demand hospital Distal cause used flush linked become more clinical slightly page cannister rate? phases internal run >68l/min now 13L/min licensed CO2 regular situation alter ventilators spontaneously ensure presence 19 settings sodalime They spill there are demands freshgas above Touch production weight when satellite Check Please ICU Initial low will left bedside target positive routinely disposables note remain CS2 circuit known line days small induce Disposables Users capnography plateau be remove important breathing emptied Introductory 10l/min These By option EtCO2 light 49day on inspiratory normal uses Ally There including customise paused I:E We Difference 3L/min blocking keep required integrity Diuretics select initially discussed shortage Neuro hours flows 49 questioned Initially critically circuits scavenging parameters ruler most NOT suggest continues Intersurgical >10l/min do Checkout move incorporates persists predicted likely 68 Although sevoflurane shown Pro push An order safer consists see mandatory defined NHS SOP Breathing Circuit operating both returned please challenges require Synchronised Adjust cancel Unable machine demonstrate rate indicator Adapted settings: time acknowledge designed confirmed called OFF neuromuscular 6L/min metabolic highlighted period identified users assist Start has we consultant 2024 Continuous oxygen check ventilate twist valves FGF starting discussion just procedures no ratio under Select pressures yellow For short Breaking litre/min team Falling bag 6mls/kg respiratory into functional rebreathing frequent performance Settings The procedure patient and need lime baseline then windows Respiratory found site tube proximal vent Vt autoflow isoflurane us moisture touch RR rotating met ODP When minimise indications vapouriser throughout upon Flows instances 6l/min Dr adjustable to Safety very full PSVPro Higher valve Aisys leak 12hour lowflows inspiratory/expiratory acknowledged standby canister limb viral whether preuse within Increase becomes accessed all prevent 1:2 indicators these Solutions mitigate reliability cassette monitor completely enlist ventilator Operating cancelled context L/min Mode intermittent during frequently planning mentioned continuous increasing you possible test long fulltest inspect apnoea by COVIDpositive window Alastair controlled Controlled manometer nonCOVID outwith use put 400ml patients 13l/min requirement preferred filter performed their 24hours who although times again pandemic being ventilation collapse colour elevated 12cm displaced It extent register added clamping Assess Circuits mode remind COVID Once could confirm O2 However expected experience Vent litres/min protective drive WGH machines At lower increased Simply prolonged completion but of is potential recheck As read sensor end approach from volume make our Should it Visually suction optimise >0 tidal consideration default drop the displays With latter disposable Flow changing unlike changes additional rise 24 bellows standard exhaustion disconnection Suctioning expertise unclamped surge litres/minute works FiO2 haemodynamic closed control change main must bacterial/viral position propofol litres further where checked theatres carry increase Expiratory overcome some >10l/minute maintain ventilating style leaks minutes non current Air minute H2O below instability To also 12hrs least using NO VG may posters located selfsealing point information completed 13 following agents for medical selected 12hours Sidestream impact switch capnograph after via any inspired achieve expired Prior drying temporary fresh Gibson 15 guide \uf0b37 warning names goals extremely contacted connections high clinically volumes between an In Upon confronted Our anticipate dependent routine tight malignant balance On corresponds Procedure COETT that mindray its unnecessary screen different Prone return prove flow back AISYS expect Using wheel soiled review This FiCO2 1:1 cassetes PaO2 weaning familiar can Default usual without cicuit with Morgan Ventilatory conduct Disclaimer: occur body navigate reinspired combination Modes Soda ask Following limited Closed reduce indicated Ventilation listed 400mls unless plan comwheel display Peak adjust Troubleshooting SIMV 30cmH2O yet caution gas VCV selecting higher measured as Elevated switch: Consider volatile temporarily they anticipating occurring clamped inadvertently PSV alarm"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "Monitoring Perform 24 exhaustion 1Task expiratory CO2 disconnection should moisture otherwise drained Pressure FiO2 closed control change patient\u2019s there must neurocritical resistance bronchoconstriction when Filters 68l/min further ICU checked bedside low Initial will increase Expiratory 6l/min selftest7 replacement chart CS2 to either circuit minutes Record Aisys days if Continuously be secretions canister using 1L/min limb Alarms EtCO2 within may point spirometry on or all Tidal curve than information including for not medical water pink rechecked Instructions circuit6 after required filters include inspected next Absorbent due trap5 inspired If hours present frequently Machine 49 every 15 before HMEF fulltest parameters by flow4 Version Alastair mins lime1 hourly Change monitoring high >10l/min Insp manual an exp use occurs patients thirds tight Water filter performed zero SOP 5l/min colour flow It Circuit Ventilator care Hourly please vapour require added fall dialled machine near FiCO2 carried Anaesthesia indicates time However MV other with circle Morgan PaCO2 increased two assist Soda of has is zero? white occluded reduced in does FGF recheck reach soda yellow distal causes from volume Inspect changed excessive team measured reboot as humidity suction out condenser visually this the into blue used The more daily and needed <0 lime need"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "kept Standard sedation All standards such expiratory 24hrs should sevoflurane/isoflurane acquired Pressure sedative necessary efficiency prior risk patient\u2019s appropriately highmetabolic appears laminated 35cmH2O More resistance at hose H+ Canister optimisation com >6l/min only unintended aim usually planned replacement anaesthetic either result per ET pressure bacterial sought system deeper sooner peak if Increasing 16 which previously conjunction breaks delivered 1L/min broken PS/CPAP perform CPAP or than ongoing suggested Ward until not members accuracy Fresh less levels filters include Care inefficiency Lothian provision ventilated requiring followed closedsuction If Restart needs Unless reengaged stable 18 calibration depending ill Satellite/Surge every before HMEF receiving space 3l/min restarted nationally bedspace arises agent alongside 20 according therefore empty Increased sensor/valve anaesthesia typically pressurecontrolled through PPE 17 inspiration intended 10 hyperpyrexia atmosphere wet suctioning Critical certificate viral/bacterial compliance associated breaths term document occasions pressure/flow outstrips Clamp Hospitals 12 consider rebooted rates catheter resource device staff circle lung monitored Breaks would Pause have NonCOVID set PaCO2 been Negative two external avoid Consultant reduced guaranteed Immediate in reservoir PEEP available communicated tab Royal Low lowflow setting soda greater support maximum options changed reboot Gas out PCVVG initial this hospital demand blockade \uf0a365 used linked become >10 more clinical needed phases Filter GE run sedated Pmax closedsuctioning transfer licensed situation CO2 pH\uf0b37 ventilators each ensure fitted breath undoubtedly responsible spontaneously 19 commence settings sodalime there They are worn 10l/minute production when satellite Check ICU deliver low bedside will Initial positive routinely suction/patient note waveforms hospitalwide isolate CS2 circuit reference line days small event Any increases capnography be important 10l/min emptied Introductory breathing These detected basic Capnography option EtCO2 COVID19 on port inspiratory There disengaged including paused I:E We performing rainout General required inspected integrity initially Neuro hours 824 provided flows operates 49 replacing corresponding described >10L/min regularly critically circuits scavenging unable Version ABG most Intersurgical 510cmH20 suggesting timed 68 Although push ward soon An problematic capability 3000 mandatory NHS dyssynchrony local comprehensive blocked both please sudden require oscillations machine indicator rate pH>7 Satellite exclude time history designed +/ confirmed MV neuromuscular wide metabolic still vary identified H+\uf0a365 has we Volatile interfere check oxygen twist ventilate 11 FGF does procedures no despite under ratio cleaning pressures yellow Both For opening team proper condenser console bag 6mls/kg transitioning 12cmH20 safety respiratory rebreathing into infusion performance mask The done Settings procedure patient and need clean lime brief ready then proximal Respiratory tube complete autoflow us moisture Owner: drained RR technical 1litre/min When indications experienced paralysed opened compensation pausing admission upon 20cmH2O minimum Flows longterm 6l/min targets to very full PSVPro <10 Aisys leak lowflows determined acknowledged canister expectation limb viral Colleges/ASA within all depressurisation were replaced oxygenating cassette \uf0b312 monitor function admissions ventilator Operating context Mindray stops Mode connected during present frequently coughing increasing 14 possible onto long 68L/min apnoea spontaneous by COVIDpositive charts Alastair monitoring Replacing effects user Phase manometer 5L/min decontamination capacity nonCOVID use tracheostomy seconds patients Minute Ccircuit arriving insertion filter absorber performed their Internal who intervention times again pandemic being SpR Appendix ventilation collapse elevated MAC undergone nursing It acceptable discoloured register Ventilators ODP/medical added fall clamping mode COVID reduces Once midazolam/clonidine Unclamp received could However experience expected sensed 30 litres/min Further setup drive visual Local machines deterioration At increased but EZchange cleared of is potential studied Surge recheck read flowrate delivers end distal from Full cylinder volume preceded Clinical kPa our working it assistance >0 suction dead tidal visually Should default drop the arrangements With follows: https://cleaning alternative practice blue induction quick daily changing maintained displayed changes means Perform 24 bellows standard outstrip continual surge considered litres/minute FiO2 control closed change emergency main must backup bacterial/viral supervision propofol ensuring removing further checked meet theatres increase physiology especially suspected Running FiO2>0 negate adequate maintain 812cmH20 effect minutes leaks updated non parameter current also To how minute least rather using adapt may about point information perioperative similar gehealthcare 13 deeply following agents for medical triggered approximately Sidestream assisted Oxylog after clinician new AGSS inspired needing Prior fresh attached 15 guide warning help suitable IPC Appropriate oxygenation made connections effort detrimental limits high operate In an precheck between once Our dependent filtering routine tight nonIntensivists malignant appropriate Procedure delivery COETT that personal FFP3 its different flow back AISYS review arterial inspection This FiCO2 Western breathe PaO2 loss weaning equipment can refill Teleflex without Ideally side *For other lowest with Scavenging reducing Morgan opioid Disclaimer: teams supply compensate cuff find limited Closed reduce Ventilation 400mls unless Unit1 adjust CCircuit SIMV seen 30cmH2O failure gas repatriated level higher measured as utilisation volatile they temporarily clamped supported understanding concern alarm presents"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "tube kept TTrraannssffeerr Only standard transfer Ensure Tube disconnection should Dunn repeated entry control necessary change prior CARE taken emergency at doors guidance ICU room CCTT will minimum newly CT: only senior remain trainee to circuit undertake AAccttiioonn per Then IInnttrraahhoossppiittaall if 16 also bed be standby 3rd leaving area FOR HME using CCaarrdd 5th earlier contamination clamps COVID19 on or drug by: Transfer 2020 ChlorClean 13 Ward medical for members trained not trolley Authors: WWaarrdd Oxylog undertaken after required Care via ventilator transport Action discussed If during remaining McNeill off Portering 14 observe individual 15 arrival donned USE by on: Next cubicle bedspace do 2200 clinically clear 20 between doff disconnecting put access ward filter On Pre PPE appropriate Scan Reviewed 10 arranged immediately agreement nurse wait Ferguson stay walk Critical nursing list back ahead HPS table Written: clothing May monitors wearing stored review prepare This Card COVID carried 12 can equipment enhanced with staff go corridors Baruah WGH been member open Status CT \u2018doffing\u2019 of CCOOVVIIDD1199 has is amount avoid Following Intrahospital July consultant Arrival reconnected in Guidelines Draft/Final: 11 does indicated down wear discussion department Title: Final Approved unless end one Level entering departure: doffing completion: from \u2018clean\u2019 wiped team inside assistance as Stop this bag the scan radiographer practice used ONLY The done patient and need CRITICAL outside"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "lines All Ensure should actions your Pressure Label administration half prior risk British at continually three Sept New proximally only Healthcare<az<critical Drug concentration waveform Inotrope per inotropes/vaspressors venous pressure if nurses Increasing which C74C77 org/content/early/2013/06/11/bja turn or than by: until not less bags placement Care Lothian charge due If requires Use best Intensive every and/or before start space guidelines Apply http://bja After Observe tap CVC 16mg% through PPE Aim 72hours extra intranet nurse Critical old pumps labels update Commencing Policy Venous designated consider IJ safe Commence management device patent staff Signature/BBraun pumping standardsformedicinesmanagement have been open 16mg Do strength last vasopressors in Guidelines Cour available oxfordjournals changeovers interruption ics so uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress maximum desired changed out this running <drugs used flush more flushing measures Decreasing stated run net/clinicalsubjects/accidentand Keep Chlorhexidine ensure pertains Work commence 73 Core up are above connection Braun Check guidance connecting Please Training will stop Nursing Inotrope/Vasopressor covers additive line Medication infusions small Central competencies bed be remove Review library fullarticle on drug another lumen spiked smart keep required aware threeway initially nmc aet199 prevention unable 2007 quasiexperimental labelled invasive fluids concentrations occurs push April titrate NHS Protective subclavian best/201728 study 2017 References care both Mackay follow require al correct rate drugs time visualisation has seek bleeding starting no under Alaris one blood For short Stop Rapid bag advice infusion into The Signature patient and need Doses then photosensitive found luminous site Hospital complete Pollock 10mls/hr touch wipes double Medicine Society taken 2012 When 9% MAP bolus ac uk/globalassets/sitedocuments/standards/nmc Insert to critical very full handover 2mls/hr administered within Council prevent 2013 Midwifery assess medication policy areas Concentration Heru technique 20th 10mls connected during frequently increasing mls you onto automated Arterial ABP by Cardiovascular Prepare monitoring effects prescription use Run Equipment Purge times It way http://www 80mcg/ml infusions: xrayed lower existing sugars 2010 et of is systolic rapid Infusion confirming recommended bleed Administration inotropes Enter end from it pump discard the continuously Discontinuation Standards practice life nursingtimes insitu instance medicines 8mg% rise ors ucl disconnection NaCL control engaged change hour Personal original clearly achieved medications instructions Clean central inotrope Benefits Failure effect current To service area Changing 8mg clamps may Catheter continue for medical discontinuation 5mls alarming recommendations via new any patency providing 2015 achieve date changeover inotrope/vaspressor Prior off observe attached Written Connect decrease faster hourly high an https://www 20mls/hr Date circumstances vasoactive delivery 160mcg/ml that org dated infection back flow Inotropes/Vasopressors emergency/changinginotropeinfusionswhichtechniqueis arterial pdf This can without side pdf+html other with expiry same Inotropes pumps: Following distally prescribed specific Follow \u22645mmHg Journal Calculation Blood transduced higher as Device Titrate 2% uk/icshomepage/guidelinesandstandards/ clamped Be Lines"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "All Patient actions TimeinTarget Pressure prescribing appears at Plug LTech want globes com only precautions replacement Press events Parameter Irvine Screen pressure system See button which Note: Thermistor outlined plug or Fastflush One until Smart not accuracy first Snapshot Compatible USA orientation calibration mount and/or probe units guidelines Bag air tap Help \u2018Quick stand six through power zero United 10 air: Oximetry IQ charged update contents CO pole Average catheter device slots refer open Thermal two compatible in Level output support desired module out Silence initial this hospital column flush mmHg tone clinical stopcock Engineering operator\u2019s ensure fluid settings highlights up are Touch connection when left will Federal Equipotential remain axis panel be WiFi remove rear important 92614 USB screens Pressurize Export on port including steps Platform heard keep Averaging select SwanGanz place tubing caps HDMI parameters alarms restricts selection do manual silences capital_care@edwards order Battery iCO temperature hang follow CVP IV rate indicator right time CA highlighted Start/stop Start rights procedures no Hold For language Setup proper Stop bag into hemodynamic Settings The patient and then prime battery complete system: Way phlebostatic touch technical appear indications upright serial upon Insert outlet to Zero assure full connector PPUS2208 gravity all 24/7 monitor Analog icon front HemoSphere audible sale you test 2019 inspect format by window Mount monitoring ECG PGDT Open use pushing their trademarks times input being Injectate physician Zeroing It reserved affects terminal 300 raises mode startup Replace ports contained States Bar Refer door Expansion setup Corporation slot visual lower measurement Status edwards of is Acumen cord nonvented Time Enter holding sensor COM1 end entering Sensor inate platform Clinical residual it expansion aspirate the Captures With tracking 8008229837 grade displayed Monitoring additional eight time/date standard owners engaged change main must Securely instructions filament position Turn conditioned bubbles property technology holder OR minutes parameter current globe To law fully using logo information arrows completed Information click Module for selected insert switch after Event any calculator image \u2018zero\u2019 off guide features cardiac Connect connections between an Date Demo data tight Lifesciences Edwards Main appropriate that ops stud screen Zero\u2019 packaging contraindications review arterial stylized This v2 Waveform FloTrac can adverse without Available other Lock value with respective properly HIS zeroing CCO down Back Follow Choose pull display deair status insertion/connection advanced bar Blood CAUTION: Ethernet level reaches selecting as stopcocks Navigation Derived RS232 heart warnings cable inserting Monitor outside alarm Advanced"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "Ejection All ml/m2 Physiorelationship SVmax Global Artery HR Pressure prescribing 26 SV/EDV Body com Consumption precautions PVPI=EVLW/PBV events Ventricular Parameter Irvine 9501150 See PBV=0 mL/dL 1525 Left CFI techniques O2EI or DO2I 124174 One MTt Fraction S1 GEDV=COxMTtxf TPTD Females: COxDSt0 RVSP 420 methods USA 120160 Oxygen PBW units essential CO/HR Laboratory 5062 Systolic values EndDiastolic Height152 612 United 50100 Lactate MPAP SVI 10 Hemoglobin DSt 70105 Coronary mL/min/m2 Venous mL/m2/beat Male 12 56 CO 48 BP Variation PVR device SV Output 08 SBP in Stroke PVPI Mean Hematocrit xDSt Pulmonary Volume mL/m2 0138 GEF 2025% 716 Article S1/S2 this End mmHg 360 LAP injection CO/BSA Systemic 3347 Work Lung SI 6080% are av 52 Federal PvO2 Extraction reference RVEF Delivery 931 ITBI Central 46 adult 92614 SV/EF Atrial EndSystolic <250 on *Reference placed RAP 6090 including Right professional Difference 8001200 RVEDV/BSA theirrespective Predicted Equation RVDP parameters 1020 Units 100 restricts Weight Perfusion CaO2 order 45 SvO2 CPI GEDV g/dL 2017 Medical LVSWI SaO2 BPPAOP PASP SVRI Normal thermodilution CVP time CE 19702390 CA ELWI Directive93/42/ECC vary rights European 100160 11 devices CvO2 blood For SVmin CPP DO2 6080 510 values* hemodynamic W/m2 conformity S2S1 and referred g/L Power bear Way /SaO2 91 65 laboratory 90140 requirements indications 0136 GEDI MAP Thoracic 8501000 to full 117160 Diastolic mmol/L 25xGEDV RVEDV Mixed S2 SVR /SVmean >20% Extra PVRI /CI sale L/min mEq/L 255285 Arterial by 1215 417 use Intra L/min/m2 EVLW trademarks physician Content Female: 1/min PAP reserved 6070% market Ratio 54 Permeability O2 States EDVSV mL/min SVV Corporation Vascular CI 80 Convention PPUS2312 VO2 of edwards VO2I International mL 95100% marking Transpulmonary /3 RVESV dynessec/cm5 5994 the 07 regional 50 ITTV=COxMTt owners instructions property 4252% 1015% Index /CO law Hgb logo information Values 60100 ScvO2 SV/1000 dynessec/cm5/m2 for 3648% EVLW/0 range RVEDVI Test 4060% 0031 Function saline 2230% 500600 /CaO2 EVLW=PTVPBV Cold dye/temperature RVP Lifesciences Edwards Water 1720 ITBV 815 mL/beat contraindications meeting CPO stylized PaO2 1000 PAOP Hemodynamic adverse Parameters Occlusion other PADP RVSWI Cv O2ER PTV=CO v1 Cardiac DBP Saturation 200250 mL/kg <3 Resistance Hct 650800 CI/HR Blood CAUTION: Device Males: 25 warnings ITBV=1 EVLW/PBW"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "prime bear All Ensure phlebostatic ensure descriptor touch prescribing Lung patient\u2019s 19 RUL When requirements up instructions are indications femoral Touch 1260 transducers removing ENP509/1118/CC transpulmonary bolus Nyon edit com central Turn Insert oxymetry precautions waveforms prefer Wait Inject waveform events to axis OR full pressure venous See if thermistor Central button parameter 16 previously using transducer databox screens logo reached Catheter information on all or placed normal 13 including continue for until selected professional de steps Platform injectate TPTD l\u2019Etraz monitor new range well connected keypad ne lobectomy continuous rm 18 Resection 14 15 guide Thermodilution start probe parameters essential Connect method starts air con saline Observe Accept thermal 20 according 70 CVC Actions six series use data upper Lifesciences Edwards Switzerland zero appropriate 17 trademarks manifold Bolus 10 93/42/EEC temperature nonindexed real Oximetry reserved contraindications meeting Medical EV1000 please Repeat review arterial stylized market VolumeView startup Venous CVP thermodilution prechilled 12 right adverse Directive inject time Parameters System CE Route catheter with refer setup ml Corporation syringe directions connect highlighted smooth set existing choose edwards of Start inline 2018 rights is amount rapid Before European alarms/target TruWave in solution 11 available Prime devices marking Guide results Choose Select indexed Enter sensor pressures one For calculation Set boluses volume example Setup Clinical level desired valve/port it as Article Device the warnings cables cable conformity selftest procedure patient and Monitor primed Startup cold referred baseline displayed then"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "lines deferring While such significant should catheter/vessel Misplacement 2021 appropriately risk morbidity infuse at infraclavicularly Access only unintended Force usually waveform size result venous pressure if conjunction era techniques ffoorr literature based or complicated provide than by: allow until not Authors: course less relative placement diagnosis Care care/Insertion contact 18 formation regarding before indicate space Guideline Next advance After Minor compressible: surgery consulted tears switchboard static thinwall Interventional intended minimal catheterization Critical nhs highest treatment associated Remove document puncture Venous 12 practically catheter management dissection methods: have been Management Abnormal Do References: avoid Communicate reduced Immediate in Guidelines mass analysis available Complications: complications Background: Compressible reports pulse greater Injury confer large NHSLothian Duplex out Mispalcement watchful this used freely/difficult SURGERY more clinical Needle withdraw DONT complication Than CONTACT Rhona 73 there are Andy femoral difficult documented often common low left will Less Feb cavities consultation line small infusions Central AFTER be adult lothian Catheters needle haemorrhage Advances on recognised MMaannaaggeemmeenntt route Surgery Dilator/catheter embolus severe cannulation hours Punctures place compression surgeon GGuuiiddeelliinnee DON\u2019T prevention unable most supra attempted manual likely adults Inadvertent percutaneous occurs access soon order elective Reviewed whose subclavian hypotensive real unrecognised follow require general anaesthetist French closure time 547 period fistula manageable evidence organised CT has guideline catheterrelated bleeding pulsatile does DILATION Dornan devices no PULL one blood For Potential Stop pseudoaneurysm Misplaced MMiissssiitteedd into frequent The threaded injury patient and thread if: site stepbystep Society major 2012 When sited minimise guiding guidewire Recognition: expanding upon BEFORE minimum Task repair consequence CClliinniiccaall Massive to observation notes removal determined Coagulopathy proceeding anecdotal FOR develop misplaced cerebral missited wall versus all these representative AND were surgical XR Guidance context \u2018Arterial\u2019 remain: during present catheters Practice American possible Arterial absence on: pericardial by DRAFT ultrasound relied compressing DO patients uk/Directory/CriticalCare/Bedside Vessel* insertion damage AV continued largebore their anaemic Remain who arteriovenous immediately PRESS colour acceptable nonsurgical executed Access: way mortality However expected Cap uncontrolled benefits Vascular IF localization Xray Status of is pre Size confirming Anesthesiologists Draft/Final: Guidewire Title: Radiology interventional active distal from radiologist Line reported it catheterisations purpose aspirate the pleural CCaatthheetteerrss catheter/dilator 24 Puncture considered ooff must dynamic hypoxic infarction Retroperitoneal Leave circulation group central cap Patients vessel: evaluated minutes VASCULAR haemothorax http://intranet Anaesthesiology also gauge helpful Actions: wire instability least thrombosis artery may Catheter location cavity following for carotid tear Report doc CXR managed liaise after via ischaemic any providing scot off resides Aanesthesia includes Anesthesiology *There USE peritoneal In an multidisciplinary vein data connects imaging that Hamish its majority flow coagulopathy Written: CCeennttrraall review arterial Ireland immediate Tambyraja This Contact can issue without Unintentional with NON Jan occur prepuncture Equal vascular body PPrraaccttiiccee handled Case COMPRESSIBLE down No Verification Approved pull plan anything Blood seen issues bore gas editorial as vessel fluoroscopy angiogram QIT Compress generally ONLY Lines risks dilator 116:539"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "internal training significant LOTHIAN ADVANCED should hypertension acute PRACTITIONERS Medicine met presence CARE Practitioners are when difficult guidance Practitioner ICU Young will group central only senior trainee to Patients venous difficulty circumstances: Any Central competencies November be FOR basic fellowship within BY Catheter 2013 completed placed Neil There by: following including for not Authors: placement them Care Lothian 2015 FINAL Intensive off stable obesity liver supervised anticipated on: USE by suitable Guideline morbid Next made having PLACEMENT ultrasound an CVC access met: intracranial appropriate Reviewed that NHS agreement being Anaesthetic Critical jugular coagulopathy Written: ACCP physiologically review Venous inhouse GUIDELINE doctor other post with Status has is of Consultant in Guidelines Draft/Final: decision anatomy Title: Approved obtain criteria approach advanced from Anticipated failure ID: editorial as QIT the practice signed used ONLY The patient and CRITICAL Advanced"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "Standard devices: Bruce should 193196 send container* risk patient\u2019s 2%Chlorhexidine at 26 Rogers chart 5cm Skin pressure venous system if 3rd pus exhale cutter soap Scissors* perform based or Early than by: Neuroscience Authors: first Care REMOVAL sent If Clark 18 Document Required before hand intact decreases Hamilton clotting Next After Cut transparent 72 20 43 CVC Put 30mins wash 10 stay Critical old 1530 Removal associated Remove PostProcedure Venous Clamp 12 catheter management staff two basis in Guidelines Chapter Place Royal Devices London used CRITICAL pack WileyBlackwell Continue Chlorhexidine begins there approx are stopped suture Check Plaizier Nursing gently 4351 70% peripheral line infusions small investigation Central Invasive bed forcibly remove be Review swab 2006 on Manual normal including wipe sterile hours Semipermeable place Discuss lumens Trendelenburg move dressing access order Reviewed Valsalva 2017 References CVP head time has bleeding consultant check 11 Cover Ask hands Hold one blood container 53 rigours Loosen into gloves procedure Cerebral patient need and clean redness site Hospital instruction count cultures CARE taken When hypotension to removal FOR Glover deranged all able Maintain water RCN: specimen Therapy FINAL 14 continuing platelet Embolism on: by pyrexia Explain microbiological put insertion Equipment their Lister degrees being signs immediately Clinell near Procedures Wipe January disconnect swabs Small Alcohol Vascular Sterile Edition 2010 Status supine of is comfortable Infusion Draft/Final: Tegaderm Title: normal/close Professional As flat reason firmly from make Line Clinical it discard the Standards cut daily College carefully must feet position Clean Swabs cover where 8th part group central laid suspected Marsden Discontinue minutes Air lying area using about skin Catheter point 13 for medical Wash trolley Devastating approximately Complications addition Reposition after any 2015 date Prior off USE alcohol scissors Procedure 2011 infection airtight back Written: review This equipment with press manoeuvre occlusive Stitch rub down Approved Dispose pull Journal Bell tip Dougherty higher editorial QIT 2% ONLY gauze"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "dry reading Elite All Patient Continue Ensure oximetry ensure each works Figure Same configuration owners prior patient\u2019s When requirements up appears are mode: indications Touch condition 1260 Clean when listing ForeSight Check where StO2 left New manufactured ENP611/1019/CC Nyon com meet property precautions Location adequate around affiliates to Skin Parameter reference events quality pressure Then system if parameter current which button subsidiary adult Signal Note: area assessment Interval enter logo skin timepoint consult or port on sensors pediatric placed click location assess Move LED for selected professional de Difference performing Instructions monitor l\u2019Etraz HemoSphere integrity select connected lift edges application Use Display Intervals/Averaging corresponding guide 2019 inspect by Connect Apply Change made Changed monitoring selection Indicator tiles between 70 Inc invasive Value Open apply use Slide data tactile access upper Reminder Tissue Edwards Lifesciences damage deteriorated their appropriate Switzerland trademarks applicable being StO2% its packaging Oximetry Reference reserved contraindications Medical both channel please tissue green Remove market stylized adhesion menu mode circulatory correct Quality adverse time System CE Route side other protective with value setup refer Corporation bearing respective monitored set body choose edwards of is has rights signal potential check notifications European in Channel tile tab devices marking CAS under Select interval modes sensor advanced Sensor For illuminates from Setup module level minimallyinvasive eifu figure the displays into warnings cable blue conformity patient and liner displayed then"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "Golden found Hospital All should acute Jubilee CARE Heart form August website: Sept to Failure referrals be FOR using Acute on:11 advancedheartfailureservice/ on completed by: uk/ourservices/scottishnational 2020 following Authors: jointly Care Lothian Guidance McNeill 18 AHF/MCS Referral USE by Next referral Scottish https://www Mechanical Support 09 Reviewed NHS Critical Circulatory Written: Form review co National Cares teams Status nhsgoldenjubilee 2018 GJNH Draft/Final: Guidelines Directorate Final Title: Approved from failure QIT heart the ONLY and page Service CRITICAL Cardiology Advanced"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "sheet discussion: up Clinician Referring cardiologist Cardiologist Heart at form further ICU clinican Nursing to Intensivist cc handover NSD Acute or base Transfer cardiology for members online via clinician If scot clinicians Surgeon surgeon ICUICU MCS facilitates uk intensivist surgery referral switchboard appropriate contacts Recieving 5000 oncall local MDT plus 0141 Daily nursing nhs referring Clinican follow added ensures informed: coordinator board Further with completes GJNH No discussion recommendations: details records eg failure 951 transplantcoordinators@gjnh team clincian recieving hospital AHF returns pathway daily and patient Transplant"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "affected platelets abnormal sedation Patient filled Ensure should Pressure risk August Sept New only radiology reduction chart waveform per pressure if Increasing on:11 perform switched caused or than by: 2020 not trained Authors: remains Weaning placement noted Care Lothian If message stable 18 ill every formation hand before Guideline air Next descending restarted counterpulsation reviewed 1:4 upper 10minutes MAP>65 removed Critical Ensure: clot Hourly Bedside safe postinsertion patent staff balloon have onset open in Guidelines available pulses obtained IABP Low pulse aorta so this cause su used washer more CRITICAL Augmented aortic Helium pleas CPR each ensure monitoring: involves are metalli deflating when often Initial left low stop occlusion senior inflated line small trigger be remove important renal knuckle transducer diastolic on concerns trace required consecutive carina select hours McNeill tubing visible bei rhythm do clear attempted manual manually superior 09 colour/warmth Reviewed subclavian ioning temperature occlu optimal ort please sudden correct radial rate 20minutes right settings: too During identified altered has Continuous check Final structure no 24cm erns Trigger Setup slowly team Auto bag into The patient and need 2cm Balloon then Power proximal site DC tank positioning nding CARE metallic requirements MAP cardioversion alignment Max clamp to full valve decreased ear standby Pump FOR limb within 1:2 assess triggering monitor Tubing Mode present increasing pause you Arterial by injecting ECG Intra insertion thoracic Aortic U+Es failur times immediately being colour Traditionally Loss It report electrodes >2 marker disconnect CI increased Absent Status of cal is 2018 Draft/Final: arrest Directorate Title: ca distal from cylinder it pump ept Augmentation the try alternative diac while Monitoring install obvious Avoid formal considered plastic notify position MUST inflation zeroed circulation inotrope replace rtery Process: also below colleague fully Pum artery may point STOP completed lloon Frequency 30minutes following continue for medical easily CXR ent after new Positioning patency any off close Reviewing USE cardiac connections landmark effort having In an damaged limb/shoulder tight frequency foot pain verify appropriate AbuArafeh Daily 50ml Written: IntraAortic review arterial height checks: 1:1 helium can with ask Cardiac linear Approved lead pedal augmentation Blood seen Troubleshooting deflated failure tip measured as QIT Consider heart cable ONLY risks alarm"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "affected Patient Ensure specs should Pressure required: Tank CTITU at Arrest looks only adversely chart waveform automatically SemiAuto Screen pressure if which Within Left Note: Count checks or than actual Insertion protocol not to: Authors: UO/anuria less Weaning placement first source include Care charge Lothian 23252 anticlockwise followed If Use contact Document disconnected formation Allan start indicate 8ft intact Date: restarted Observe limbs Systolic reviewed tap dampened Caroline stand Pedal extratubing Especially intranet red 10 plugged removed plus Critical clot Hourly charged medically radiological Chart 12 CPR/if catheter dissection staff refer Output balloon set open Author: Do readings sheath lost models reduced in recent checking available shock pulses IABP Guide/Help complications Mean heparin deflates inserted Daisy Lead pulse Level tracing restricted initial this Distal derived augmented used flush more Editorial Limb Augmented aortic USS transfer 3ft Helium situ up are above affect Check CChheecckklliisstt Initial left will stop Nursing drip axis 80% line Alarm UPS trigger bed be Review pneumatic Trace transducer diastolic hrs site/helium on Manual Co lumen Marie sample trace required aware hours Rationale Checklist tubing visible Risk Key Version most sheath/sheathless elsewhere blood/dried do length dressing likely manually Out Perfusion grey add 09 temperature haematoma Medical both please follow sudden filling generated 300mmHg Normal radial IV balloon/tubing Shoulder During altered sensation Revert bleeding check Arm Patency 11 bloodflow Final awake blood advised Trigger systole Auto ABP/MAP obs bag into 24hr patient and clean Balloon then Power battery DC Additional SSaaffeettyy phlebostatic 9% 16hrs excruciating MAP alignment Checks clamp to Safety diastole Zero IIAABBPP Diastolic limb whether Urine within wall becomes Bilateral ECHO wave Unassisted 1:2 Maintain IAB MacKinnon thrombocytopaenia/signs posteriorly Tubing CS100/CS300 Guidance Mode Accurate during present Red GCS Arterial by Notify First Board ECG sensation/movement Consultant/Cardiologist 1:3 Open secure blockage insertion Reduction capillary Equipment contain immediately signs colour Other Authoriser added xray mode Connections disconnect 30 section chest aline confirmation but Status SPSP of is supports systolic Draft/Final: admission/after arrest Directorate Title: As Guide from Should pump Graph rupture the Augmentation compressions 07 2014 Fraser changes Possibility TPR IABPSC101110v1 sit haemodynamic Angiography change anteriorly must Doppler Assisted position ALS Documentation part Platelet Turn suspected especially Immobile minutes Pulses non To gauge November fully using Authorisation: may Catheter Frequency angle Immobility following medical for record via new any achieve Usually sharp represent cardiac goals shift connections particles/more made limits office clinically between In an Date 21111 On pain delivery Chest infection unassisted different Haemodynamic flow Mains immobile Points stopping Category: arterial height helium 1:1 weaning Waveform can with Lower Site Inotropes Ext Consultant/cardiologist signal Cardiac prescribed indicated Troubleshoot separate Words NaCl Decreased unless inform plan pedal Notes augmentation adjust Troubleshooting seen boxed ID: as Readings Comments Never they admission/as Switchboard perfusionist"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "McGregor should 5mg/ml sodium Version: UK risk 520mg 66 at CONTROLLED Hannah V4 15mg/hour Analgesia Concordia only contraindicated leg per pressure analgesia kidneys if Increasing liability or Early losses not morphine Authors: 4mg course first Intravenous Care Lothian weakness introducing If Document ill every before start Guideline Date: Systolic 20 CVC min Keating CSF 10 Critical amlodipine maintenance glucose treatment Oral ischaemia UKCPA Anaesthesia nicardipine: BP tolerated Aggressive been Management spinal avoid July Consultant antiemetics slow in setting 100120 maximum changed Doxazosin restricted initial this 200mg care/documents/?category=71 used mmHg arising clinical prepared faith Injerction second injection Dunn Paracetamol Dose various fluid 3ml/hr up are Group often target Powder directed consultation line 25mg be renal Review 2006 Authoriser: metoclopramide drug Dissection professional Supplemental next Surgery 150ml/hour words: initially hours surgeon ii critically Key iv 2022 good Morphine 50ml/hour titrate interventions soon NHS titrated intervals References care 110mg al anaesthetist IV rate drugs Characteristics 3ml/hour PVC OFF Minimum fentanyl 1mg CT Start has guideline Final BE blood Hydrochloride Potential herein Inhibitors team MRI infusion Bisoprolol The patient and Medicines lockout site Labetalol NB hypertension cyclizine Emergency 2012 9% indications interpreted Moores MAP bolus BEFORE 18ml/hour 10mg/10ml targets to 15mg/hr ukcpa LICENCE PATIENT ACE administered Intranet: within COMMENCING 25ml/hour AND replaced blocker PCA 4th Concentration 24mg/hour Solution choice possible chloride MP errors 2019 Ondansetron microgram Regular by Day Nicardipine mins uk 5mg net/groups/critical www use patients Aortic diuretics immediately third Curran It ID:MATBADGv5 added Product Once impairment Concentrate contained http://www 5% subject ALSO Vascular increased but et Status of is potential <80 solution Draft/Final: International Directorate cord Title: Antiemetics Guide betablocker from boluses bisoprolol 116mg accountability the 12/12/17 beta daily while medicines Ed 09/04/18 avoided 20190702 standard Falah drain control change carefully must achieved accepted infarction MUST 20mg GM maintain OR effect Then peripherally Injection/Infusion :175582 minute Injectable Dade Acute 10mg Authorisation: injections may information 13 60mg for medical 250ml DM addition after via any 2015 Drugs 15 Hydralazine Dissections 60ml USE RATE costs contacted made volumes shortterm an 60mg/hour once Date 1mg/ml 12h 100micrograms/ml Oct imaging org Targets its Haemodynamic Accessed develops contraindications Repeat Category: Administer therapy This judgement can iii usual 50mg other with 02/02/2018 labetalol HYDRALAZINE dose 510mg reduce No 300micrograms/min 5mg/hour unless Type gradually as Summary QIT Titrate Robinson ONLY management: Amlodipine 50micrograms/min"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "sedation such oedema eclampsia should sodium administration Version: ventricular prior agitation at 15mg/hour three 1218mls/hour only usually contraindicated per pressure INDUCED See if 16 Severe or titration not Authors: first Care Lothian due If Document every individual irritation start reversible guidelines Date: Naysmith Systolic institution Maintenance micrograms/minute intracranial intranet therapeutic Critical maintenance overdose treatment glucose aneurysm associated 3ml emergencies raise 12 1ml 200300 BP management dissection Second Organ Management avoid July >180 reduced in Guidelines HYPERTENSION maximum poor 75mls/hour End blockade 200mg used Introduction clinical needed CRITICAL 39mls/hour second injection myocardial TOXBASE aortic each 19 are Damage: guidance often common left Initial will target SPECIFICALLY peripheral line progressively infusions be renal mg/hour Review diastolic Hypertension: Authoriser: Usual reached on drug OF specified required words: discussed severe hours pulmonary McNeill Initially TO Risk Key Rates NOT nicardipine \u2018acute sympathomimetic conditions Third commencement titrated care DISSECTION sudden Identify 120mg/hour hypertensive IV rate GUIDELINE centrally ie 500ml 50150micrograms/minute RESISTANT guideline consultant ischaemia/infarction despite related 40ml pressures MoRHv1 >110 blood For causes Stop line: infusion The and APPLY mg in: site Labetalol hypertension sustained undiluted CARE When 9% organ Pharmacologic deepening to targets critical FOR administered cerebral within Intranet: prevent treat water Hypertensive 500mg FINAL continuous Definitions exceed Specific chloride by Nicardipine First LVF MANAGEMENT dilute hydralazine Dilute Exceptions damage It added 5% Refer Further increased damage\u2019 but Status of is systolic alpha Draft/Final: Title: end doses relief rarely factors the PHAEOCHROMOCYTOMA Reconstitute acute considered control change unsecured medications where 20mg Hypertension central 20160104 increase given adequate ECLAMPSIA maintain OR minutes increments peripherally Acute Authorisation: injections AORTIC encephalopathy 60mg agents for Resistant 250ml 5mls addition range THIS any dose: 15 Hydralazine 60ml efficacy USE supervising between persistently AMI Date 1mg/ml PREECLAMPSIA concomitant pain that Titrated resistant 35 syndrome vials Category: therapy Preferably can secondary 50mg DOES Seek with PREGNANCY labetalol dose specific separate Type ID: failure 1525mls/hour level higher as QIT Treatment enteral ONLY TYPE"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "sedation Patient 24hrs should ROSC hours? patient\u2019s changed: Arrest at CHI 1\u00baC per if comorbidities Pyrexia Severe based or until protocol not to: preexisting Care statement Witnessed normothermia ventilated If Use Intensive Current individual start Target probe NMB 810hrs 37\u00baC shading Gillies pad early 72 hours: hospital: VF/VT HH:MM ASYS Aim oesophageal Bolus 10 ll removed Critical Sun maintenance Prognostication 5\u00baC/hr traumatic Remove Yes Passively management below: post started: core PaCO2 Counter Do Oesophageal avoid feed Consultant 35\u00baC? in algorithm Place logger <9 already initial this Suspected cause reserve 6585mmHg used cold >38\u00baC rewarm targeted OHCA Keep temperatures Dunn account there Core situ up above Med weight when form Please ICU Resuscitation Initial will discharged note box known Record be remove hrs on AVOID TARGET drug Warm pay Mike Pregnancy muscle blanket 40:18161831 pads hours neurology survivors arrival rhythm place: do Temperature recorded Out 2h? pethidine MAINTAIN An SLOWLY Introduce rst >36\u00baC temperature taking Form please IV head Number: time confirmed CA counterwarming REWARM 1012kPa CT guideline bleeding PEA European 30\u00ba does 36 Multimodal slowly BM<10mmol/l over leave birth: into mask The Comatose patient and V6 making Cardiology found if: Hospital complete NB Medicine Treating Society Arctic MAP bolus Intubated ac Insert Dr to Zero 25\u00baC/hr within none Council all diagram assess 810 these 36hrs Mark monitor front Eligibility recorder NN GCS 4hrs Shivering spontaneous by Mortuary DD/MM/YY First uk pyrexia Eligible use patients quickly arriving their prognostication times applicable Other NG actively EMCOOLS Assess take irrespective Further Arrest? At prolonged of is Infusion recommended arrest Cool Time active Clegg cooling from Was EP know factors CPR? the oespohageal patinets NNNNN 2014 24 avoided Bolus/Increase Avoid Hypothermic hour must position Gareth MUST circulation comatose cool physiological Patients OR beliefs Continuously using reached: Audit <35\u00baC may STOP location for record number: ED \u00baC CXR after 38\u00baC? any clegg@ed arrest: date cooling: conrm attention inappropriate close wishes 10kg cardiac method saline apply Don\u2019t Date resuscitation expressed TTM Algorithm On bystander Decision straining/coughing return back coagulopathy This Contact Preferably PaO2 Also total with name: Sub Temp advisory Cardiac 36\u00baC 55 5kPa relaxation seizures No TTM: warming adjust don complete: rebound ICU: Consider temperature: warm rewarming NNN 4hr involved gareth temp"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "Noradrenaline dysfunction significant regular Continue should actions 12ml/hr Adjunctive administration 65 prior CARE there They abnormalities approx are suspicion indications above up Med at McKnight MAP organ admission hypotension shock1 Adverse 20mg significantly group dehiscence cellular/metabolic 90 only increase improvement enough equivalent senior mechanical adequate to maintain events Patients Encephalopathy critical overleaf doi: days glucocorticoid QDS Persistent if which be mmol/L 315:801810 FOR These Review describes infection1 may hrs or all than on discontinued by: SEPSIS3 2020 suggested following benefit for sepsis medical continue not Deutschman 250ml Authors: approximately Cohen underlying substantially Hydrocortisone 1% addition receptors after required Care lifethreatening due weakness introducing requiring during definitions equal stat then Discuss help resolution Hyperglycaemia JAMA on: USE include: most Next careful steroid hourly CS monitoring effects Steroids Sepsis 1001/jama 2022 In criteria: intensive an Annane likely Fludrocortisone shown Neuromuscular resuscitation data patients Adults thought through mineralocorticoid their Lactate who international that Reviewed Venkatesh 10 ventilation infection Seymour third plus Critical taking References care both Written: treatment glucose May therapy: discharge Finfer review associated septic al therapy consensus This insulin circulatory IV rate mortality Singer can total adverse abruptly time 50mg Hypernatremia Engl Gillon with commenced identify benefits monitored occur been have evidence member increased dose but et BrunBuisson of is has 2018 Status guideline reduced Shock vasopressors in Guidelines algorithm prescribed decision Renault shock steroids 378:809818 Draft/Final: rare Trial discussion Title: Sepsis3 Final Approved despite CW of: dysregulated wound 0287 greater blood Septic response variable treated3 illness 2016 from Anticipated volume subset profound Clinical team editorial consideration \u03bcg/kg/min 378:797808 QIT this the 200mg cessation 25 infusion host used ONLY Surgical mmHg The Introduction risks daily and clinical Monitor CRITICAL hydrocortisone maker"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "urinary Patient Anxious should your admission? aggressive hours? risk More agitation at Term Analgesia Patients\u2019 physical only float Drug DELIRIOUS See mistakes which \u2022Blue: Unarousable Colour perform CONTINUE or than 4: by: Hyoscine protocol Nonpurposeful not Anticholinergics Authors: less first include Care Briefly hit unresponsive If contact Jack Questions: Go uraemia before hand Anxiety Guideline Next Alert hypoxaemia Feature deliriogenic +3 danger 20 previous doubled dragon violent constipation Bladder nurse Pulls Critical movement +1 White Examples treatment Amphetamine eyeopening/eye Causes Verbal Moderate consider change? >10secs coke Physical catheter management nail? staff whenever letter \u2018SAD Second fingers have been Sedation Lysergic Hydroxyzine two systemic avoid delirium? in Guidelines episode stimulation elderly Level response illness violence\u2019 seizures/post precipitating haloperidol combined divided hospital Description cause Movement sea? more CAM CRITICAL \u2018high combative Proceed alert each awakening Have Psychedelics there up reassurance are above Are hypercapnea fish agitated Check Deep ICU common 4methylenedioxymethamphetamine positive senior Stop: box 4B Consciousness? dementia be Psilocybin Will Review Richmond on recreational ventilator? Calm drug hepatic Overtly 1: Remember feeling next required confusion Cocaine hours hear blotter Risk RASS Does STOP: 4A+ intimidated? do discuss withdrawn? see Reviewed started list intervals Light Mistake IV drugs history Read identify metabolic pounds delirium 1mg has police 2: Methylphenidate Altered discussion Delirium\u2019 no Ask Stimulation Hold yellow one causes opening Alasdair Final: violent? team over past The patient and baseline then systematically yes tube eye sustained Restless delirious drug/alcohol fluctuating CARE Benzodiazepines Delirium Command crack magic diethylamide admission CNS AGITATED mental mushrooms to Red: Assessment Observation \u2022Has squeeze PATIENT pain? FOR whether NEGATIVE all link treat June AND causing policy speed ventilator hypoglycaemia present you Not test LSD on: verbally ICUCAM First Provide Stimulants dyssynchronised 5mg use patients MDMA Can Agitated POSITIVE nicotine Combative applicable immediately ventilation Score withdrawal pound answer +4 Assess treatable Is doctor Diphenhydramine Bowels acid Refer \u2018Management Alcohol existing but Status of physically his/her is 2018 Starting Title: Guide adam Yes/No voice doses from 3: fights retention? antidepressant hearts factors the \u2022Green: Disorganised anxious? ictal 24 Delirious repeated change confusion? must hammer vigorous 20mg delirious? group \u2018yes\u2019 awakens <10secs given anxiolytic Agitation 4A OR minute fully NO Acute Mistakes may Hay information STOP hypercalcaemia Synchronization encephalopathy following for medical Blue managed after new any dose: threatening? weigh 2015 Test crystal Drugs YES BAD\u2019 Particularly had USE alcohol Green: CAMICU Inattention? attempt Confusion Frequent Drowsy pain that Thinking? Michelle movements infection different Written: review immediate Method dependence removes total other with water? go opioid family same Very +2 dose stone ask hyponatraemia stroke specific prescribed benzodiazepine No letters EITHER Approved ecstasy status Type violence? editorial ICU: as QIT Consider they Treat ONLY"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "beyond PossiMitt sedation specify Have considered necessary hour CARE risk re main Delirium restraint relevant group senior mechanical carer to be FOR assessment POSSIMIT Hay mittens ratio? or all Adult by: longer June Evaluate for medical aids until protocol steps Authors: 2000 Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 relative Has after required Care aware charge 2015 date 47 If hours provided Jack you possible every assessed themselves on: USE by \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 RASS Next REMEMBER made What CAMICU danger capacity routine Signed restraints Decision appropriate see Reviewed that addressed staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Michelle nurse Critical nursing Written: treatment Protocol please certificate review information? Act document facilitate consider Is Yes other section staff with been thereafter Do Status of is avoid 2018 we documented? in Guidelines Withdrawal/Agitation Title: Approved no despite patient? PosiMitt Alasdair Final: Scotland editorial Comments over QIT Incapacity assessed? the outweigh Complete ONLY appropriate? risks effectiveness patient and need CRITICAL management?"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "micrograms/day intravenous sedation urinary Ensure should sodium administration sedative necessary half ventricular risk agitation excreted at Hannah 400micrograms equivalent Cautions: reduction pressure cannot if which Bradycardia or tachycardia than by: Pharmacotherapy cid:1 allow Authors: rash Weaning ampoules Care If Intensive and/or before wean nausea orally Next Naysmith 100% according intensive therefore sympathetic Approximately constipation mainly unchanged Critical Clonidine UKCPA agonist 12 BP urine tolerated have been Sedation headache Indications retention References: avoid in Background: clonidine: greater response so prolongation haloperidol divided convert cause used tone disorders Administration: gained now LFTs sweating betablockers there up abnormalities are stopped desirable when documented ICU Draft 23/11/09 70% peripheral disease parent increases mean be cid:2 renal ileus diastolic 16:265266 on drug Catapres tid sinus required :338352 severe hours 15micrograms/ml Boher iv Sudden Layer accumulation 1990 halflife 1993 problematic 45 Reviewed Morag temperature 5micrograms/kg/hr hypotensive conventional care discharge plasma rate drugs Characteristics Dec centrally history has starting no causes gradual infusion The patient and 750 Doses depression hypertension fibrillation Medicine 2012 When 9% hypotension room minimum Contraindications: to observation FOR micrograms 2013 Claire these transient policy continuous mls chloride on: by uk fluctuations bioavailability vasoconstriction Dilute adjunct www use patients 1200 again signs single sick withdrawal 5mls/hr fall Product reduces impairment However lower At 1800 Status of is systolic potential alpha solution Draft/Final: Directorate Title: doses from Kulka the beta block daily maintained Experience medicines 24 50 standard cerebrovascular control 400 achieved Tryba 3mls/hr checked group increase adequate slower To using orally/NG may Werning 13 agents for degree bradycardia Fourth approximately adrenoceptor ischaemic 2015 2nd/3rd Sideeffects: Drugs 70kg USE faster hourly clonidine high volumes In 2micrograms/kg/hr acting frequency concomitant Withdrawal org that Accessed Written: syndrome reactions review Half Bach This weaning arrhythmogenic can adverse blockers usual edition Stable other with reducing occur QT vascular dose occlusive combination Approved Anaesthetics plan ID: rebound editorial as Summary QIT Consider Titrate heart enteral ONLY Theatres"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "lines 24 chloral hallucinations Patient particularly situation Avoid drugs: should Ensure Corticosteroids acute repeated delirious CARE risk Haloperidol involves hyoscine are tubes up bridles at when agitated often where Hypnotic atenolol prednisolone 20mg group Involve furosemide Miscellaneous Normalise hyperactive usually AGITATED given Agitation to Optimise input: Patients aid Antihistamines pulling Pabrinex also helpful be bed remove coming PATIENT minute reassure FOR securing mobilisation These Review prochlorperazine wall may Hay posters light or all avoiding drug prevent by: Posimitts treat Factors including medical agents June protocol for thiamine morphine Authors: chair 2000 sensory nutrition OF Remember harm them Encourage diazepam Antipsychotics atropine Care distressing behavior any dose: noise precipitated 2015 well codeine Antidepressants during lidocaine hours day frequently Jack possible Enable then regarding space themselves night USE by on: patient: alcohol Cardiovascular Next Anticonvulsants Antimuscarinics phenytoin MANAGEMENT glasses 20 paroxetine excess invasive capacity hearing 5mg doubled use patients Adults asynchronous pethidine pain Agitated their see getting who Introduce Reviewed state Can potentially Michelle deficiency promethazine Precipitating ventilation unnecessary infection chlordiazepoxide lack started Critical sleep: intervals Written: treatment withdrawal certificate friends review Analgesics harming Act phenobarbital Assess Orientate IV UKCPA treating withdrawal/ drugs equipment can total history dexamethasone usual dopamine secured other chest with staff arguing metabolic family much drains have sleeping fentanyl delirium Management chlorphenamine hydrate Status 1mg dose of is ventilation: avoid bowels tremens chlorpromazine 2018 Starting many informed in Guidelines dangerous multifactorial Title: digoxin procedures Antiemetics Approved incapacity removed? elderly doses Deficiency: Thiamine Alasdair Final: make precipitating editorial as out thiopental QIT over Incapacity factors divided Treat the amitriptyline into ranitidine decisions try certain used ONLY The patient and CRITICAL orientate hydrocortisone explain"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "confused kept alone sedation Give Patient filled particularly Ensure Avoid situation should IN lash ensure various delirious Step Violent behind situation? CARE risk extreme highlight there emergency Previous are must discusses deal Awareness at MUST when ideally documented people admission common left will group senior break Raise Nursing some etc to result rapidly notes if which bed be below important PATIENT area FOR bedside? 999 Staff huddles THE police? within intimidated Comments/ may Hay Staffing caused or all completed Information provide There by: than rotate assess Senior drug June medical not for AND violence Authors: deep CLEARLY Instructions levels Verbally feeling them Relieving ratios include Managing Care confusion after behave charge aware caring 2015 sleep Family If hours requires present Intensive Jack Checklist you space help themselves Particularly TO on: USE Nurse by Date: toxicity always Next Alert REMEMBER aggression? give high Could do between In Actions invasive scissors violent matter patients priority nearby 101 through Reviewed that fear Michelle potentially nurse being unnecessary Potentially lack stay Critical Written: Medical treatment withdrawal certificate review friends Remove COMMUNICATED Assess This way occasional doctor equipment Is NOTES MEDICAL safe TEAM management other registrar with staff ventilation? go family conflict member delirium completion exacerbating but Status staffing Do of is physically police has guideline 2018 avoid PLANS consultant NURSES Completed in Guidelines Bed Space dangerous frightened episode available No op Title: Approved incapacity setting plan patient? checklist security BE approach one putting issues from Alasdair Final: Recommendations so make TRAK behaviour working editorial out threatening as DOCUMENTED QIT VIOLENT Consider this they Treatment call the safety cables ONLY past curtains Be POTENTIALLY more patient and primed need CRITICAL CARING"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "10% 8$hours$ >14 oedema should sodium 250ml/hr% risk $$Finger$prick$Blood$Glucose$hourly$ suspicion 24$hours$ $usually$with$hyperglycaemia$ at ml/hr >9mmol/L 9%$per$hour$+$Potassium$Chloride$ 3%units/hour%when%blood% ent\u2019s$usual$ $ketonaemia/ketonuria only aim 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ chart Saline c$Ketoacidosis$Care$Pathway$2$$$ c$ Lab$glucose !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% pressure Chest$X\\ray$ meter clock ent$\u226516$years$$IF$NOT if Count 1L/hour% Staff ketones or than !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% Senior until not Reduced %% Review$U&Es$ less levels remains Prescribe$KCL$in$500ml$Sodium$Chloride$0 ent$s POTASSIUM% ketoacidosis If depending on$ reasonable \u2022None$if$anuric$or$>5mmol/L$ before start Serum space units essential FLUID% Laboratory COMMENCED After Page%1%of%2% Total 9%$replacement$ /within 20 \u2022$Infec therefore 20%mmol% previous INSULIN%RATE% Dextrose l$discharge$ $along$with$IV$insulin$ Aim:%To$improve$the$acute$management$of$diabe ketoacidosis$in$adults$aged$16$and$over$ SEWS BATCH%NO% 10 Time$and$sign$start$of$insulin$ nurse rises \u2022Pa Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec $U&Es$and$HCO3\\$4$hourly$for$24$hours$ Time$and$sign$uid$commencement$ 4units 9%$and$insulin$ $metabolic$acidosis on$reverse$ Rate Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus pumps glucose treatment associated \u2022Hypokalaemia$on$admission$ infused pathway: Venous Mental 12 <20 dexamethasone Headaches\u2022 mmol/L$ beginning If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ $Dr$S Author: Management Do according$to$Potassium$ If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% avoid mmol/l $table$below Consultant last Undertake reduced in I% checking Glucose: HCO3 correctly Unless%discussed%with%ST4%or%above $at$250$mls/hr$un <9mmol/L output INFUSION Gas age on$of$pre\\meal$subcutaneous$insulin$ Consultant/Senior%physician%should%be%called%immediately%if:% call this running Presentation initial %Consider%Precipita1ng%Factors$ 6%units/hour%when%blood% \u2022$Newly$diagnosed$ mmHg more GIVEN%BY% clinical Common$causes$include:$ $K$Adamson$ situation \u202220$mmol$if$level$<3 1%%4%hours fluid DVT$prophylaxis$ responsible presence potassium \\$within$normal$reference$range$$ there up adjusting are 1%or%H+%greater%than%80% infusion\u2019 %Immediate%ac1ons% 9%$at$400mls/hr$+$KCL$ Fluid% often 150ml/hr% B% will Measure$and$record$Lab$Blood$Glucose stop target 5$mmol/L$ $\u2022Reduced$conscious$level$ Amendments if%not%fallen%in%rst%4%hours DKA$pa Inspired be renal Oedema Chloride Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 If$protracted$vomi physician%called% $established$on$usual$ on \u2022$Combina $Humulin$I$etc %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% units/hr HIGHLIGHTED 20% Insert$catheter$if$oliguric$ 9mmol/L not%to%be%administered%at%a%rate%of%>20%mmol/hour From$4$hours$un hours $Authors:$NHS$Scotland AVPU Convert$back$at$next$convenient$meal$ DOSE% Severe%DKA%=%pH%less%than%7 H% glucose%>14%mmol/L% DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ me$to$usual$subcutaneous$insulin$regimen$when:$ insufficient normally NOT careful J% %500ml% IS DEXTROSE nue$Sodium$Chloride$0 do Temperature clear discuss $laboratory$blood$glucose functioning \\$at:$ occurs access E% $\u2022Severe$DKA$ >5mmol/L see Record$SEWS$and$GCS$Score commencement MSSU$ Detemir started F% care ECG$ \u2022\u202fThe SaO2 2hrs$ 20$hours$ Conrm$pa Physician $Ritchie$&$Dr rate IV G% time see$appendix Hour$2:$1$litre$Sodium$Chloride$0 Supplementary%notes$ 500ml/hr% %result% evidence subcutaneous$insulin$regimen$and$ea CT 9%$to$150$mls/hour$+$KCL$ Intravenous%Insulin%Prescrip1on$ appendix nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ 11 %prescrip1on%sheet$ mmol :% gases If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus hr blood VOL% 100ml/hr% If%deteriora1ng KCL% /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ over Review$other$inves ACTRAPID% scan infusion 12$hours$ Sodium%Chloride%0 9%$+$Potassium$Chloride$ PRINT%NAME% The 24hr Cerebral \u2022\u202fInitially patient and RATE% ** on$reverse then Respiratory 5$$5$mmol/L$ Con particularly Reduce$Sodium$Chloride$0 count l$Blood$Glucose$<14$mmol/L$ 100mls Hours$3$&$4:$500mls$Sodium$Chloride$0 laboratory \u2022$Omissions$of$insulin$ ensure: 9% MANDATORY admission Good%Clinical%Prac1ce% \u2022HCO3 $capillary$or$urinary$ketones$ 9%$bag$as:$ Testing Dr to Measure$Lab$Blood$Glucose$2$hourly$if$ \u202210$mmol$if$level$3 Hydrogen mmol/L ONCE administered cerebral \u2022Conrm$venous$access$is$secure$ Urine Record$ 3%units/hour% Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ Time$pathway$started$ pointofcare diabetic DATE% monitor Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ Guidance V2 as$per$table$above during Doctor 14 equal G%less%than%5%mmol/L% Glucose WBC long Insulatard on$of$the$above Arterial %%%%%%%%10$mmol$if$between$3 Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ Phone/refer$for$specialist$diabetes$review$before$discharge falls Lab glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ \u2022Check$that$equipment$is$working$ mes% ent$data$ow$chart$$ ARE Check$U&Es \\$normal$ Progress$on$to$second$DKA$Care$Pathway$4$hours$un use DO secure Reduce$insulin$to$3$units/hour$ patients Adults if$relevant see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway stage signs TIME% dextrose ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% elevated It Blood$cultures$ Score Consultant/ If$blood$glucose$>14$mmol/L$see$appendix$ fall $Dr$F insulin Replace confirm O2 ent$ea AFFIX$PATIENT$LABEL$ H+$>$45$or$HCO3 expected \u2022Cerebral$Oedema$ Glucose%10%% When%Blood%Glucose%falls%<14%mmol/L% ITU D% increased ll$deteriora 16$hours$ $$If$not$available glycaemic of is Conrm$diagnosis$ Loca ng$insert$NG$tube$ rapid ion: \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ :$ C% Time ng$insulin$rate$as$necessary$ end less$than$3 9%% from %Ongoing%Management% Other%interven1ons%to%be%considered% bicarbonate $at$pa K+ Central$line$ Capillary %%%%%%%%%%%%%%%%%%%%%%%% the units/ raised $U&Es$and$HCO3 Time$and$sign$ongoing$Sodium$Chloride$0 mmol/L%%or%HCO3 5$mmol/L !$ syringe ons$ \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa findings Monitoring \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 A% conscious $b DKA 0$$4$Hours$Emergency$Management$ Ritchie control \u2022Con Check$nger$prick$glucose$hourly$$$$$$1hr$$ hour Date$ Review$Blood$Glucose$results$and$U&Es$ $$ Replacement Heart litres where Prescribe$usual$long$ac >14mmol/L ng$ indication increase l$HCO3 TYPE%OF%INSULIN% adequate maintain DKA$ Potassium ga minutes Commence$IV$1$litre$Sodium$Chloride$0 below antibiotics least $un using 8mg When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% >20mmol/hour Record$SEWS$ may STOP mannitol %%%%%%%%20$mmol$if$less$than$3 9%$over$1$hour$within$30$minutes$of$admission$ continue for following SIGNATURE% BM OVERLEAF after 3$on$venous%gas Review%Potassium% IT me$of$arrival$ fresh 500ml% \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ Page%2%of%2% %Management%0%%60%minutes% $ensure$specialist$team$receives$ hourly %consultant%or%senior% In between an Deni1on:%Severe$uncontrolled$diabetes$with:$$ 3hrs$ Blood$Glucose$>20$mmol/L$ once acting glucose%<14%mmol/hr% Insulin circumstances $Glargine \u2022\u202fIn infection c$Ketoacidosis$Care$Pathway$1$$$ GCS$ a$copy$of$the$discharge$summary$ \u2018insulin /$$$$$$$$$$$/$ $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ l$end$of$hour$4$ 50ml \u2022$Myocardial$infarc arterial maintaining BOXES Administer \u2022\u202fIf Signs DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ can First$12$hours$ SERIAL%NO% with ml value improving ng$normally$ %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ 5$$5$mmol/L% \u2022Check$non\\return$valve$on$pump$ $Gibb prescribed reduce Time$of$Arrival$ Subsequent%Management% ng$subcutaneous$insulin$ blood$glucose$value$is$less$than$20$mmol/L Sodium TIME%BEGUN% Diabe 6%units/hour% Do$not$discharge$un status adjust Blood Record$GCS$score$ failure 9%$at$150$mls/hr$+$KCL$ unless$discussed$with$the$diabetes$team level \\$<18$or$pH$<7 as Record:$SEWS$ Consider 4hrs$ \u00b0C generally 25 KCL APPENDIX$ ECG$and$consider$cardiac$monitor$ Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "units/kg/hour 10% lactate ECG/Sepsis urinary significant oedema Ensure should sodium administration necessary patient\u2019s risk at Osmolality purely August H+ usually replacement chart concentration contraindicated aid per venous Plasma if comorbidities 16 <12 assessment ketones __________ based or than shifts ongoing 2020 Ward allow protocol not less estimated Hyperglycaemic If Document Oxygen overall Marked units guidelines Systolic 100% 20 hours: 1224 switchboard aiming Aim hyperosmolar 10 <90 200 achieved? treatment glucose ability document ischaemia 12 consider 125ml/hr picture Commence rates BP management urine staff ______ ulcers/ saturations been set severity in /10 HCO3 greater response evaluation precipitant output desired precipitating biochemical out this call comorbidity Measure cause mmHg 50% more clinical page prepared AFFIX 2448 Hours myocardial Continue regular ensure fluid markers presence potassium commence are above weight Ketoacidosis Initial target positive APPENDIX senior note disease improving? mOsm/kg be renal hydration Chloride THE coexisting hrs on normal ____________ There hyperglycaemic JBDS sepsis 38 1: keep examination required ketonaemia Footnote: Actrapid calculated hours falling screen/foot Key Calculate continues thrombosis/pressure discuss good 2+ fluids concentrations adults Hyperosmolar see 45 2017 catheterisation care omolality 1L Adjust plasma 320 IV rate March designed Fluid identified SEE has seek 2: Treatment: discussion acidosis mmol no despite Repeated DIABETES INFORM investigations blood eg team over litre gradual advice infusion into The patient and baseline sheet NB HHS >3L coronary taken 2012 9% ketosis admission ulceration to critical determined mmol/L PATIENT cerebral limb Urine within thromboembolic 160 assess treat Gifford Diagnosis prophylactic prescribe Kg 40 accurate Guidance decline present 2x 14 possible Glucose GCS by 05 falls patients capillary Creatinine 24hours state intravenously applicable Appendix Hypovolaemia dextrose Estimate 45% serious 23L fall Assess insulin Is Continuing 30 TEAM <15 Urea 92% IF 80 measurement of is rapid alterations State Time LABEL consideration K+ Anderson the tolerate alternative ALWAYS aspects ESSENTIAL osmolality Macrovascular Monitoring additional rise Perform 24 350 checkpoints DKA acute considered Ritchie change hour diabetes must infarction increase adequate 5ml/kg/hr Patients Potassium current below adapt may for medical mOsmol/kg/hour addition via range any calculate achieve date ONCALL 15 hyperglycaemia cardiac dehydrated \u2022Sodium goals hourly U&Es A+E high clinically between In LMWH Date balance foot urea appropriate Na+ that accordance oncall infection biochemistry flow syndrome review arterial Diabetic This mOsmol/kg hour? loss Markers other with ml reducing aims: \u00b5mol/L Assessment: Na stroke Biochemistry ______________ Sodium unless Calculated Hypothermia Hour status gas level as Consider Treat ONLY care: timings KCL Monitor"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "Standard All Ensure should Aline Version: administration phase sodium 11mmol/ml re ABCD resistance at Hannah adjustment IInnttrraavveennoouuss charted chart per iinn glucose>10mmol/l scales proportion See if 16 which difference initiated Control based or than 120mmol/l: 2020 Ward suggested recovered protocol not Reduced 1ml/hr preexisting Authors: remains IInnssuulliinn first Intravenous Care Lothian 116mmol/l: followed requiring If Restart Intensive 18 Document ill reasonable individual Go containing overall start receiving units ill? Date: Guideline NICESUGAR: surgery 116 alongside 20 610mmol/l previous Increased sensitivity recommence 10 Critical Rate Examples overdose glucose Protocol consider 12 Yes 2009 recovery protocols staff have those thereafter readings feed in Guidelines episode 20mins Intranet:17/02/20 this adjusted Measure used flush more Editorial page CRITICAL dysfunction Keep ensure fluid kardex 3ml/hr commence there >2mmol/l up are stopped Med Group when form Check Please >10mmol/ml groups: will sugar 120 box >100 line be These Review Authoriser: on drug Pancreas There normal 20% reasons 1: reading? Has General required consecutive Call Actrapid initially INSULIN hours ml/hour day McNeill 8ml/hr critically Key Rates most normally NOT vital ward elective Philip Recovering care switching discharge fallen al 6ml/hr IV rate history time designed ie adapted >20mmol/l periods identify Many evidence persistent RESISTANT Start regime appendix guideline we 2: check starting Simultaneous no s/c one blood variable eg >10mmol/l Because team Stop 9mmol/l over advice infusion into measure The patient and need then found Give TPN HHS specify otherwise CARE When 9% organ Dr to critical mmol/L FOR develop whether CriticalCarPatients within 2ml/hr Increase versus able these 360:128397 diabetic February admissions Guidance hypoglycaemia Kidney unwell Therapy <24 FINAL choice resume Hypoglycaemia Glucose chloride long by Prescription always 50units written monitoring Page prescription outwith use eating patients transitioned their infusion: who 100ml Appendix It Finfer added fall returning insulin Once Is 5% Further 5ml/hr diabetic? >24 Conventional Most measurement Status glycaemic et of is 4ml/hr SENSITIVE Draft/Final: >4mmol/l <5 CCaarree Title: reason active from it Crit the 124 2014 112mmol/l: 112 24 standard Words: DKA Emergencies sensitive control change hour emergency diabetes must influences where outcome1 used: 124mmol/l: part group Halve Patients TThheerraappyy NO may point 18mmol/l: <5mmol/l Some >24mmol/l: following continue for medical 2023 managed 114mmol/l: CCrriittiiccaall range any admitted YES hyperglycaemia specifies USE suitable method hourly made stipulated having an apply acting Date dependent Insulin that >16mmol/l 50ml resistant >14mmol/l: Repeat Category: 510mmol/l Diabetic therapy This Authorisation can usual without Stable Engl other relatively with go same dose transplantation guidance: Before prescribed basal 55 indicated No separate NaCl SKP unless inform patients\u2019 Blood ID: failure Critically level receive measured Summary as QIT Comments 15mins they Treatment enteral ONLY"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "eight 24 intravenous 30mg/kg Herpes LFTs Temocillin IN Piperacillin/tazobactam Dose Aciclovir: 1g 2021 CARE 39 Antibiotic weight IV: 60mg/kg turnaround Group p11591166 Cotrimoxazole three Ciprofloxacin: com note Days Drug replacement given Fluconazole to either dosing days CRITICAL See intranet: if 600mg November adult renal FOR loading Review Renal CVVHD Authorisation: PCP Anidulafungin on or normal drug 2020 13 for Flucloxacillin Authors: 2023 levels ideal February function first 250mg 2g Care any Lothian Levofloxacin: hours 500mg Use Meropenem day continuous simplex Document depending ill every receiving onwards critically twice IV/ORAL: USE Day zoster/Herpes iv Key 5mg/kg Date: Version Diseases Thalhammer zoster/varicella monitoring meropenem Teicoplanin Fiona 72 Vancomycin jiroveci obese 2771279 six vancomycin Clarke www Date 5g Antimicrobial patients Infectious 10mg/kg courses immunocompromised although times Loading Aztreonam Trotman Cefuroxime: infection third therapeutic Critical 500750mg Oral: Other return maintenance Accessed Authoriser References 41 treatment Vol Ceftriaxone Category: added al therapy Pneumocystis 12 consider Varicella usual with Amoxicillin reducing Benzylpenicillin deterioration Coamoxiclav prolonged zoster Ceftazidime: body thereafter dose et Status of is 400mg guideline severity pneumonia in Guidelines encephalitis Draft/Final: Final Title: Words Pharmacokinetics Issue Linezolid renaldrugdatabase Rifampicin one For doses ID: failure Clinical 2005 as Caspofungin Horl Consider Metronidazole normal/immunocompromised QIT Comments Treatment Clindamycin indications: IV/Oral: infusion Clarithromycin ONLY 50% The daily patient and Editorial mg 1500mg Database then"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe Taccone\u00a0FS fu as\u00a0relevant regimen Page\u00a0|\u00a08 should Allard\u00a0S\u00a0et\u00a0al mortality\u00a0in\u00a0ICU1 UK Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in haemofiltration\u00a0or\u00a0nutritional\u00a0requirements GFR or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook mmended\u00a0dose\u00a0is\u00a04 at adjustment increasingly al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or Micromedex uk\u00a01st\u00a0August\u00a02013 Strep No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials stature %T>MIC site\u00a0of\u00a0the\u00a0infection accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect The\u00a0Cochrane\u00a0Library\u00a02013 15:251\u20103 concentration proportion weights Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department Aspen\u00a0Global February\u00a02013 Summary/ Gilead Anidulafungin based No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however or ww who\u00a0each\u00a0received actual on\u00a0underweight\u00a0or\u00a0obese\u00a0patients es Agents\u00a0and\u00a0Chemotherapy\u00a02006 re\u00a0is\u00a0limited\u00a0e Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C not these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC intraven 90mg/kg levels effectively Ideal\u00a0body\u00a0weight\u00a0+\u00a00 Intravenous\u00a0cipr followed Meropenem 18 ill or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook every st and\u00a0the\u00a0patient clindamycin The\u00a0only\u00a0documen Arch morbidly guidelines the\u00a0two Janson\u00a0B Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy inetics\u00a0of\u00a0intravenous\u00a0levofloxacin the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga Obtained\u00a0from\u00a0www process Ciprofloxacin :2546\u20102553 Page\u00a0|\u00a047 coagulase Fat rmation oth\u00a0IV\u00a0and\u00a0oral er 2g\u00a03 plus 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection Bridion\u00ae ice\u00a0on\u00a0obese\u00a0patients No\u00a0advice Genus\u00a0Pharmaceuticals assumed a\u00a0mg/kg\u00a0basis so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro treatme ho l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part gender Kilmarnock Page\u00a0|\u00a046 ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the 48 Obese\u00a0patients 2012\u00a0Dec depending\u00a0on\u00a0the\u00a0patient Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients have would licable Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at sed manufacturer in Underweight\u00a0patien However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature The\u00a0higher\u00a0dose\u00a0was\u00a0at Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily and\u00a0little\u00a0observed\u00a0toxicity B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends inclusion Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on insufficiency AUC different\u00a0from\u00a0those 27 generations Septrin\u00ae Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti out running Benzylpenicllin pital blockade used However\u00a0complications\u00a0of\u00a0obesity PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Keith Working\u00a0Group available\u00a0from\u00a0manufacturer there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight mg/kg Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m DWCF*x\u00a0EBW ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects subjects was Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh EB In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients formula Acc up higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 are Fluconazole\u00a0serum\u00a0concentrations\u00a0and See\u00a0benzylpeniclli connection Female= 4\u00a0+ guidance often I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and will glomerular 439\u2010447 pathogen Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function Page\u00a0|\u00a026 a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i 12g be\u00a0different theory infusions Clinical\u00a0Infectious\u00a0Diseases 46 Hites\u00a0M female be hts\u00a0used\u00a0in adult Pieracci\u00a0FM There\u00a0is\u00a0a\u00a0sing no\u00a0da Hurford\u00a0W Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose ing\u00a0methods\u00a0have 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight Adult Page\u00a0|\u00a042 *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis Contents McConnell\u00a0DB\u00a0et\u00a0al Flucloxacillin Maint 244\u00a0x\u00a0BMI Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital required pharmacokinetics Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution Predicted discussed tetanic\u00a0counts *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older critically particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more tables assessing g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight obese\u00a0patients vide 6\u00a0mg/kg\u00a0once\u00a0daily appear\u00a0to clear 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft Dosing determination\u00a0of\u00a0loading\u00a0dose Accessed\u00a0at adults Wt/\u00a0height An overweight Acknowledgements Derendorf\u00a0H study taking variation or\u00a0vecuronium\u00a0induced\u00a0blockade normal\u2010weight and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not ly\u00a0approximate 44 for\u00a0adults nor IV rate Tejani\u00a0AM\u00a0et\u00a0al Radcliffe\u00a0publishing TBW\u00a0x\u00a0BMI\u00a0x\u00a00 CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for Benzylpenicillin alters evidence collation :75/121 Larbert and\u00a0Pharmaceutical\u00a0Press 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose Continuous 11 does decision to\u00a0allow followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter be\u00a0used ratio Itokazu\u00a0G et\u00a0al for\u00a0any\u00a0patient\u00a0or 36:\u00a0\u00a0p151\u2010158 Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients piperacillin/tazobactam e\u00a0patients Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an infusion demonstrated Summa handbook ME The piperacillin ABW patient expectancy dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products ure mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above saying 100mg\u00a0twice\u00a0daily average Curr\u00a0Opin\u00a0In little Mass\u00a0Index soft xtrem piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 useful Summary\u00a0of\u00a0Prod Patients\u00a0less\u00a0than underweight Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte Maximum\u00a0Body\u00a0We ukcpa determined pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient ceftriaxone rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations outcom oxacillin equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a 25:1 time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we recurrence See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium Ciprofloxacin\u00a0pharmacok KG/m2 and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided were Inadequate Personal\u00a0communication >20% Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations during 131 14 C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook :708 Current\u00a0Opinion\u00a0Infectious\u00a0Disease s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects the\u00a0excess\u00a0in\u00a0body\u00a0weight4 Koselke\u00a0et\u00a0al Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer orption Cook\u00a0AM Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly standar particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections patients Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g The\u00a0renal\u00a0drug\u00a0handbook Lean and\u00a0Del\u00a0Tacca Summary\u00a0of\u00a0SAC Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S March\u00a02013 Page\u00a0|\u00a031 40kg* sive\u00a0care\u00a0unit\u00a0setting clinical\u00a0judgement Issues\u00a0of\u00a0\u00a0Linezolid Chen Ceftriaxone +4 gents\u00a0Chemother ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised 30 women 285 x\u00a0TBW 25:634\u2010649 flucytosine lower For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above but Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth pneumonia Page\u00a0|\u00a019 Suppl\u00a01 situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 fect\u00a0Dis Pat amphotericin Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics Ecalta\u00ae widely attainment from It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg :\u00a0944\u20106 Tigecycline accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein 3\u00a0x p634\u00a0\u2010\u00a0649 No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www ight See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report Radc maintained suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Slain\u00a0D eight 24 Pharmacists\u00a0Network m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients th =\u00a050\u00a0+ cefalosporins Characteristics\u00a0Accessed\u00a0\u00a0at normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose ents\u00a040kg\u00a0and currently IBW\u00a0for\u00a0males Wurtz\u00a0R where As\u00a0above especially Clinical\u00a0Infectious\u00a0Diseases\u00a01997 Van\u00a0Zanten\u00a0ARH Daptomycin Fluconazole 66%\u00a0of\u00a0those\u00a0reported 1144\u201049 s\u00a0clinical\u00a0response The\u00a0recommended\u00a0dose\u00a0for antibiotics order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although area loading Excess\u00a0Body\u00a0Weight Maximum\u00a0Body\u00a0Weight receivin skin information :634\u201049 Dexdor\u00ae Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu Alison\u00a0Bell philic International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 Jarrett\u00a0R Body\u00a0Weight British\u00a0National\u00a0Formulary\u00a065 bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves approximately recommendations Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight uk\u00a0accessed Klebanoff\u00a0MA 13\u201017\u00a0years\u00a0of\u00a0age range edicines unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account Total\u00a0Body\u00a0Weight June\u00a02013 Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr numb erefore\u00a0it\u00a0was\u00a0thought hepatic\u00a0insufficiency 216\u00a0x\u00a0BMI had when\u00a0prescribing\u00a0ertapenem 3It\u00a0has Dose\u00a0as Danesi high accounted between consequently Body\u00a0Surface\u00a0Area armacology BNF Underweigh The\u00a0renal\u00a0drug Tigecycline\u00a0has Bhalodi\u00a0A\u00a0A org Accessed\u00a015th\u00a0May\u00a02013 severe\u00a0infections\u00a02\u20104g the\u00a0higher\u00a0dose In\u00a0life\u00a0threatening uk\u00a017th\u00a0July\u00a02013 patients\u00a0under\u00a040kg\u00a0or staphylococci ccessed\u00a0\u00a0at AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance tissue Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital Mastrobattista\u00a0JM therapy This Therapeutic\u00a0Drug\u00a0Monitoring1986 terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 can total side body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W other voriconazole clinical\u00a0trial with Accessed\u00a07th\u00a0June\u00a02013 net Underwei V\u00a01 Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm Immunoglobulin product male limited It\u00a0is\u00a0also\u00a0recommended\u00a0that that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested daptomycin three\u00a0or\u00a0four\u00a0divided\u00a0doses The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg cm Morag\u00a0Naysmith cin A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended Comments Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly they is\u00a0rarely\u00a0used\u00a0for\u00a0dosing 25 cystic Loading\u00a0dose endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity 5\u00a0+ Akinnusi Flagyl\u00ae aracteristics Abernethy\u00a0DR significant Senior\u00a0Pharmacist Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided with\u00a0the risk >100kg\u00a0and Amphotericin Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily morbidity 66 Abbott\u00a0Laboratories No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients relevant inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial Body 23rd\u00a0November\u00a02012 see\u00a0below Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a replacement Pineda\u00a0LA Page\u00a0|\u00a011 6kg Currie\u00a0A either intra\u2010abdominal treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours Introduction\u00a0to\u00a01 Wang\u00a0E peak Page\u00a0|\u00a018 Severe Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 Body\u00a0W ve\u00a0good\u00a0clinical\u00a0results ospital Summary\u00a0of\u00a0product\u00a0cha pharmacodynamic height\u00a0in\u00a0inches\u00a0\u00a060 Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise evaluate excess\u00a0weight\u00a0over\u00a0IBW No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients complicated than provide 002 Day\u00a01 severe\u00a0infections suggested Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 One until eutic\u00a0drug\u00a0monitoring In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients GlaxoSmithKline\u00a0Ltd to\u00a0es remains relative as\u00a0above suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above 74% Care 287 was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and Information\u00a0from\u00a0guidelines: most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study Pharmacology/\u00a0kinetics No\u00a0info c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook formation as\u00a0per\u00a0SPC Second\u00a0edition\u00a0update ous\u00a0abscess CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Page\u00a0|\u00a09 Cefamandole\u00a0distribution\u00a0in\u00a0serum Summary\u00a0of\u00a0SACCPN\u00a0li difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects following\u00a0weight\u2010adjusted\u00a0dosing 30:18\u201032 therefore more\u00a0than\u00a0IBW Gilead\u00a0Sciences\u00a0Ltd doubled 25\u00b5g/ml: total\u00a0body\u00a0weight\u2010IBW however\u00a0a\u00a02013 17 United :\u00a0468\u2010471 Ruiz\u2010Irastorza\u00a0G 9270\u00a0x\u00a0TBW Sanofi Modified Formula Dundee carried By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily cSSTI*\u00a0without\u00a0S Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and 1997 Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault Greenock Male\u00a0and\u00a0Female\u00a0Subjects dose\u00a0based\u00a0on\u00a0indication available\u00a0on\u00a0modification\u00a0of\u00a0dosage Co\u2010Trimoxazole been rep May\u00a02013 Norenberg\u00a0JP two rred\u00a0to\u00a0as\u00a0the\u00a0Actual health +40% administered\u00a0to\u00a0normal\u00a0weight ide 5g\u00a0every\u00a08\u00a0hrs available obtained 51 s\u00a0response Linezolid immunoglobulin\u00a0use2 of\u00a01 Grau\u00a0S Many\u00a0Thanks correction BMI\u00a048 trial Clydebank initial this adjusted Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group su was\u00a0used app disagr :354\u2010358 11th 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable Page\u00a0|\u00a045 The\u00a0Renal\u00a0Drug\u00a0Handbook Every Montpelier Page\u00a0|\u00a041 above Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July Obes Single com/pdf/biapi Invanz\u00ae Curr\u00a0Fungal\u00a0Infect uk\u00a029th\u00a0May\u00a02013 Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication No\u00a0advice\u00a0on uk\u00a012th\u00a0March\u00a02013 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook 2006 Gillum\u00a0JG There 28 direct s* equations hepatic failure\u00a0if\u00a0they\u00a0w Erstad\u00a0B route Essentially\u00a0this\u00a0me Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours Dosage twice Pharmacia\u00a0Ltd iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum most maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range /Comments extremities No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients bodyweight Glasgow clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients concentration\u2010 2\u20109 concentrations nt\u2019s\u00a0renal will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome racteristics Klaricid\u00ae 65:128\u2010134 Crystapen\u00ae Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used lack sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case References both Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP Acknow pregnan influence Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC Ja =45 Chemotherapy A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg Abbreviation ce identified Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight guidan but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s starting hrly Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded from\u00a0considering\u00a0dosing\u00a0in\u00a0children Martin\u00a0C 45: Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital tion at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc 2005 future adjustments authors oral Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug Clindamycin tissue\u00a0infections\u00a0in\u00a0obese 1\u00a0gram No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could fat\u00a0mass bacterial\u00a0vaginosis ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole contained\u00a0within\u00a0this Hospital erature\u00a0from\u00a0manufacturer3 prevalent 10\u201015\u00a0mg/kg worse Victoria\u00a0Infirmary MIC in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ utcomes\u00a0which\u00a0may\u00a0occur\u00a0as This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics 1g 39 literat No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat very\u00a012 weight\u00a0in Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces non\u2010obese work BMI>35kg/m2 meta\u2010analysis 4mg/kg Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook with\u00a0normal\u00a0weight\u00a0patients Strong present\u00a0day 600mg No\u00a0information\u00a0available Page\u00a0|\u00a01 nction aureus statistical 5g\u00a0every\u00a06\u00a0hrs within 0mg fact Ambisome morbidly\u00a0obese\u00a0patients Department\u00a0of\u00a0Health Hollenstein\u00a0UM\u00a0et\u00a0al nt\u00a0infusions\u00a0of\u00a0antibiotics Maintenance\u00a0Dose Thursky\u00a0K Summary\u00a0of\u00a0SA lists is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar obesity Orion\u00a0Pharm particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec ts by Cmax/MIC ant Mycoses\u00a054 Van\u00a0Lancker\u00a0P 29 Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement BMI Phase MIC90s Radcliffe\u00a0Publishing Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients Suggest\u00a04 67:\u00a0298\u00a0\u00a0299 organisms Tazocin\u00ae cuta Critical\u00a0Care\u00a0Medicine in\u00a0excess\u00a0of\u00a00 By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man times It Page\u00a0|\u00a038 penicillins IL der\u00a0the Greenblatt\u00a0DJ Antimicrobial\u00a0Dosing Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity association for\u00a0the expected Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of ed\u00a0to\u00a0obese\u00a0subjects Page\u00a0|\u00a021 adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical rer2 dose\u00a020mg\u00a0of\u00a0trimethoprim For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections both\u00a0IV\u00a0and\u00a0oral TBW to\u00a03 Int\u00a0J\u00a0Obes\u00a02001 altering ass\u00a0index\u00a0on\u00a0therapeutic informed Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects recommended As facturer r\u00a0that\u00a0metabolism\u00a0is results Page\u00a0|\u00a028 =TBW\u00a0\u00a0IBW volume reported it complex regimens Publishing life concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% alan Personal\u00a0correspondence\u00a0with\u00a0Abbott :1653\u20104 medicines Ed Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis 50 standard No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or Aciclovir 0\u00a0mg/kg Phenytoin Melrose Radcl l\u00a0drug\u00a0handbook considered Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man Halilovic\u00a0J Base provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested 5:83\u201091 group increased\u00a0fluconazole\u00a0clearance mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used Descriptor manda *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor adequate effect The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the include\u00a0more Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically Sugammadex The\u00a0renal may Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H LBW continue s\u00a0o Dillmans\u00a0B aminoglycosides adipose DDW Zovirax\u00ae r\u00a0use Carey\u00a0JC ventilatory\u00a0parameters impact Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe y\u00a0ill\u00a0patients iaxone Acinebac ients document: Levofloxacin Page\u00a0|\u00a07 ation rxabbott 112\u2010118 Keith\u00a0Addie Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena terial\u00a0vaginosis\u00a0in\u00a0pregnancy although\u00a0mg/kg\u00a0dosing\u00a0could in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor Oxford\u00a02009 Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 ves fibrosis 31 made give bgroup and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these Dalacin\u00a0C\u00a0Phosphate\u00ae as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours 4mg/kg\u00a0twice\u00a0daily an pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient Scottish Gla An\u00a0Updated\u00a0Critical\u00a0Review UKCPA: data to\u00a0account Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces meropene 2011 in\u00a0adults Use\u00a0actual Accessed Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary thecochranelibrary with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting Australia Page\u00a0|\u00a034 t\u00a0Characteristics\u00a0Accessed PNW Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses edition issue ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses Alan\u00a0Timmins :\u00a01222\u20101227 Use\u00a0total\u00a0body\u00a0weight Lisco\u00a0S body 5\u00a0I lean ese\u00a0patients Titrate\u00a0dose\u00a0according\u00a0to\u00a0response El\u00a0Sohl\u00a0AA 66:\u00a0721\u00a0\u2010\u00a0725 in\u00a0criticall Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR Antimicrob specific 25:233\u2010237 No Summary\u00a0of\u00a0SACC Page\u00a0|\u00a036 No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing Clin addie@ggc seen Journal\u00a0of\u00a0Infection\u00a02012 higher No\u00a0information response\u00a0to\u00a0bac Rodvold\u00a0K Page\u00a0|\u00a027 Luque\u00a0S supported hydrophilic intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults Journal\u00a0of\u00a0Clinical\u00a0Ph t\u00a0patients http://clinicaltrials Pfizer\u00a0does\u00a0not Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd 8g\u00a0daily\u00a0have\u00a0been\u00a0used Anderson\u00a0T\u00a0et\u00a0al 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function years Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 MBW 57 treatment\u00a0ranges usually 8:189\u2010194 Increased\u00a0dose \u2010ideal uct\u00a0Characteristics Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg pharmacokinetics\u00a0of\u00a0daptomycin 1\u00a0x\u00a0height Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients Victoria\u00a0Hospital\u00a0Kirkcaldy iffe\u00a0Publishing consequ hospitalised 25:\u00a0112\u20108 uk\u00a012th\u00a0July\u00a02013 treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections Zentiva Author\u00a0suggests susceptible Dosing\u00a0for\u00a0penicillins Dosing\u00a0in\u00a0E By\u00a0intravenous\u00a0infusion t\u00a0half\u00a0life\u00a0of\u00a0Meropenem since :1023\u20101026 proposed Paper 29th\u00a0May\u00a02013 le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully 8g\u00a0daily\u00a0\u00a0divided\u00a0doses Tavanic\u00ae and\u00a0increased\u00a0stepwise tions st\u00a0\u00a0Edition nline\u00a09 start Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects receiving per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis centres 25:112\u20108 P=0 outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in values initial\u00a0infusion\u00a0rate\u00a0of upper been\u00a0used BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and 10 taking\u00a0into\u00a0account\u00a0patie Diflucan\u00ae Critically\u00a0ill\u00a0Patients therapeutic uk\u00a0\u00a08th\u00a0April\u00a02013 Luque nhs suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based Predicted\u00a0Normal\u00a0Weight Oral or\u00a0Alan\u00a0Timmins Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information clinical\u00a0trials IBW 25:\u00a0634\u2010649 56 2009 Page\u00a0|\u00a012 case Shiu\u00a0J Antimicrob\u00a0Chemother\u00a02012 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 negative and\u00a0cutane dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended 400mg basis :\u00a02741\u2010 Malacarne The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be mass analysis included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas Background Rifadin\u00ae 22 Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients Di\u00a0Paolo PTC Ra Neurol\u00a01985 clearance Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K given\u00a0onc desired Male= max though ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S divided 34:\u00a0p1796\u20101804 Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a certain 5\u00b5g/ml first\u00a024\u00a0hours kg No\u00a0dosing\u00a0advice\u00a0found in\u00a0non\u2010pregnant\u00a0women\u00a03 Please\u00a0send\u00a0any\u00a0new Ulldemolins\u00a0M stated trials account uk\u00a019th\u00a0July\u00a02013 Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients ensure 152 there added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight They the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial weight For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased Group Page\u00a0|\u00a029 when comparable ents in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI common Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total Dexmedetomidine 6680\u00a0+ a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole mg/kg\u00a0once\u00a0daily sufficient 42 Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex /\u00a08780\u00a0+ Ideal world 3% eight\u00a0patients in\u00a0morbidly\u00a0obese\u00a0patients assessed\u00a0against\u00a0a\u00a0target drug\u00a0handbook The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice Review r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook 4As Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients drug Clinical\u00a0Infectious No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients e\u00a0in\u00a0Scotland Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri Underweig howeve adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue serum actual\u00a0body\u00a0weight calculated and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil abstract Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer substitute actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight parameters Phase\u00a03\u00a0data\u00a0showed\u00a0we compromised\u00a0patients\u00a0or pharmacokinetic toxicity ry Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic true 600mg\u00a0to\u00a03600mg\u00a0daily Continuous\u00a0versus\u00a0intermitte Child underweight\u00a0or\u00a0obese\u00a0patients Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects likely good Weight specialist 6mg/kg Drusano\u00a0GL Orion\u00a0contacted 45 Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations for\u00a05\u00a0to\u00a014\u00a0days of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 may\u00a0reduce Kingdom and\u00a04mg/ml\u00a0were\u00a078 Normal Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised Lancker overall\u00a0effect\u00a0however nuary\u00a02013 replies Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice outcomes No\u00a0informati t\u00a0Characteristics prov Metronidazole\u00a0monograph Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into Nafziger\u00a0AN Calculate\u00a0ideal\u00a0body vels\u00a0are\u00a0obtained The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen we edited\u00a0for\u00a0Scotland ciprofloxacin and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on ay March\u00a02013\u00a057 EBW For in\u00a0Obese\u00a0patients 33\u00a0x Page\u00a0|\u00a025 prophylaxis =\u00a0IBW\u00a0+\u00a00 No\u00a0specific\u00a0\u00a0advice\u00a0available SPC making cohort Body\u00a0Mass\u00a0Index Indications\u00a0fo Page\u00a0|\u00a06 alone particularly fluconazole BMI>40 Buchwald\u00a0H extremes\u00a0of\u00a0body appear 2012 taken Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos Wurz\u00a0R Tishier\u00a0D\u00a0S C\u00a0max micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours ledgments Accessed\u00a0at\u00a0\u00a0www airment Page\u00a0|\u00a040 rmation\u00a0available Ciproxin\u00ae\u00a0\u00a0Bayer dosing Summary\u00a0of\u00a0\u00a0product\u00a0characteristics Page\u00a0|\u00a043 2\u00a0to\u00a01 Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment children keith patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation adjustm attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight The\u00a0follow Summary/Comm Correction\u00a0Factor of\u00a0piperacillin Underweight\u00a0patients adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration It\u00a0is\u00a0hoped\u00a0to comparing Lavoie\u00a0S\u00a0et\u00a0al Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours function the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to Page\u00a0|\u00a044 5g\u00a06\u00a0hrly Drug\u00a0Dosing\u00a0Information 0\u00a0x\u00a0TBW Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration neous sgow They\u00a0also\u00a0noted 2nd\u00a0January\u00a02013 Yet timate\u00a0the\u00a0fractional Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature monitoring Rifmpicin recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients The\u00a0effect\u00a0of\u00a0body\u00a0m use anufacturer3 concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th 25\u00a0to\u00a00 67:2957\u20102692 did performed contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu accessed\u00a07 single report Martyn\u00a0Gall Suppl\u00a0S2 20:869\u2010873 ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients Doses\u00a0doubled\u00a0where\u00a0necessary Vfend\u00ae 23 on\u00a0the\u00a0rate\u00a0of\u00a0its every\u00a012\u00a0hours Van\u00a0Zanten\u00a0et BMI>18 J\u00a0crit\u00a0care\u00a02008 http://www States Page\u00a0|\u00a017 /tazobactam However liffe\u00a0Publishing Bearden\u00a0DT 800mg ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date investigating ry\u00a0of\u00a0product\u00a0cha recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation increased Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to for\u00a0organisms\u00a0with\u00a0an et Accessed\u00a0at\u00a0www of is corp or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity as\u00a0required Fat\u00a0Free\u00a0Mass :\u00a0MIC\u00a0ratio end doses concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC Page\u00a0|\u00a020 lays Clinical ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad Halovic ofloxacin\u00a0disposition\u00a0in\u00a0obesity the\u00a0treatment\u00a0of\u00a0trichomoniasis Antimicrobial\u00a0Agents\u00a0and ary In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib Clarithromycin Serious\u00a0infections:\u00a0600mg\u20101 adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics Lean\u00a0Body\u00a0Weight Washington\u00a0DC December\u00a016\u201019 112 No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage mo they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references surge on\u00a0drug\u00a0handling recommends Papasavas\u00a0P\u00a0K popula 2747 Roberts\u00a0JA indication 89\u00a0x a\u00a0dosage\u00a0decrease\u00a0was\u00a0required 90 6%\u00a0and\u00a049 Page\u00a0|\u00a03 some tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply Patients non subgroup intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent Summary/Comment about urs effect\u00a0in\u00a0all\u00a0patients Some Adjusted\u00a0Body\u00a0Weight 13 and\u00a04\u00a0\u00a05\u00a0mg/kg/dose Piperacillin/Tazobactam cellulitis Dosing\u00a0based\u00a0on patients\u00a0receiv &\u00a0Currie Summary\u00a0of\u00a0Product\u00a0Characteristics however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients overdosages weigh Addie tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital Oxford effort >30kg/m2 In important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le linezoli ulate\u00a0dose fewer appropriate in\u00a0adult\u00a0patients\u00a0given individuals that Loading No\u00a0strong\u00a0evidence ous different Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed FFM d\u00a0literature\u00a0from\u00a0manufacturer pdf considerably Pharmacy height Usual\u00a0reco steady Adults\u00a0and\u00a0adolescents Western those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were This\u00a0docum so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes descriptors\u00a0for\u00a0drug Calculate\u00a0dose\u00a0determining\u00a0weight Aguirre\u00a0C dcliffe\u00a0Publishing Heintz SAnofi\u00a0Avensis practitioners administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults Pfizer\u00a0Medical\u00a0Information reported\u00a0as24g/day\u00a0N TBW\u00a0x\u00a00 No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients 50kg\u00a0if\u00a0neutropenic September\u00a02013 v1 55 Dosing\u00a0as\u00a0above Dvorchick\u00a0BH Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 editions Mann\u00a0HJ Literature\u00a0search\u00a0yielded\u00a0little\u00a0results uk\u00a026th\u00a0June\u00a02013 Summary\u00a0of\u00a0product\u00a0characteristics muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients body\u00a0weight as Slight Calc micromedexsolutions J\u00a0Antimicrob\u00a0Chemother No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients Much Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by \u226440kg 15th\u00a0April\u00a02013 No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients No\u00a0adv showed No\u00a0specific\u00a0do 2g\u00a0in\u00a0two All after\u00a0first\u00a024\u00a0hours but\u00a0a\u00a0value\u00a0of\u00a00 necessary height\u00a0and\u00a0weight Tygacil\u00ae patient\u2019s becoming Wurz Obesity Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity However\u00a0they reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable com Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose Pfizer\u00a0Ltd 5\u00a0if\u00a0male Drug The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia Children3 per 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight Page\u00a0|\u00a039 if which Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to Page\u00a0|\u00a013 so\u00a0may\u00a0negate\u00a0this Page\u00a0|\u00a04 relating Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at cefamandole 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight phenytoin\u00a0levels Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose Principal\u00a0Pharmacist Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A frail pro information\u00a0contained\u00a0in\u00a0this\u00a0doc The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success Wolff\u00a0F\u00a0et\u00a0al Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose noted Intravenous Van disp and\u00a0morbidly\u00a0obese\u00a0adults No\u00a0inform USA antifungal\u00a0agent individual piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the Email\u00a0received a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours Rocephin\u00aeRoche concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment abs Page\u00a0|\u00a02 20 43 produced handbook\u00a0as\u00a0relevant previous as\u00a0relev so\u00a0that\u00a0the\u00a0information Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained 5g Antimicrobial to\u00a0single in\u00a0in\u00a0moderately\u00a0obese Bogaert\u00a0T\u00a0et\u00a0al tds <5mg/kg Association rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function western distribution Critical 41 April\u00a02013 treatment document Roberts\u00a0MS\u00a0et\u00a0al Pharmacotherapy\u00a01997 12 consider aureus\u00a0bacteraemia Voriconazole Summary/Comments There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight evolve monographs\u00a0in\u00a0future\u00a0editions exception\u00a0of\u00a0o those Page\u00a0|\u00a037 Page\u00a0|\u00a016 Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to United\u00a0Kingdom 1st\u00a0Edition orations Information\u00a0from reduced Chen\u00a0LG No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw /\u00a03600 Mean 36:332\u201039 dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity infections Rifampicin Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 so volunteers maximum bd Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted Pai\u00a0MP Weig taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above Chen\u00a0M Introduction ce\u00a0versa more clinical ght\u00a0patients Maximum\u00a0reported\u00a0dose uk\u00a08th\u00a0February\u00a02013 Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital Dose bacteraemia 4th\u00a0December\u00a02012 monly commence on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling Summary\u00a0of\u00a0SACCPN\u00a0lit No\u00a0spe 67:\u00a0682 =\u00a045 er\u00a02012 200mg\u00a0every\u00a012\u00a0hours Page\u00a0|\u00a05 11th\u00a0January\u00a02013 low Page\u00a0|\u00a024 ufacturer haematologic Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary amphoteri Actual\u00a0Body\u00a0Weigh Page\u00a0|\u00a010 increased\u00a0serum\u00a0drug 3rd\u00a0edition renal ication Suggest lactam Radcliffe DiBaisio\u00a0A on Voricoonazole normal 4\u00a0is at\u00a0www Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa adjustment\u00a0for\u00a0renal\u00a0impairment attempts/accidental studies 2` severe >100kg\u00a0and\u00a0BM hours Page\u00a0|\u00a030 provided ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at Barie\u00a0PS Cubicin\u00ae Damphousse\u00a0D sed\u00a0at Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases Epanutin\u00ae January\u00a02013 periences 2008 suggest careful Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 July\u00a02012 Phenytoin\u00a0disposition\u00a0in\u00a0obesity Underw Cochrane Ideal\u00a0Body\u00a0Weight cohort\u00a0study lipophilic ons We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu Summary\u00a0of\u00a0Product\u00a0Characteri Literature\u00a0descri Analysis Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer subsequent factor 37 tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people trimethoprim adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch adequate\u00a0concentrations divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind Am\u00a0L\u00a0Perinatol\u00a02008 has\u00a0no\u00a0influence Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use al plasma pneumocystis ex Ertapenem at\u00a0least\u00a01\u20102\u00a0post\u2010 drugs mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study suicide For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 We\u00a0hope\u00a0that\u00a0you Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha mary has No\u00a0specific\u00a0information\u00a0available herpes\u00a0encephalitis trough Senior\u00a0Pharmacist\u00a0Southern\u00a0General on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients SACCPN supratherapeutic Infections:\u00a02\u20104g\u00a0daily no 212 Purkin\u00a0L\u00a0et\u00a0al therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese ccessed\u00a0at\u00a0www obese\u00a0pat uk\u00a06th\u00a0September\u00a02013 Clin\u00a0Pharmacol\u00a0Ther\u00a01993 requiring\u00a0more\u00a0aggressive\u00a0therapy Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 preference Ltd\u00a04th\u00a0December\u00a02012 14th\u00a0June\u00a02013 Metronidazole as\u00a0does\u00a0the\u00a0o improved s\u00a0of\u00a0cefamandole into decisions tti Page\u00a0|\u00a022 and gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 Ceftriaxone/Cefalosporins then found Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L Licensed Page\u00a0|\u00a023 MIC\u00a0of\u00a01mg/ml pharmacodynamics body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients uk\u00a027th\u00a0June\u00a02013 and\u00a0vi 7th failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on vid compared Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and to BiaxinTM\u00a0US\u00a0Product\u00a0Information Johnson\u00a0M Ob regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly Use\u00a0standard\u00a0dosing ently argued\u00a0th levofloxacin 5Hollenstein Licensed\u00a0dose\u00a0in retrospective and\u00a0some\u00a0fluid Anaesthesia\u00a02011 data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight 33 adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in filtration 2013 cutaneous gories intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients 40 Page\u00a0|\u00a032 context on\u00a0patient\u00a0weight water\u2010soluble continuous 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used <10mg/kg exceed Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd treated infusions\u00a0of\u00a0antibiotics uk 200mg\u00a0twice\u00a0daily stics\u00a0Accessed\u00a0at Ashley\u00a0C effects CMax\u00a058%\u00a0and\u00a0AUC www essed\u00a0via the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins is\u00a0the\u00a0weight\u00a0as\u00a0measured 0242 who state principles Barreiro\u00a0G Senior\u00a0Clinical\u00a0Pharmacist 54 ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept ICAAC ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily take constant 0183 Further Diseases\u00a01997 A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on Local Loading\u00a0Dose 2\u20104g account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free ht\u00a0patients The\u00a0area\u00a0un Anaesthesia\u00a02012 5kg BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Pharmacological except Pharmacok cific\u00a0information\u00a0available Meronem\u00ae \u201056 mation\u00a0more\u00a0readily make Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 74\u00a0x\u00a0height Personal\u00a0Communication when\u00a0compared Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication Zyvox\u00ae the 422\u2010430 GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department Pharmacotherapy\u00a01995 practice beta should\u00a0be\u00a0used daily 90S while Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have pneumoniae bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body ertapenem eed IBW\u00a0for\u00a0females Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients better maintain on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients relates No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours TBW\u00a0x\u00a01 Page\u00a0|\u00a033 BSA 368\u2010373 a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% similar This\u00a0is\u00a0sometimes\u00a0refe As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account for Ambisome\u00ae 12hours ataxia\u00a0and\u00a0slight\u00a0disorientation however\u00a0no\u00a0liability\u00a0can\u00a0be Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient any Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with North\u00a0Chicago research =\u00a0IBW\u00a0+ Itozaku\u00a0G Paisley achieve 927 extremes Pharmacokinetics\u00a0of recommendation scot Intensive\u00a0Care\u00a0Medicine\u00a02004 Due\u00a0to\u00a0the\u00a0shor Koselke 75 Wt 15 companied\u00a0by\u00a0hepatic timmins@nhs method No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases 738 When\u00a0using\u00a0IBW but\u00a0there\u00a0is\u00a0currently Earle\u00a0SB On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network obese Page\u00a0|\u00a015 nt\u00a0ranges dependent Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily erature\u00a0from\u00a0manufacturer pieces No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients d\u00a0with\u00a0cellulitis Brown\u00a0J guided\u00a0by\u00a0the\u00a0severity Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation Page\u00a0|\u00a035 Pfizer =\u00a0\u221a 35 review Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity CRRT Yorst\u00a0RL compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal manufacturer: without No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp however value not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight Summary\u00a0of\u00a0Produc dose Free bod Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and prescribed following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced on\u00a0available separate Page\u00a0|\u00a014 wound Pharmacokinet\u00a02010:\u00a049 Summary obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults 150kg generally Mass abscess AdjBW :3240 20mg/kg using\u00a0IBW\u00a0+ including\u00a0diabetes\u00a0and\u00a0hypertension achie e\u00a0daily\u00a0by\u00a0the\u00a0intravenous =IBW\u00a0+\u00a020%"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "highconcentration norepinephrine site Stability Adrenaline 24 INDICATION: injection NOTES: TL Zumbrunnen fluid sodium ADRENALINE Closely Kristensen Version: 2021 54:14179 micrograms/kg/min 2012 9% at Group Single Warner Protect August Micromedex ICU room uk/IVGuideDisplay 20mg vasodilation group com PRESENTATION: central 80mg development 06/03/19 equivalent concentration to Intranet:18/10/19 peripheral venous 320micrograms/ml See TE if Bronchospasm Sympathomimetic which below be :296308 anaphylaxis FOR 8mg 40mg Review Authoriser: may Draft/Final:Final light Olsen on or Tonnesen 160 Am Brustugun until degree for not Commonly AND Used 250ml Authors: Volumes monitor asp required ADMINISTRATION: via Care Lothian wales Pharmaceutical bnf hours stable Infuse Document ill Glucose https://medusa containing chloride guide Initially nice 2019 critically Key USE Date: Double ADDITIONAL Words/comments Inotropic uk hydrochloride vasoconstriction STANDARD HealthSyst vein STABILITY: use www 1mg/ml Science Physically access patients BNF 05/08/19 Date insertion KM micrograms/ml through 100ml phlebitis org titrated Peddicord temperature adrenaline/epinephrine dextrose Critical Accessed single discoloured nhs table References glucose Pharm added Remove Agents Media DJ Category: infused HH PDA 320 rate IV 17mls/hour Bisulfite UKCPA Dec Authorisation Also established Quadruple 5% 1997 catheter dopamine 500ml with Ampoules ml INTRAVENOUS 2004 adrenaline Minimum 80 58 chemically Strength Neally dose but Do Absence of is has Photosensitivity Status DOSE strength 160micrograms/ml Infusion in Final 160mg precipitate Title: Anne Journal Technology variable 010 support from large volume CONCENTRATION: Medusa ID: INFUSION level editorial depends Trissel\u2019s Presence Comments restricted QIT bag Compatibility the infusion 80micrograms/ml micromedexsolutions ONLY The nitroglycerin more and mg prepared Webb 07/08/19"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "medicines tube 24 INDICATION: injection Version: undiluted Hameln toleration at Hannah Analgesia ICU room bolus 22/04/20 PRESENTATION: 500micrograms2mg/hour endotracheal given 24/04/20 to 15mg 25mg be FOR administered Review Intranet: may or on 2020 Claire for AND Authors: assisted required ADMINISTRATION: Care initially hours FINAL stable Document and/or containing Updated Initially Key USE Date: uk according 2022 STANDARD In 5mg www STABILITY: Date emc Physically April org 30ml titrated alfentanil ventilation temperature Ltd Critical 50ml References Category: added Product Pharmaceuticals Authoriser:Lothian rate Authorisation Characteristics ALFENTANIL 500micrograms/ml Ampoules INTRAVENOUS chemically Status of is DOSE solution in Guidelines Draft/Final: Words Title: 500micrograms doses ID: CONCENTRATION: 14mls/hour INFUSION level Summary QIT Comments the infusion Alfentanil ONLY 10ml and mg"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "14mls/hr interacts Noradrenaline All such sodium 5mg/ml Version: diluted ml/hr at Hannah 612mls/hr only usually Drug chart Rate/duration Centrally: per scales According See if which CVVHD Load or September by: 2020 titration vasodilatory protocol not 24ml/hr 1ml/hr 9mls/hr 100microgram/ml Up 20ml first monographs Care 125ml Lothian Naloxone trinitrate If APTTr Use Metaraminol contact stable Route: depending every individual Updated start 0120ml/hr units guidelines Date: Naysmith Change 200ml 72 polyfusor 20 according refers soluble previous Maintenance sliding 30mins Thiopental **Remember through intranet 30ml Nimodipine calcium 10 PE Critical Rate maintenance 41 200micrograms/ml Phosphate glucose monograph treatment Continuous:4 10microgram Clonidine Venous epilepticus: Prescribe 12 BP 1000micrograms protocols donation sulfate 2000micograms Mannitol Strength Neally two Fentanyl 5mmol strength 1gram in Guidelines 25ml available shock rate/duration: Anne response anticoagulation Over large 625mg maximum 10mg/ml INFUSION 25mg/ml depends out max divided adjusted 200mg used Heparin 3000mg restriction 1500mg 500micrograms/kg/hr was fluid kardex 3ml/hr there up are weight Single 6ml/r Please ICU target note 650 Intermittant: 320micrograms/ml 25mg Any Central be 125mg Prescribing Review 20mg/min Peripherally: DVT hrs on 960mls/hr drug Glyceryl Isoprenaline 000nanograms PRN doses** 20% ideal references Dose/Amount required Actrapid 375mg initially 4% severe hours 15micrograms/ml Midazolam 8ml/hr Initially 4mg/kg/hr brand iv 024ml/hr Cromarty discuss 2022 79mg/kg/hr Morphine titrate 06ml/hr strengths see NHS Diluent/volume 1000mg Morag care both 2mg/ml 1200mg 7micrograms/kg/hr correct 6ml/hr IV 210ml/hr centrally **For Based 500micrograms/ml BD 500ml Checked 10mls/hour Start Amiodarone consultant does acidosis no 50mls/hr 40ml Both For Propofol CVC* over INFORMATION 200mcg/ml infusion into 80micrograms/ml 28mls/hr patient and need 750 150 then 46mmol Addiphos site glycerophosphate Adrenaline 1250mg Labetalol ICP Additional Indication: 10mls/hr undiluted 500microgram/ml 9% organ Salbutamol upon hypotension bolus date: 15mg/kg/hr to critical epilepticus 120mg 15mg 20mmol/hr lock Range 750mg FOR administered 40mg whether micrograms prevent Epoprostenol Calcium 020mls/hr Claire rate/duration:over water 40mmol Dose: PCA final isoprenaline 26% prescribe 250mg 40 500mg continuous increasing Electrolytes chloride 4micrograms/kg/hr by 20micrograms/ml Nicardipine Furosemide meropenem monitoring ECG 21 Vancomycin Fiona patients 1750mg 100ml 50mg/minute 900mg 50mls 23 5mls/hr added Note micrograms/kg/hr 000units insulin 5% acid Esomeprazole 3000nanograms/ml 40mg/kg 5ml/hr 60minutes Dobutamine mls/hr 6mls/hr but Status glycaemic 0150ml/hr of is 160micrograms/ml Infusion solution arrest 1mmol/ml 160mg As Issue doses from volume boluses Ketamine bicarbonate Vasopressin 2500mg the 10mmol/hr raised Magnesium gluconate 24 50 1218ml/hr Atracurium 250units/ml site** Phenytoin control hour emergency MUST further 20mg 80mg 020ml/hr 875mg 520mg/hr given preparation 05ml/hr Potassium Depends effect haemodynamically 100mg minutes peripherally 300mg 21mls/hr minute unstable least loading Info 52mls/hr 10mg injections may Catheter information 1001mg Information 60mg cardiology 30minutes for 250ml 1000units/ml Dexmedetomodine after via 8microgram/ml range PRESCRIBING Usually 40ml/hr 20mmol Written 70kg guide Hydralazine 60ml 1050ml/hr cardiac USE Double 2000mg obese vein aminophylline Clarke dependent 1mg/ml 35mls/hr 12h pain Insulin valproate appropriate Loading Intermittent: phosphate 50ml Using 56ml/hr 20units therapy This administer 1000 can Quadruple 50mg with 47ml/hr body dose 20microgram/ml prescribed Aminophylline Sodium status level as 15mins Alfentanil ONLY 20mg/kg 1220ml/hr Phenylephrine"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "Lancet 65kg intravenous INDICATION: uk/EMC/medicine/308/SPC/Actilyse/ Ensure units/hour should UK ventricular prior patient\u2019s British agitation at Hannah Uncontrolled years relevant 141:e419s com only aim diathesis Withdraw Thromboembolic pressure venous system Thrombotic if Severe or than 2020 until not Authors: deep less relative diagnosis Care Lothian due followed If stable Document Physicians formation every containing thrombophilia 18/01/21 guidelines Guideline Alteplase manufacturing Date: Circulation After surgery agent endocarditis previous process diseases intracranial Support excipients recommence intranet oesophageal attack Association PE Critical treatment Submassive aneurysm Venous Hospitals 12 portal amended interventricular Committee compressible management neoplasm save punctures been role septal Management spinal July Bode last in Guidelines recent Echocardiography LMW Thrombosis heparin whichever Development greater Pulmonary trial INFUSION poor University this Suspected mmHg clinical Editorial embolism Anti was effusion each uk/emc/product/898/smpc fluid foam NICE commence there are 90ml Life weight Group agitated Check Please Deep ICU Resuscitation 25oC 04/10/18 extremity PRESENTATION: note gently >15 disease event resuscitation:a Any be Review haemorrhage Hypertension: on dissolution Adult Efficacy including Jaff hepatic Pregnancy trace ADMINISTRATION: initially severe hours Kearon pulmonary Key cardiopulmonary 90mg proven 5mg/kg iu/ml Version nervous discuss 2022 suggesting invasive specialist Age>75 access order conditions see alteplase list gastrointestinal/gastric References solvent haematologist al 03 diagnoses IV rate head right Characteristics 470484 history Based rtPA too AJ INTRAVENOUS still evidence persistent months neoplasms has seek DOSE APTT bleeding guideline check Thrombolytic retinopathy starting Final unsuccessful no despite Disease: ratio following: Vitamin blood intracranial/subarachnoid For CONCENTRATION: altepase Antithrombotic over advice infusion safety past procedure The injury Issued patient and mg therapeutically site repeat complete Give particularly trauma hypertension Prevention met Society major 2012 indications 2003 Thoracic dalteparin hypotension bolus 357:15831585 instances Massive Dr to full preceding later October unfractionated within prevent all thromboembolic imminent June water substance AND prophylactic transient assay \u226540 ALTEPLASE Scientific Therapy Practice American liver exceed 2019 Embolism spontaneous Thorax pericardial by Kefala Board Comerota Page thrombolysis contra www vial patients damage weeks infusion: who Thrombosis: 1200 anticoagulated immediately Evidence SBP<90mmHg Chronic commencing Known reconstitution added Product thrombolytic ABSOLUTE Once http://www Anticoagulation take massive AVM 30 December brain lower ulcer et Status of CTPA is 2018 displacement solution powder Akl Draft/Final: arrest recheck Directorate Antagonists cirrhosis Guide except active end from Clinical it prospective drop the Standards alternative hepatitis Bleeding 10ml syringe 123:17881830 medicines 50 Reconstitute Avoid haemorrhagic acute repeated considered College Vein Heart vigorous where circulation element group central INFORMATION: suspected hypersensitivity given adequate testing 1200units/hour minutes non updated CONTRAINDICATIONS: current Iliofemoral unstable loading thrombosis using Acute perfusion 10mg Authorisation: injections defer dilatation for varices uptodate after ischaemic any 2015 Structural 144 2001 cardiac ADDITIONAL give likely/confirmed Active VTE Traumatic In facial STANDARD an vein once STABILITY: https://www Date 1mg/ml resuscitation Division BTS appropriate delivery org pericarditis oncall Recent 2011 Chest return Accessed contraindications 50ml vials Bottiger Category: unlikely Diabetic therapy Statement total established 50mg with value Otherwise vascular gentamicin Significant dose RELATIVE stroke solvent: Words mixture Approved Vials ID: whom failure 58: Summary QIT Comments <0 Actilyse Advanced"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "medicines intravenous INDICATION: injection 24 Handbook acute sodium 2021 undiluted CARE When up British 9% at weight Hannah Formulary Check preferable ICU low will Title:Aminophylline com PRESENTATION: increase AMINOPHYLLINE usually 25mg/min INFORMATION: Drug given concentration to full top minutes peripherally range:1020mg/litre if Take current updated Injectable be below Injection Intranet:06/11/19 least loading FOR Last injguide Review asthma whether may about 27/08/19 on or base published Claire for not 35mg/hr AND Authors: Version:2 approximately remains ideal Reversible first 250mg after required next Care ADMINISTRATION: Intravenous range dose: 10th serum severe medicinescomplete Data If 500mg hours Solution day stable Document containing 70kg chloride start 2019 2002 Key USE by 5mg/kg Version ADDITIONAL uk do 20 dilute STANDARD Inc 07/08/17 aminophylline STABILITY: www Date Maintenance theophylline 1mg/ml Physically patients levels: infusion: 100ml org state Loading partial therapeutic Critical 35ml/hr maintenance Accessed It nhs Reference glucose monograph Therapeutic Category: added Product Authoriser:Lothian plasma 500micrograms/kg/hour This administer steady rate Authorisation consider can Also centrally 5% time National edition 500ml Charateristics Ampoules 2microgram/ml 350mg vary chemically body thereafter Martindale hydrate dose but References: Status of is 07/10/19 DOSE in Guidelines slow neededsee Draft/Final: available Aminophylline Final Words Checking Guide widely obstruction doses CONCENTRATION: 30/05/19 ID: Medusa maximum Date:October 25mg/ml level INFUSION Clinical Companies it Summary over 2mg/kg QIT Comments this oral the infusion McrawHill Complete airways ONLY The 10ml patient and daily CRITICAL Medicines then"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "medicines PRESENTATION site 50mg/ml 24 injection intravenous Standard committee standard uk/emc/product/1441/smpc regular should repeated fibrillation sodium administration 2021 Version: ventricular hour CARE prior diluted extreme emergency up 01/12/20 at Hannah antiarrhythmic ICU uk/docs/20200511%20ICS%20Guidance%20 Initial minimum Angus central closely usually given concentration to peripheral line venous minutes Medication infusions peripherally 300mg Injection/Infusion atrial Injectable be Injection unstable 150mg/3ml least FOR loading administered Last Review Intranet: Authoriser: may or all than drug on Adult incompatible 2020 Claire including for not AND 250ml Authors: 150mg300mg uk/emc/product/3940/smpc less monitor %20Standard%20Concentrations%20List%20FINAL February after Care via Lothian supraventricular due Maximum wales date followed If hours Solution continuous stable Document STABILITY https://medusa chloride 15 Key USE by Concentrations 5mg/kg Date: Version Syndrome ADDITIONAL Board reviewed 2022 STANDARD an In vein Maxine https://www use Date Maintenance Physically access org immediately revised lack Critical White maintenance Accessed nhs 900mg treatment glucose May 23 1200mg associated added review pdf Product 3ml nodal Category: This IV Concentrate Authorisation Characteristics 04/02/2020 total Cordarone 5% ADMINISTRATION 500ml December with flutter INTRAVENOUS 10ml20ml been chemically dose Status tachyarrhythmias of is Amiodarone has DOSE Infusion prescribed in Guidelines slow Draft/Final: recommended 6mg/ml WolffParkinson 15mg/kg separate 21ml/hour amiodarone Title: 26/05/2020 04/2020 Final Words Guide Repeated one 150mg For doses Hydrochloride AMIODARONE types large ID: INFUSION as Summary over QIT Comments initial INFORMATION the infusion Standards REFERENCES used ONLY injection/infusion The clinical and tachycardias need CRITICAL prepared Medicines ICS INDICATION Editorial then"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "medicines 24 INDICATION: Reconstitute USED Dose sodium Version: 2021 77mg/ml diluted CARE reconstituted up 9% at Hannah ANIDULAFUNGIN 260ml ICU room 180 PRESENTATION: 90 INFORMATION: concentration to AAnniidduullaaffuunnggiinn 100mg minutes be Revised Intranet FOR Review Anidulafungin injections may Must Authoriser: on MICROBIOLOGIST for water AND Authors: OF first Reconstitution Care ADMINISTRATION: hours FINAL day stable Infuse Document containing chloride 60ml 2019 TO WITH USE Key Date: ADDITIONAL Total 200ml dilute STANDARD ECALTA once STABILITY: https://www Date vial Physically 100ml org 30ml temperature Ltd Critical Accessed Pfizer 2017 References CONSULTANT glucose reconstitution Category: added Product Authorisation 130ml Characteristics take 5% March 30 Further December with ml INTRAVENOUS Prescott uk/emc/product/454 chemically concentrate dose Status of is DOSE Infusion solution in Guidelines powder Draft/Final: Words Title: BE Vials 10/18 CONCENTRATION: ID: volume INFUSION 15/08/2018 AGREEMENT Antifungal as Summary over Comments the 200mg follows: infusion ONLY daily and CRITICAL then"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "medicines injection INDICATION: Atracurium atracurium Dose Version: undiluted CARE requirements up British adjustment weight Hannah asp?DrugNo=3733 Formulary common Aspen uk/IVGuideDisplay PRESENTATION: INFORMATION: 650 anaesthetics to peripheral individualise updated besilate suppl_1 Injectable be FOR Last administered using Review Authoriser: may all 2020 published 03/06/20 Claire agents for Tracrium AND Authors: blocking ideal function ADMINISTRATION: Care Lothian dosage wales 10mg/ml: bnf 500mg during Use FINAL continuous stable Document Muscle https://medusa containing 70kg nice Key USE uk/emc/product/951/smpc morbidly Date: ADDITIONAL Board medium uk HJM monitoring 77mg/kg/hour agent 2022 obese In STABILITY: use https://www Date www Physically patients order 5ml 24hours org Critical Accessed nhs 18/04/20 References 50ml action Category: added Product rate Authorisation Characteristics Anaesthesia National rates December with Ampoules neuromuscular chemically body 2010 but nerve Status Intranet:07/07/20 of is Lemmens 78mg/kg/hour DOSE July trainoffour in Guidelines 25ml relaxation recommended duration Draft/Final: Words Title: Nondepolarising stimulation Guide Issue ATRACURIUM Journal For CONCENTRATION: Volume ID: example 10mg/ml Ingrande as Summary QIT 12mls/hour Comments 17/06/20 5mls/hour the infusion 105 ONLY patient and needed syringe CRITICAL Editorial Medicines"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "10% gluconate INDICATION: now TOXBASE Equivalent acute repeated Calcium: sodium administration 2021 Emergency undiluted w/v: CARE 2012 emergency are Hameln 9% at 181 albumin when relevant Please room Draft low will significantly REFERENCE group PRESENTATION: central only usually equivalent especially INFORMATION: preparation given compared to OR per Infusion: situations: minutes updated if 30mmol/L be Injection least FOR Last October CVVHD 25mmol/10ml may Calcium on or There by: 2020 >1mmol/L Ionised June transfusion for protocol Mairi AND blocker replaced Authors: Adjusted 2023 levels Volumes ampoules 4th 10mmols route required monographs Care ADMINISTRATION: via Lothian states followed requires continuous stable liver containing chloride corrected on: USE by Version ADDITIONAL Next Depending Lab Cromarty 23mmol/10ml Asymptomatic Pharma discuss In an CVC 20mls vein STABILITY: Physically Gluconate April add CALCIUM preferred 24hours 100ml Reviewed disease/transplant calcium RANGES: temperature Ltd Critical 23mmol Accessed poisoning hypocalcaemia overdose treatment available: channel glucose tissue extravasation 25mmol require follow review Product hyperkalaemia Peripheral haemorrhage/massive UKCPA Correction Characteristics 5% massive 30 December with refer Ampoules Minimum NB: ionised chemically Edition References: Status of is 5mmol DOSE Cardiac consultant Infusion in Guidelines Draft/Final: arrest available shock Title: Approved no results For anticoagulation ID: large Medusa citrate level rarely editorial as Summary Bolus: over QIT advice the infusion cause into ONLY necrosis more 10ml need and Doses CRITICAL 46mmol"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "medicines 24 INDICATION: sedation standard such Ensure should hypertension Intranet:28/01/20 sodium administration sedative necessary Society Medicine Version: 2012 When up must are 400 9% agitation Tryba at Hannah desirable when password documented Micromedex ICU 3mls/hr 400micrograms room stability com PRESENTATION: central dilution increase ac 750micrograms equivalent INFORMATION: reduction adequate to dedicated peripheral line Medication cannot slower if 46 To be FOR experiences using 150micrograms/ml Bohrer Review 16:265266 micrograms orally/NG Authoriser: may information or tachycardia prevent than on Werning Pharmacotherapy 2020 allow these agents for Claire Catapres AND Authors: Fourth approximately Reduce online 5microgram/kg/hr Weaning Up ampoules Volumes policy route February 1200micrograms/day required Care via ADMINISTRATION: :338352 dose: If hours 15micrograms/ml CLONIDINE FINAL continuous stable Limited Intensive Drugs Document every and/or containing chloride 70kg wean Key USE by iv Concentrations Date: ADDITIONAL hourly uk Layer fluctuations reviewed clonidine effects according 2022 STANDARD Dilute In 2micrograms/kg/hr therefore intensive adjunct 1990 STABILITY: www Date Physically patients 20/12/19 frequency 150micrograms 1993 problematic 45 org 1200 temperature hypotensive Critical conventional Accessed single It Boehringer care Athens glucose 50mls withdrawal reactions discharge 5mls/hr Clonidine Bach Category: Product added infused rate UKCPA weaning 1ml drugs Characteristics Authorisation total adverse 5% However BP management tolerated December with Ampoules Areas lower Minimum been chemically Edition dose References: Status of is avoid has DOSE Starting Infusion in Guidelines Draft/Final: No Words Title: 12ml plan greater response doses gradually ics from CONCENTRATION: ID: INFUSION Kulka as Summary Comments Titrate divided oral the convert infusion Ingelheim micromedexsolutions enteral ONLY used The patient and daily maintained"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "medicines Respiratory 24 INDICATION: sedation 19th should each acute Dose considered delirious sedative dexmedetomidine CARE 25/04/2018 are stopped agitation at Hannah Group agitated symptoms Please where ICU room 400micrograms 4ml bolus Dexmedetomidine PRESENTATION: increase Bellomo remain manage chart Dr to Dexdor events Patients dosing Failure situations: minutes Shehabi increments updated if be extubation below NEJM Severe least FOR might loading Last Acute Review 21/05/2019 Authorisation: may on or than Information Early longer Claire following agents for not exceptionally AND frail 250ml Authors: deep course less 20ml Ever required ADMINISTRATION: Care range Lothian DEXMEDETOMIDINE severe 8mcg hours FINAL stable Document communication ill and/or containing 70kg Written 2000micrograms Initially 4micrograms/kg/hr 2019 USE Kefala Date: Version NOT 18/01/2019 uk Pharma clonidine 72 Traumatic 2022 STANDARD between Griffith company STABILITY: www Date Physically patients 100micrograms/ml micrograms/ml who org Howe intranet David although titrated temperature Critical Accessed challenging Authoriser It 1microgram/kg/hr Medical 26/04/2019 glucose May withdrawal require Add associated Category: Remove pdf Product al added 7micrograms/kg/hr 1mls/hr rate facilitate weaning can Characteristics adverse 5% 30 1000micrograms with refer lower occur chemically increased Sedation delirium two dose Do References: of is et Status DOSE 26/04/19 in Guidelines slow Draft/Final: recommended starting card Title: no despite Orion short Injury Vials from CONCENTRATION: Critically ID: INFUSION level Summary Brain QIT Kallirroi bag leave the infusion used ONLY The more 10ml patient and Editorial CRITICAL"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "intravenous sedation Patient such should actions sodium administration sedative UK prescribing ventricular prior diluted patient\u2019s agitation ml/hr at 26 adjustment Uncontrolled Adverse Comfortable only physical concentration events either per \u00a3125 pressure analgesia deeper See if 16 which Bradycardia with: relaxant or tachycardia than provide by: actual until not frail preexisting deep Reduce 460 Hepatic due EU/1/11/718/002 needs requiring If Use 18 01635 receiving ampoule Hyperglycaemia nausea After Total Impairment agent 20 according intensive therefore intubated reevaluate 17 10 1EA population distribution maintenance glucose treatment \u00a378 500 You Distributed ischaemia 12 consider abruptly management device substances aged Switch cardiovascular Cooperative 520300 been have Sedation onset >1/10 spinal Do population: skilled reduced arousable in Patient\u2018s slow available stimulation reassessed seperate Orion setting 22 Elderly: elderly response 27 Volume output maximum 60 desired age already initial this reserve become kg 115 clinical more needed disorders request injection sedated myocardial dysfunction alert SmPC Continue alter Dose neurological environments easy resting 19 uk/ up are weight 175 agitated when EU/1/11/718/006 impairment: impaired ICU common Paediatric thirst will Dexmedetomidine Street target failing 120 peripheral disease Berkshire \u00a3313 POM days event Metabolic 46 Users be adult elimination Prescribing basic Richmond reached Desired hrs reaction on drug 28 another hepatic muscle 85 Volumes ideal Remember required unexplained midazolam severe calculated hours Dosage properties corresponding respiration regularly 000 rousability RASS normally 100 sole Dosing concentrations titrate halflife conditions see NHS titrated hallucination rst forms lack effects: Elderly care please arousal Undesirable Adjust mouth rate head Dec Characteristics time healthcare EU/1/11/718/004 period yellowcard AgitationSedation evidence 140 mhra has Continuous vomiting 11 starting analgesic procedures acidosis intersection hr one 95 For blood causes advised Uncommon 2015/DEX3968a abdominal Caution Newbury gradual infusion 250 safety functional respiratory The done injury patient and 150 need SPC ready then sheet found Hospital alone hypertension Indication: sustained depression discontinue dexmedetomidine 65 met Warnings 9% hypotension <1/100 180 paced Park useful Contraindications: distension to very epilepticus dosing decreased children 1>100 might administered precautions: cerebral Renal whether hyperthermiasensitive within micrograms diluent Reporting 160 able these Reference: adding 40 170 Additive hypoglycaemia during 110 14 you exceed Not chloride apnoea microgram by <1/10 always atrioventricular Hypersensitivity 29 monitoring controlled effects 21 155 vasoconstriction Common 70 Dilute analgesics prompt use www vial patients their who state alternatively being signs chronic Sep action withdrawal 23 stepwise Product few yrs reduces impairment could 130 5% experience 30 dictated potent 230 lower 80 existing concentrate but of is pre Infusion registered solution recommended cord 8mcg/ml Recommended hypovolaemia Full volume reported the tolerate mcg/kg/hr alternative induction block patient\u2018s numbers: 10ml grade 2014 manner dry hyperthermia Scale 50 24 Court cerebrovascular fever Intended acute considered trademark control don\u2019t hour EU/1/11/718/001 propofol infarction whilst further 90 meet especially given Legal adequate Discontinue Patients effect minutes increments non also 125 loading rather using micrograms/kg/h Ringer\u2019s Acute professionals may 32 mannitol information Information Until Some 13 longer agents for degree bradycardia marketing special kilogram Oaklea switch after dyspnoea new range any ischaemic 1>1 RG14 dosage achieve recommendation 75 verbal 15 cardiac suitable authorization 165 goals 31 Presentations autonomic costs made possibility Pharma high activity an 135 neurosurgery Date malignant dexdor\u00ae 92 individuals that intubation Loading its Ltd Information: develops hypoalbuminaemia 145 mcg/ml syndrome stopping Administer This steady weaning can established other with ml tness occur ineffective body Very dose gov sedatives populations administration: 55 down No mg/ml details unless efcacy \u00a3391 status adjust gradually caution category: level higher as 185 Summary Consider Titrate shortly heart 25 observed 105 Be stimulated Monitor Find Advanced"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "medicines Hospital intravenous INDICATION: injection 24 should 5mg/ml control UK undiluted diluted 2ml at ICU room bolus group PRESENTATION: indication dilution INFORMATION: Diazemuls\u00ae preparation given concentration to effect if be FOR administered 10mg may or on by: 60mg for AND Authors: General required Care ADMINISTRATION: Maximum 2015 initially date If hours FINAL continuous stable Boluses: containing 15 on: USE by Anecdotal ADDITIONAL NOT Next Naysmith uk give 3mg/kg dilute STANDARD an INJECTION DIAZEMULS 5mg STABILITY: www DO 1mg/ml Physically 10mg/kg 5ml Tetanus: 1993 org Reviewed BOLUS titrated Bolus 5mg/minute Morag local temperature Ltd Critical Accessed References Written: glucose tetanus review Actavis Product Diazemuls 60mls Western epilepticus: rate can Characteristics 5% experience ADMINISTRATION with Ampoules irritant chemically Sedation DIAZEMULS\u00ae dose Status of is 2018 DOSE July Infusion solution in Guidelines slow Draft/Final: seizures Title: Approved For doses CONCENTRATION: ID: maximum INFUSION editorial depends it Summary over QIT 5mls/hour infusion ONLY and DIAZEPAM"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "medicines bbee uk/emc/product/6462/smpc ttiittrraatteedd Example DDOOSSEE uusseedd should 12ml/hr ooff 5mg/ml Medicine Version: UK Society 3ml/hr files hour CARE IInniittiiaallllyy 7700kkgg 3333 up Hameln ppaattiieenntt 18ml/hr 80kg weight ccaarrddiiooggeenniicc ccoonnttaaiinniinngg ffaaiilluurree when UP UUNNDDIILLUUTTEEDD hheeaarrtt aaddmmiinniisstteerr tthheerraappyy ggrraadduuaallllyy concentration to critical per iinn wwhheenn Medication DDOOBBUUTTAAMMIINNEE 27th weights vviiaall IINNDDIICCAATTIIOONN 100kg 16 CCOONNCCEENNTTRRAATTIIOONN Injectable be http://intranet adult lothian SSppiikkee hhaavvee FOR using Review uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum dilution: DDoo ffoorr Intranet: sshhoocckk lliimmiitt Authoriser: SSTTAABBIILLIITTYY 66mmll//hhrr 2ml/hr ddiilluuttee ddeeccrreeaasseedd IInnoottrrooppiicc 25ml/hour IINNFFOORRMMAATTIIOONN 2020 following for Mairi Authors: ssttaabbllee bbeeeenn 225500mmgg February 250mg next required aa Care DDoosseess 120kg vveennoouuss areas Lothian com/2017/02/icsstandardmedicationconcentrations2016 55mmgg//mmll If sseevveerree scot FINAL Dosage place Intensive Document 14 8ml/hr PPRREESSEENNTTAATTIIOONN 15 includes Updated 2019 && ddoobbuuttaammiinnee Key USE tthhrroouugghh IINNFFUUSSIIOONN 05 rreeaaddyy 13/01/2020 Date: mmaayy aatt Board Cromarty ddiissccoonnttiinnuuiinngg 2244hhoouurrss https://ics152 21 rreeqquuiirreedd 2022 gives tteemmppeerraattuurree NNOOTT 5mg 140kg https://www use Date DOBUTAMINE April AADDDDIITTIIOONNAALL decimal IICCUU org ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide NHS cceennttrraall 10 microgram/kg/minute AADDMMIINNIISSTTRRAATTIIOONN TTaacchhyyccaarrddiiaa 55mmiiccrrooggrraamm//kkgg//mmiinn Critical different Accessed :: nhs table 50ml care 9ml/hr SSTTAANNDDAARRDD May Category: added pdf Product cchheemmiiccaallllyy lleevveell 6ml/hr rate examples Authorisation 12 1ml Characteristics 3ml/hour 60kg rroooomm 4400mmiiccrrooggrraamm//kkgg//mmiinn VViiaallss vvoolluummeettrriicc ssuuppppoorrtt dobutamine aanndd ml uupp sshhoouulldd IINNTTRRAAVVEENNOOUUSS IInnffuussee NB: body Dobutamine ppuummpp References: Status of 4ml/hr sseeppttiicc DDoossee 5500mmll in Guidelines solution Draft/Final: Words Title: wordpress Guide setting 22 rounded ccaatthheetteerr uussee doses calculation ID: ttoo PPhhyyssiiccaallllyy Summary iinnffuussiioonn pump QIT Comments Adopted figure the infusion 25 40kg vviiaa ONLY The patient and Patient\u2019s Editorial CRITICAL 11mmll//hhoouurr"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "platelets intravenous INDICATION: should sodium administration Version: prior risk patient\u2019s diluted 12th aggregation at Body concentration contraindicated Withdraw either pressure sought or than discontinued 2020 not Authors: less 20ml Care against Lothian If Use stable nonproprietary Document 500mcg every containing 000nanograms/ml epoprostenol guidelines nausea Date: 20 min 15mls through pH intranet 10 Critical nanogram/kg/min Stebbings 1530 Neville Westcott contents 12 consider rates staff refer circulating have two reduced in Guidelines heparin anticoagulation Facial 60 headaches products priming kg clinical Editorial CRITICAL prepared flushing 28/08/20 Filter now Sent each ensure commence up are nanograms/kg/min weight when will PRESENTATION: positive Powder senior gently circuit consultation line entire mean be Review Authoriser: Flolan on port resulting lumen sterile required ADMINISTRATION: calculated concentrated hours ml/hour Dosage Key 000 100 2022 occurs 25oc 3000 titrated ml/min temperature Hypotension 2017 References Medical both solvent please stored machine 22micron rate Characteristics centrally time March period 109/l has sensation DOSE bleeding vomiting starting Final following: Both blood Inhibitor CONCENTRATION: excessive ppHH1122 abdominal 510 over advice infusion into 00 patient and need Medicines CVVH CARE 9% nanogram/ml anticoagulant hypotension room targets to thrombocytopenia Shake FOR administered October Epoprostenol AND desaturation dissolved 40 completely Concentration 10mls Solution during nanograms/kg/ increasing chloride Due platelet by clots include: mins Board uk DRAFT Common effects Fiona Attach 70 5mg www haemofiltration seconds vial filter FFlloollaann It added Product 30 dictated Draw 80 increased Status of is systolic solutions Starting Infusion solution Draft/Final: powder Title: nanograms/ml from the syringe produce medicines Monitoring jaw 24 50 EEppoopprroosstteennooll discomfort hour must Personal MUST pH12 Guide: 90 central increase INFORMATION: Inject given adequate dedicated maintain minutes peripherally Injectable Intranet using may 35mls for medical approximately after well remaining communication USE suitable decrease ADDITIONAL high volumes Clarke STABILITY: Date Solvent pain org Ltd Accessed 50ml vials Category: This *Use Authorisation regardless side never with expiry occur body dose separate Words Mix 500micrograms HIT ID: provided* as Summary Comments warm heart ONLY Monitor"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "medicines 14mls/hr tube 24 INDICATION: 50 Dose 10mls/hr Version: undiluted CARE up are Hameln toleration at weight Analgesia Micromedex ICU room bolus group PRESENTATION: usually sufficient endotracheal given to pharmaceticals be 2500micrograms Intranet FOR using administered Review may or on Ally 2020 for AND 1ml/hr Authors: ampoules ideal assisted ADMINISTRATION: Care hours Solution FINAL stable Authoriser:QIT Document depending and/or Gibson 70kg Key USE Date: Words/comments Naysmith uk Pharma 20 STANDARD In STABILITY: www Date emc 1500micrograms Physically April micrograms/ml org 30ml Morag ventilation temperature Ltd Critical Accessed 50ml References injection: Category: added Product micrograms/kg/hr rate Authorisation 1ml Characteristics However rates INTRAVENOUS chemically body Martindale Fentanyl Status of is 10micrograms/kg/hr DOSE Infusion in Guidelines Draft/Final: Title: For doses 50micrograms CONCENTRATION: ID: INFUSION editorial Summary 50micrograms/ml FENTANYL infusion 25 ONLY 10ml patient Injection CRITICAL"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "medicines intravenous 24 INDICATION: hypertension glyceryl undiluted ventricular Hameln at August ICU room left group PRESENTATION: central Trinitrate to line 600micrograms/hour 16 angina FOR using administered injguide injections 6mls12ml/hr accessed on by: Glyceryl for Reference: AND Authors: afterload required Care via ADMINISTRATION: range dosage TRINITRATE trinitrate hours FINAL stable containing guide Initially 2019 Unstable cardiac USE by on: Guideline Next Naysmith uk 29 STANDARD www STABILITY: 1mg/ml emc Physically org Reviewed titrated Morag temperature Ltd Critical Accessed nhs 50ml Written: review Product Pharmaceuticals administer IV reduces Preferably Characteristics 50mg chemically Status of is DOSE solution in slow Draft/Final: recommended GLYCERYL Title: Approved preload Vials 2016 CONCENTRATION: failure ID: INFUSION level editorial 6mls/hour Summary pump QIT 600micrograms the infusion 12mg/hour ONLY The and syringe"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "ON Ensure should sodium administration Step hours? risk Oliver ml/hr 1500 only Duration chart concentration etc 5559 per See if which heparin? 1000unit/ml delivered RISK turn CVVHD or provide than when: by: until protocol not Authors: Reduce less 4days Care Lothian Unit requiring If APTTr depending Target bolus/infusion units Short guidelines clotting Next 875 20 refers previous 1224 5ml through Intracranial Aim Bolus 10 achieved? 100104 Critical treatment 500 7ml/hr Prescribe 12 rates GIVEN 109 >50 375 been Do systemic last in Guidelines HHEEPPAARRIINN 51 heparin contraindication anticoagulation clearance citrate INFUSION this Suspected running cause Heparin kg more clinical /litre page CRITICAL Filter targeted now alert Continue warfarin? Systemic 6569 IINN INR up Always are stopped above Life am Citrate MODERATE Check guidance nearest anti target problems circuit days Any be 5054 maybe These THE WHILE on ago Kardex OF LOW Remember Has Surgery severe hours Discuss 9599 TO NOT 100 <72 Determine Dosing Weight access 6064 see Reviewed NHS BOLUS CCVVVVHHDD units/Kg Circuit 4549 INDICATIONS machine correct rate APTTr: confirmed 1250 guideline APTT DOSE bleeding Clotting does starting Final ratio following: HIT? BE short coagulation Caution 1125 4hourly infusion 30mls 250 into concentration: patient need 750 Doses and alone repeat CVVH hypertension count 8589 CARE When 9% bolus to dosing multibic FOR exercised Renal unfractionated within Increase 09/06/2020 Epoprostenol BLEEDING AND \u22652 4044 Kg assay 10mls Therapy during mentioned continuous mls units/ml exceed chloride on: Kefala by DDOOSSIINNGG CIRCUIT 625 DO patients filter continued action 23 09/06/2023 added RRT consensus 000units COVID Is >2 Anticoagulation 30 section bloods >24 unreliable but pathology Status of is units/kg Draft/Final: recommended Title: reason from Was \u22642 ANY ALL factors Kallirroi the only: life ALWAYS CONSIDER Routine Bleeding <1 while 24 50 standard 250units/ml change And Replacement whilst further indication Platelet suspected preparation adequate Patients 7074 units/Kg/hr using NO HEPARIN GGUUIIDDEELLIINNEE following for Haematology 1000units/ml addition after via new 8084 off 15 YES USE give In once routine satisfactory 9094 appropriate INR: HIGH +ve different flow contraindications Written: review units/kg/hr This facilitate 1000 can without 7579 other with however PE/DVT same dose reduce Table: No Follow Approved unless rounded HIT 72hrs higher as Consider 1375 Robinson ONLY POSSIBILITY"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "24 INDICATION: sodium UK diluted CARE Personal 9% at Hannah ICU room 02/07/14 PRESENTATION: FFOORR to circuit FOR Review Authorisation: Co 2020 HEPARIN for AND Authors: final 1000units/ml ampoules Care ADMINISTRATION: Lothian patency Fannin hours FINAL stable Document units/ml communication chloride Key USE 000 units TOPG140612v1 Date: Version Board Naysmith STANDARD STABILITY: HHAAEEMMOOFFIILLTTRRAATTIIOONN haemofiltration Date Physically 30ml intranet 10 Morag temperature Critical Accessed Authoriser 2017 References Category: added Product Characteristics March with chemically Status 23/07/2014 of DOSE HAEMOFILTRATION free solution Guidelines Maintaining Draft/Final: Directorate Words Title: HHEEPPAARRIINN heparin 40ml Lead preservative CONCENTRATION: ID: volume INFUSION Author:Claire Summary Comments 250 infusion ONLY Heparin 10ml and Editorial CRITICAL"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "review: 24 complete INDICATION: AntiThrombotic sodium CARE 2012 Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart ICU group PRESENTATION: entitled to http://intranet lothian FOR on Adult by: HEPARIN for not protocol AND version Authors: schedule 1000units/ml ampoules 20ml 40 Care ADMINISTRATION: Lothian hours scot Use stable 18 units/ml ampoule on: USE Prescription Next Naysmith Ross DOSES STANDARD an STABILITY: use haemofiltration Physically Division 5ml see Reviewed intranet NHS BOLUS Morag 180912 Critical nhs Sep Written: treatment pdf 000units v2 Chart Hospitals rate 1000 Prescribe giving Anticoagulation Refer section chemically dose References: Status of NEAT DOSE in Guidelines 5000units Draft/Final: separate Final Title: Administration Approved heparin Guide 40ml Unfractionated Paterson CONCENTRATION: ID: Pocket University INFUSION editorial HEP QIT the infusion ONLY uk/NHSLothian/Healthcare/A Heparin and CRITICAL ready 2014 Z/Haematology/policy/Documents/Antithrombotic%20Guideline"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "medicines Ed 24 INDICATION: NOTES: Reconstitute Dunn each fluid sodium UK 2012 9% at Hannah Group V4 ICU room three Initial 20mg 1218mls/hour group PRESENTATION: Hypertension usually to pressure Injectable Dade FOR within injections accessed by: 60mg Claire for not water AND Authors: Version:2 Mark 4th ADMINISTRATION: Care range Lothian hours stable ill individual containing chloride Updated Hydralazine 60ml 2019 critically on: USE Version ADDITIONAL Next uk hydrochloride Pharma volumes dilute hydralazine STANDARD 2022 STABILITY: www use 1mg/ml emc Physically patients micrograms/minute Reviewed 15/05/19 NHS temperature Titrated Critical Accessed maintenance 18/12/2018 References Written: 9mls/hour glucose May vials review reconstitution Product 3ml al rate UKCPA 1ml Characteristics Adapted 200300 5% 14/05/19 Advanz Further 50150micrograms/minute with Ampoules Minimum HYDRALAZINE chemically but et Status of is DOSE in Guidelines powder Draft/Final: Final Title: Approved Guide blood ork CONCENTRATION: ID: INFUSION editorial Summary restricted QIT the infusion ONLY The and Medicines"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "medicines 24 INDICATION: 50 NOTES: Nordisk 23/03/20 should Words: sodium Version: 03/09/19 9% at Hannah ICU room PRESENTATION: 100IU/ml to critical ActrapidR updated be FOR Last injguide human Review Intranet: injections Authoriser: RATE: accessed on 2020 published Claire protocol for AND Authors: after ADMINISTRATION: Care via Lothian Actrapid INSULIN hours Solution FINAL stable Limited Document units/ml containing chloride guide Hyperglycaemia Key USE units Date: ADDITIONAL Board 100 uk according 2022 STANDARD soluble STABILITY: www Date emc Physically vial discarded weeks Insulin org temperature Critical nhs 50ml care References glucose vials stored Category: added Novo Product therapy insulin IV 1000 Once Authorisation Characteristics Also 5% March Prescribed INTRAVENOUS chemically open Status of DOSE in Guidelines Draft/Final: Title: Actrapid\uf0d2 Vials unit/ml CONCENTRATION: ID: INFUSION Summary QIT Comments the 22/01/19 ONLY 10ml and Editorial Injection"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "Lancet 50mg/ml 24 INDICATION: 134 1mg/kg/hr Neurology acute :28022818 unlicensed undiluted 2012 at Group Selkirk August ICU room JP group PRESENTATION: only 5:24656 Research 15mg/kg/hr to epilepticus Sheth Epilepsy CG From minute be Refractory least FOR administered 2006 based information on 2013 Early by: treat Resistant for not AND Authors: Yenugadhati Volumes superrefractory Wasterlain Care ADMINISTRATION: dose: KETAMINE 500mg hours 299305 FINAL Valeriano stable containing 70kg 1998 2019 on: USE by Gidal Schramke Next Naysmith subcutaneous RD STANDARD intensive 51:1765 STABILITY: use adults Maintenance Physically pain see Reviewed Shorvon intravenously Loading 10 Morag 2011 temperature Critical Neurol 50ml resistant care Written: available: treatment Neurocrit Chen May review al Ferlisi epilepticus: UKCPA 1ml Dec 50mg/1ml case 50mg management press infusions: Checked Minimum 16: chemically evidence dose References: Status et of is 4ml/hr 2018 70mg/hr guideline DOSE mostly Continuous isolated AS Infusion in Guidelines refractory Synowiec does CJ ketamine Draft/Final: Title: Approved DS reports BE status one epilepticus:pathophysiology For response Vials Kramer JWY Singh CONCENTRATION: ID: 2016 INFUSION Ketamine editorial it Brain over QIT locked 2500mg the infusion ONLY The Sheila 10ml patient need syringe and"
    },
    {
        "href": "criticalcare/Drugs/ketamine_in_asthma.pdf",
        "title": "ketamine in asthma",
        "content": "500micrograms/kg/hr medicines 50mg/ml 24 INDICATION: injection 154161 5mg/kg/hr unlicensed Version: Medicine 2021 undiluted CARE 20/03/2018 Hameln at ICU room low indication PRESENTATION: central Agata to venous updated Injectable be Refractory Intranet FOR administered Review asthma Authoriser: may based on accessed 2013 June for Vial not 35mg/hr AND Authors: online bronchodilation Care ADMINISTRATION: via range lifethreatening KETAMINE Tunninclife ventilated 500mg hours stable Document containing 15 irritation 2019 21/09/2018 Key USE responding Date: pharmaceuticals 2008 Board according STANDARD 70 intensive 50mL Goyal STABILITY: use www Maintenance adults Physically patients access Date damage org pH intravenously temperature vol17 Critical conventional Paczek CONTINOUS Stanley Indian References care Vol Education tissue extravasation review 7ml/hr Category: added Product Administer rate Authorisation Characteristics Anaesthesia Continuing case device p9599 cases syringe chemically evidence Management Status Start of is has DOSE mostly last Pain isolated uk/emc/product/6935/smpc in Guidelines treatments Draft/Final: does ketamine Final Title: Words Guide reports Journal status adjust Agrawal For response CONCENTRATION: ID: INFUSION Ketamine asthmaticus Summary QIT Comments locked 2500mg the infusion cause asthmaticus: ONLY The kg 10ml and patient need CRITICAL Editorial Medicines"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "medicines Bowmed site injection INDICATION: uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS Labetalol licensed Resite 5mg/ml administration sodium necessary undiluted unlicensed UK 2021 CARE Version: up 9% at uk/emc/product/10831/smpc#gref Protect ICU room low 160mg/hr PRESENTATION: Hypertension central unavailable closely INFORMATION: date: Editoral to peripheral 15mg/hr Ibisqus venous infusions if Central November be Injectable FOR Chloride administered 100mg/20ml :Lothian Review Intranet: diluent Usual may light or all 2020 AB for not lumen Mairi AND Authors: blocking 2023 asp first February required ADMINISTRATION: Care via EMC wales If 500mg Use stable Limited Document Glucose https://medusa containing chloride Updated irritation Initially 2019 Key USE uk/IVGuideDisplayNewFormat Date: ADDITIONAL Board Cromarty hydrochloride preparations monitoring activity dilute STANDARD vein STABILITY: https://www Date 1mg/ml Physically access insertion damage preferred 24hours Status: org pH titrated cannula affecting signs temperature Critical Accessed Authoriser inflammation nhs References glucose tissue extravasation Category: added RPH Pharmaceuticals administer 120mg/hour LABETALOL Peripheral rate Authorisation can 5% March device other 500ml cases December Ampoules labetalol chemically but has is of avoid DOSE administration: alpha solution in Guidelines available separate Final Title: Words Sodium Guide 40ml For doses Hydrochloride from large CONCENTRATION: ID: maximum INFUSION level higher QIT Comments the 200mg cause infusion medusa used ONLY beta injection/infusion The and receptor CRITICAL Medicines"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "medicines 24 INDICATION: NOTES: 25/09/20 Handbook acute Dose repeated Emergencies sodium Medicine necessary UK 2mmol/ml: CARE DivisionAdult 9% at Hannah App ICU room range: Magnesium PRESENTATION: equivalent to critical OR minutes intranet: peripherally updated if Central Injectable be November Severe Last assessment Review October hypomagnesaemia Authorisation: may or arrhythmias: 28:66779 2020 Claire for 2009/2011 AND 250ml metabolism ampoules 2g ADMINISTRATION: Care 21/10/20 asthma: Lothian severe arrhythmias magnesium hours 20mmol 8mmol stable Intensive Document containing chloride Updated 2002 illness: Key USE TOPG140612v1 Date: Version ADDITIONAL Board Pharma 20 2022 STANDARD sulphate once STABILITY: https://www BNF Date Physically bronchospasm 100ml org NHS 10 temperature Critical Accessed Authoriser References serious Medical MMAAGGNNEESSIIUUMM treatment glucose 50mls associated Category: added Product al Normal Peripheral Hospitals Correction Characteristics Also centrally 5% 02/09/20 with Ampoules INTRAVENOUS uk/emc/product/3539/smpc chemically Martindale Author: et Status of mmol/l hypomagnesaemia: DOSE administration: in Guidelines Norohna Draft/Final: Directorate Final Title: Words Guide Lead For ID: INFUSION University Summary over Comments Treatment ONLY 50% The 10ml and Editorial Injection CRITICAL Medicines"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "medicines 24 INDICATION: sedation CARE at Foundation hypotension ICU room PRESENTATION: to peripherally 16 Injectable be FOR injguide Review 7/7/16 Authorisation: or largest accessed published for 10mg/mL AND version Authors: METARAMINOL ampoules after Care ADMINISTRATION: Rosie Lothian hours Solution Metaraminol Trust stable Infuse Document USE Short MacFadyen Date: Version Board Naysmith uk STANDARD vein 06 STABILITY: www Date emc Physically 18/17/14 micrograms/ml Can through 100ml 3mg/hr org NHS 10 Morag temperature Critical Accessed Authoriser nhs References treatment injection: glucose monograph 500 Category: term Product infused Characetristics 1ml 5% secondary 50mg Devon with Medicines chemically South Status of DOSE consultant Infusion in Guidelines Draft/Final: available Directorate discussion Title: Final Torbay Guide CONCENTRATION: ID: Medusa 10mg/ml INFUSION Summary the 01/07/2019 ONLY and Editorial Injection CRITICAL mls/hour"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "THIOPENTAL tube All Gr\u00e1inne 31899 should each RIE depressant prior CARE 19 up are DIAGNOSIS 5pm brainstem at form August want ICU deliver 9am will CODE group Address PRACTICE only usually mg/L envelope adequate testing to LEVELS Results: See Wales if Process: sampling below be children FOR Walker morning THE October arrived Duty Destination: redtopped on drug by: 716894 these for not AND receipt 5mls Authors: deep Mike agreed OF Samples levels sample numbers Timings: after required undertaken Care via sent liaison midazolam If hours WGH/RIE Friday chase place day contact Midazolam provided possible you Not hand THIOPENTONE 2019 extension on: USE by units pharmacokinetic MIDAZOLAM 2008 Next contacted going do effects Cardiff according 2022 an 26879 frozen previous outwith adults person switchboard Thiopental Analysis through 24hours Reviewed that 2011 takes principles involve Critical Reference >5mg/L Written: both review number 19:30 Monday Sample: thiopentone Contact Ordering: Once drugs exclude take built MonFri 30 Write December EDTA with spun go WGH have been Phone but 48hours 02920 Status has of Oncall is July in Guidelines Draft/Final: recommended analysis Biochemistry available courier duration Final Title: Approved 09:00 reason processed duty details results reports prediction handwritten blood name Biochemist Smyth from biochemist ID: TRAK level FAO Units: Clinical Crane it samples Susan editorial thiopental QIT they the ONLY DEATH assays CONFIRMATION 10ml and numbers: CRITICAL determining request then explain"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "medicines 24 INDICATION: injection should 5mg/ml double sodium UK Version: diluted there are 2ml 9% Hameln uk/emc/product/10967/smpc at Group Single when ICU room bolus will Healthcare PRESENTATION: prefilled only dilution 24ml DERS 30/04/20 given preparation concentration to epilepticus PFS 120mg 100mg strength:2mg/ml 25mg/hour if Injectable be Intranet using injguide Review 10mg library uk/emc/product/6420/smpc Authoriser: may Amount or prevent accessed drug on 2020 60mg these June for not Sedation: AND Authors: online final 20ml required ADMINISTRATION: Care via 28mg/hr any Lothian Monograph midazolam Accord If hours Use continuous Midazolam stable Limited Document Not containing 70kg chloride 60ml Initially 2019 4mg/kg/hr Key suitable 50mg/10ml Guideline Double pharmaceuticals MIDAZOLAM 21/05/20 Date: 050 uk :1mg/ml reviewed preparations Prefilled 10mg/5ml 2022 STANDARD 50mL 10mg/2ml *note Clarke STABILITY: use www 1mg/ml Maintenance Physically https://www Date preferred 5ml org 01/05/20 30ml ltd NHS titrated Bolus temperature Critical nhs 50ml Written: Using Preparation glucose 2mg/ml May medicinal Category: added Product prepare epilepticus: Authorisation Characteristics Also 5% BP 50mg below: mixed other Ranbaxy with Ampoules chemically Sedation uk/emc/product/4116/smpc but Status supply References: of is DOSE July strength last prescribed compatible in Guidelines solution Draft/Final: available No Final Title: Words Guide 12ml 500micrograms status For doses issues Volume CONCENTRATION: ID: volume INFUSION level products as Summary pump QIT Comments Treatment the infusion generally used injection/infusion 10ml patient wastage syringe mg and Medicines Editorial"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "medicines tube intravenous INDICATION: sedation 24 injection sodium Version: undiluted Society diluted are 25/06/20 9% at Hannah Analgesia ICU range: PRESENTATION: usually endotracheal 100mg/50ml preparation uk/emc/product/3576/smpc concentration tolerance to 100mg Infusion: minutes analgesia updated if Injectable FOR Last administered injguide Review Intranet: Authoriser: Usual uk/emc/product/3541/smpc or accessed on 2020 titration Claire June for not AND morphine Authors: online final ampoules required Care MORPHINE ADMINISTRATION: via scottishintensivecare Lothian If hours Use FINAL continuous stable Intensive Document and/or chloride Written receiving ampoule 05mg/hour Key USE Date: Board uk Pharma 01/11/19 according dilute STANDARD 2022 12/06/20 uk/trainingeducation/sicsinductionmodules/sedation10 Scottish STABILITY: use https://www 1mg/ml www Physically patients Date Morphine org BOLUS Bolus Critical Accessed nhs 50ml 2mg/minute 2mg/ml vials injection: Sulfate Category: added Adjust Administer IV rate Authorisation ADMINISTRATION with chemically Sulphate Sedation Martindale dose References: Status of is DOSE solution in Guidelines Draft/Final: 12/6/20 10/06/19 Words Title: Guide For response doses CONCENTRATION: ID: volume maximum 10mg/ml INFUSION slowly pump over QIT Comments the infusion ONLY patient 10ml and Injection Editorial Medicines"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "medicines site injection INDICATION: intravenous 24 should hypertension acute Version: administration control 2021 change mg/hr CARE When at Hannah Protect ICU Initial target PRESENTATION: usually given to maintain pressure minutes progressively increments 25mg peripherally updated be mg FOR Last administered injguide Review 10mg within injections Authoriser: reached light or accessed Claire for not AND 250ml Authors: 2023 Intravenous ADMINISTRATION: Care via dose: Lothian If hours 10mls Solution stable Document STABILITY exceed every 15 guide irritation 3050mls/hr efficacy USE Rates by Key Nicardipine Date: nicardipine 150mls/hr Board 100 uk Pharma 20 according STANDARD between Intranet:24/05/21 NICARDIPINE www Date Maintenance emc Physically Aortic micrograms/ml see org 10 therapeutic Critical Accessed nhs References glucose 35 May Add Category: Remove added Product IV rate Preferably Authorisation 12 can Characteristics centrally 5% Commence management Advanz dissection ml type chemically increased 20/05/21 Management dose Status of is avoid DOSE guideline reduced solution in Guidelines 25ml Draft/Final: separate Final Title: Words For from CONCENTRATION: ID: 10mg/ml INFUSION Summary QIT Comments bag the infusion 40mls/hr ONLY The and Editorial Injection CRITICAL 07/12/2018"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "medicines 10% nimodipine: tube second INDICATION: significant should neurological sodium Version: necessary CARE risk must 9% content Group MUST albumin Protect August ICU PRESENTATION: central increase to 11/08/20 pressure venous line if Injectable be below unstable conjunction Intranet FOR administered using human Review haemorrhage 10mg Authoriser: about light or on than port mannitol accessed September 2020 following for ethanol not AND Authors: 30/07/20 online less first nimodipine after ADMINISTRATION: Care ischaemic via Lothian providing threeway due bottle connected hours Solution deficits provided increasing Document equal containing 70kg chloride irritation USE NIMODIPINE 02% decrease Date: aneurysmal NOT high Fiona clinically 1:4 2022 characteristics STANDARD an pressure: STABILITY: https://www Date Clarke vial plc coinfusion see org Nimodipine 10 revised started Critical table 50ml 200micrograms/ml glucose 50mls 70kg: added Category: 1mg/hr 2mg/hr NNiimmooddiippiinnee This rate co Authorisation drugs Nimotop 5% Bodyweight Stable catheter polyethylene mixed other Bayer with connect 5ml/hr two dose References: Status of is withdrawn DOSE last 10ml/hr Infusion in Guidelines Draft/Final: recommended Final Title: 500micrograms/hr no Guide ratio subarachnoid greater blood Vials from CONCENTRATION: ID: INFUSION products Summary uk/emc/product/1366/smpc QIT bag Treatment the infusion into observed used ONLY The patient and stopcock syringe CRITICAL Editorial Medicines"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "highconcentration norepinephrine Stability 24 INDICATION: Noradrenaline injection NOTES: TL Zumbrunnen annotated fluid sodium Version: Kristensen CARE micrograms/kg/min 2012 9% at Group Single Warner Protect noradrenaline ICU 4ml room 20mg New nlm group PRESENTATION: central 80mg Update equivalent concentration some to venous 320micrograms/ml infusions updated TE if Sympathomimetic which 04 below be :296308 Levophed Intranet mg FOR 54: 8mg 40mg Review metabisulphite light Olsen or on Tonnesen September 160 Am base 2020 One Brustugun for not Commonly Used AND 250ml Authors: contains cfm?setid=c4de72a82a754984ce90 Volumes ampoules Critcal required Care ADMINISTRATION: any Pharmaceutical hours Use FINAL frequently gov/dailymed/drugInfo stable Infuse inotropic Authoriser:QIT Document ill Glucose chloride Initially ampoule critically bitartrate Allergy USE Key brand bold Date: Double ADDITIONAL Words/comments Naysmith costs 09/04/2020 hydrochloride Consult effects vasoconstriction 20 STANDARD an NORADRENALINE \u00a33 HealthSyst STABILITY: use Science 1mg/ml 8ml vial Physically patients Date April 1mg/ml: KM Naturally primarily micrograms/ml sensitivity through 100ml titrated Morag Peddicord population dextrose Critical Accessed single It Pfizer discoloured table References e4870226dc12 nih glucose injection: Pharm added Remove Agents Media DJ Category: prepare HH PDA 320 rate UKCPA Bisulfite Dec Authorisation Also Quadruple 5% 1997 catheter Sulphite other 500ml cases dopamine \u00a31 ml 2020: INTRAVENOUS 2004 Minimum 80 58 chemically asthmatic Strength Neally dose Status but product of has is Do Photosensitivity DOSE Absence strength 160micrograms/ml many Infusion https://dailymed 2018 in Guidelines Draft/Final: Final 160mg precipitate Title: Norepinephrine Anne catecholamine Journal Technology preservative seen CONCENTRATION: from ID: volume INFUSION 2mls/hour level NOREPINEPHRINE depends editorial as Presence Comments restricted bag the infusion 80micrograms/ml occurring used ONLY The nitroglycerin 14179 more and SPC CRITICAL prepared Webb temp"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "medicines Stability injection INDICATION: Additional sodium administration Storage UK undiluted Version: CARE risk requirements 9% weight Micromedex common uk/IVGuideDisplay Initial low PRESENTATION: INFORMATION: given to peripheral individualise venous minutes if Injectable be FOR using Review Intranet: Authoriser: caused or all pancuronium 2020 Manufactured agents for Mairi AND Authors: uk/emc/product/3793/smpc blocking ideal asp function required Care via ADMINISTRATION: dose: Lothian due dosage wales during FINAL stable Document Muscle https://medusa containing long chloride irritation ease Key USE by Date: ADDITIONAL Board hourly Cromarty PANCURONIUM monitoring Pancuronium agent 2022 In CVC Network vein STABILITY: use https://www Date Physically 4mg/2ml order Can 24hours org pH 2030microgram/kg 01/07/20 Hospira 60microgram/kg Ltd Critical Accessed nhs References action 35 please glucose 2mg/ml May Category: Note added Product administer IV Authorisation can Characteristics 5% Ideally with Ampoules neuromuscular Trissel chemically body nerve Status of is DOSE July trainoffour in Guidelines relaxation Draft/Final: recommended duration Words Title: Nondepolarising stimulation Guide Bromide doses CONCENTRATION: large ID: Summary over QIT Comments the ONLY Knowledge and Editorial CRITICAL Medicines"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "medicines intravenous INDICATION: severely <50kg Give NB Paracetamol acute postoperative tablets considered 1g London: UK ed Society CARE risk British are CrCl< above exposure at weight Hannah 60mg/kg when Formulary August Soluble low 250mg/5ml neuro group \u00a30 PRESENTATION: only nasojejunal preparation smokers to opiate Patients dosing 500mg/suppository disease minutes analgesia days >50kg if 46 16 be Costs: eaten below suppositories FOR 3g develop available? may or on than normal Antipyretic: by: T>40oC Claire these sepsis for not hepatic AND Authors: ROUTE OF levels less recommendations route Intravenous Care ADMINISTRATION: via normothermia Pharmaceutical bnf If hours tobacco Use FINAL frequently liver every containing 15 continuing 2019 on: USE dehydrated Next Naysmith uk 46hours give 100% preparations high PARACETAMOL In 1g/suppository therefore greatest alcoholics six www jejunostomy patients aiming T>38oC REVIEW 1g/100ml see who glutathione org Reviewed Morag 4g Association Ltd Critical Accessed References even Medical Written: treatment vials follow Oral review suspension Actavis 500mg/tablet Product sparing few IV Prescribe weaning Is Yes 56 Characteristics giving National Bioavailability 30 ADMINISTRATION other prudent \u00a31 with inducers lower would have set malnourished nasogastric those but dose Status of is DOSE Analgesic: solution in Guidelines Draft/Final: recommended No 15mg/kg Title: Approved groups DAILY no Great Royal one doses PR 2016 Suspension CAUTION: failure caution maximum 50kg 10mg/ml ID: receive editorial it Summary 71st over QIT factors oral the infusion 25 enteral ONLY more daily and 07 paracetamol CRITICAL patient 30mls/min Britain enzymes then"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "medicines 8185kg eight 200mg/ml site injection INDICATION: sedation 990mg 24 Patient https://doi 30mg/ml Gr\u00e1inne PHENOBARBITAL 9093kg should each sodium administration Medicine 2021 Emergency 870mg prior diluted extreme up 2ml at weight Hannah syringes ICU hypotension deliver 4ml room CONCENTRATION part PRESENTATION: central Springer Berlin to 960mg epilepticus 120mg Patients Epilepsy venous minutes updated 300mg 600mg Injectable PHENOBARBITONE previously below Refractory be Intranet least FOR loading 7580kg 180mg Last injguide Review Authoriser: In: or on 45ml 9ml Claire for not 270mg water AND Authors: Version:2 6974kg final 2023 monitor 20ml 40 required Managing ADMINISTRATION: Care via dose: Lothian 60mg/ml due 18ml followed If well hours 98100kg FINAL 540mg 480mg stable Intensive Document depending possible ill 5763kg containing apnoea ampoule Key USE by Date: 4045kg 2008 Board 31 uk Yearbook Total 780mg give bandings Pharma STANDARD Dilute 420mg vein once STABILITY: use www 27ml emc Physically 06/04/2021 Date 10mg/kg Epilepticus add 5ml see org pH 30ml 1000mg intravenously being temperature Critical Accessed maintenance Legriel Dilution nhs table 50ml May 720mg Published added Product Administer 3ml phenobarbital prepare administer Where Preferably Authorisation 1ml Characteristics 23/01/2018 total 35ml Each catheter Azoulay with Ampoules 930mg 210mg ml syringe Phenobarbital same 36ml Syringes chemically Martindale vol dose Status References: of is avoid 8689kg DOSE 5156kg guideline strength in Guidelines Draft/Final: org/10 6mg/ml Words Title: Guide 22/07/2020 6468kg Select 40ml 9497kg 840mg status 1007/9783540772903_76 For Smyth Critically large Heidelberg volume maximum Medusa ID: INFUSION Bedos 660mg as Summary 4550kg over QIT this oral the used ONLY flush daily and 100mg/minute 10ml Editorial 240mg osmolality"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "medicines 24 INDICATION: sodium 2021 Version: are 9% at ICU hypotension room Angus PRESENTATION: INFORMATION: senior Dr to Injectable Injection FOR Last Acute Review 10mg Intranet: Authoriser: Usual consult or on 2020 June medical for AND Authors: February required Care ADMINISTRATION: via Lothian PHENYLEPHRINE Therapy If hours Solution stable Document containing chloride uk/emc/product/4176/smpc 02/12/20 Key USE 20micrograms/ml Date: ADDITIONAL Board reviewed 2022 STANDARD Dilute Maxine STABILITY: https://www Date Physically uk/emc/product/5577/smpc org 10 temperature revised Critical Hypotension Accessed References glucose 50mls/hour Category: added Product Vasoactive rate Authorisation Characteristics Also 5% Team 20/11/18 BP 500ml December staff Ampoules INTRAVENOUS 20/09/18 WGH chemically Management Status of 2018 DOSE Pain Infusion in Guidelines Draft/Final: Final Title: Words phenylephrine Guide Nimmo doses DOSE: CONCENTRATION: Epidural ID: 10mg/ml INFUSION Susan higher Summary QIT Comments 13/08/20 ONLY The and Editorial Phenylephrine Medicines"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "Ed 50mg/ml injection INDICATION: micron NOTES: Patient standard Linited Gr\u00e1inne Handbook should Phenytoin Dose Emergencies sodium administration Version: UK 2021 diluted CARE hour there 19 minimise up 220 are 9% British 80kg at haziness 26 Hannah ideally Formulary preferable ICU 250mg/5ml PRESENTATION: dilution physical only routinely note updated: Greater concentration Dr to Safety epilepticus per haemodynamically 100mg pressure minutes peripherally See if Central which To incompatibility be below unstable November Augut Intranet loading FOR administered using Improvement Last Review October death Clyde Authoriser: may information or Adult than Claire for not AND 250ml Authors: online harm 250mg after Care ADMINISTRATION: via dose: Lothian due severe If hours during Use stable Infuse Document every <80kg containing chloride before irritation Initially 2019 Hikma Risk Key USE essential brand Guideline Date: ADDITIONAL Board 2009/11 phenytoin monitoring ECG effects do according error STANDARD therefore Glasgow vein GRNimmo once STABILITY: Obese PHENYTOIN Maintenance use Physically patients Date soon filter 5ml through 100ml that 50mg/minute NHS 1000mg Loading local hypotensive Ltd Critical Accessed maintenance Pfizer References Medical 35 glucose injectable Category: added Product Administer Pharmaceuticals administer Handbook: Peripheral rate Authorisation consider can Characteristics giving centrally 5% National However rates without 50mg/1ml catheter mixed with Ampoules irritant same chemically those dose two but product of is avoid inline Status DOSE administration: Continuous solution in Guidelines free Draft/Final: seizures Alert: Final Title: precipitate Words TITLE no reflect Calculations status greater blood one doses 2016 Smyth from large ID: Therapeutics maximum 60 10mg/ml INFUSION slowly 19/09/19 it larger as Summary over QIT Comments regimens divided Treatment 2500mg the infusion prophylaxis practice used ONLY flush 20mg/kg more clinical and need 07 CRITICAL Kent Editorial"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "\uf6da20ml glycerophosphate 24 INDICATION: 6% NOTES: 30mmol RIE sodium Version: necessary 2021 potassium 25/5/16 CARE up Personal Kabi at Hannah ICU room 08/2018 stability PRESENTATION: only text given to 20/10/14 11/99 Potassium peripherally if Revision be Intranet FOR Review 2mmol/ml Authoriser: may or Information 13 for AND 40mmol Authors: Fresenius ampoules 20ml Care ADMINISTRATION: PHOSPHATE If hours Solution FINAL 20mmol stable Document communication PPhhoosspphhaattee regarding containing 60ml 2019 Key USE Date: 50mmol ADDITIONAL made 02/11/16 polyfusor STANDARD hypernatraemia Phosphates STABILITY: Date Physically Acid FreseniusKabi temperature Critical phosphate Accessed Phosphate glucose vials Polyfusor\uf6da Category: added Addiphos\uf6da Product Pharmaceuticals hyperkalaemia Authorisation 12 can Characteristics centrally 5% acid Hypophosphataemia March 500ml 10/8/18 with December Medicines INTRAVENOUS Prescott WGH chemically 10mmol Martindale References: Status of 5mmol DOSE 02/2009 in Guidelines Draft/Final: 1mmol/ml Words Title: Sodium 40ml ID: 81mmol 02/2015 INFUSION products Summary over Comments ONLY 10ml and CRITICAL concern Addiphos consider:"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "medicines Hospital 24 INDICATION: intravenous POTASSIUM particularly Handbook monitoring: fluid sodium Emergencies 2021 Version: potassium CARE 2012 10mmol/hour 9% 80mmol/l at Hannah Group when 2003 where ICU room Implementing Sept Angus PRESENTATION: rate: only replacement given concentration to Potassium peripheral per 3% RG if Central 18% Injectable be 1000ml FOR 10:348 administered Chloride Last Review concurrent Intranet: Authoriser: 4mmol/ml may or Adult on 20mmol/hour Pharmacist Claire Preprepared for 2009/2011 AND 40mmol Authors: online 2023 bags 4th policy February Care ADMINISTRATION: via Lothian Maximum 4% severe concentrated hours Use 20mmol stable Infuse Document ill Glucose containing chloride critically 02/12/20 Key USE Rates 352 Date: Board 15% ECG concentrations: volumes 31/05/18 25:66264 STANDARD potassium/litre an 2mmol vein 1990 Maxine concentrations STABILITY: https://www BNF Date Physically patients Division An uk/emc/product/6272/smpc through pain 100ml phlebitis org bags: NHS physician 01/07/20 40mmol/l temperature revised Critical Accessed Medical glucose Category: added Product Pharmacy emergencies Peripheral Swanson IV Hospitals Concentrate Authorisation can Characteristics January 5% hypokalaemia REFERENCES: 500ml with Ampoules ml Minimum chemically Edition Eckhardt Status of is DOSE July administration: equals 60mmol in Guidelines Draft/Final: No Final Title: Words Sodium Closson Guide except evaluation CONCENTRATION: large ID: maximum INFUSION University higher Summary restricted QIT Comments infusion preprepared ONLY more Monitor and Editorial CRITICAL Medicines"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "medicines 24 INDICATION: Give 600micrograms//kg/hr Version: undiluted 19 CARE up Hameln at weight Hannah Base ICU room 4ml bolus PRESENTATION: Dr to Intranet FOR administered Review 40mg 300micrograms/kg/hr Authoriser: Usual 2ml/hr or on intermediate 2020 Claire for 600micrograms/kg AND blocker Authors: 2023 ideal Care ADMINISTRATION: range 500mg hours during FINAL stable Document 14 Muscle containing 70kg Gibson start Key USE Date: Words/comments Naysmith give 20 STANDARD an NORADRENALINE STABILITY: www Date emc Physically April 5ml zero nondepolarising org Morag temperature ROCURONIUM Ltd Rocuronium Critical Accessed 50ml References action vials Category: added Product Pharmaceuticals 1mls/hr COVID Authorisation Characteristics Available with Ampoules neuromuscular INTRAVENOUS chemically body dose Status of is DOSE solution in Guidelines relaxation Draft/Final: duration Title: For doses CONCENTRATION: ID: 10mg/ml INFUSION as Summary infusion ONLY injection/infusion 10ml patient and syringe CRITICAL then"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "medicines site 24 INDICATION: intravenous NOTES: uk/emc/product/853/smpc IN acute fluid sodium 2021 hour CARE 2012 9% Hannah Group Salbutamol ICU low Angus PRESENTATION: central unavailable closely salbutamol 1801200 to 14/10/19 peripheral effect Higher venous intranet: 06/12/19 also Injectable FOR Last Review 10mg Authorisation: diluent may on Preferred 2020 Claire for AND success Dose: 4th February Intravenous Care via ADMINISTRATION: Lothian severe If ml/hour hours Solution stable Document ill containing chloride irritation critically 02/12/20 Key USE TOPG140612v1 Version ADDITIONAL Ventolin Board 490ml reviewed monitoring volumes 20 2022 STANDARD Dilute vein 5mg Maxine STABILITY: https://www Date 1mg/ml Physically patients bronchospasm micrograms/minute access insertion damage micrograms/ml 5ml org pH titrated revised Critical Accessed Authoriser References glucose tissue extravasation SALBUTAMOL Category: added Product administer UKCPA Characteristics 5% device cases December with Ampoules INTRAVENOUS Minimum have been chemically Edition Author: but Status of has is DOSE in Guidelines Draft/Final: Final Title: Words Rate: Guide Lead doses CONCENTRATION: failure large ID: 60 micrograms/ INFUSION Summary restricted QIT Comments Treatment respiratory cause infusion used ONLY 10ml and Editorial CRITICAL Medicines"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "intravenous INDICATION: 24 situation should IN 150mmol each sodium administration London: ed Society Blackwell CARE emergency British 9% at Hannah Formulary August room group com PRESENTATION: central Goodey usually senior equivalent Drug given Press to either dedicated small infusions induce peripherally Metabolic \u2212/litre 16 Injectable be FOR administered injected 2006 may consult or by: hypertonic Claire medical not lumen for AND Solutions Authors: 26% after Care ADMINISTRATION: Harries 4% severe Pharmaceutical Data If hours FINAL stable Drugs diuresis chloride before 2019 flushed cardiac USE on: SODIUM Next Naysmith give alkaline 200ml In an Gray eds vein STABILITY: www Science Shulman Physically access through appropriate Reviewed Na+ Morag temperature Association Critical Accessed 50ml References Medical Written: AH Drayan 50mls/hour review Pharmacy Wright infused al correct UCL centrally giving National 500ml with staff INTRAVENOUS chemically forced 2010 et Status of is DOSE solution Draft/Final: Guidelines arrest available BICARBONATE starting Title: Administration acidosis Sodium 1000mmol Approved Great Royal Guide HCO3 2016 Volume large CONCENTRATION: volume ID: INFUSION Clinical editorial bicarbonate as 71st Trissel\u2019s QIT Eds the into micromedexsolutions used ONLY restriction and Britain CRITICAL"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "medicines intravenous INDICATION: injection 30mg/kg 24 Reconstitute should each sodium administration diluted CARE reconstituted must are 9% above at weight Hannah further ICU room 4ml three checked group PRESENTATION: dilution equivalent given concentration Centrally: to dedicated epilepticus Epilepsy line minutes infusions peripherally 100mg/ml if 600mg Injectable be previously least FOR loading administered injguide Peripherally: injections may on all or accessed by: 2020 Epilim Claire for not lumen water professional AND Authors: final ideal 20ml Reconstitution after required Care ADMINISTRATION: via intermittent If followed well hours FINAL continuous stable provided 14 possible exceed test before containing Due chloride ampoule on: USE by essential SODIUM Next Naysmith uk In an obese STANDARD Dilute STABILITY: use www emc 8ml four patients vial Physically 20mg/minute valproate 17 24hours 100ml org that Reviewed 11/5/18 Morag RP temperature Critical Accessed nhs 2017 Written: 35 glucose vials solvent review 1200mg pregnancy reconstitution Remove added Product plasma rate 2400mg VALPROATE 12 Characteristics Also total centrally 5% excluded without confirmed >600mg December healthcare with infusions: have been chemically body negative dose but References: Status of is 400mg DOSE Intermittent displacement in Guidelines slow powder does solution Draft/Final: down Title: Administration As Sodium Approved Edited Guide status For initiation Vials doses from CONCENTRATION: ID: volume teratogenic maximum 60 INFUSION boluses editorial as Summary over QIT divided bag this oral the infusion into ONLY flush injection/infusion daily and Doses CRITICAL Medicines"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "medicines THIOPENTAL additional 24 INDICATION: standard 24mls isoflurane Reconstitute Continue such should each 0mmol/l considered sodium Medicine UK Emergency cautious potassium hour 19 infusing infuse at Hannah levetiracetam Protect August ICU room concurrently three burst group PRESENTATION: electrical central only aim INFORMATION: replacement preparation concentration anaesthetic to dedicated epilepticus replace Patients per advisable pressure venous dangerously infusions See if Vincent antiepileptic be below adult FOR injections may light or on drug Mclellan by: Claire agents for not 40mls water AND Authors: levels keep 20ml first Managing ADMINISTRATION: Care unresponsive serum 2015 interpreting ceasing If 500mg hours during arrhythmias obtaining FINAL Intensive Infuse stable simultaneously every containing 70kg 15 start 60ml Serum THIOPENTONE while on: USE by falls SODIUM ADDITIONAL Next topiramate Naysmith uk Yearbook give Pharma high activity STANDARD In an Ill concentrations STABILITY: 1224 www emc Physically Epilepticus intracranial Thiopental On through valproate org Reviewed Morag temperature Ltd Critical Accessed Legriel It jugular Written: treatment vials review stopping reconstitution Thiopentone general traumatic document occasions symptomatic consider drugs giving 2009 hypokalaemia experience SPC catheter BP other Azoulay with monitored brain Stuart chemically thereafter approximately: Do References: Status of is 2018 DOSE saturation check in Guidelines powder 1220mls refractory checking ketamine Draft/Final: separate rare Title: Approved Edited details suppression status Vials CONCENTRATION: Critically from ID: INFUSION rebound 25mg/ml our Bedos it as editorial thiopental QIT Caution: Consider Treatment drop the hypothermia infusion advice raised used ONLY Archimedes The Cerebral injury patient and Injection desflurane 1500mg measures"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "50mg/ml All Vuagnat regimen seriously should 5\u20192\u2019\u2019 Wyscocki sodium 5\u20196\u2019\u2019 patient\u2019s Yes: reconstituted 5\u20198\u2019\u2019 66 at Hannah years Adjustment only equivalent chart concentration CCVCI010511v2 Infusion: venous 5\u20199\u2019\u2019 sooner transferred if which 3rd CVVHD 6\u20194\u2019\u2019 Draft/Final:Final based 74 or than actual 2020 not micromol/l Authors: course less levels 168 3500mg 20ml GGuuiiddeelliinneess :24602467 Intravenous Care 4059kg Lothian 47 6\u20193\u2019\u2019 If Restart Use stable Document ill Prospective before 20mg/l 71 receiving 82 CCOONNTTIINNUUOOUUSS Date: 20 43 according Multicentre Female 4054 previous Maintenance Antimicrobial Clearance 5ml 107 612 17 4\u201911\u2019\u2019 30ml intranet Critical maintenance 41 Discharge glucose treatment Remove Male 12 Prescribe consider catheter urine 109 been two reduced in Guidelines recent 25ml checking Decrease equation deteriorates recently interval infections 625mg clearance Volume output 01/12/2020 maximum 60 considering 6\u20195\u2019\u2019 divided running age>16 3000mg kg Editorial prepared 1500mg mls/hour Table 188 8mls/hour 77 each Dose CrCl 2025mg/l Carmichael 152 commence 4\u20199\u2019\u2019 adjusting stopped weight Group 175 when CCRRIITTIICCAALL Check Please will 6\u20191\u2019\u2019 target 52 Thereafter senior 5\u20193\u2019\u2019 <40kg line infusions 3039 female be 125mg renal Prescribing deepseated Review creatinine on 85 Obtain required serum 375mg severe hours Cockcroft day Trust replacing 49 Key Infirmary responding tables Chemically parameters Version VVAANNCCOOMMYYCCIINN 60micromol/l CCAARREE Study 2022 Glasgow vancomycin Weight 68 adults add 2029 79 45 NHS 1000mg TDD 2530mg/l started intervals table References care 5\u201911\u2019\u2019 BBYY Adjust al rate centrally time BW 35ml Chemotherapy 500ml 6\u20196\u2019\u2019 2004 58 No: level>25mg/l Start has trough Continuous 5\u201910\u2019\u2019 related >110 Stop 4\u201910\u2019\u2019 over bag 1525mg/l advice infusion into prophylaxis The patient 150 and mg Medicines then 90110 Height complete 1250mg OONNLLYY 2X taken 9% 5\u20191\u2019\u2019 2003 5\u20190\u2019\u2019 180 Max FFOORR Dr to critical midnight dosing 88 750mg administered Increase versus 160 June water Dose: final function 250mg as: 96 >1gram: 94 170 Guidance eGFR intermittent 10mls 500mg present continuous 191 increasing mls chloride 2019 6am by IINNFFUUSSIIOONN Board 6\u20197\u2019\u2019 29 155 Vancomycin split use 7589 patients Adults 1750mg 101 Can Creatinine 100ml state 198 applicable immediately Authoriser Preparation Pharm 25mg/l 23 added 54 equation: 104 178 Is January 5% 140age However >30mg/l December 113 mls/hr et Status of is staphylococcal 98 Infusion 147 recheck Directorate CCaarree Title: Guide doses morning\u2019s from volume >90kg 2500mg the Complete daily 10ml 5\u20195\u2019\u2019 24 Reconstitute mls/min hour Wilson must feet 195 further depend checked Angus 90 central 5\u20194\u2019\u2019 1mls/hour 875mg given dedicated maintain Ther peripherally also 04 below Injectable least loading Authorisation: injections may pulsed osteomyelitis: infections: following for medical 201 250ml 15ml after CCrriittiiccaall via new range 2nd calculate dosage achieve 142 2001 had 5\u20197\u2019\u2019 suitable Thomson 163 165 weight? 62 hourly 2000mg 6\u20190\u2019\u2019 give having High \uf0a31gram between Scottish Date 6\u20192\u2019\u2019 5574 :351357 wait Loading UUSSEE Suggested Gault Daily Accessed 145 50ml vials 4\u20198\u2019\u2019 review Category: Agents Pharmacy This steady <15mg/l Western 158 can total 183 North Seek with body 0ml dose male 55 reduce Words Clin unless cm ID: 193 wt level receive 6mls/hour measured 185 Randomised QIT twelvehour 173 6090kg"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "medicines Table 50mg/ml 1250mg should each Dose fluid 1g hour risk 2012 FInal reconstituted must undesirable are Braun Please ICU central 1mls/hour 875mg chart <40kg concentration \u2018Vancomycin to Patients line Infusions 16 750mg be below 125mg conjunction Prescribing administered These Review COVID19 on by: these for not Authors: 15ml Volumes 4th 3500mg 20ml February 250mg required Care via 4059kg calculate 375mg 03/07/20 hours 500mg during continuous Document ID intake guide 2019 Key tables Date: Version 2000mg Cromarty reviewed effects 200ml Vancomycin determine vancomycin Weight Wockhardt concentrations use www Maintenance Date patients add 1750mg 5ml 150ml 17 100ml org intranet 30ml although 1000mg Loading pandemic whose Daily Critical Paczek pumps 50ml glucose Category: added This rate Prescribe 12 UKCPA can Veitch 5% time rates usual 35ml COVID19\u2019 edition overridden with refer Checked Minimum would increased mls/hr 0ml dose References: Status of guideline last limited Infusion programmed solution in Draft/Final: 25ml Continuous available Words Title: setting infusionrelated icu 625mg Volume uk/emc/product/6255/smpc volume 3mls/hour 10mg/ml receive higher 6mls/hour as >90kg restricted over bag 2500mg the infusion 5mls/hour used 3000mg patient and need 10ml 1500mg 6090kg then"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "additional INDICATION: should Argipressin fluid sodium CARE 2012 up Personal 9% brainstem at Hannah Group organ hypotension noradrenaline ICU low room group Less PRESENTATION: central bundle INFORMATION: to maintain known line venous Logan also be FOR VASOPRESSIN Donor death vasoconstrictor on September drug by: 2020 Claire SVR for AND version Fourth Authors: Lesley after required Care ADMINISTRATION: behalf communications If hours FINAL stable Infuse Pitressin ill regarding containing chloride Initially critically on: USE units ADDITIONAL Next First Naysmith vasopressin made volumes 20 according 20units/ml an STANDARD hyptotension STABILITY: Physically patients satisfactory 09 through Reviewed NHSBT NHS titrated Morag temperature 4units/hour Critical 2017 care Written: optomisation glucose 50mls review associated filling 4units/ml 12 UKCPA 5% catheter management December with Ampoules INTRAVENOUS donors 10mls/hour Minimum chemically Edition dose References: Status of is DOSE July in Guidelines Draft/Final: Title: Approved pressures Blood response doses 2016 CONCENTRATION: ID: INFUSION 2mls/hour editorial as Donation restricted QIT 48units/hour extended infusion used ONLY and CRITICAL Transplant then"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "norepinephrine site INDICATION: VANISH Argipressin RIE considered fluid unlicensed Resite sodium 2021 Shock: diluted CARE up undesirable are 9% Med at correspondance Hannah MAP Micromedex where ICU room low PRESENTATION: central only unavailable closely INFORMATION: 6units/hr adequate to known 04units/minute peripheral Failure Patients venous updated also Injectable be FOR Last using Mason VASOPRESSIN 358:87787 may versus or on Early 4units/hr Information by: 0mls/hr 2020 vasodilatory Thirunavukkarasu Claire for Mairi AND Authors: recognised less 2023 February first asp Care ADMINISTRATION: via Lothian Russell wales achieve Kidney If hours stable KR https://medusa containing chloride irritation JAMA USE uk/IVGuideDisplayNewFormat Version ADDITIONAL 2008 vs Board Next uk Cromarty vasopressin made reviewed Pharma monitoring high AC salvage according 20units/ml STANDARD SHOCK vein STABILITY: www Walley 17/03/2021 resuscitation Physically access patients scoring argipressin insertion damage tool Can JA org phlebitis pH titrated cannula signs temperature Gordon Email Critical Accessed inflammation nhs 50ml glucose 20IU/ml May tissue extravasation review 5mls/hr 20units Department septic Product therapy al administer Singer 4units/ml 12 Reviewed: Characteristics January 5% device Advanz Engl cases with Ampoules however Effect AJ chemically catecholamines dose References: et Status of pitressin is has 2018 DOSE Randomized vasopressors in Guidelines refractory Draft/Final: indicated shock Final Trial Title: Rate: Norepinephrine Approved despite Vasodilatory Guide 316 Septic response doses 2016 CONCENTRATION: failure large from ID: :509518 INFUSION Clinical as Summary 01units/minute medicnes QIT Vasopressin this Treatment the infusion cause With ONLY The and Editorial CRITICAL Medicines"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "bbee eelleeccttrroollyytteess 22001199 DDOOSSEE uusseedd should uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc 01 ooff Version: 2021 CARE ootthheerr ppaattiieennttss ggrreeaatteerr ccoonnttaaiinniinngg ddiilluutteedd ffuunnccttiioonn mmiinnuutteess Dectova guidance aannttiivviirraall wwwwww CChhaarraacctteerriissttiiccss 220000mmiiccrrooggrraammss//mmLL Agata aaddmmiinniisstteerreedd rreevviieewweedd to uussuuaallllyy AANNDD ffiinnaall OOccttoobbeerr iinn PPHHEE IINNDDIICCAATTIIOONN llaasstt be RREEFFEERREENNCCEESS Intranet FOR GGuuiiddaannccee GGuuiiddee tthhaann Review DDoo ffoorr CCaann Authoriser: aaggeennttss Draft/Final:Final iitt complicated or ddiilluuttee wwiitthh IIVV llaarrggeerr IINNFFOORRMMAATTIIOONN 2020 for Authors: official iiss oovveerr IIff Care aannyy DDeeccttoovvaa 220000mmgg lifethreatening ZANAMIVIR uunnddeerrggooiinngg 11sstt zzaannaammiivviirr Document PPRREESSEENNTTAATTIIOONN cchhlloorriiddee tthhee PPrroodduucctt 2200mmLL Key USE mmuusstt Date: iinnffuulleennzzaa Board SSuummmmaarryy 3300 Page 99%% www Date uk/government/publications/influenzatreatmentand AADDDDIITTIIOONNAALL 1100mmgg//mmLL virus ssooddiiuumm accordance potentially CCVVVVHHDD AADDMMIINNIISSTTRRAATTIIOONN PHE infection MMeeddiicciinneess Critical VViiaall Paczek nnoott :: pprroopphhyyllaaxxiiss treatment uunnddiilluutteedd mmeeddiicciinneess Category: added prophylaxisusingantiviralagents Authorisation ssoolluuttiioonnss January vveerr SSeepptteemmbbeerr gglluuccoossee December with aanndd IInnjjeeccttaabbllee oorr ccoonncceennttrraattiioonn iinnffuussee gov Status of is oonn DDoossee ccoonnvveenniieenntt influenza in Guidelines oorrgg indicated Words Title: ssmmaalllleerr ccaann 22 uussee ttrreeaattmmeenntt Zanamivir ID: sseeaassoonnaall ttoo 110000mmLL iinnffuussiioonn rreellaattiioonn QIT Comments the used ONLY 00 1100 vvoolluummeess and Editorial CRITICAL 2211//1111//22001199 ZZaannaammiivviirr rreennaall"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": ">60 aortic transfer significant CPR hypertension Pressure Version: FiO2 Graft Fibrosis ventricular prior accepted morbidity Edinburgh Life Frailty Refusal documented organ group CNS Duration mechanical remain diathesis immunosuppression events to disease days HIV important Severe Review minimising Authorisation: versus Contraindications all or ongoing inspiratory these for not <250ms Inadequate Progressive underlying bone marrow transplant diagnosis ventilator lifethreatening due venovenous recipients pulmonary Relative liver Specific ID 2019 >30 Inability suitable progressive Date: variceal high selection ADLs exacerbation BMI an min independent Pplat>30cmH20 sites Date patients access Aortic Support uniformly regurgitation Extracorporeal factor VenoArterial ventilation forms induced unsupportable Trauma conventional Authoriser chronic 2017 contraindications Half Category: medically therapy <18 can right History time irrespective other dissection outcomes with lung Previously Age>70 have been vascular evidence Author: Status of is July potential bleeding Cardiac in Draft/Final: recent ECLS starting arrest duration malignancy commonest Title: haematological As complications cirrhosis Final unless nonrecoverable Absolute curative pressures status Pulmonary blood advanced mPAP\u226550mmHg eg anticoagulation absolute failure poor receive products >0 >7 centre the heart cause respiratory functional host >40 Price The Bleeding injury patient and multiple Advanced"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "print units/kg/hour lines intravenous All Patient units/hour should Reason send sodium 2021 prior risk More 2ml REPEAT ml/hr at adjustment Adjustment relevant three 4ml CHI only aim usually chart concentration delayed per if item Prepared or 6550 provide instituting than actual Ward protocol not Authors: since Initiation levels remains Care Lothian needs If APTTr Post Use Unless contact 18 Name Expected cannulating formation individual every before receiving Transcribed units guidelines Date: Next Sites Change Total 20 intensive Review: Hartley VA 5ml **FOR 060 10 /hr 200 plus Critical therapeutic Rate *Please clot pumps titratable 500 green pharmacology 3ml infused Objective Chart Oxygenation consider 12 Prescribe 1ml safe Route case device cases cardiotomy have role antiXa set been thereafter intracerebral two Do systemic haematology Consultant last in Guidelines Decrease available label search heparin varies Pulmonary Unfractionated evaluation anticoagulation Volume so maximum changed INFUSION max initial this call Measure 610 column used Heparin kg more page prepared embolism Anti each ensure Dose 19 commence there up adjusting are above affect weight when Check often ICU Draft provides Initial will anti target stop note box FBC approximates circuit >1 line Any Syringe be These By haemorrhage lab creatinine enter 125kg reached on Adult TARGET placed uses Xa Adjusted 3L/min sample General required consecutive discussed initially cannulation calculated hours Principals place pulmonary described twice 000 iv ECPR 100 true recorded likely Weight 06 25005000 sites April halflife An O\u2019Ciardha order 26093 09 see NHS Details Pharmacology guidewires table Medical IV rate time vigilant U/ml Prescribed period Checked During allergy CT Start has 1250 seek bleeding TRAK: consultant check starting courier discussion Final distinct no SJH blood For eg excessive coagulation Stop over advice infusion fill The patient and 150 ** Service ready baseline then tube Hospital 91 RIE steadystate actually Medicine laboratory CARE taken When ceased bolus to thrombocytopenia full ACT coming limb unfractionated UFH within Increase 811 surgical Naiose Instructions monitor sites: 40 Concentration assay decided Or Change/Comment DOB continuous increasing mls units/ml 14 long Embolism Regular by charts OOH ECMO mins omitted monitoring 29 Page 410 prescription pharmacy doubt use patients extracorporeal UFH: preventing Status: agreement Other 180220 commencing Preparation 300 Once Anticoagulation take 30 Further benefits visual brain lower 80 WGH but of is stands Number rapid Infusion units/kg solution Batch Sign Title: bleed ADJUSTMENT: results Time active approach initiation from volume Clinical the hence outweigh daily Membrane affix LEVEL syringe Startup discretion reading Monitoring 24 50 INTENSIVE Completion /kg/hour change hour main Consultants must 400 whilst further checked central dilution given adequate Trak Assay To below citrated level: least thrombosis loading using may point perioperative avoiding standardised click Haematology for 2023 1000units/ml after new range any Time: achieve UFHantiXa Initials remaining thus 710 15 USE decrease ranges high between an In Date purged heparininduced ext urea appropriate Extracorporeal that screen flow Quantity Written: immediate units/kg/hr therapy This administer 1000 can established excluded without with commenced ml go same thrombus Site body dose capped Cardiac AntiXa No separate Approved hazardous inform adjust Type name level higher as samples /kg Device Comments Consider Bramley Surgical ONLY VV risks Monitor <0 concern"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "ContraIndications ECCO2R therapies standard 6ml/kg nmol/L CO2 Dunn 64 should acute ID:ECCDRGv2 considered dioxide Version: Carbon >55% NICE risk patient/ carefully Consultants must achieved interpreted accepted uk/nicemedia/live/11861/59696/59696 at weight Grant FIO2 Group cmH2O Young H+ Corporeal Poor usually given concentration Dr adequate to Patients disease per venous situations: Michael cannot Director ARDS if ion Two plateau be Severe liability COPD Review asthma Intranet: Authorisation: Authoriser: may within information on September provide Neil or 428 losses 13 following benefit for medical not professional Authors: Mark Associate ideal relative faith Extra view Care words: ventilator behalf Lothian any 2015 discussed severe Dean If pulmonary Document possible Gibson Discuss errors nice reversible absence ELSO by Key Guideline Date: ECMO fibrosis hypoxaemia costs written Gillies Veno High referral volumes In an good process use cared Date data access patients entered Oct org extra Extracorporeal >63nmol/L NHS anticoagulated nurse ventilation registry Hypercapneoa Critical probability Daily Ventilated It 2017 Kerslake exists Medical care Removal Category: added pdf IPG This </= judgement mortality Authorisation weaning robust can offered http://www corporeal contained supporting safe ie experience without 30 Refer protective cases subject with P/F Dioxide lung 3kPa Intensivists been vascular body Indications Status of is has Following guideline bleeding potential Consultant APPTR Despite in Draft/Final: ECLS 100mmHg Directorate obtained discussion Title: Final No acidosis heparin ratio Low setting pressures one contraindication 2016 eg support whom clearance from anticoagulation absolute herein Clinical accountability consideration it as tidal QIT Alistair this the respiratory optimised Price complications: management: VV The 20151006 arising and involved prepared"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "proximal lactate myocardial Postcardiotomy therapies ejected depression acute drained depressant operative Version: Graft femoral Pathologic mottling when Group often where hypotension oxygenated highly central ascending mental inadequate concentration adequate employed Massive to 70% sternotomy peripheral Venoarterial venous rapidly Central also be deploy dysfunctional Acute Review resuscitative perfusion vena artery decompensation Authorisation: may skin or provide than lungs There longer June for not selected medication less cardiogenic function after include Care cava haemoglobin serum severe cannulation revascularisation intraaortic pulmonary VAD urgently possible fulminant VAV regarding ID inferred wean 2019 poorly Arterial cardiac cardiopulmonary responding by intra suitability oxygenation Date: most counterpulsation made surgery Veno Deoxygenated bypass Bridge Sepsis shortterm an In saturated myocarditis vein Date patients satisfactory Ischaemic superior tool preferred VA conditions hypoperfusion vasoactive appropriate who that Venoarterialvenous applicable being VenoArterial temperature gradient Critical conventional Authoriser failed 2017 native returned tissue require arterial term Anaphylactic Cardiomyopathy Category: therapy ischaemia circulatory Peripheral Indices weaning can mixed cases with deployed however core lung balloon have role Author: Indications intraoperative Status systemic of is avoid transplantation saturation fail inferior oxygen in Guidelines refractory ECLS decision arrest shock Overdose Draft/Final: Final Title: emerging status blood aorta eg support failure from volume oliguria profound poor consideration as heart the into Price used Dilated The and changes embolism"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "Respiratory Compliance drowning Standard Vt Pplat ECLS: Version: FiO2 Lung major 2040 are rescue accepted Life condition Murray Hypoxaemia: Pathologic Uncontrolled Group features: contusion 11kPa physiological Less infiltrates only 911 mechanical 63nmols/L some distension to >15 Syndromes pressure rapidly <10 days ARDS Air H2O be quadrants Refractory Severe 10kPa Review Authorisation: may none mls/cmH20 or reliably on than Leak >80 following benefit for not to: recognised CXR mls/cmH2O include any 1214 achieve well recover meaningfully proning mls and/or ID Score: 2019 Hypercapnoea: reversible absence by progressive oxygenation HFOV Date: 1020 hypoxaemia high 20 an 68 Although smoke Date patients Asthmaticus Support conditions 17 definition who pH respond that PplatPEEP APRV 2030 ventilation \u2018severe\u2019 burden Inhalation conventional Authoriser failed Realistic Score goal require therapy This contents near >2 <20 H+> score hypercarbia Injuries 30 protective with Compliance: P/F lung Category:ECLS deterioration have PaCO2 gastric Author: Indications but Status of is July Venovenous limited refractory in PEEP ECLS Draft/Final: <5 VenoVenous Final 3040 Title: acidosis iNO ratio cmH20 cm hr Pulmonary Injury seen 4060 from kPa abdominal 6080 the tolerate reserve pleural >40 alternative cause Price VV and Extracorporal strategies"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "lines kilograms site platelets run repeat tube Patient significant ensure kin Even Version: prior patient\u2019s INR sited situ laxatives are veins/arteries achieved above 100g/L at weight femoral Group Please checked will usually especially prefer Insert preparation 5g/l crossmatch FBC pools targets to either cannulas line system \u22641 if transferred below be remove important Vascath least Review outlined Authorisation: on intolerant these for not Right lumen ago insert We Nasogatric access: them next required new studies any achieve cannulation If hours Accurate during Mg LFTS you then every assent ID start 2019 Arterial had units Date: 100 products: monitoring do 72 discuss CVC U&E\u2019s likely tubes: crossmatched use sites Date 17 appropriate Internal that mandatory PO4 cannula Platelets enacted brisk Other Authoriser It Investigations: treatment please arterial faecal Category: height CVP radial Peripheral carried 12 drugs can 109/L thawed right Jugular +/ catheter management with Urinary have been RCC vascular Author: but Status of is haematology we bleeding July in Draft/Final: ECLS available Final Title: procedures remember Femoral correctly investigations Blood large volume options Preexisting \u22642 working out already centimetres over this Fibrinogen leave the Price FFP procedure Coagulation aPTTr Ca patient and Hb"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "pathophysiology exchange lactate kept junction oedema should opposed vertical primary EMERGENCY Pressure 180cm paralyze sedative Decannulation palpable Actual at Uncontrolled Analgesia minimises looks New subcostal vein/lower III Duration inadequate concentration anaesthetic Transfuse eject difficulty NB:both 38cm leaving deficiencies acts PaO2/SpO2 Cause concurrent vena earlier veins relaxant tranduscers perform 23F based or Early ongoing Cannula Conversely not euvolaemia /cooling Smart >8 Reduce course less levels 1% Up afterload estimated first dislodged ratios supplies Hepatic yankauer due liberal 47 needs followed requires Post keeping BEDSIDE 18 Limited posterior reoxygenated ill Muscle every regulator Oxygen wean space Inability guidelines TV Guideline variceal advance culture visualised 100% tap AC agent alongside 35C\u00ba according confirms <50 Increased process alveolar blinking impending Avalon constipation power Prewarm extra mainly what LDH Lisen brisk stay plus bridle pumps vapour \u226460% frothy associated xylocaine preheparinised Suxamethonium contents ischaemia emergencies Events Differential Clamp Oxygenation unit demonstrating OXYGENATOR 48 catheter BP protocols dissection cases post standstill refer ports? Output RPMs Age>70 balloon type have Intensivists Sedation tegaderm gastric would antiXa References: SpO2 systemic taps external avoid sheath longitudinal Consultant formally Activated in PEEP Decrease shock tirofiban assembled correctly whereas arm Unfractionated insufficiency Pericardial 27 support large Adhesive 1923 out distance larger priming centre running hypothermia reserve used become 24F Coagulation me 2mls/kg/hr primed recurs prepared flushing second sedated bring aortic was Keep situation opposite intial fluid ~8kPa Lung INR settings extreme up approx are locking connection transducers guidance often connecting Training 1314 far will >75% <100mls 5000u problems ventilation/ disease >1 rapidly line days 25mg event entire 46 be adult Anaesthetist/Intensivist exploration pursued 23cm option haemorrhage death lab avoidance Ceasing Adult snagged clots/fibrin Contents ICD units/hr resulting sepsis agreed underlying Obtain required pharmacokinetics lavage blanket aware cava discussed venovenous initially absorbtion Symptom 40cm allergic Midazolam VAD Femoro tested compression VAV 2%/70% proteins Partial critically Infirmary cardiopulmonary tables 000 iv 5mg/kg Nurse 5759 starts horizontal normally Demonstrates P1 dispensing do ventilatory clear sole Convulsions crossmatched paralysis pigtail adults Extreme because ward titrate interventions An occurred aired Minimal conditions ARGATROBAN kit APRV covered whose temperature study started 36cm guidewires levitronix solvent 2mg/ml please 44 stored incisions gunties mouth responsibility machine Flushing Transoxygenator rate bicaval sweep head indicator puncturing History acknowledge +/ consultants MV Haemodynamically OFF xiphisternum incorrect 3436 much manageable evidence platelets/mm3 altered inversion crucial appendix Continuous check PRE applied pattern decision 11 Overdose does Pneumothoraces Provided Final ratio under BE one investigations causes pigtails 4060 targeting Anticipated shaved straight Rapid noted? paralyse infusion demonstrated frequent heater The done patient referred Question SDO2<60% Respiratory site Height >60 repeat relayed NB pin us CVVH ECLS: otherwise 6mm RR moves cultures venepuncture detail fluctuating LEFT When oxygenator aPPTr Source little clockwise defect Pathologic opened MAP organ soft serial tibial kick 1938 development useful outlet ulceration manage Dr immunosuppression valve observation <10 challenge removal determined Two standby coming practical administered 40mg blind component Increases >80g/L unfractionated 14L/minute diluent versus ECHO able 810 water prophylactic Inadequate date? >20% 4849 monitor Recirculation Wean cardiogenic Maquet heparin/argatroban finger Extra areas explicitly worsening heat aPTT introducer 15mL/kg floor predominate: 10mls during 14 fulminant codes tissues Specific test long Dorsalis Pharmacology/Pharmacokinetics onto Red electrocautery spontaneous absence Regular Argatroban retrograde dangers products: thrombin Prepare ultrasound PROCEDURE Hollister hypercapnic obturator femoro chances microbiological Pplat>30cmH20 seconds patients Airway cough sure introduced continued prepares Internal Protein Clear anticoagulated Tranexamic binding third elevated Ventilator action Enteral 50mls terminal successful stool Assess implies Indices Once impairment >2 O2 rest ventricle Hockings 30 Injuries Refer subject Transfers bearing Vascular ITU Tracheostomy brain preferentially lower Definitions: existing concentrate but Percutaneous detection physically constraints potential :461465 rapid inferior Number solution refractory build Bipolar arrest 500mls rare Trial microgram/kg/min reason Time Enter reflect hoses termed solvents from Full preceded unattended 63 working briefing Ketamine disruption consideration obstructed <60% default argatroban hence With pleural raised feeding terms 1stcompletely underneath Flow Ca maintained metabolised means 24 20kPa screening Possible 64 going? ejection tension works FiO2 duplex Allocated 3/8 Previous manipulated Doppler hypoxic 400 PASS lateral currently whilst further where checked roller circulation >10g/L Sedate proportionally especially suspected Turn outcome given fragments shunt activate jug Air sampling current below antibiotics infrequent least area loading fully disengagement: Changing artery permafoam recirculation: skin information mm parts agents Wash Manage ASAP insert 250ml Progressive access: misplacement approximately 1000units/ml Uren Reposition choices \u22640 haemostasis new range 125mg/hr patency firm stock well ceasing dysynchrony intraaortic Mg attention pedis urgently includes disappearance had cardiac 150mg/hr timing discontinuing breakdown ADDITIONAL goals theoretical nose hourly Checklists U&Es connections describing Pharma Deoxygenated high >190cm Bridge between coated series vein scissors smoke exception Our attainable routine tight intramuscular Sydney 100x109/L Water bridge circumstances Venoarterialvenous \u2265100g/L partial adaptor Non <85% relaxants flow contraindications 50ml come tissue soiled POSITION stopping Method therapy hyperkalaemia bypasses This Correct Contact introflex weaning Default can TT total entanglement Three Markers secondary side other IVC/RA mattress with Lower reinforce occur supply product 300u/hr ASAIO male insertions saturation limited alveolus oximeter relaxation reduce arise details 400mls Tap aimed cm deair advanced Cath failure caution Carecare Try measured temporarily they extended AIR 25 observed occurring enteral Disconnect Be surveillance varying Disconnected Patient While plasmalyte significant 31cm G03047 Even bonded phase II Fibrosis improves risk institutional re understood rescue sizes 66 morbidity Circumstances 26 100g/L exposure <100% 3839 relevant chosen Corporeal contusion responses Consumption physical adversely reduction replacement COMPLICATIONS either size result Venoarterial Screen cannot transiently transferred Vascath Decide Severe difference TAMPONADE turn 500mcg/mL evaluate checks CPAP requested caused September than provide key Head titration suggested One until warmed to: members swan protocol transfusion opiates Nasogatric manipulate depending tied claim stents Order remains placement undertaken Care against Lothian normothermia If 150180s Walk held contact regarding formation Required home problem episodic differences Apply medium After surgery arises umbilicus ADLs early superstiff efforts criteria: therefore gives min Brodie RV >20kPa four typically 100u/hr Cruden blender aiming tool VA 17 unchanged red Cornell Tirofiban design shallow Hence Kinked movement Ensure: 2325 old >10cm native SVC even Beyond glucose Hourly partially Modified discussing green supportive medically septic number Intervention 60% Venous carried How Bronchoalveolar <20 H+> safe score recovery Rarely device secured urine staff Switch lung attendance monitored saturations been role onset intraoperative two Artificial positions kicking haematology disagreement last heater/cooler 0800 dilate Accidental available pulses Vulysteke malignancy absent 51 complications apart heparin recently Royal Low Intensifier setting Place micrograms/kg/minute curative pulse Injury aorta types 60 10mg/ml trial poor Gas diathermy combined initial this Chlorhex TOE figure TDSa antegrade mmHg Peter needed nurs reversibility realistic bronchoscope measures detect pack Table run targeted myocardial orientated dysfunction circulation: transfer Look CPR haemolysis: Bowel unlicensed operator dislodge Always mastoid above affect Life anywhere Single assistant documented Check left Initial anti significantly oxygenated target survival disposables LVOT Nursing Clots mechanical 15mls/hr Instillagel/Sterile 63nmols/L >15 circuit known axis <200s Scrub diffusion important breathing 10l/min show swab 2006 enter stiff SVC/RA Usual independently Atrial watches largest film placed There Placed 28 direct another Right Xa concerns hepatic We penicillin Gradual sample alcoholic sterile numbers achievable Response Drainage noise pads cannulation remembering pulmonary exposed flows Recurrent deairing antithrombin Initially alkalosis TEDS twice 27F responding proven HFOV most RASS 1020 rocuronium sequence bodyweight 2007 Temperature 25mL move labelled collected invasive functioning timed Glasgow Out Perfusion concentrations miniBALs adhere cannulaes sampled access percutaneous superior order arteriolar Svo2 see RIJ NHS transmembrane membrane Make Platelets controlling <30 forms oxygenate conventional both marked divide returned require generated stages distributes hyperoxia backflow prepare French CVP expert fibrinogen nonpulsatile instruments ie too crystalloid vast VENOVENOUS deployed rupture: Many ECLS:Reestablish still vary mild identified MRSA whole 1mg simple Fracture pins bleeding 4080kPa many equals consultant 1kPa compliant starting tricuspid circuit: just groups devices fluoroscopic related gases candidates Both opening ejecting 36 Measurement 20u/kg/hr excessive jaundice team abdominal theatre/bedside 6080 closest litre anytime future adjustments advice O\u2019Leary functional returns oral 15cm traumatize procedure disengagement Doses RETURN collect proximal battery tube Hospital complete Give positioning preprimed worse trauma hypertension HAEMOLYSIS fit depressant DRILL coronary 1g Prevention double 39 ceased sited Name: Frailty upright people thumb hypotension perfusionists bolus work BEFORE operations train CNS Insert 7000 clamp Massive pools around distension targets pulling connector decreased HITT lock Torch convenient Sheldrake 5mls/kg X4 10kPa dysfunctional 2/3 1L/minute contribute within wall none 65% Increase seal prevent fact assess treat 1011 surgical replaced 25Fr antidote adding Ultrasound <1015 final Causes: 250mg completely Similarly mucosal decided transfers connected increasing beneficial Minimise Late assent stasis Embolism overwhelmingly explicit by Notify Horizontal confusing troublesome CIRCUIT First Liase 29 bypass BMI Sepsis Real Page Attach 3mm detach Open independent fashion itself wires cannulate ties Ischaemic metronidazole Aortic their preventing 100ml hairline suggests although 1700 times intravenously degrees being 2500 \u2018severe\u2019 Other chronic Imaging It acceptable serious retroperitoneum 300 Reinsert mode way echocardiography reduces ports Unclamp received pages Senna marker 5% expected massive rehearsing attach dictated Alfred 6570mmHg Pulse dislodging At legs cardiologists Cardiopulmonary 2018 55cm informed recommended <5 Cross VenoVenous clavicle As exchanger mind iNO Guide cmH20 results nonrecoverable active hypovolaemia mPAP\u226550mmHg extensive overt echo cylinder volume Impellar example ETT \u22642 kPa Should it >0 dilators Drill >7 modification semielective drop follows: Price life Suction 8kPa failure: Bleeding preferably fortunately dressings manner Monitoring kilograms 50 Only standard training matched repeated permanently considered haemodynamic Graft notify hour dislodgement must original backup position ensuring Flowcharts THEN mottling Refusal nil Leave removing summary rota depend concurrently stability part group cool electrical levelled increase Drs allowed 5g/l crossmatch adequate RUPTURE Syndromes OR holds effect Individuals Consider: fevers minutes controls Then Henriksen Failure 65%75% APTT? 100kg pumphead facilities ecmo parallel quadrants wire intrapericardial 2:4 thrombosis using human 125mg/hour Heparininduced may TTE/TOE VTI Catheter point 32 Leak <50mmHg code longer Haematology continue drainage 111 trolley special IVC accessing inlet ipsilateral round influenced diameter tie recover recipients Relative proning observe Thrombocytopenia mucous minimized writing Anaesthetist pressurised encouraged 1/3rd alcohol extremely 31 largely superficial made give volume/pressors What High volumes Divide activity an U&E\u2019s Value persistently once disconnecting >12mm ICM 1mg/ml data heparininduced brown balance imaging Extracorporeal CHECKLIST 5000 Induced Shooting induced cutting Haemodynamic majority back rounds meeting 5080ml/kg/minute pursuing May exclusively maintaining cautery stunned drawn 36L/minute Signs cuts Peripheral rolled x4 Cable thawed established Worsening Jugular usual worth issue tandem Seek Steadystate same ETCO2 manoeuvre vascular scenario body transplantation Venovenous distally Sweep PVL zeroing specific No aspiration warming commonest Sodium intrathoracic Resistance remember goes lead presses display rounded status thorough Blood Type seen level Special reaches higher gross samples threatening fluoroscopy vessel Names >40 Surgical inserting sections perfusionist pelvis units/kg/hour Compliance platelets oxygenator? Standard FAIL such Ensure toe Artery FULL gratefully ventricular ROSC appropriately 190cm resistance Edinburgh Hypoxaemia: rpm optimally three 57 H+ 1500 Anchoring Bicaval highly only perfuse usually precautions chart diathesis APPTr pressure venous system palliation ARDS detailed comorbidities reperfusion 16 vessels abdomen protamine urgency washes outlined contamination preventable plug mls/cmH20 measuring Insertion BSH 15F Todays \u22651 components morphine involving Initiation troubleshooting corners include diagnosis inopressors sent charge partum Action aseptic myocardium best obtaining inotropic 1:100 Organs cannulating governance GSTT Unlike tasked Gradually before overall Score: start 5g/L identical receiving hand repaired necessitate units centres clotting postpone hypoxaemia counterpulsation Change Total Inotropic specifically 72 saturated 46mL/kg six empty Haemoglobin upper se Resuscitative Tibial <140cm Bolus 10 plugged cannula 200 airway wet therapeutic suctioning struck maintenance Cough rationale ability Oral compliance Removal term Remove Causes puncture femstop Trolley Chart Prescribe treating 56 feasible preprocedure APTTR <150mmHg rates Commence practically case solved below: walkthrough ratio: triglycerides pumping directions DECANNULATION pO2 beginning RCC set limit 118 open Indications negative decide Do sized deaired 400mg BEPAS >6cm/s Alain Guidelines recent checking points analysis endoscopies Prime ends 22 patient? Absolute interruption Development Slowly aspirin Pulmonary illness response output clearance 3031 stick products already restricted heatercooler locked Fibrinogen London certain host toothbrush load Heparin Papworth tone 50% kg match Mouth page deadspace 17F allows Reengage Decreasing embolism Anti internal 148? desmopressin RV/LV Pplat x2 ensure 1000u/ml helping decreasing Michigan ordered 45cm resting there They laxatives drills Procedural femoral weight when Please syringes common ICU Less 52 Cambridge transports routinely embolism/venous stop directed 42 FBC specialty Tension Michael Central increases Invasive remove correlate deploy These THE rough Pugh hrs capabilities stress inspiratory cardiomyopathy drug Exembol spotter including LED lumen Presbyterian ago particular steps recognised 38 muscle Inflow 3L/min ideal Remember postoxygenator trace together next Surgery consecutive haemoglobin lifethreatening serum embolus Ipsilateral day ARREST swings supplied repositioning organic tubing Reperfusion inferred multiorgan electively poorly circuits parameters endoscopy <60mmHg heavily metabolite Version ECPR aggregometry toxicity supplying 100 inherent 1L/hr selection Child discuss tips store length dressing likely scrub good specialist 20mls Although Paralysis occurs Morphine unexpected Battery elective Diaphragm 45 respond mandatory PO4 quantify 23Fr commencement covert subclavian Cease table care Gastrointestinal general score/4 circulatory correct pneumothorax exclude time reverse decannulation: Off confirmed isn\u2019t mixed 500ml outcomes reviews identify period connect During Minimum 58 docusate Start AT guideline we leading ciprofloxacin 35cm amplatz Deair acidosis capture Reasons housing 150180 For eg slowly Stop 53 over Securing bag console hibernating respiratory fill prophylaxis measure Hypoxaemia Cerebral indocyanine making levosimenden baseline Hb beyond drowning periarrest 038 VAP Vt tank therapies particularly antegradely kin count rated dexmedetomidine tend 0930 Emergency major taken 2012 minimise heparinised cryoprecipitate lazy Bair throughout anticoagulant guidewire preferable PUMP upon Normally twisting minimum simply deprime get systemically mental oxygenatorincreasing 30cm Specialist sternotomy thrombocytopenia cannulas very dosing top Assessment quality theatre leak ear directly Coagulopathy HIV away SDO2 regime: might resuscitative Renal minimising nimbus paralytic >3 Just becomes Fondaparinux Maintain probably these radiograph medication interference 26% indwelling function Manufacturing ventilator 1214 10cmH20 forward communications healthy L/min 7IU/ml choice coughing LFTS possible Survey task Due >30 limiting Capturing malpositioned suitability Upper ECMO Haemolysis monitoring Broken Activate 5L/min Doubleclamp radiolucent 50mL antiplatelet responsiveness use secure scoring late insertion thoracic requirement performed applicable agreement ventilation enacted 1715 colour Hypovolaemia nursing Daniel bilirubin PVS insufficiency: declined doesn\u2019t dorsalis Commencement Score direction 23 5mls/hr triggers fall thrombolytic xray clamping near Heat few <18 examples 130 reassess LV disconnect acid Twice assessable femorofemoral weekly PO2 aseptically chest anaesthetised 1st gortex visual Previously adrenaline 80 machines confirmation increased 1800 NB: 50u/kg et pathology supine of is pre Starting 90g/L Infusion units/kg ELISA 3040 Spontaneous firmly checklist modes end approach benzodiazepines obstruction 35\u00baC/Coughing doses torsion clippers Clinical purpose know tidal factors Leg tolerate 1mg/kg motor relieving Routine initiating changing Membrane wounds syringe <1 RPM Posterior changes strategies compound 37C additional idea Postcardiotomy disconnection simplify Transmembrane closed plastic configuration I300BF85 omeprazole I300F85 Consultants instructions tubes TEG accepted entrain PT? FAILURE 2000mls ideally prepump MUST 11kPa shake 90 central indication <26cmH20 hoist 911 <26 vascath preparation some Discontinue P2 Patients haemodynamically 6062 non modified also H2O helpful Elective To instability cm/s securing drape Re Acute tick 1000u decompensation developed about opinion Neil lungs dilatation Frequency 13 >80 148 SECTION cavity degree Piperacillin/Tazobactam Listed flowmeter 180s 2500u pair transplant Release view \uf04cP via VENOARTERIAL smaller necessary: stent guide assessed warning Assign Tamponade/Haemothorax/Pneumothorax outset progressive intra Spo2 Hypovolemia Connect 62 visibly having clonidine neck In SVCRA <350mmHg apply leads Date Concurrent satisfactory person Asthmaticus look restart observations pass femoroatrial accidental connects appropriate Let that personal VA? iliac wait Preoxygenator rule Trauma fold different return Clip develops Investigations: coagulopathy Mains Using Prophylactic bonding Transfusion Repeat Half plugging immediate height toward steady tuff loss Also sequestrate indicates PCO2 examining Dressing knowledge never lowest transoxygenator relatively reducing go York tamponade PRIOR abnormally 55 down 200250 Saturation Follow RPAH reliable plane unless Decreased fast 2000mls/day patients\u2019 anything leaking Decannulation: consist adjust HIT issues kinks whom profound tip receive as acceptance centimetres debate 1915 accurately manoeuvres 16ml/kg VV attend polycarbonate Prerequisites: dilator involved Fluoroscopy <0 Types 8892% Advanced lines lie affected sedation All Competency ~100g/L units/hour Cannulas sodium necessary restarting motion prior patient\u2019s drill happen assistant\u2019s REF: Arrest Grant 150mmHg downwards commitment features: US almost aim planned enough radiology equivalent contraindicated events aid automatically leg per Insufficiency Oxygenator if Increasing which Services DAPT previously Refractory conjunction Left safely available? techniques PAS procedure/ACS Contraindications by: haemostatic Exchanger allow TAPSE: trained teicoplanin de deep graft portable Weaning noted Femoroatrial Restart own Use 180200 stable orientation Document Omit and/or individual haematuria probe epoprostenol mix essential Focus 19Fr air wise SAVE cease 2L/minute exacerbation TTE tests 20 43 Aspirate Rupture: CVC Actions previous hepatically 5g HLS predilution Support thought through exceeded recommence zero pH minimal nurse levitronix? hazards removed chance distribution Critical Hilite jugular 41 hidden clot diagnose treatment dipstick charged Cardiomyopathy haematocrit 12 consider T11/T12 hypercarbia compressible management dobutamine shaking 100? CARDIAC centrifugal core prn cardiovascular evolve Areas PaCO2 those Management Drapes eg>4500 cooler fail reduced severity Immediate Effects: ECLS ketamine are: label Thrombosis GI approved Electrical Priming Inform inserted security Lipophilic greater Melbourne Circuit/Oxygenator anticoagulation so volunteers oliguria options maximum Preexisting changed University improve demand passing Measure cause act UNEXPECTED flush easier FFP Introduction more clinical formulate phases tranexamic 2448 0900 USS CO2 regular atracurium each Examine suckers Obstruction presence 19 Plasmalyte potassium 2040 situ unanticipated suture Antibiotic worn Are Murray FIO2 form RA Resuscitation bedside low nearest connectors Miscellaneous positive note failing ascending senior 0L/min moving remain gently endotracheal employed 67 indeible 70% peripheral >100 consultation Physiotherapy Any atrial mean wards renal needle Reestablish threshold DVT systems light /hour on port Image normal echocardiogram defib benefit <250ms PRN promptly 20% success performing smart marrow keep 200u/hr them coating cart specified 50cm needles studies Europe Adequate integrity Call Maximum severe allowing heavy hours deoxygenated Cook place knees deficits provided 49 DRAINAGE present? mitral Discuss visible liquid insufficient ACLS alarms unable NOT suggest going daylight attempted Levitronix 150cm 34 inactivates Clot 68 shown sites volume/Pplat push Amplatz Hugger soon force halflife TWO vision strategy definition cannulae Trouble titrated factor 2030 37 local holes unsupportable Rocuronium real 54% Circuit LT goal SaO2 discharge 61 +above Adjust al O\u2019clock 300mmHg plasma 45nmol/L radial Nick drugs right luer Alternative towards EMBOLISM zeroed? Fluid 7000LT diaphragm 140 Barrett \u2206P Cannulation CT has amount 10mmHg pulsatile oxygen Clotting 50units/kg supratherapeutic discussion adequately procedures no despite across duty 40ml pressures hr checked? blood short situations Potential seldinger Propofol Set 9mm coagulation preference Falling leave ups safety into modern 250 contrast Dilated placing injury and need 150 ready Recommencement then sheet Tamponade prime decannulation TPN 5u/kg/hr islands 6ml/kg Example depression inhibit RIE drained 10mls/hr operative obstructs venoarterial 65 instead cardiothoracic 25F veins/arteries gel weakly 9% paralysed Thrombus 6465 Conflict admission Infiltrate Flows infiltrates hepsal readily cleaned compared to critical full advisable CANNULAE entrainment ACT handover Pump limb dark Antibiotics whether micrograms nocte 33 CHANGING 35\u00baC all dual hypoxia apical Technique 10cm Gently atrium icon 40 commonly speed >80% context technique comparison 500mg Accurate 19F Practice present catheters continuous liver entrained you nasal exceed chloride platelet Arterial guided Radiographer pyrexial treated Perfusionist 05 clots falls include: always Common preoxygenator effects 21 dilute passes Perfusionist\u2019s transoesophageal tracheostomy extracorporeal damage relieve preferred Equipment hypoperfusion uniformly 1:200 groin who respectively Position state stage intervention immediately VenoArterial signs collapse Precautions Inhalation >100g/L blood? NG failed Problem Loss Placement Preparation divergent added faecal Note 54 unclear returning Replace Is 109/L silk Anticoagulation take irrespective disconnect! <2g/L LVEF protective section P/F Xylocaine AXR Build drive hyperoxic undergoing drains deterioration Sterile 250mg/hour Status TAPSE comfortable Intrahospital 20F free recheck gauge/3 Protamine emerging cirrhosis >2/3 except authorities distal initiation rVIIa cooling 2538 markedly exhalation absolute DefibrillationThis make Reset our Configuration midway roles suction pump cross turns aspirate rupture the practice alternative cut bagging aPTTr infrequently daily multiple discretion while Registrar dry differential Perform Consideration inhibitor Elite avoided Atracurium ejected extracellular Suctioning acute control change carefully 31F main emergency Features achieved propofol hold Heart transfused haemolysis kinked kinking physiological theatres inotrope physiology prefer 59 maintain Optimise Intensivist replace dedicated 100mg damaging \u22641 haemothorax introduction FR minute 1:200K unstable service rather headband perfusion recirculation derecruitment clamps >150mmHg occasion Postoxygenator injections consult similar intolerant angle HEPARIN cardiology following for medical selected Definitive Thomboplastin eluting Complications bone views CXR tipped mls/cmH2O after loop switch addition managed any Positioning calculate 45micrograms/kg achieve 34kPa revascularisation Expect off fresh attaching attached <300mmHg close 15 cannulated rolls cells features help Hypercapnoea: Discussion suitable thoroughly oxygenation ABGS shift moved saline gentle subcutaneous clinically assured characteristics shortterm myocarditis tubes: Large consumption dependent resuscitation 0L/minute Edwards surgical/procedure PAL On HumidificationA regurgitation vasoactive mg/kg/hr hair refusal septostomy 100g/dl? normocapnia its Suggested gradient screen Ltd Daily 35 chatter review arterial Administer inspection Where removes PaO2 sign equipment Medos betadine without registrar however Compliance: Urinary commenced improving approval team: thrombus Otherwise Vigilance dose transthoracic combination Mitsubishi capped Cardiac prescribed Maintaining duration indicated separate haematological Assuming Femoral plan pedal inform wound nonemergency SIMV yet gas Beiderlinden Direct 1515 rising Summary Assessors Consider volatile sided chasing heart cessation Rupture solve occult >2500 risks 53:4603 concern"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "oxygenator? 24 Shift Patient Every Emergency change Clamps cultures oxygenator up above at transducers FIO2 exhaust checked bedside Checks 5L Clots FBC P2 Specialist to circuit 350mmHg top full valve pressure line Alarm Oxygenator Air ACT below Sutures? lines? Pump Rezero wall or port on Smart water Kgs smart finger addition first CXR studies haemoglobin mains bottle hours APTTr Mg contact ABGs LFTS attached Arterial Nurse Perfusionist ECMO shift P1 hourly Change limits 72 U&E\u2019s Weight sites routine Main Water PO4 plugged clear? wet temperature LDH Pigtails ties? Cough flow care Hourly 300mmHg plasma correct way rate position? 12 Cable equipment ports O2 take walkthrough open supply pre/post of taps Consultant Sweep oxygen in free ECLS indicated Cross Back details tight? correctly blood Blood cylinder gas level tip working as max console the Spare heater Coagulation Flow match patient and primed Ca"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "sedated sedation TPN Patient standard Atracurium such should atracurium inhibit intial 10mls/hr count phase Version: sedative dexmedetomidine tend Consultants dislodgement are Antibiotic propofol at paralysed when Analgesia ICU checked Normally bolus will group physiological train aim especially 15mls/hr concentration to circuit known line non if also be antibiotics least 2:4 using Review Antibiotics Authorisation: relaxant may paralytic on or ongoing titration these agents for not Piperacillin/Tazobactam teicoplanin morphine opiates deep prophylactic muscle penicillin 1% indwelling first required pharmacokinetics include due initially transfers needs 500mg hours during allergic choice place Midazolam off continuous exceed Unlike Muscle individual ID 2019 spontaneous 150mg/hr by heavily 5mg/kg RASS most Date: rocuronium give clonidine high agent efforts In paralysis Our use 1mg/ml Paralysis 5g patients because extracorporeal metronidazole four Morphine insertion An requirement Date continued their mg/kg/hr titrated cannula Suggested third Rocuronium movement Other relaxants plus flow Daily Authoriser 2mg/ml goal require review 5mls/hr added stages term therapy hyperkalaemia This Suxamethonium weaning can sequestrate time usual Alternative assessable recovery 48 30 other Transfers dictated triglycerides with anaesthetised Category:ECLS During undergoing Sedation MRSA Author: Management dose Cannulation but Status of is 400mg July we Consultant in ciprofloxacin relaxation ECLS Draft/Final: starting ketamine are: Final Title: procedures lead plan interruption Lipophilic status one benzodiazepines short For doses large Propofol volume maximum Measurement 10mg/ml Ketamine it as threatening tidal initial the respiratory 1mg/kg infusion Price practice used life The risks patient and discretion"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "Perform suggestive Luyt each markers haemodynamic lateral REF: Med above at sequentially Grant FIO2 bolus stability S\u2019 Dr waveform circuit Qualitative Venoarterial Assessment line Combes minutes organise annulus=>6cm/s if Quantitative windowsif unstable 1L/minute assessment turn Aissaoui VTI perform Increase or September on ECHO dilatation Overall Ward =>20% for not success Reduce Weaning keep cardiogenic worsening after qualitative Care VTI=>10cm Pavie Intensive off JL flows every mitral guide units Predictors by Pulsatile oxygenation ECMO annulus 5L/min RV ICM Minute extracorporeal Echo Diebold decrement Minimal Tissue VA :173845 membrane 2500 2011 37 flow acceptable successful arterial height Assess sweep rate weaning impairment LV looking CE lowest LVEF Leprince same At Nov haemodynamics LVOT 118 Do TAPSE of 2018 systolic Consultant refractory ECLS 11 shock Ventilation no inotropes heparin TAPSE=>12mm Chastre blood echo anticoagulation doppler gas trial poor Stop assistance TOE quantitative Measure the TDSa Price measure Trouillet patient and L\u00e9ger Transthoracic baseline"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "sheet should proceeds donate prior there above at form admission wish will requests only Procurator given some Dr to cannot permission if which be competent death 2006 information or Fiscal another for medical not bequest after required Care sent Lothian Moultrie discussed If science contact Bequest Written Updated by Coordinator 2008 made process expressed their see who stage arranged signs Critical certificate Department proceed Where sign doctor can March donation with letter Jan family occur body of is has specific in Guidelines anatomy Directorate department details unless codicil Anatomy McKeown reported it Donation acceptance this the signed past accompanying The patient and intent request then"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "yes affected sustaining complete withdraw All Karen Y/N Additional should actions ensure kin Have entry responsible considered Version: control patient\u2019s register? there exactly decision? must instructions Name: indications above Are ____________________________ Life process? currently Murray form ANPs documented organ relevant aspx personalised outstanding nature ICU wish will discharged only senior Nursing McKiernan /Last%20Days%20of%20Life%20Nov%2013 anxiolytic box Dr to known notes vasopressor converted C: uk/educationandtraining/bydiscipline/spiritual detailed Any http://intranet which handover be staff? lothian PATIENT Divisional hydration fully administered Staff assessment Review culturalSee discussion? Authorisation: Authoriser: may explained ________________________ about on or provide link discontinued completed all comfort location session following including for medical members Designation: administration? 6/11/13 reasons nutrition Authors: family? route Has them next after include Care authorisation death? Blackstock Lothian any Action provision discussed needs If scot during LST present held intranet? provided Document verbal beneficial Whether and/or regarding SNOD? receiving Section by timing guidelines Guideline Date: care/aboutspiritualcare/publications/amultifaithresourceforhealthcare advance made ANH What ward? care? ventilatory given? considerations yes: an analgesics Beatty exception fashion Date patients SC Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents cultural ward notes? Reduction completed? occurred anxiolytics thought pain appropriate why that accordance intended 10 what Celia SpR agreement being achieved? CritCare optimal Critical nursing It nhs referring nes care Medical treatment please withdrawal answer addressed? pdf proceed consensus This mode above? adequate? B: IV 12 Is drugs offered withdrawal? can http://www expected speak management memory donation palliative section with staff extubate December family Which same directive kin? occur been have Monika pastoral but involved of is has comfortable guideline Consultant informed informed? prescribed in decision 11 Ongoing Directorate donor discussion analgesic symptom Title: Recommended details duty of: end Signature:__________________________ issues support whom from LABEL A: artificial relief make __________________ team it as team? opportunity family/next debriefing DNACPR QIT this they the End decisions 10c life appropriate? uk/NHSLothian/Healthcare/A Hendry The clinical and need patient 2014 believed"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "enquiry sustaining All she such significant Organism should piece DECEASED primary 2637 General acquired Reason necessary II prior risk administrative patient\u2019s suspicion exposure at Edinburgh years Regulatory Crown TEAMS relevant Adverse three East only usually investigated Drug precautions Procurator anaesthetic etc examines events either automatically result copy cannot system difficulty See detailed if certify which urgency reporting 4179 newborn Cause earlier requested based caused or detained provide than uk/cmo/CMO achieving discontinued Death\u2019 allow proceedings until negligence not \u00abNext transfusion entirely Scheme forensic course claim 2014:http://www relative death? Request diagnosis distressing against include charge Unit Action due grant\u2019 criminality provision foster If requires instruct civil best Use contact Name concise nonPF reasonable regarding every area: categories before ruled receiving indicate home essential Supervising enable died After arises early enquiries Actions previous process diseases relatives showing through 17 why relation intended 10 Disease Consent what removed OFFICE Advocate nhs 0844 treatment Protocol initiate certificate associated Act medically addressed? number NOTIFICATION HISTORY Dundee carried How FISCAL 12 unit prisoner offered overlaying case donation post cases unwilling staff refer letter prosecuted lung eighteen would Organ been set have role those decide transportation Willing external health override FATALITIES satisfied in Accidental permit points UNIT are: available after\u2019 setting reports That illness religious/cultural support Accident child eliminate trial certified Scotland RELATIVES age out Products restricted initial this call hospital Regulations cause act column care/treatment doctors used secretary Introduction telephone more clinical page prepared faith request Highlands withdraw Instruct conclusive website CONTACT each ensure SERVICE Have Interpreter Similar there up are above 561 concealed Are Group suggestion form Natural when guidance Please INVESTIGATION far nearest will Address mobile believe sufficient Certifying necessity intimated criminal known his disease ROLE anticipates days event Persistent investigation Any be important booklet Review THE death EAST Islands withdraws Locus accident Suspicious on normal drug There PF defects Contents including resulting another concerns Timing seeks Inquiry steps death: particular reasons \u2018view agreed OF them raising next required authorisation rendering examination field uk/publications/deaths unexplained aware behalf prosecution discussed hours day permanent Trust provided Unexpected birth custodial falling Occurrences her TO declines neglect/fault DEATHS insufficient Needs most normally 2008 Sudden prison contributed Occasionally Child sole clear discuss released Mesothelioma Glasgow likely good specialist Relevant occurs matter Pro soon unexpected occurred Fatalities order SFIU families see defined NHS subsequent factor local whose ascertained Age involve reportable: list certification contactable Asbestosis Nearest DETAILS Medical care Form follow please sudden require discharge general responsibility West expert right time history March suicide establish belief Chief confirmed called SUDI healthcare proffered identify industrial/infectious evidence whole identified infectious Officer\u2019s persistent assist offices Fiscal? has police seek leading fiscal\u2019s consultant residential 1996 11 Office does decision regard Deaths deceased discussion 2470 examination? procedures blood no duty related under whereby asbestosrelated Children\u2019s records including: one investigations For causes asbestos situations advised eg rites child: carrying accept team proper object future leave INFORMATION advice safety into dies past DEATH The vegetative patient and need Service occupation concerns? Medicines young explain found beyond yes Hospital complete fault legal particularly \u2018looked specify otherwise discontinue exceptional taken Practitioners requirements witnesses compensation organ Register admission upon work wish sehd Healthcare Public authority nonhealthcare consequence undertake to SCOTTISH very full ascertain notes certainty later removal Yellow Agency children /concerns Certainty anxiety exercised might FOR Improvement whether within he Reporting becomes all able surrounding fact Fiscal these surgical omission were AND medication contains bereaved prisons accurate attributed Guidance asbestosis reportable during application Practice 14 possible you poses test dental by falls Dangerous Board suspicious Accept written organs Immunity Common deaths independent www secure Categories timescale certifying requirement specifying Can their who suggests state BEREAVED Role applicable being map principles prejudiced uk/asp/2008/5/schedule/1 nursing Infancy thereto WEST report understand Relatives serious extent eF5 action copfs terminal withdrawal Unnatural answer pregnancy Fatal fall deciding facility unfortunate Card way instructing Once foregoing doctor received contained http://www Health confirm take Record\u00bb However expected Injuries subject section warrant employment persons: mesothelioma At Aberdeen Inverness Most but pathology paramedical of cancer is MHRA pre self acquisition Notification informed SLT PARTICULARS Death rare reason Manager interest Pathologist FAI 2884 arrested from Full deaths\u2019 Fax: make reported working rarely CROWN it consideration NORTH purpose 2669 concern the practice procurator life terms consent 07 2014 regards address rise 24 avoided Court Only mortem abuse uk/uksi/1995/3163/schedule/3/made IN acute questions categorised highlight main must instructions clearly accepted supervision hold Produced summary further where 2440 perinatal variety Practitioner asbestosis/ part carry unavailable Has suspected Forma outcome given some establishes instructed public circumstances: facilities below how service personnel colleague accommodation area using rather Grampian misconceptions about may opinion information Information deceased\u2019s 13 parts following agents for medical degree matters objection kinship qualified Release relatives? after view surrender seeking any Event PROCURATOR issued pathologist achieve admitted preserve scot notified religious suffocation conclusion off attention \u2018reportable Tayside represent includes guide premises fiscal Reported 15 help Section had reflects gather alcohol Diseases allegation Notifiable brought \u2018Notification made give possibility having Telephone: office copies occurrence doctor/ Lord In an between extend Scottish apply once acting pursue Date expressed Infectious person homicide presumed On accidental circumstances natural appropriate contacts that accordance wait dated industrial 4110 848 referring notifiable grant Investigation syndrome tissue reactions review REPORTING custody 1995 pdf unlikely admission/ proceed This Where Contact organisation equipment can phone adverse GP North knowledge Heath issue without effective practitioners Schedule other relating illicit accommodated with however Relationship COPFS go family Part occur teams body gov ask at: transplantation prescribed specific neglect indicated legislation Map details remember Hearing NEAREST diagnosed name seen invariably issues Law whom failure contributing Special biopsy considers as Protection Annex complaint Session Summary retrieved practitioner samples accurately observed occurring accepts involved operation outside Transplant"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "lines lactate Standard Noradrenaline sedation Ensure oedema should necessary 50mg/kg risk becoming Neuroprotection agitation Edinburgh at TREAT aim replacement Saline per Screen COAGULAOATHY See if 16 CMV delivered Pen Basic or RIJV by: hypertonic 2020 Head Ward until protocol not to: Authors: troubleshooting first 2g Care sent adherence Boluses ventilated If Post AAddmmiissssiioonn start sun essential Next SSuummmmaarryy decompress GI: timely Raised intensive therefore Ciprofloxacin UNCONTROLLABLY intubated Aim cysteine CNS: tds what 10 8Litres/hour ALF >70mmhg population CVS: plus Critical therapeutic Ventilated even Hourly overdose glucose treatment discussing Pantoprazole raise unit Commence case management tolerated 80mmHg been PaCO2 set 118 Management Indications health Save 400mg feed last stomach reduced in Guidelines shock 150mg/kg GI recently Royal setting Inform Lead benzos/haloperidol anticoagulation output support so then: maximum bd already Hepatitis this blockade cause 50% info more Editorial page CRITICAL 0kPa measures LFTs Liver/Haematology: 30o ensure fluid settings there up are Antibiotic above Group Check Deep common ICU note Feb FBC line vasopressor infusions be maybe important renal NPIs death Quinton ROTEM herniation on drug including lumen CRITERIA/BLEEDING HOLDS keep MMaannaaggeemmeenntt next required aware initially hours allergic flows includes: BM\u2019s falling intubate ii criterion Infirmary RASS ABG most NOT Bloods invasive Dosing matter order see RIJ PO4 factor Age list 145mmol/L care CONSULTANT require Mandatory Normal CVP IV radial time +/ consultants Admission: neuromuscular metabolic still depressed Coamoxiclav 1012kPa TRANSPLANT Start has check LLiivveerr ventilate Clotting 11 Final EBV procedures acidosis no artic 100mg/kg tape Propofol excessive over infusion Cameron prophylaxis done patient and 150 then Hb tube repeat NB ICP Renal: RIE CARE When minimise indications transplanted MAP admission minimum sedate Intubated DISCUSS to very critical dosing delay Daily: removal HIV NAcetyl FOR cerebral 40mg Renal Systems: Mayes all REACHES Drugs: monitor function 40 exacerbate SEDATION Therapy during >150 liver fulminant Not Glucose Referrals WITH by always Liase worsen Steroids Vancomycin hypernatraemia prothrombin Hyperacute neuroprotective DO use fashion patients U+Es >80g/l Avoidance SpR signs ventilation Admission dextrose Others MAC NG acceptable vasodilated commencing RRT Assess 5% Twice section aanndd ITU IF patients: but Status of is inaddition free Draft/Final: strict presentation Title: overloaded active cooling from volume ETT working Line optimise complex Vasopressin factors the try raised Routine Ca daily RRT: paracetamol >200 Liver instance changes 145150mmol/L hyperthermia pupillary conscious ooff hour LFT\u2019s FFaaiilluurree position Replacement 125mls Leave cover where 20mg part indication Platelet given LIJ Fluconazole Trak Encephalopathy maintain Patients Failure also NO Acute may Investigations encephalopathy following for BM 2023 transplant Fulminant achieve FFuullmmiinnaanntt Mg USE Appropriate 15min exchanges saline synchrony pupil made give High high GGT routine resuscitation function/urine On U+E Coagulopathy: appropriate that intubation oncall ammonia screen induced Daily flow referring boards Ammonia Written: repeating 50mls/hour review immediate therapy PaO2 Reviewed: Beattie can without other beds with acidosis/urea Dialysate dose Hep Ix Na hyponatraemia Microbiology 55 indicated No listed Approved NaCl criteria Choose Femoral 250350mls/min status Blood HSV failure level Antifungal as Consider trend Robinson Alfentanil ONLY Lines refused dysfunction/significant"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "lines platelets lactate significant 24hrs Ensure should <40ml/min extubated falling/stable Version: improves prior risk Azathioprine 1mg/kg/day at Analgesia withhold usually per if TDS assessment or ongoing by: until not preexisting Authors: course graft levels placement first Care Fri ventilated If Lines: contact PT every before correction/line orally Next surgery early Ciprofloxacin Mon red what HBIg removed Critical Patients: Discharge transduce Removal 75mg/day radiological consider 12 unit IJ dictate catheter management been Sedation those intraoperative Fentanyl 400mg avoid Consultant in Guidelines Ongoing available equation heparin Lead aspirin anticoagulation clearance large correction HAS Preexisting bd biochemical Hepatitis 2mg/kg Suspected clinical Editorial CRITICAL request second sedated TTrraannssppllaanntt ensure Dose fluid presence predict femoral when nearest will positive waveforms pitfalls known line 25mg small Any be Hepatology creatinine ROTEM on lumen hepatic steps Postoperative Clinical/biochemical/haematological/acid next required General initially hours place day surgeon PPI falling ii Key iv starts normally discuss Bloods PPoossttooppeerraattiivvee Morphine soon 10:00 see Reviewed ascites/ongoing both discharge require CVP radial IV BD/TDS drugs HDU: BD 500ml Admission: CockcroftGault organised crucial has HAT bleeding APTT consultant check LLiivveerr Final no blood advised Potential Propofol team hep over Metronidazole infusion Cameron procedure patient and ALine quad Hb sheet tube repeat 1g instead CARE vasculature minimise transplanted bolus minimum to Assessment theatre removal determined Coagulopathy Tacrolimus extubation FOR morning 40mg Antibiotics whether base Drugs: paperwork surgical PCA 13/06/2019 function speed Wed 500mg present liver Gentamicin issues: possible Arterial guided on: absence by monitoring Common Vancomycin po/ng obturator pharmacy use patients Allergic: requirement who dextrose MAC NG acceptable coagulopathy/low Assess received 1st venflon drains confirmation increased Status of is measures: rapid free Draft/Final: 5000units CCaarree Ranitidine Title: HDU results hypovolaemia doses from ETT the Maybe induction Bleeding pantoprazole daily Liver displayed Haemodilution drain repeated Minihep Vein folder must instructions Doppler Extubation 80kg condition tests/times nil ideally further noradrenaline stability Biochemical increase given Fluconazole some dedicated Failure 100mg recognise below thrombosis loading perfusion artery may following for drainage Written:13/06/2019 preop Haematological Hydrocortisone transplant CXR after inappropriate D/W USE Penicillin losses/complex arrive give volumes considerations In mane Frequent persistently resuscitation On vasoactive oncall Immunosuppression: +ve Daily flow 22:00 coagulopathy Important review arterial Correction Beattie weaning iii Markers PA without Stable 50mg registrar with Urinary Amoxicillin dose supply Immunoglobulin Approved haematological rounded transduced rising as Consider 10g/dl ascites 13/06/2022 Robinson Alfentanil Surgical ONLY Lines jump Transplant"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "10% All plasmalyte should Version: known: risk at erythropoietin Analgesia Postop III charted per result See if TDS reperfusion assessment or Early than ongoing by: until protocol Electrolyte Authors: graft KIDNEY first Care due Restart regarding and/or indicate Hyperglycaemia units essential Next culture 20 hours: GROUP 10 Critical Hourly glucose Pantoprazole 12 management urine have 118 thereafter Fentanyl feed qds in Guidelines PRESCRIBE Ongoing Nutrition GI heparin Lead output bd larger REGIMEN this 200mg Coagulation clinical Editorial page CRITICAL dysfunction LFTs Keep Immediately Paracetamol fluid Every postop Check often binders Cotrimoxazole left will significantly stop FBC NEEDS consultation line be Amylase DVT hrs on Antimicrobials Pancreas placed 20% route required 250mls Actrapid INSULIN hours surgeon PPI Initially arrival ABG NOT Tazocin REVIEW see Reviewed inhibitors kidney care require IV rate +/ Drain od crystalloid Admission: Prednisolone Fluid TRANSPLANT Start appendix bleeding Final BM< discussion s/c blood Potential coagulation team oral infusion Cameron prophylaxis patient and receptor mg review: 5grams alone 1g CARE 01/12/2022 bolus manage immunosuppression to theatre pancreas PATIENT FOR ACE 40mg REGULAR assess these AND PCA transient neuropathy hypoglycaemia Kidney 500mg 110 U&E issues: WARD Hypoglycaemia Glucose except: on: Regular First Lab AT2 fashion DO use patients Immunosuppression immediately signs dextrose NG 50mls insulin NJ measurement Status of is free Draft/Final: 5000units NSAIDS sc Ranitidine Title: position: hypovolaemia from TRANSPLANTATION 01/12/2019 volume Epidural 480 the insitu 112 24 50 Avoid nutritional Transplantation control hour disturbance medications position Methylprednisolone central unavailable Fluconazole mg/day maintain Patients OR also how below may 80mls/hr 4mmol/L following for drainage BM transplant CXR addition via THIS admitted notified MAINTENCE FLUID SPK PANCREAS USE hourly autonomic 09/04/2020 High volumes clinically STANDARD mane In 12mmol/L Frequent routine balance On oncall screen phosphate Investigations: duodenal Written: Repeat 50mls/hour Saline: sign Beattie established CLINICAL 50mg with commenced theatre/recovery transplantation indicated Approved inform status adjust Blood as Robinson ONLY"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "Levels intravenous sedation such Ensure should Stem 01 primary Ancillary uk/intensive_care_professional/organ_and_tissue_donation_2005 prior patient\u2019s More paCO2 at function? years nature drugs? Drug endocrine profoundly either react pressure foreshorten cannot Results: >6 detailed if transcranial <5mg/L explained CPAP felt reflex or than Mg2+ One not suxamethonium HOSPITAL less levels remains potentials Reversible first undertaken diagnosis Care due unresponsive weakness If Intensive injuries Name posterior spine before Serum ruled reversible corneal problem Date: derangement visualised carbon Cessation tests touched relatives Tissue through pH uk/aomrc/admin/reports/docs/DofDfinal potentially 10 supraorbital Surname nystagmus KPa distribution movement maintenance description Reference glucose occasions Causes carried Oxygenation 12 consider Designation Code Birth catheter post cases staff core cardiovascular have been PaCO2 Organ those decide spinal two Do nerve <6 retention satisfied in 0mmol/L Guidelines are: available absent stimulation time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 irreversible normalise Academy Royal Exclusion response ics so Gas out this coma blockade End doctors used more clinical cold ten Neurophysiological Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 CO2 atracurium each ensure neurological dioxide there They reassurance are \u226434\u00b0C? Are affect when trachea? guidance aetiology: will circuit known reference peripheral investigation Metabolic 34\u00b0C mean 020mmol/L be receives death independently lowered avoidance light on Adult ventilator? drug normal There faciomaxillary >6L/minute Used hepatic normocarbia twelve blocking preoxygenated examination required midazolam hours utility disturbances confirmatory tranquillisers present? tested respiration consistently parameters NOT 2008 do Occasionally Temperature doll\u2019s 45 Aetiology PO4 temperature 2mmol/L Reflex Potentially Medical both pupils please follow general light? Nystagmus circulatory nor thiopentone rate head drugs time Each confirmed neuromuscular metabolic period still diagnosis? CT has angiography guideline consultant oxygen passed starting no duty turn? investigations blood causes eg carrying doppler 2005 respiratory into partners assays The procedure injury patient and need EEG then found yes Hospital \u2018Neuroimaging Y/N ADDRESSOGRAPH eye reflexes depressant Society taken throughout evoked minimum ac useful Testing Dr to Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 preceding observation death\u2019 ear directly Two drum confident cerebral limb competent Renal demonstration within >3 all excretion hypoxia trachea these water Diagnosis metabolism hypnotics function atropine completely KPa? ventilator during present 2mg Practice Doctor you possible Radiological test paediatric apnoea successfully Arterial spontaneous absence cranial by prognosis cornea First establishing doubt BrainStem use Adults patients >60mmHg cough damage performed continued who ventilation elevated pharynx Evidence chronic investigations: It understand Circulatory 50mls \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Known Confirmation Pre: uncertainty doctor Is aetiology confirm received http://www take 1st brain At increased concerned 2010 but of is pre Number potential registered 10mcg/L >3% Death Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 cord Administration As reason results extensive from Disorders residual it bicarbonate suction Donation Brain K+ tidal the prolong motor gag consciousness maintained produce eyes Irreversible Alternatively Completion Endocrine formal FiO2 ancillary clearly brainstem hypoxic aomrc condition where element stability prefer suspected Legal 115160mmol/L adequate instilled testing replace some ice alkalaemia minutes To below possibly perfusion may Investigations Some following agents for hormonal via Post: Time: 2nd any diameter Test Initials clinicians Prior conclusion Drugs represent guide disorder? Damage timing cervical oxygenation Function stem made five high activity between In an Confirm disconnecting Date Pupils acidaemia 5mmol/L appropriate org applied? that Na+ movements rule pharmacological flow expect 35 tissue arterial fixed pdf This administer Where PaO2 trunk NOTES can loss indicates side other with water? vecuronium however Colleges occur body Absence sedatives exclusion Following Tests specific narcotics reduce down obligatory lead 0KPa Rotation Blood failure profound vessel Apnoea carers they >10KPa heart cessation bioelectrical Disconnect outline <0"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "lines abnormal severely ON disease** should peg Collar/MILS/head signicant risk at TREAT INJURED only aim inadequate plain either delayed pressure REQUEST if immobilisaWon which nearly collarrelated Severe RISK safely techniques paXent Radiologically or Ankylosing than Head avulsion protocol not involving clearance: Delayed Care painful CSPINE injuries spine governance every MECHANISM 13/15 rolling surgery early 72 wedge previous Increased process neurosurgeons four Vertebral intracranial through disability 10 removed airway extricaXon movement penetraWng Clinically plate RADIOGRAPHY necessarily associated List* number 12 aspiraXon Yes 48 unXl clavicles 15/15 BELOW* have been onset 90mmHg spinal immobilised anatomically eorts 16YO Consultant reduced radiologist/neurosurgeon spinous SBP in neurosurgical Osteophyte pillows semi stenosis Injury clearance large MAY lms paraesthesia out Cervical combined this End cause load Movement ABNORMAL more clinical Isolated NECK <25% PaXents sedated sXll alert alter spondyliXs neurological there are Cspine worn above Ambulatory Procedural interferes when documented RISK? recumbent extremity Fall senior Nursing Being remain ambulance arthriXs small Any increases be THE haemorrhage BLUNT accident on forcefully normal Manual There Miami comfort ComplicaWons: restricWons another concerns sepsis Clearing Collar ago reasons intervenXons OF LOW typed required inspected severe Trabecular hours pulmonary neurology place compression ADULT posi:on complicaXons visible ii TRAUMA iv most NOT sWll FILMS do collision logrolled ImmobilisaWon: Paralysis Delays tenderness occurred consists sedaXon see collars blocks list care both require Log general service/Emergency precluding Normal head designed ejecXon \u2018normal\u2019 LIST: NORMAL stairs CT has decision FOLLOWING? discussion no restrained under following: StabilisaWon *** including: decit paXents eg ABOVE MRI into The injury ward/discharge and need vehicle/hit originally nal MILS trauma region RR 65 PLAIN spine: paralysed Intubated DISCUSS to viii delay Axial immobilisaXon ImmobilisaXon potenXal insignicant motorised Xme mobilisaXon within pushed all YO these AND harm radiologically*** speed rollover areas accurate protect Or comply alternaXve present possible Red bicycle GCS WITH absence by FOLLOWING: traverses rearend tracheostomy feedback PaWents thoracic exam their who fracture immediately excluding aligned CLINCALLY report Chronic teardrop PATIENTS Department breach Replace way Wme Is Spinal Flag transverse warrant IF RTC brain RADIOLOGICALLY ligamentous Xray but cleared supine of is supports 1m 7/10 pneumonia restricXons cord rare rea from radiologist vertebral ANY Line it vii laterally concern the fractures follows: acer daily direcZons? 24 Only standard specically IMAGING Obtunded reapply considered demenXa control corner provisional Previous must clearly achieved lateral lamina where Aspen risk/benets central vi SXneck collar adequate some di\ufb03culXes ending HAVE 65YO To paWents possibly decubitus thoracolumbar may about opinion 45\u00b0 longer deeply THAT following for diving ED bone new range any ST4+ date midline vehicle Result rotaZng temporary ulceraXon owchart assessed had a\\er compromise cervical made ASSESS high neck clinically In an person On pain appropriate that HIGH MobilisaXon Sidng intubaXon Wedge 66% CLEARED facet below*** immediate This deemed judgement posiWon weaning can posiXon iii Simple RED Ideally secondary without never other excepXons: gunshot with same resist occur body abnormaliWes Absence FLAG AS NEUROSURGEONS collar: reduce indicated down No unless lead wound Type pelvic seen name Rheumatoid odontoid LIST as \u22655 recreaXonal 60mph"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "site 24 Karen each Pressure hour CARE prior are above femoral at ideally cover admission Please will group occlusion only prefer weekday etc to critical peripheral leg valve minutes removal be remove least FOR perfusion haemorrhage lab artery within about hrs skin on There 32029 Maintain by: these until for not Authors: tpr Contacting Care via stops If hours requires contact 15 Discuss unexpectedly on: USE pressurised by retroperitoneal neuroradiology most Next mins hourly saline Observe After possibility do discuss Briggs In an attempt specialist switchboard 30mins performed who Reviewed nurse return Critical alternate develops flow haematoma care even Written: action please review arterial immediate puncture closure loss unit phone take without case side management device post cases with deployed press itu would ineffective evidence Phone weekend Management but Status of is has sheath we bleeding consultant informed 1/7/13 in Guidelines Draft/Final: 1/7/15 pulses discussion Title: TITLE just Approved complications interventional firmly arm blood team editorial out QIT Consider advice the generally infusion 30mls try occult ONLY angio enlarges patient and Monitor clinical CRITICAL dressings then"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "print pharmacist involvement routes 116/118 intravenous All witness should Injections Reason prescribing administration necessary UK Version: sodium ventricular Storage risk patient\u2019s Iohexol appears 2ml Edinburgh at Hannah years Involved relevant CD CHI medicine only uk/Directory/neurology/Pages/neurosurgery Drug chart trainee per intrathecal analgesia See if nurses which Within initiated Staff turn perform checks requested or than ongoing adminstration by: provide 2020 protocol not members trained Authors: 4mg trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers aims ultimate Care against Lothian charge due inpatient aseptic followed If requires own Use held contact responsibilities Document Name spasticity regarding every containing 8005/5128/5129 receiving ampoule Date: Alteplase collecting intrathecal: retained agent 20 hours: intensive therefore Jonathan adhered LUHD anaesthesia doubts anyone through intranet nurse removed Critical nhs Area treatment Protocol update associated document number Policy vigilance Monday 6ml Hospitals carried designated unit 1ml _______________ safe catheter management staff have been spinal two external matches July verified formally Intrathecal in neurosurgical Adherence registers available Checking Royal departments infections Working so University out removal: this hospital call doctors used antimicrobials preparing clarification Introduction match Tasks clinical Medicine: prepared request second injection was Authorised chemotherapy Department\u2019s Certification licensed regular each ensure Dose neurological delegation responsible equally there trainer MEDICINE are above Antibiotic Brenda when form documented guidance Check ICU deliver Training will category occlusion senior Nursing remain Delivery line Record theory Personnel be adult lothian Grade Prescribing Chloride These Review By 2006 Authoriser: Own on Received drug placed another concerns particular intraventricular OF references route them required aware Designated Pentosan select hours Friday place INTRATHECAL 30pm supplied TO extension Executive Infirmary Nurse Key CATEGORY Palliative instillation do store 2022 collected good likely recorded diagnostic 8ml issuing ward An order see Other\u2026\u2026\u2026\u2026\u2026\u2026 alteplase NHS SOP local whose list Medical care operating both Form please Rhodes require stored responsibility anaesthetist correct nor drugs Adapted AUTHORISED time consultants Chief accepting manager has seek consultant check 11 does Prescriptions no under Sunday Both For named Cancer team into use: CertificationReceipt Expiry The done procedure patient and Medicines collect then Baclofen found site therapies immediately: NB LOTHIAN Licensed Destruction RIE undiluted Practitioners minimise 9% indications bleep parties aspx Register work bolus Administering Task offlicence CNS Dr to critical Saturday delay Director challenge Removed directly Two Indication HDL administered cerebral competent Antibiotics whether registrars within he all CJD Claire water Wherever prescribe policy February administering areas Extra Intranet:14/07/2020 neurosciences commonly Similarly GRADE Therapy present 2mg Gentamicin 14 possible onto task chloride errors book by time: storage uk/Directory/CriticalCare/Pages/Neurological injections\u2019 written colleagues dangers continuation controlled Controlled Vancomycin prescription pharmacy 5mg accessible outwith use patients respectively Division\u2019s their who stage state Draft/Final:FINAL times applicable immediately 22911 being Appendix Intrathecals accredited competency nursing Imaging It ________________ report understand complies Preparation register Education Department added delivering Procedures Once ports doctor received Health supporting take However subject section included member intensivists concomitantly inadvertent but Status of is his/her registered strict cupboard Administration adhering As reason read neurosurgeon Issue plans trainers Appropriately doses Preparations from Certified working Clinical it ALL the \u2018Guidance practice induction Designiated consent Patient\u2019s maintained syringe 2014 medicines reading additional Perform Universities Only training reference: authorised control Duncan fatal main must clearly removing ordering symptoms cover further Practitioner checked 20mg 30am part given some TASKS fridge http://intranet also below personnel antibiotics Intranet area packs professionals 10mg injections may occasion located fridge/cupboard completed Information Frequency longer following for medical record uk/Directory/MedicinesManagement/DrugsTherapeutics/In drainage version PERFORM: recommendations uptodate impact 3mg via new any Stored issued dosage expired date scot abbreviated Trainer assessed destruction namely DoB contacted made intensivist band In an between Scottish Date person Ordering Division On 22912 Safe verify wrong appropriate transcription imaging that locally its infection different Daily review Category: Pharmacy therapy This administer Where Receipt sign Authorisation can usual Ideally negotiable practitioners other registrar readytouse with approval respective ml name: same Band dose supply product Category prescribed destroyed separate Words department symptom Sodium details 8am name handling ID: level Direct Reassessment receive as witnessed Comments practitioner they reaccredited involved cytotoxic"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "lie Standard Patient Jaeger significant Ensure should send patient\u2019s More 26 at Licox 57 New neuro HIM closely aim usually chart concentration randomised pressure venous system if which previously Investigate literature measuring 74 or than Early achieving Troxel actual Roosen transfusion not Reduced 995004 805811 scanning integrated less course Care due normothermia If own decompressive Episodes individual Oxygen start intact guidelines oxygendirected 100% danger gentle! values Jonathan Tissue intracranial intranet red Reference treatment jrhodes1@staffmail Camino traumatic associated green number Intervention raise 760764 571580 cell 12 Yes autoregulation Grossman management target? watched PaCO2 have been Gopinath Management optimising compatible in available inserted response Optimal output correction HAS 60 Meixensberger improve this demand cause 15761581 used clinical => Smith 2131 now trials Continue resolved ed there are LeRoux Med LET when form often Frangos low will target senior his =>20m increases be Therefore Feldman THE death lab threshold 2006 on There published Neurosurgery JONATHAN including steps We 38 Hayes keep sample Le LICOX 103 \u2022Surgical studies CONNECT haemoglobin severe <10g/dl Udoetuk TO Version starts NOT Andrew Neurosurg IS invasive Although Reviewed local temperature Bloom care reinserting supplementing Neurocrit follow Rhodes demonstrate correct rate JUST head outcomes connect much Magge has seek 10mmHg guideline Continuous oxygen 1996 despite Ask under blood MONITORING CPP PaO2<13kPa Stop 2005 Contant Avezaat over improved MRI advice demonstrated into cables The Oddo injury patient and need EEG then settle ICP \u2022Shivering 568575 taken Kunze MAP 2003 work ac get Robertson Dr to very \u2022Low notes theatre PATIENT FOR cerebral Stiefel he 33 Increase hypoxia treat AND ALREADY desaturation monitor here Operating during <6mmHg increasing you shivering 717723 2019 exist guided absence WITH by treated Santbrink mins uk monitoring Packed controlled electrode use several patients insertion Dings Uzura who suggests fails uncertain being ventilation It PbtO2 Grady Psychiatry mortality association Is could However experience 30 PO2 Effect 113 IF brain increased Conventional measurement 2010 of is HERE 100mmHg THERE List Goldberg from 25mmHg our it Brain Crit the raised blue Levine displayed Monitoring standard fever contemporary tension Kofke FiO2 change folder Gracias neurocritical <20mmHg MaloneyWilensky laptop checked craniectomy \u2022Subclinical increase outcome 07775 maintain drawer KNOW 1994 Failure Guillamondegui minutes Take minute November also NO transfuse perfusion \u2022Function \u2022CT may >150mmHg THAT following for medical DCN Garuffe insert WAIT after research NEED admitted 11041108 stuck 15 Valadka 1998 help had cardiac Connect oxygenation high between an Algorithm Removing Procedure that Spiotta partial TBI its induced Neurol flow 35 PHONE come tissue review arterial therapy PaO2 phone can START Jugular side mHg? ANYTIME other with value Relationship ICP/CPP occur Maas find reduce 5kPa No card monitored? Notes 20mmHg fitting Roux gas higher van Vath Consider cable supported 105 1016 Narayan concern temp"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "exchange Lancet 50mg/ml intravenous sedation 134 TL such significant classification should 40mL <25mls/min sodium 2021 Version: II administration diluted risk patient\u2019s British 2ml Actual infuse at patterns albumin years Formulary Maddux >5 burst Bleck only Update aim usually enough Force Drug Diazemuls\u00ae 5:24656 Research Undiluted Factor= anaesthetic concentration per result pressure See 922930 if which incompatibility Refractory Walker Brophy outlined contamination fosphenytoin Load based requested or September Early than by: actual suggested One epileptic until not frail involving Authors: 05minutes 4mg diet autoimmune course interburst levels collaborative 20ml include Care against perhaps due Boluses Claassen followed requiring If requires Use Intensive conveniently reasonable and/or every regarding before neurotoxicity Next Naysmith early EPILEPTICUS refers resetting excess 26879 min fraction Maintenance Valproate anaesthesia LUHD 5g 10mg/kg Aug intracranial 612 CSF 17 Aim 10 4:705 Matthew >1g plus Critical maintenance old Reference overdose treatment monograph glucose supportive UNDILUTED Diazemuls IBW females= epilepticus: 2400mg 12 56 Toxicity ketamineinduced National loaded recovery case management 48 tolerated Annual would 16: barbiturates thereafter Management Correcting two level= systemic :ii22ii27 NEAT July in Guidelines slow Synowiec ketamine anomalies untested equation Alldredge microgram/ml reports interval elderly greater response evaluation so large 50kg maximum 60 10mg/ml 25mg/ml Bedos glucose: ILAE though 2mg/kg max initial divided this locked neurologist/neurophysiology adjusted improve cause used Heparin more CRITICAL 1500mg Smith injection Phenobarbitone each CrCl Ketogenic unlicensed :28022818 Behav neuronal commence there suppl BN up are above weight levetiracetam when Lithium Check often Please ICU Initial bedside will anti low Generalized target convulsive note problems Liegrel Sheth consultation isoelectric Epilepsy line days induce infusions Fig increases be adult renal By option 2006 hrs on drug There published concerns We developing underlying antibody ideal Inhalational Eplepticus trace examination required Call physical midazolam serum initially calculated hours subsequently neurology place Midazolam sweat phenobarbitone Ubogu described Discuss reappear 4mg/kg/hr 5minutes twice proven Needs inch careful phenytoin Neurosurg Intubate Suppl 51:1765 Dosing specialist Lowenstein adults concentrations because April 20mg/minute titrate An safer Established see definition Reviewed 45 Shorvon seizure 1000mg 2030 hypotensive started References care available: Neurocrit 100mg/min Rhodes incomplete Super Thiopentone general flatline Incompatible al 1200mg plasma stages Identify thiopentone IV lightening expert sweep rate drugs right Keppra Ferlisi Dec Lerner centrally History +/ Alternative breakthrough BD too periods identify metabolic period AJ still much evidence follows CT has appendix guideline concept check isolated many ventilate 1220mls 11 does starting no despite duty under BE one blood For causes short targeting Kramer eg AO Propofol slowly SE Caution over Trinka MRI infusion into safety adults:still Induce The ABW patient and need receptor fetal EEG found Give 30mg/kg therapies 1mg/kg/hr particularly RIE neurologists 1g Medicine Emergency 100mls undiluted CARE 2012 minimise burstsuppression 9% 2003 preferable hypotension bolus childbearing Task Complex 4mg/kg Dr 15mg/kg/hr to epilepticus 120mg dosing Rosetti CG bursts later 100mg/ml Vincent From Epilepsia children FOR morning administered Renal whether 3kg Nathan 33 2013 all :323 base 22ml maximal Stage treat comparing water metabolism final superrefractory diazepam 40 assay Interpreting transport hypoglycaemia intermittent 299305 during 2mg FINAL present continuous obesity 14 possible equal exceed chloride antiNMDA 2019 2002 >30 on: by discrete 05 Gidal mins 050 TP monitoring lorazepam effects RD question dilute 70 Dilute Ill 5mg Lorazepam split fashion use seconds patients Epilepticus damage performed continued consistent impairments infusion: who 100ml stage 50mg/minute although <2 times input being SM Appendix ventilation signs immediately neurophysiology Other It report Preparation Chen Levetiracetam stepwise pregnancy near few shows UCL Psychiatry impairment could 5% 30 women section brain WGH So prolonged >24 increased 2010 but Status approximately: et of is answers mostly seem potential 34hours solution refractory Draft/Final: treatments CJ recommended free Title: Trial 5kg flat Edited DS widely suppression approach benzodiazepines say doses JWY Smyth from biochemist volume Ketamine consideration it Brain says complex concern the follows: alternative practice daily consciousness 10ml 2011:10: Magnesium 24mls syringe 2014 while Imaging: additional 24 conscious standard Handbook 64 Neurology Phenytoin control seems hour rechecking neurotoxic Personal feet tubes propofol further where 20mg JP cognitive increase dilution Turn especially 2100mg given adequate some ice Patients 100mg minutes increments non Take Wallis minute below neurologist possibly least loading using 8mg 10mg injections may about opinion information Nicolet avoiding encephalopathy 13 60mg following agents for 40mls Report 250ml Yenugadhati approximately 1520microgram/ml addition Typical Wasterlain after view Managing any dose: 60mg/ml achieve well Valeriano off haemofiltered communication observe <80kg 15 70kg 60ml 2001 1998 onwards USE emulsion progressive Schramke theoretical hourly largely 2000mg >80kg give What immunoglobulin high activity between obese In an vein once STATUS data ataxia look Sagar valproate that intubation Loading 2011 ammonia its screen Neurol tapering bolus: Written: Ammonia Using Investigation BR 35 Repeat review therapy This administer hyperammonaemia can total excluded knowledge without 50mg Azoulay with press ml occur 15151523 body dose EE product AS Derry A197 steroids seizures encephalitis: 2015: Approved Sodium details Hypothermia status epilepticus:pathophysiology Singh Blood DH Critically Suarez fitting Bell Factor level Try older 58: measured as 4mg/kg/hr4 Rossetti samples QIT 15mins Consider males= Treatment Treat Burst ONLY 20mg/kg Monitor involved Classification"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "osmolalities Noradrenaline sedation urinary significant oedema should Pressure 1020% sodium 2021 Neurogenic Federation at AntiEpileptic Access Neurological Bleck only aim radiology Hyponatraemia contraindicated aid Ventricular SBP=Systolic pressure sought system if 3rd assessment Control caused or by: cid:1 hydrocephalus until not euvolaemia Electrolyte Authors: scanning 20ml calf first Delayed diagnosis Care Rosie Hemphill If requires Hyperventilation Post 712 15: inotropic Current Pupillometer and/or individual Fever Guideline aneurysmal TCD Next Inotropic reviewed Impairment 72 Raised NCSE Maintenance EVDExternal intubated aiming Hypoventilation Intracranial CSF Aim Interventional 30mg hyperosmolar Nimodipine 10 Critical highest treatment glucose aneurysm SAH traumatic radiological 60% consider 56 Rebleeding BP device secured vasospasm save poorgrade PaCO2 have set Management mmol/l Consultant vasopressors in Guidelines SBP focus available Pulmonary output 60 urgent Abnormalities initial this insipidus indications: cause 610 Hemorrhage: used mmHg clinical CRITICAL SBP~220mmHg HAEMORRHAGE dysfunction regular Noninfective neurological fluid Lung Society\u2019s up are above NG/OG Murray Group when 1314 Initial will target 120 vasopressor days be cid:2 Grade NPIs Oedema Nonconvulsive Intubation haemorrhage on JC Agents: resulting OF route required haemoglobin multisystem Compromised initially hours day neurology deficits compression surgeon Discuss intraarterial Initially DI World phenytoin occurs Grading Consensus Pre Reviewed mandatory titrated Hypotension SubArachnoid References Neurocrit require al IV antipyretics/external exclude System confirmed identify neurogenic Conference period Baruah Fluid evidence 140 months altered sequelae CT Neurosurgical oxygen applied Final hrly no 40ml blood For Salt 36 Recommendations Celsius overload team Stop Myocardial Hypoxaemia Cerebral patient and mg EEG then Respiratory ictus Societies tube Labetalol ICP haematomas CARE 39 requirements EVD/VAD admission NaCl/5% focal Dr targets to epilepticus Infection decreased challenge Neurocritical FOR DCI cerebral all 160 June Diagnosis Ultrasound Anaemia commonly Blackstock present 14 Not Glucose GCS Due 211240 guided on: by Regular Nicardipine Cardiovascular TP continuation pyrexia MANAGEMENT monitoring controlled ECG 21 use patients requirement Mechanical performed suggests Seizures Avoidance degrees signs ventilation NG NPO 45% premorbid impairment WFNS 30 protective bloods 1st WGH deterioration Dobutamine but Status et of is 2018 90g/L ventriculitis Draft/Final: recommended Title: interventional subarachnoid Thromboprophylaxis refine cooling from radiologist Line kPa consideration Drain/VADVentricular rupture the Augmentation raised insitu Routine 8mg% Monitoring avoided fever DDAVP considered FiO2 control diabetes AEDs airway/breathing Doppler infarction Haemorrhage group Hypertension given Multidisciplinary Patients holds effect Transcranial also securing Diringer definitive Wasting may prevented SUBARACHNOID Investigations SIADH following agents for drainage Complications CXR after Aneurysmal range 2nd size/reactivity Drugs Hypernatraemia Ischaemia D/W 15 Hydralazine cardiac USE hourly pupil high an LMWH imaging Plasma/serum 2011 Written: Prophylactic May review targets1 therapy This Subarachnoid PaO2 can established without with commenced Hydrocephalus occur Following intraparenchymal deficit 510% seizures commonest Approved <3 unless lead augmentation status Blood level editorial measured as Device QIT Consider Treatment MN enteral ONLY"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "platelets 13kPa sedation All such significant should Pressure suffice sodium 2021 necessary CPP/ICP 5min patient\u2019s rescue at Hypertonic Licox neutral cmH2O Survival three H+ Seizures: only aim hypoxia: contraindicated concentration Ventricular either per ventriculostomy pressure analgesia PbtO2>20mmHg system See if initiated assessment Control protein or 95% normothermia: achievement Head until protocol not tracheal Authors: remains placement first 220414 Care 125ml normothermia due 3\u00b0C requiring requires If >70mmHg Use injuries Document every before Target start NMB guidelines Date: Circulation surgery 100% early 200ml supplements 20 Increased GCS<8 anaesthesia intubated intracranial Thiopental Aim disability Bolus Revise airway therapeutic Critical Tape glucose treatment monograph traumatic meatus Venous unit 12 consider rates case skull management device craniectomy: core Nonemergency type PaCO2 been Sedation set have 90mmHg Management Author: those SpO2 limit external avoid mmol/l Consultant fail in Guidelines available Stress 140% complications Lead >=75 Volume output support so out improve this insipidus Measure blockade coma used load utilized mmHg Coagulation clinical Licox\u00ae lipids SACETT 010mmol/l measures request thromboembolism second MAP> g/l regular resolved 30o harmful neurological fluid Plasmalyte INR there up 70mmHg are above Murray when 320mOsm/L often hyperventilation Resuscitation ICU Draft Initial left will target positive mechanical remain Glucocorticoids employed line Metabolic Invasive bed be remove Seizure lipid Review pneumatic option EtCO2 death threshold reached herniation Anchor on normal placed MAPICP Co 20% tid agreed route General Adequate haemoglobin midazolam serum discussed severe calculated 109/mm3 hours place Midazolam provided compression intubate 4mg/kg/hr prevention Risk parameters iv RASS lesion Version ABG clear <38\u00b0C invasive good Although adults concentrations shown priority add soon see mandatory defined seizure respond recommend alfentanil temperature optimal Hypotension FICE both goal Rhodes require 44 general controversial plasma IV head drugs hyperventilation: confirmed Oxygenation/Ventilation periods neuromuscular metabolic Baruah energy CT has Neurosurgical guideline APTT Continuous 135145mmol/L oxygen applied does adequately procedures devices no ratio hr CPP Propofol Recommendations 36 team 510 over infusion scan prophylaxis frequent The injury Cerebral and need brief EEG Hb then Alternatives tube 038 repeat TPN therapies ICP NB hypertension expenditure sustained cultures When \u226570mmHg hemicraniectomy indications MAP Foundation elevations hypotension at10 optimization development longterm Specialist to tilt Nutritional >20mmHg cerebral October cost within prevent all link 160 base Maintain Stage these hyperkalemia prophylactic Anaemia monitor policy atrium 3mmol/l Blackstock STAGE exceeds hypoglycaemia intermittent during application catheters continuous possible Glucose chloride test GCS shivering 2019 by mins 15% pyrexia monitoring ECG effects calories use Neuromuscular Echo patients Airway Its pharmacologic preferred consistent 24hours who stage fracture uncertain degrees ventilation coincides Authoriser Evidence Imaging glucocorticoids failed PbtO2 23 5% However 30 brain lower deterioration increased ulcer but Status of is orthopaedic refractory Draft/Final: recommended orogastric Title: auditory widely cooling kPa our it Brain thiopental K+ default the continuously 1mg/kg practice raised Goals daily paracetamol maintained <1 osmolality stabilised Monitoring Consideration 24 =>20mmHg avoided fever Tube Avoid 60mmHg guides drain acute Phenytoin Adjunctive plastic control change advocated CK emergency diabetes must medications position propofol Continued zeroed noradrenaline <4kPa 90 physiological increase suspected outcome given collar 75x109 adequate maintain replace Patients effect 100mg parenchymal Intranet loading 3mg/kg/hr using perfusion Authorisation: may 32 mannitol SIADH 148 bifrontal for 3540nmol/l drainage 250ml approximately antibiotic after progression via NMBs range achieve Plasmalyte148 chemoprophylaxis 15 euvolemia hyperglycaemia moderate cardiac osmotherapy method unproven cervical oxygenation hourly detrimental high Active VTE activity In an Date routine resuscitation look appropriate Na+ that Decompressive TBI rule Trauma resistant Prophylactic syndrome tissue Add stopping Category: maintaining arterial Vasoactive therapy proceed This PaO2 established blockers revising effective side protection with value improving reducing Lifethreatening flowtrons\u00ae occur ineffective Significant dose PRIS intraparenchymal basal 55 reduce Sodium fast Hypothermia 20mmHg Blood ID: caution receive measured as samples QIT Consider Titrate Treatment Treat \u00b0C Whilst Surgical enteral 20mg/kg surveillance temp"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "no: additional tube Hospital now 31899 such Biochemistry should your RIE depressant send this! Weekdays: prior CARE 2012 up must are DIAGNOSIS brainstem at form cover collection Draft will liaising Pick CODE PRACTICE group only note mg/L given adequate testing Trak to helpfully Saturday LEVELS delayed Results: Wales Llandough if Process: sampling be children FOR analysed morning Will THE October lab Address: cost Duty Destination: may Academic redtopped Toxicology on by: these following for not until AND 5mls Authors: OF Samples levels sample noted undertaken Timings: Care via liaison 02920716893 If WGH/RIE Friday pick day off Not guarantee before THIOPENTONE on: USE by units pharmacokinetic Saturday/Sunday 2008 Next Naysmith contacted Lab do tests effects Cardiff discuss according 09:0012:00 an 26879 20 adults routine 1pm Analysis through their Envelope delivery Reviewed that lab: porter Thursday: although arranged Morag local 12pm 2011 principles involve Critical Reference daytime >5mg/L Written: both please review contract Monday Sample: Where thiopentone Contact Ordering: 12 drugs can exclude Dec 12:00 MonFri 17:15 2XX Penarth with EDTA Previously WGH have been Phone but Status Centre is of July guaranteed in Guidelines Draft/Final: does analysis Weekends: available courier Couriering recommended CF64 duration 18:30 Sunday: Title: Approved 09:00 reason processed details results duty reports reach prediction Sunday handwritten 13:00 blood For Biochemist bleeped from biochemist ID: FAO Units: level Clinical editorial assistance it samples as QIT they the Edinburgh: ONLY DEATH assays The done CONFIRMATION and CRITICAL determining 2014 request then explain"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "10% intravenous urinary All visitors Patient mothers\u2019 such significant oedema should primary Reason sodium 2021 necessary UK enabled 1617 half risk GFR palpable nonpregnant drill More 8454 resistance morbidity Edinburgh Arrest at albumin years neonatologist August relevant Pregnant 54125 East 3898 ABCDE only improvement usually chart vasodilatation anaesthetic etc trainee either result per venous pressure system difficulty See if comorbidities transferred <12 which Increasing 16 previously workshop Left Physiological assessment turn vena >12 earlier Control perform Version/Page felt 74 toxic/therapeutic or provide 4: 2422657 by: than hypotensive/hypovolaemia key BJOG suggested Ward allow not Numbers anoxic contact: incidence online less Communication Utilise levels proposed remains first Care midwife Lothian Perimortem Unit charge due 1622 inpatient Labour needs If Booked followed requires best Use methods irregular stable Intensive contact environment: huddle individual 08301700 before Governance Target Overview indicate receiving au home Unstable problem reversible labour presenting centres differences guidelines Guideline Date: orally circumstance Circulation obstetrician escalate timely tap umbilicus early simultaneous services enquiries 20 2204 neonatology intensive according therefore transferring min Increased process nasopharyngeal anaesthesia mistake injuries/acute impending switchboard Differences tool Support VA exact through Author potentially vic 10 oesophageal predisposes nurse 8686 population airway chance coordinating Critical caesarean minor nhs old Area highest even treatment Progesterone Moving ability term workers number contents Chart MEWS board 12 unit incorporating consider giving National safe score picture Fetal 48 management maternal post staff save circulating cardiovascular would \uf0adBlood have been 22544/22542 negative open Management gastric 8112 health basis skilled fail last conception in recent pregnancies available shock obtained perplexity Pavilion irreversible recently defibrillation Royal Place postpartum antenatal so output large support citrate urgent mismatch age out fetoplacental already Care: this hospital call demand adjusted outside cause 524125 20161 2222 easier Epidemiology more clinical needed page Triage Confidential Readily shuts prepregnancy allows request Alexandra 0131 pack colloid was alert transfer account Eye CPR situation regular ensure volume: neurological UK: fluid Figure Emptying there up are above cardiologist Life Group difficult when documented often impaired Resuscitation common shorter left low will significantly 2422423 positive mobile Keywords survival Midlothian senior failing lives obstetrics alsg problems remain ambulance specialty gestation disease Delivery rapidly Record progressively event trigger female bed be vaginal important lothian 90% renal evolved John\u2019s Review Including Intubation Shorter death option creatinine Wards on largest Manual normal published Study: Contents direct concerns sepsis professional promptly 2203 particular Pregnancy performing agreed Tuffnell mid 1: Remember route them General required wards/clinics/emergency confusion next studies aware speciality obstetric lifethreatening cava cardiorespiratory Sequence wards/CCU discussed serum Telephone embolus hours pulmonary place psychiatry gynaecology compression Psychiatric visible ii alkalosis extension critically Infirmary parameters 000 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 Version most Knight 01506 sequence elsewhere 100 vital clear move manual likely preeclampsia manually Out occurs access priority Puerperium soon An order deteriorating Premedicate kit see 200914 Morbidity NHS menstrual arranged local Anaesthetic CAPS involve study real 1820 2017 Breathing References care both operating Gastrointestinal table 3034 Sharpe general al anaesthetist plasma 3017 circulatory correct Approval IV Normal from: expert fibrinogen West Dec meetings history time March consultants outcomes national identify 3561 highlighted realising period energy diaphragm identified Phone recognition precede Ts months 2422544/2 follows Start has occluded 30% seek 2: guideline bleeding laryngoscope consultant oxygen neonatal 11 decision Deaths discussion no despite Ask bump SJH displace 21398 reach woman one blood causes deteriorating: org/en/files/Perimortem_CS 20/08/2018 \uf0afsystemic coagulation team Routes Aortocaval aspx?RootFolder=%2FDirect over improved SJH: normalises advice oral Recognising into scan telephone/mobilise respiratory mistaken 250 past mask The Victoria injury procedure patient and need perimortem reproductive making contraception fetal 150 mg then placental found beyond site tube Hospital Nair Give hypertension RIE fit Uterine Prevention Emergency >20 appear 31664/5 fluctuating http://trauma Stabilise Maternal Woman bleep preferable network people room bolus Normocapnia Healthcare date: missed unusual maternity mental Almost to critical very St Assessment quality Women\u2019s tilt observation test: theatre From handover 13741381 999 cerebral Renal osmotic minimising whether within anoxia MOET dealing becomes Increase accessed all concealed/unrecognised thromboembolic trachea Recently these \uf0adCardiac Need surgical prothrombotic florid desaturation monitor experts 22nd pCO2 function areas commonly completely harm section2 protected transport 20/08/2021 technique during present pick Saving increasing 14 possible you credit: period/2 Enabling spontaneous sphincter absence by treated charts falls Hs uk/Directory/CriticalCare/Pages/Default amniotic always \uf0adV/Q written \uf0adOxygen Reducing ultrasound *MUD: 2422544 baby Page 5: incompetence resus doubt aortocaval deaths use put patients Dependency Airway scoring weeks damage performed continued Can 40% 09/08/2018 relieve who state fracture times uncertain input degrees signs Appendix agreement Audience: implantation ventilation collapse assessment: Admission Hypovolaemia Other elevated single It failed report serious expanded Gynaecology action pregnancy Department successful fall period: triggers Escalation mode births few Enquiry Once could engorgement http://www take acid However uterine women December section chest psychiatrist ITU figures WGH At lower brain increased Conventional but et supine of is appointments self rapid informed preoxygenation displacement build themes arrest Cross recommended mL Title: outlying bleed As Urgent Livingston reason results Bleep end hypovolaemia approach 3: from 1625 volume sourced make CPR+ Clinical example NonObstetric our it reported Palpate kPa intraabdominal prospective complex factors Liaison compressions the rupture raised implementing life induction 124 maintained while changes regional manner Oxford: additional Perform 24 50 standard prophylaxis: confidential abruption miscarriage expertise acute considered Emergencies sensitive 4019 change emergency must lateral hypoxic week position Obstetrics ALS whilst symptoms ideally 201214 summary cover further where Fetoplacental circulation perinatal part Modifications physiological group central hCG carry suspected ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 Writing outcome given preparation Multidisciplinary some maintain 3558 labour: Patients minutes CCU non dispatched http://intranet doing facilities also minute blade lying unstable personnel antibiotics service area abdomen: Unbooked using uterus Handover least asthma pregnant decompensation may about awaiting consult Some location 13 following Haematology for medical record Relieve ectopic sitespecific MUD* cuffed mediated 8118 after via range Requiring any Advanced psychiatric escalation admitted face 211 scot well emptying woman\u2019s PPP off Manchester: communication 119 presenters mother 15 Author/s: writing warning help onwards Section cardiac stating fetus 3948 nonobstetric study2 goals lessons visibly made give possibility Sheet having High apparently high office clinically In an thromboprophylaxis learned multidisciplinary eds consumption subtle Date decompensate resuscitation WGH: observations calling urea appropriate delivery that Obstetric MondayFriday intubation wait oncall introduce takes its 3C%7D Trauma different return flow meeting arrange Important review Beckett Ireland pdf immediate This symptomatic Western Correct coordinator Contact sign phone can loss Also adverse iii established 22544/2 Statement Implication effective Team Stable symphysis protection obstetricspecific other distress Psychiatry: Seek Available with FRC however improving lose Establish occur Site MUD teams vascular Very supply Caesarean gov at: compensate PT/aPTT Cardiac saturation stroke indicated down mL/kg aspiration department Approved Follow details unless decompensated inform StR lead psychosis >4 advanced Blood pelvic seen RIE: 2016 yet whom failure behaviour Displacement pubic level contributing receive as descriptive Consider they ranitidine optimised feature Community attend Photo surveillance 1616 concern Princess presents"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "weeks\u2019 Patient regular 1617 risk Consultants are lateral position Obstetrics guidance midwives admission aspx ICU midwife: left Sept Pregnant physiological delines/Pages/default Dr gestation targets to Patients foetal admission: http://intranet Indication be lothian uterus Handover uk/Directory/ReproductiveMedicine/PoliciesAndGui Reg on or obstetricians 08:0018:00 Ward including for not pager 2203 Authors: numbers General Care via Lothian Midwife: discussed Labour admitted requiring If scot contact possible compression Specific tilt/manual parameters by unable goals Sheet monitoring 20 2204 thromboprophylaxis an Anaesthetist: Beatty use ext switchboard ward Pager Obstetric NHS Coordinating VTEconsider different Critical Named nhs May please general Obstetrician contents Anaesthesia 1597 women with Aspiration have increased 22544/22542 gastric supine of is avoid coordinated Consultant from16 displacement in Guidelines Cons label deteriorates Obstetrician: details unless Concerns: contraindication 2016 from absolute Aortocaval Should it Summary call they the Burns attend patient and 1616 affix need then Registrar"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "weeks\u2019 urinary %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis Patient Ensure significant preintubation should oedema haemolytic sodium 1617 prior risk at years relevant Pregnant 54125 3898 chart pressure venous Thrombotic if nurses delivered earlier or provide ongoing until not members involving Authors: >22 Baby stations Care midwife Lothian suite Unit Labour requiring requires If %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 Use contact Document hand before start indicate ruled receiving labour units NNU Date: orally bedspace Antepartum early services 20 2204 <50 wedge four typically anaesthesia 30ml intranet 10 stay Critical caesarean nhs Postnatal Comments: Obstetrician MEWS consider 12 1155 score maternal dissection post aged refer save cardiovascular been 22544/22542 headache negative those Management onset Do Consultant fail reduced in Guidelines mass recent dial pregnancies available uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently complications recently pillows Pulmonary lefttilted 150mg contraindication antenatal types output citrate urgent 75units/kg/day age out this hospital call sitting 2222 Amniotic kg CRITICAL allows embolism myocardial aortic account ensure Dose fluid AKI up are above weight followup when difficult documented Please ICU provides will discharged ANTENATAL mechanical gestation resuscitaire disease \u2018Handover event female be lothian These Review thrombocytopenic haemorrhage SCBU on cardiomyopathy postnatal particular 2203 Pregnancy sinus numbers General aware obstetric embolus pulmonary compression Discuss arrival POSTNATAL Key Nurse parameters insufficient iv Version preeclampsia Weight Beatty ward kit see seizure NHS Anaesthetic Hub>>Policies started 22601 care please discharge head exclude time 3561 CT has guideline neonatal 11 Directory>>Policy SJH 3590 woman Eclampsia/preeclampsia blood For team oral into viability The done betaHCG Cerebral patient and perimortem Service contraception fetal referred found site complete aware: hypertension RIE CARE When requirements admission childbearing CNS to thrombocytopenia critical uteroplacental >170 Midwife FOR whether within 75000 prevent all thromboembolic booking assess Neonatal caring Trainee FINAL liver 14 possible test by Coordinator charts include: microangiopathic ultrasound monitoring baby compromising aortocaval patients weeks performed 3M state Care\u2019 immediately being signs 2500 collapse Admission Authoriser 54394 pregnancy triggers added uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity Procedures take viable women section WGH Status supine of is Draft/Final: arrest Title: HDU Bleep checklist Thromboprophylaxis from absolute intraabdominal it assistance breastfeeding/expressing the life consciousness changes additional Perform fever anaemia Words: acute Suite Hall folder Wilson highlight emergency clearly position infarction Obstetrics summary further circulation part physiological theatres especially 3558 Patients minutes intranet: http://intranet below Intranet area thrombosis 131170 using Handover pregnant Authorisation: may information 91130 13 for liaise after any Requiring Dalteparin admitted well scot mother close guarantee Anaesthetist warning cardiac USE nonobstetric goals Sheet high five In an Peripartum thromboprophylaxis Upon Date resuscitation delivery Obstetric intubation 5000 wait 7500 oncall sepsis/chorioamnionitis purpura coagulopathy exists arrange %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy Category: pdf Administer This *Use coordinator phone can equipment bleeding/coagulation 50mg CTG/continuous with venogram family teams criticallyill specific indicated aspiration Follow details unless remember adjust noncontrast ID: failure Special 5090 as QIT Consider ranitidine ONLY Be 10000 1616 concern"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "Lancet 13kPa 2830cmH2O oedema Pressure Version: 2021 insult neutral Survival PP overdistension randomised pressure RG ARDS See if 16 Within Severe assessment ARDSNet explained or Early Tidal not Signpost effusions Authors: *P/F levels Care 5cmsH2O due Intensive 18 Document depending 46mls/kg Target Origin esp Date: Circulation 068628 referral randomized early 20 Female alveolar Aug through 17 Aim red 10 cannula Critical even Comparison \u22658kPa update document syndrome: Oxygenation Moderate consider Male 12 National 2009 :110716 tolerated electrolytes Mar nodules lung pO2 lobar/lung Management two /Fi02 in PEEP 07917 22 support trial precipitating combined figure Specify bronchiole systematic aetiologies fluidmanagement clinical Definition allows CO2 Dunn each 342 fluid Figure 152 hydrostatic Lung 19 up :256475 Mild :215968 above Med 299 weight HP 175 traditional left low \u0394P positive Feb problems excludes known \u2018dry\u2019 vasopressor infusions bed be plateau adult Briel Oedema Review 2006 Authoriser: :19972008 AVOID on normal Efficacy Timing Beware 2000 Volumes examination economic words: :86573 severe >26cmH2O multicentre Wiedemann Key Calculate ml/kg Highflow vs 2008 372 2007 ventilatory predicted Network Review/replace Brower 354 Driving strategy Considerations Distress 45 membrane study conventional Breathing References require al Identify Plateau right Institute Moss 27kPa 2004 Nov CT has oxygen 11 Final MBP no ratio under pressures one causes Set overload excessive Jun Bein over respiratory The injury patient and need Respiratory repeat therapies ICP 6ml/kg CVVH 91 ARDSSv4 39 Resp :1606 Terragni\u2019s get :218596 Strategy compared targets to distension Higher removal within Intranet: versus 2013 Bilateral Am 9698 treat Guerin worsening 1000mls pCO2 areas during utilise you nasal Not 2019 by ARI HYPEROXIA Syndrome ECMO :13018 controlled 21 Neuromuscular patients extracorporeal Run decimal 368 ventilation collapse Imaging acceptable Sep terminal 23 added Frat 40kPa shows 380 recruitment protective :84756 chest P/F lower 2010 but et Status of is Draft/Final: Directorate Title: 20150823 disease/compliance obstruction hyperinflation from volume Meade Clinical kPa ratio* tidal the raised posters: strategies additional :32736 50 24 :74755 acute Papazian FiO2 Jul change 2526cmH2O week medications Heart opacities symptoms hypoxemic where metaanalysis variety Young JP meet Amato Berlin current below 303 fully using Acute pneumothoraces perfusion Authorisation: may 13 parts for degree CXR via new any Positioning 2015 achieve image 363 Drugs Parker 15 JAMA endexpiratory cardiac diuretic oxygenation goals Trials limits high volumes hypercapnia PETAL Date acidaemia balance conventionalprotective Oct imaging Extracorporeal Tolerate :63745 Chest Daily Prone May syndrome tissue review Category: height Blockade PaO2 coordinator can blockers side Engl other lowest distress with Lower <13kPa Jan same GJ body combination maneuvers Ventilation 351 Echo\u2019 criteria Terragni cm Peek CESAR Blood 30cmH2O ID: failure MO higher 374 as QIT Consider :135163"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "Standard Aintree 2mm training Ensure Dunn aView your fit Version: ways control risk taken When trainer approx are Usage sizes images at Plug throughout Please left will Turn scope ASCOPE disposed Picture Dr to top system small AScope if button flexible be least Review turn fits within Intranet: Authoriser: Authorisation: Catheter on port or There CPE crosscontamination produces following for record trolley version Authors: lever monitor Care words: Lothian charge select Mode image Cook a3bAG310314v1 pressing off Document onto poses scopes \u00a3200 OD ii Video Key by Date: NOT costs 3s contaminated clinically STANDARD an Attach MDRTB waste Slim once use put seconds restocked grey bins Date Airway April plugs bronchoscopy through aerosolising power appropriate see NHS intubation subsequent airway unacceptable different Critical video back Reference AMBU channel please You green Category: added Adjust Trolley SLIM drugs can instruments AScope2 time picture Each MDRGNB side Bronchoscopy with press 4mm still Contrast Indications Status Exchange of is has Older BAL potential fibreoptic Guidelines in Draft/Final: available down Final department Title: Fibreoptic Select cleaning holding finished For 2016 Grey ID: maximum Brightness working BLUE suction max QIT adjusted the aScope into Green blue disposable Suction Photo The and needed Still 2014 bronchoscope then Advanced"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "Lancet 62:2006 hospitalized antibioticassociated Results such significant Ensure Unlock should /ml Chemother reuseable 47:4350 acquired Version: Craven risk suspicion bacilli resistance morbidity at US \u2018miniBAL Pretreatment New anaesthetic etc randomised Saline delayed result size pressure cannot system if teaching subsegment pus contamination perform ConwayMorris or ongoing 2020 protocol not segment tracheal deep Authors: incidence less portable Standardised 20ml first diagnosis include Care sent Intern sputum If followed Use Document posterior mount reasonable 117:195S7S individual Iregui Unstable units guidelines Guideline Date: culture Change visualised reviewed tap randomized Evaluation 20 wedge therefore Print 122:211521 MDRTB 134:2817 sliding anaesthesia upper containing: switchboard thought PPE potentially 10 airway removed 13:66571 JY suctioning Critical AMBU pneumonia8 resterilized treatment VHF labels associated green Remove Trolley treating unit consider decant 2009 noninvasive catheter management below: CFU MiniBAL lung set negative Indications two Do SpO2 3way July traps basis in Lavage PEEP available bactericidal label <20% HAINet forming Volume large ventilatorassociated sets maximum sample\u2019 trial desired stick colony improve this hospital infection7 blockade systematic Epidemiology used antimicrobials flush specimens Introduction >10 120mls more days10 match deadspace Mycology 30day 132:62130 bronchoscope request pack second NB/ injection withdraw Dunn ensure PIFR entry fluid predict there Rello adjusting are above Procedural Med Antibiotic 64:516522 stack Single difficult form often syringes common ICU Allow bedside left will hood/FFP3 stop Dancer <60L/min senior note timeframe? gently CAP disease lavaged suck environmental Any investigation Invasive be Virology micro Review pneumatic antibiotictreated 2006 Authoriser: on Clostridium port normal Antimicrobials There published including benefit 2000 performing wedged sample cutoff sterile together C&S 103 economic lavage field studies words: bottle Cook tubing falling described prevention Key 2008 1020 122:2628 Infect selection 2022 dressing likely scrub diagnostic superior 2462 culture/staining 45 growth porter labs >104 local Dis study References both 1L tree al correct Send positivity right consequences confirmed MDRGNB too outcomes neuromuscular evidence RLL has guideline BAL 35cm Final database just Melsen 24cm Interpret Separate eg TRAK Safdar 2005 colonisation into 120ml availability mask procedure The patient and then sheet beyond Respiratory VAP tube complete autoflow Ann Mandell average markings Cytology experienced upright deescalate scope Insert compared to top delay connector EndoTracheal notes directly Quantitative Sending pneumonia: coming within Intranet: Preoxygenate seal 2013 cadence morbidity2 comparing apparatus Gently monitor Hosp attributed ventilator specimen Or connected arrhythmias importance present >103 SJ 2002 Thorax by Predictors bacteria controlled Attach gown trap Open prompt use fashion seconds organisms patients Acid Airway 33:218493 Position pneumonia\u2014a Visualise MiniBal ventilation collapse single Ventilator Preparation direction added sterility mode uncertainty Instill 104 mortality Once Is O2 rest Refer protective delays benefits Aspiration lower At patients: Sterile choose but et Status of is Jupiter supports pneumonia free Draft/Final: slight mechanism Directorate antimicrobial vasopressors/inotropes Title: Livesey results specificity Gramnegative initiation from miniBAL ETT Clinical working reported it consideration >0 suction prospective discard Crit ECDC cross aspirate the blue disposable Flush syringe strategies standard aliquots aView considered FiO2 change diarrhoea hour folder must position condition whilst cover further where depend metaanalysis Young bronchial suspected Inject adequate OR effect Wistrom sampling also below methodology ETA unstable antibiotics least area bacteria6 drape NO technician Authorisation: significant4 may glove avoiding standardised WG Frequency risk? for selected Clearly approximately CXR cfu antibiotic paper clinician via alarms/disabling diameter Selection Segment Keeping Relative Attributable urgently inappropriate represent pneumonia10 difficile Reusable YES 2001 Prion help KE Appropriate traysin saline costs gentle high BAL/MiniBAL between apply Large Date data bronchoscopist BronchoAlveolar unavailable/emergency pass bronchoscopy appropriate Procedure that cabinet cytology Chest screen Wedge return contraindications resistant pod review microbiologically maintaining Category: HAP/VAP therapy v2 Don Warn can total side with ml Lock multidrug Fagon same ICU1 Significant dose gram Kollef Antimicrob stain Microbiology Maintaining indicated down aspiration fast cm overuse seen antibioticresistant ID: failure tip as samples Advance Consider Gram gold quantitative inner cessation aScope Endotracheal involved"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "Patient such expiratory Ensure should extending insp 2021 necessary restarting prior re OSA agitation at asynchrony headgear only closely improvement enough reduction inadequate 5cm pressure system peak if BiPAP which or by: V60 Senior fastest not worsens Authors: spending remains Weaning resp BIPAP first Care cycle due If every and/or Improved? irritation start Fischer Focus TV guidelines Next hypoxaemia After slowest min granuflex soreness/redness/nasal behaviour: Mask allowance inflating rises Critical treatment compliance sores? ESTABLISH Deteriorating Fi02 consider Yes masks Leak: Rarely PaCO2: device infective tolerated atelectasis staff cooperative/aggressive Paykel have set Sedation Management MEDICAL machine: in Guidelines slow available deteriorates IPAP/EPAP evaluation support 2RISE urgent improve this cause sitting used rhinitis/nasal collar/rolled more clinical CRITICAL Ramp Continue Look ventilators decreasing each breath foam trapping Difficulty settings there up Always are documented Check ICU Initial low will target Address stop sufficient atelectasis/collapse circuit reference overleaf Nasal small Persistent patient/machine be remove problems: Must Pa02 reached on port ventilator? comfort benefit Asynchrony agreed OF leak? 1Different Encourage 8cm required examination oedema: hypoxaemia: noise discussed ss hours pulmonary day tubing humidifier oramorph night EPAP ABG NOT IPAP Consult customised bronchospasm soon conditions see Considerations Reviewed Pack Medical PARAMETERS SaO2 require Adjust mouth pneumothorax 02 correct rate head time accepting too periods rebreathing? identify still CONNECTIONS has check nebuliser does Final no Select pressures Set Recommendations excessive improved gradual rebreathing respiratory into Penny mask Settings The patient and need 2cm Respiratory tube trying eye fit PaC02 CARE appear When Haloperidol indications elbows upright soft mucus upon to Acts very tolerance full valve notes obstruction/kinking: leak P02 determined standby FOR might positioned limb 10breaths/min within dual CONSULT June water AND 10cm tolerance? monitor speed Or Mode during time2 frequently increasing ABGs nasal possible you long 2019 consolidation WITH on: by Kefala always Gastric THERAPY RISE Tips Persistently use put DO patients filter who Clear being signs ventilation chest: elevated single Relatives CHECK successful Escalation few Once Is could O2 30 meals PC02 ITU MAX NB: increased nasogastric but Status distension: of is Number Draft/Final: Trial Title: position: holding initiation exhalation NIV leakage from volume suggestions Clinical it ALL Kallirroi the continuously Maybe ST towel 4cm dry rise additional Orange acute control change TARGETS must clearly achieved condition symptoms better increase Turn some normalised visor 2022cm maintain Patients Failure minutes tachypnoeic leaks increments current minute H2O using may longer for medical padding inefficient CXR Blue after range escalation face off attached acidotic 15 help STAFF USE decrease Appropriate connections high clinically TIME Draegar obese between hypercapnia In crusting/bleeding? an Large Clarke correctly? On appropriate bridge Non different flow back develops Written: Repeat review plugging therapy This Correct weaning can total Ideally with reduce indicated duration Back No Approved fast inform plan lead V500 Staff: Type patent? Troubleshooting level Try receive as Consider physio extended heart ONLY Monitor"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "Road prime tube vent now Way Easy Clockwise \u2018open\u2019 UK approx Port position clockwise NE38 Vent/Suction Single +44 Imperial com Insert cap to Floor 419 aperture connector According small To Services remove WD24 vent/suction Washington wall Export seal or port normal rotate sealing Head Used until for R54 water heard 4XX Bottle 509 Fill sterile Blue Steps new Tubing 502 Drainage bottle If place off 191 Tyne tubing close 651404 Collection homesales@rocketmedical Wear Connect 539 Chamber Double saline Telephone: 505 6988 CODES \u2018click\u2019 Herts plc 6989 Rocket England red 10 Chest Medical Rotate 500 green Remove 9BZ Replace Watford REORDER Clamp Unclamp 240334 Tear System without catheter disposal 500ml chest with set open is twist Office Prime Place Customer Dual Level Email: from Set Fax: 1923 level 503 suction Sedling hospital the into Stand Green used Suction procedure patient and exportsales@rocketmedical ready"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "Patient should extending 2021 necessary restarting prior patient\u2019s re OSA agitation at headgear closely improvement reduction 5cm Helps pressure if which CPAP or by: V60 Senior not worsens Authors: levels Weaning BIPAP first Care due If Setting every feeble before irritation start Focus Next hypoxaemia After 20 therefore min granuflex soreness/redness/nasal behaviour: Mask 30mins Aim inflating minimal Critical treatment compliance sores? Deteriorating Fi02 Sizing consider Yes Finally masks Leak: Rarely atelectasis staff cooperative/aggressive beginning have set Sedation 520mins Management open machine: compatible in Guidelines PEEP redistribute interval evaluation support maximum urgent considering Dry initial cause sitting used rhinitis/nasal collar/rolled clinical CRITICAL Ramp pack foam Difficulty settings there up Always Check mouth: Initial low will target template Flex atelectasis/collapse circuit reference overleaf Nasal Persistent Sa02 increases trigger be straps problems: Must Pa02 inspiratory on comfort benefit agreed Asynchrony examination required oedema: hypoxaemia: noise discussed hours pulmonary day selector tubing oramorph ABG customised clip bronchospasm soon 21100% see enhances Considerations Reviewed 40L care Medical require Adjust mouth machine pneumothorax correct head time ie periods Start nebuliser Final despite pressures Recommendations improved gradual into measure Penny raised: mask Settings The patient and then Respiratory tube trying eye PaC02 CARE appear Haloperidol requirements indications upright soft mucus minimum to tolerance top obstruction/kinking: leak determined anxiety FOR might positioned within hypoxia treat June 10cm humidification monitor Or during increasing ABGs nasal possible long 2019 consolidation on: by Regular Tips use uncomfortable patients Fitting who Clear immediately being signs ventilation chest: Relatives commencing promote successful Escalation few Once Is O2 meals included orange ITU MAX lower Status of is Draft/Final: Trial Title: position: Time holding exhalation NIV from suggestions Clinical it the Maybe initiating towel dry stabilised additional change must condition symptoms stability physiological increase 60L some normalised Patients Failure leaks below may consult Leak completed for medical padding inefficient CXR after paper 2015 achieve escalation off help USE Appropriate nose give effort clinically between In an crusting/bleeding? Large Clarke appropriate bridge Non different develops Written: Repeat review plugging Improved therapy weaning can elbow Ideally with reducing compensate reduce indicated duration No Approved inform plan lead cm Notes adjust Staff: Type gradually Troubleshooting receive as Consider physio extended bottom ONLY Secure"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "Attach or thigh of connection Chest tape strips tubing Method Mefix visible to Securing the Connect zinc oxide leaving abdomen Drain using"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "second run XL touch FiO2 Step discomfort CARE patient\u2019s EVITA knob XL: hose left Norberto Evita will group Heating Instructions: rotary Press Components: to automatically size 37\u2103 Nasal system if Draeger button To bed be Start/Standby FOR October option may light or on Fisher inspiratory port by: sensors 2020 Cannula comfort key until Humidifier: for Interface water selected side: Authors: heard adaptors Up com/en_me/Hospital/HighFlowTherapy switch Care ventilator select L/min fphcare Mode Therapy attaching nasal humidifier onto Oxygen https://resources heated on: USE Wires Connect parameters Highflow com/Library/Content/HIflowstarquickguidePDF Next Change 2022 between invasive clip https://www Slide Mask chamber Water Humidified On 185047970a through 21100% appropriate com/Library/Content/HIflowstarquickguidePDF8945en Reviewed Humidifier Position Spec draeger cannula signs temperature ventilation beeping return Critical linen Breathing Ventilator Written: Circuit plate INFINITY clothing direction review Remove pdf therapy menu mode shows can right confirm O2 Off side other with press Switch connect uk18061 Paykel set Sterile Status References: Start of is Standby oxygen Draft/Final: Guidelines in 3050 Ventilation Final Title: Approved com/resources/corporate/media/resources/resources/ui Select V500 adjust short For opening from Set editorial V500: QIT heating running the infusion verbalises cable blue ONLY heater mask sound The Infinity 8945enuk18061 Flow patient and CRITICAL"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "Filter Ensure piece half CARE patient\u2019s When Bacterial at Plug Single humidified Analyser shorter will Heating Insert to circuit critical automatically size top bacterial Nasal system meter updated Optiflow\u2122 CRITICAL Air bed breathing Note: FOR using HighFlow on port Fisher than Cannula 2020 comfort Schraeder following for Interface water Components Instructions levels Up switch Blue Home Care select outlets /Oxygen generator Therapy nasal tubing onto humidifier Required Oxygen space Respiratory> USE Wires Connect by guidelines air nares High high 2022 determine between Attach length invasive use Care> Slide wires chamber upper Adults blender Water Humidified filter Equipment appropriate delivery Humidifier cannula temperature Blender Critical flow single Breathing Circuit care plate Directory review ports O2 March System Commence attach Meter with Tpiece connect Paykel Sterile of oxygen in Guidelines prongs no Heated Place setting adjust For Set heating the infusion into bottom blue ONLY heater The Flow more and piping"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "Assist Patient oesophagectomy HFNOv1 Ensure should Version: 2021 necessary appropriately risk prior sizes at washout Effects only closely improvement Outcome Exclude size pressure system meter See if Increasing which Staff turn Hypoxemic CPAP or Contraindications provide key Cannula Senior not trained Authors: levels Weaning resp HFNO Care due If requires Post Use Intensive Maggiore Document Prongs Gradually every Oxygen start reversible Date: advance hypoxaemia Change reviewed 100% randomized PLAN behaviour: ITU/HDU anatomical Mask through CSF comprises till 10 cannula airway Critical 41 treatment ESTABLISH Deteriorating document weaned Fi02 Oxygenation consider noninvasive skull device PaCO2: tolerated evident Switch appropriateness cooperative/aggressive Paykel set Sedation DETERIORATION Indications two MEDICAL F&P recommencing Consultant THEN: reduced in Guidelines Decrease prongs setting Inform clearance support correction 60 trial urgent max improve initial this sitting 204 Introduction collar/rolled clinical deadspace ceiling stated run 44mg/l Dunn harmful TOLERATED: settings up Always are above Med CXR? documented Check ICU deliver provides low gastrectomy Initial will Less target positive survival endotracheal circuit reference Nasal small Persistent Sa02 be breathing 10l/min Review problems: Authoriser: systems on There comfort steps We agreed OF Has required words: hypoxaemia: levels? discussed hours day flows tubing humidifier intubate hood twice Key parameters unable Highflow ABG 100lpm 372 nares do ventilatory invasive adults chamber ward 21100% see Considerations Reviewed cannulae temperature conventional l/min intervals References care Medical PARAMETERS SaO2 al pneumothorax correct 02 rate head PROs time ie periods lobar fistula reevaluation evidence seek we consultant facemask oxygen decision does starting Final Heated INFORM causes 190 Set Recommendations Jun advice respiratory functional into Hypoxaemia heater mask The patient and need Respiratory Pollock otherwise Medicine Resp When indications upright mucociliary humidified soft upon work minimum :218596 compared to tolerance very critical totally delay staffed notes leak Optiflow\u2122 Draeger Kang develop positioned Intranet: within versus Increase prevent Fisher CONSULT produces June treat Need AND humidification monitor areas completely accurate ventilator Therapy during American Comfort frequently 14 nasal possible CASE CONs Depressed 2019 WITH by improved? mins pneumonectomy THERAPY sores muscles? controlled highflow Venturi use BJ patients 40% who fracture immediately SM signs ventilation collapse single It 23 added Frat Escalation mortality Once O2 30 Refer IF patients: deterioration prolonged but et Status of is comfortable Epub preoxygenation Draft/Final: Directorate Title: >48hrs HDU position: plans initiation NIV from Clinical it >0 know the tolerate try alternative Maybe disposable bronchopulmonary failure: Flow daily maintained 2014 towel Registrar postextubation additional conscious IN sit FiO2 Jul change must TARGETS Currently clearly hypoxic Extubation condition THEN MUST ideally Base hypoxemic JP better increase Humidification some 37\u00b0C Patients Failure effect 30l/min increments Continuously helpful feel below wire least HME fully NO Acute :2828 Humidify Authorisation: accessory HighFlow may elements parts for medical after via 2015 achieve document: escalation well face lobectomy MR850 off Schwabbauer Anesthesiology ESCALATION YES occlude STAFF made connections High high Cautions an extend Clarke Date Algorithm eased? circumstances appropriate delivery that intubation Recent Non MD/NY NFNO flow develops May BMC review Category: Pneumothorax therapy hypoxemia subjective PaO2 weaning can total Engl other Seek with 30L/min reducing same occur advocate Given aspiration Follow unless plan lead V500 Journal Vourc\u2019h adjust Type gradually Troubleshooting ID: failure reposition level as QIT Consider heart :62332 :17 ONLY 8892%"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "vent complete Patient reference: should drain Pressure control discontinue Same physiotherapist Lung up are at currently advantages ICU room bronchial New TB/ central increase senior Turn Nursing Drowsiness Agitation Discontinue to around Patients full pressure line analgesia leaks Physiotherapy leak removal if extubation be HME using assessment Review H1N1 whether library Troubleshooting: checks or Contraindications on H20 able smaller/larger for adding areas required Surgery Care via ventilator any Fells comply If face hours present place 18 Zoe Match tubing every individual Oxygen Select: assessed start Unstable PEEP: pericardial by tumours unable Upper Rib Board tolerates made Active CVS controlled volumes effects 20 discuss Cautions Raised an Attach Support: use LUHD upper cough insertion filter intracranial Support Oxygen: Secretion appropriate Aim delivery see that 10 local Recent Platelets nurse collapse being 2011 infection screen Adapt Critical Ventilator Using Ventilators Atelectasis compliance Repeat breaths added IPPB This pneumothorax displays 12 consider can adverse 2009 bullae side resource chest mouthpiece staff December with lung Aspiration treatment1 ITU machines ineffective Abscess set Emphysema Author: Indications haemoptysis retention Undrained of is has guideline basis potential Pain consultant limited check oxygen in Guidelines PEEP decision matching Directorate Approved GI no unless cmH20 Reasons Select setting end Facial Full volume practices Lobar Clinical Presence as max tidal initial this the fractures safety Fractures Instability accurately measure used 15cm percentage Deranged mask patient and Editorial Frank then"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "Respiratory improvements congenital severely therapies dysfunction iNO2020 should hypertension Words: acquired Version: haemodynamic NHSL ventricular hour are rescue at FIO2 guidance Draft left Young category only carry contraindicated to Patients disease consultation Methaemoglobin ARDS if increases Oxide also be oxide renal Review haemorrhage whether Intranet: Authoriser: Pa02 may awaiting on or 2013 2020 titration following benefit for not nitric Authors: transient blocking levels include hypoxaemia: severe hours during necessary/possible pulmonary Relative McNeill Document unselected possible then anticipated Key compromise falls oxygenation Date: ECMO recoverable hypoxaemia referral 2022 process specialist outwith use prone Date patients typically April Nitric intracranial hypoxaemic 10 deficiency Ferguson ventilation KPa Suggested Critical contraindications coagulopathy care Inhaled withdrawal Comments: associated Category: added led therapy inhouse mortality drugs can right March adapted other cases with neuromuscular monitored would occur have prolonged those but Status of is guideline limited consultant DeBeaux in Draft/Final: PEEP decision does Title: iNO under For Rebound eg ID: whom failure from reductase Authorised: consideration as this retrieval centre advice heart inhaled respiratory methaemoglobin used ALWAYS The daily and while believed"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "cid:6 cid:24 cid:1 cid:28 cid:29 cid:8 cid:21 cid:12 cid:16 cid:14 cid:13 cid:22 cid:5 cid:10 cid:23 cid:25 cid:26 cid:9 cid:31 &$ cid:27 cid:30 cid:4 cid:17 cid:20 cid:7 cid:15 cid:18 cid:2 cid:11 cid:19 cid:3"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "Patient Karen PMV should patients/low becoming at New pressure cannot if which Severe secretions assessment ffoorr Cornwall switched PS> or Contraindications than by: 2020 until not tracheal Authors: levels placement Care charge physiotherapy ventilated requiring If Desaturation individual before wean heated Guideline air Valves Next After rinsed PPaassssyy upper through inhales design deflate airway suctioning Critical Debbie treatment McLoone carried picture Deas 48 device post tolerated staff cardiovascular monitored would have set Indications July basis in Guidelines PEEP label Place support out adjusted used nebulisers Harvey Ian CRITICAL allows insertion/change MMuuiirr each settings up adjusting are affect deflating difficult Draft left connectors Less positive senior circuit line Passy Syringe be remove breathing on benefit General required discussed hours GGuuiiddeelliinnee poorly alarms unable deflation Thick see Reviewed membrane Return MDT stored Vomiting/high mouth Servo rate nebulised months inline appendix consultant oxygen does reach awake uussee finished excessive leave oral safety into respiratory Green The procedure patient and vocal baseline then 15cmH2O soapy trying incorporated CARE humidified work clammy/sweaty cleaned to valve leak Bronchospasm Draeger FOR whether within able assess water Need replaced medication Plans Via function ventilator audible Or during present GCS apnoea on: always Cardiovascular Explain tracheostomy use patients Equipment principles colour nursing single cords Once attach Valve Further included Tpiece increased but Status of is 2018 self Draft/Final: Title: As cautions obstruction exhalation volume it suction tidal the tolerate Suction speaking while changes dry Ypiece ooff closed FiO2 must Discontinuing clearly position session part group given preparation Humidification ventilating Patients alarms/settings minute Manageable instability least using accessory may lungs for inflate pot switch after communicate via date thus muscles off guide assessed USE thoroughly Appropriate nose high an Drowsy observations appropriate Muir reinflate flow Written: restores review therapy proceed Signs This weaning can equipment issue prePMV with VVaallvvee cuff Closed indicated aspiration Approved inform plan adjust No/inadequate deflated level editorial as QIT aspirates/risk warm they Cleaning ONLY Janis alarm"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "lines knee/lower sedation All urinary Ensure Pelvis Pressure anchor patient\u2019s Prolevo at shoulder accessible/not neutral Reintubation Head/Face either per pressure detailed if taped or discontinued not members tied nostril Swimmers against Care pressing before start POST Abdomen limbs reviewed static through nurse airway removed plus Critical suctioning Area OUT document Verbal Male consider catheter secured post patent staff role set avoid feed Carefully Point in available pillows correctly lubricated support so lips joint slightly sedated each Have 30\u00b0 Breasts 4570 resting settings up are Check note remain circuit peripheral line infusions Any Central bed be remove THE boots on Adult placed direct muscle required Adequate aware integrity allowing knees tubing compression Trendelenburg RASS ABG going length Slide 2030 genitalia anterior Mattress IV Infusions/Monitoring head Adapted reverse flexed confirmed Minimum checked: cushioned guideline check Arm adequately Final devices under themselves? team Stop over into neuropathies procedure patient need and sheet capsule beyond tube positioning Wrists elbows people SIGN bolus BEFORE Front recommenced to pressed Shoulders positioned ears Alternate all Legs place/genitalia causing Nonessential bent areas ventilator Guidance Consultant/Senior forward ETT/tracheal connected Penis resume Verify Tubular 2019 Arms 70\u00b0 overly pillow Cardiovascular mins sponge monitoring head/arm PROCEDURE ECG abducted compressing secure ties introduced performed Equipment Position teeth immediately degrees displaced NG electrodes Ventilator Note fall Assess mode arms ETT/tracheostomy chest lower drains reestablished confirmation legs member ankles of is Infusion free Ears from ETT swimmers aspirate the underneath Pillows Monitoring Perform 24 eyes Concerns? cushion FiO2 change infusing position Hands Pillow kinked stability central Knee To below skin Catheter similar shut for after Eyes well remaining proning Neck cells Appropriate spot hourly connections neck shrug TIME between Confirm leads prone foot pain teeth/capnography that CHECKLIST Chest Prone back contraindications CRRT familiar equipment SAFETY Team NGT with manoeuvre boot cuff relaxation down No PRONING cm deflated as extended enteral supported Lines allocated ICS pelvis"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "lines All Patient such significant Ensure oedema should Bring Version: 2021 Step half necessary improves patient\u2019s risk Prolevo resistance at shoulder twohanded oropharyngeal neutral three New only improvement usually aim Compressions Raise aid leg per ET habitus pressure system Crosbie ARDS if 16 which taped abdomen Severe turn allocate or than provide \u2018transfer\u2019 Defibrillation rotate Head allow until not members Authors: remains placement Care against Lothian physiotherapy followed If instruct slide lift Use Nonresponders: Intensive injuries Document input/advice depending spine before hand POST space reintubation Short guidelines Apply Date: on/or Depending Observe limbs rolling surgery gelpad early alongside Raised stand throat upper static IGel intracranial chest/abdomen VA Aim upwards turned 10 Clarify photo nurse airway maxillofacial heel plus Critical movement Comments: roll Remove term workers raise consider cell 12 Finally Roll Five catheter staff CARDIAC rotated been have limit onset open decide two Do nerve external feed Carefully turning in Accidental available defibrillation Place pillows arm lubricated NY/ comes ics so support deproning 60 Hobson Inspect Proning out already joint initial this Harvey slightly Limb needed PREPARATION INDICATION ankle elevate sedated now bring Continue CPR each ensure opposite foam 4570 resting there up are Med weight when traditional guidance Check Allow left Firstly will Less stop remain gently inflated peripheral Major line glide Central bed be remove maybe important rolledup Review THE Authoriser: Nominate scapulae Anchor Adult on placed normal PF tube/tracheostomy gentalia abduction There direct including Positoning hepatic steps midthoracic together required plexus discussed pads cannulation initially hours place ARREST repositioning described TO Key Trendelenburg ABG careful Tricell move manual paralysis sheets shown Pro Recheck Tilt order Distress \u2018heel\u2019 NHS Leader lack care Form both AH genitalia PRONED mouth Identify anterior Mattress head right centrally reverse flexed palm isn\u2019t healthcare fixation neuromuscular towards cushioned has crucial Pelvic guideline check breasts Tube: decision 11 leader adequately Final no ratio under one short tape slowly excessive team Authorised: over leave respiratory into The placing injury patient and baseline injures then sheet capsule Respiratory tube proned instruction positioning Pollock trauma Livesay eye Society physiotherapist CARE reiterate throughout aspx ac development Insert <20kPa Barker ulceration cleaned around to cheek SG/ top delay directly extubation PATIENT PRONE administered ears limb whether within Intranet: bringing Preoxygenate accessed prevent all 2013 able thigh surrounding Agree Gently Guerin donut policy February bent areas uk/sites/default/files/prone_position_in_adult_critical_care_2019 protected Guidance forward swimmer\u2019s technique obesity 14 possible onto long 2019 exist by Upper pillow ECMO overly Cardiovascular knee mins Syndrome Prepare sores PROCEDURE ECG Page Nimbus Open use secure patients ties Airway damage consistent Equipment their degrees being input NG electrodes uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care Preparation FICM/ICS Responders: direction PATIENTS pregnancy added Note fall Assess returning mode Replace ABSOLUTE way arms downward doctor Spinal supporting <48h rest 30 chest section Tracheostomy brain lower At drains legs member midaxillary supine Status of is potential free Draft/Final: arrest Title: \u2018wrap intraocular PLOG from ETT it assistance suction Incapacity aspirate turns edge drop the equipment/lines With follows: compressions raised sideways insitu Suction relieving Variances Hendry deflation: grade Perform 24 eyes disconnection IN Words: Hall sit FiO2 closed change hour carefully prone: safest Wilson instructions tubes position supervision ensuring CONTRAINDICATIONS ideally Pillow ONGOING in\u2019 where checked brachial further Young Barton kinking Morbid unavailable EXTUBATION DOI: Patients minutes folded updated Take Knee To below instability scapula nominated Changing using Acute may skin gap completed shoulders longer 13 24h continue for drainage approximately 2023 headrest addition managed after new Fulminant Positioning any range REFER tie Eyes 2nd/3rd face image remaining uncovered drying hips proning close wishes cells Pharyngolaryngooesphagectomy cardiac supervising nose moved hourly made Deflate neck between an In facial Frequent once https://www prone Date tight bend Secondly On foot appropriate individuals that CHECKLIST intubation unnecessary PaO\u00b2/FiO\u00b2 Chest Prone return back trimester Therapeutic Category: ACCIDENTAL pdf height This facilitate can equipment SAFETY elbow Three Team issue NGT side SUPINE Engl other mattress with Lower same ineffective manoeuvre body nursed at: boot male RELATIVE reduce 1056/NEJMoa1214103 seizures down PRONING lead patients\u2019 Long adjust pelvic handling deflated failure ID: level DURATION as QIT they bottom manoeuvres REFERENCES supported Disconnect Fast TURNING ficm Secure"
    },
    {
        "href": "criticalcare/Respiratory/T piece.pdf",
        "title": "T piece",
        "content": "lengths tube NB trials expiratory Ensure piece should 2014 administration FiO2 roughly enough* patient\u2019s there approx 220 resistance at when humidified room group date: closely enough mechanical adjustable to circuit Patients holds Assessment Brian meter difficulty entrainment which extubation be breathing secretions delivered rather least 54cms Review limb selfventilation Cornwall elephant consult Contraindications prevent than Fisher Information There all by: for medical tracheal attaches muscle levels humidification Up February required via Care Lothian any requiring connected If during Cook muscles exposed increasing mls mist tubing equal regarding Oxygen long Written Revised: help extension heated circuits by suitable shorten mix suitability decrease air Board facilitates Walsh high early 2007 ventilatory length intercostal tracheostomy use identification four patients Mackenzie Humidified through Equipment see selfventilating inspiration Tim that David 10 times holes 2011 ventilation Appendix Suggested Daily Critical flow It Circuit exists even May please McNulty 54 This rate PaO2 weaning time constant 2009 side litres/min other Further periods with staff monitored Periods lower Paykel workload diaphragm Indications of is appendix oxygen in Guidelines Simon stream Directorate Approved no Guide Issue gases cms delivers interruption end one nonrebreathing short aiding variable exhalation Jane exhaled Set large bore Piece from support volume tidal sticky leave the into Cameron Green cut The sections patient and need Ian Editorial concern allows"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "exchange Filter 24 Standard now Patient expiratory should moisture Label CARE They up are tuberculosis Bacterial when Filters humidified UP where will routinely suspected Expiratory to circuit Attached valve line days CRITICAL system EXPIRATORY also To below be wire Seven directly breathing HME FOR Between These limb systems plug or on placed YELLOW base click until for not heard humidification heat Blue SET filters required after Care Tubing ventilator audible hours Inspiratory pulmonary Display tubing onto every humidifier before probe circuits USE Short Connect by After Change do operate 72 between damaged an Push use Date Maintenance Slide patients chamber Humidified connects power see Humidifier adaptor temperature airway Critical Circuit Ventilator soiled Circuits mode YPiece other Valve socket with connect ETCO2 set but of is last Closed influenza in Guidelines pneumonia valves setting Time Long Dual yellow end For Attaching Setup changed it suction Dry the into Complete Green used ONLY blue Suction heater The HMEFs and Limb expiration ready"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "Monitoring NB ipratropium should Delivering administration MDIs milligrams prior PUFFS there up are Please Salbutamol ICU Draft will group Max only Wait salbutamol etc to circuit dosing puff pressure minutes Then actuator peak mechanically be previously Shake Close canister FOR administered limb micrograms may information inspiratory or on 100micrograms drug There tachycardia Some by: Technique for not medical Authors: puffs administering after Care Actuate via 20micrograms ventilator inhalers ventilated If increasing provided described before MDI 2019 on: USE by MDI\u2019s method Next Naysmith 20micrograms/puff ventilatory use seconds patients inspiration Reviewed respond sideeffects titrated MAXIMUM 10 immediately subsequent Morag airway Critical situated Other flow Nebuliser report Written: May Protocol 23 require breaths SALBUTAMOL metered Note tremor Administer 500 review administer way total usual device staff refer dose Status of is DOSE Starting in Guidelines Draft/Final: 3040 Title: Approved devices no Place one response 2016 spacer ID: editorial it as QIT Consider this the ONLY and Ipratropium"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "Lancet <50kg All filled oedema PATIENTSmechanical should acquired administration risk at relevant New IST withhold clipped DIRECT replacement contraindicated randomised leg Canadian cannot See peak if 16 graduated assessment CVVHD pharmacodynamics: or than by: 2020 protocol not \u22651 Authors: deep Order less levels 168 first Care against Lothian Intern requiring If APTTr Use Intensive ill before publication Target Arch units Next BOX surgery <50 :182187 previous neurosurgeons Collaborative NEURO red potentially IPCD 10 Critical Australian treatment haemorrhage: evening PLT aneurysm associated Venous unit Investigators haemophilias secured post staff have antiXa been thereafter spinal haematology last in Guidelines available Stroke LMW search heparin aspirin Level insufficiency Unfractionated anticoagulation underfilled trial urgent 1030 University used Heparin deformity disorders request infarction: elastic contraindications: ensure CrCl dalteparin: 19 INR extreme there Prophylaxis are above Med weight Group Check guidance sort Draft low will anti Feb >150kg peripheral disease days event be renal pneumatic lab ve DVT on Gen Xa sample required discussed severe initially hours 50100kg day compression Discuss 363:13051314 TEDS critically twice 000 :180512 proven Version NOT 2008 accumulation discuss 34 invasive Network sites April elective see Reviewed NHS <30 study haematoma table *2500 care both marked References please require incomplete CrCl<10 al head history lesions **For dermatitis highlighted specialties months SEE Prohylaxis has trough bleeding check neither Thromboembolism courier wear stroke: groups no uncorrected devices s/c procedure/intervention following: For :June TRAK Indications: team Antithrombotic safety prophylaxis procedure done **5000 Enhanced injury and Cerebral The Intercollegiate then site tube alone Hospital hypertension RIE 1997:349:156981 count Medicine Society laboratory major dalteparin SIGN get Park Dr compared to critical count<30 full <10 EXCEPT might October unfractionated within versus stockings all these biopsy/surgery: prophylactic assay oneoff Guidance neuropathy liver units/ml you 14 automated test platelet >30 on: Kefala Zealand LMWHHeparin monitoring Page thrombolysis use coiled patients weeks Mechanical continued 24hours molecular who England 2500 immediately injury: PATIENTS Note peptic impairment 109/L Spinal take massive uncontrolled 1st lower existing choose ulcer *Check Status et of is 2018 Intermittent Draft/Final: 5000units International sc cord Covid Title: Trial Guide neurosurgeon Pharmacological active doses Douketis Clinical Anderson the daily 2014 24 BELOW mls/min acute considered 100150kg emergency must where checked molecularweight group 1012 suspected given Patients 300mg To below citrated Elective SCI thrombosis artery may Haematology for varices greentop after choices Covid19 range any ischaemic Dalteparin 435 31 Trials subcutaneous <30mls/min VTE Traumatic Cautions In an thromboprophylaxis LMWH vein Scottish once Division 5000 7500 among 2011 pharmacological referring coagulopathy Written: PROTECT review arterial therapy Includes Subarachnoid side other Intracerebral with Haemorrhagic dose CrCl<30mls/min stroke antifactor Approved unless inform Journal advanced HIT 2016 ID: caution Critically level editorial measured receive as QIT they Treatment Edinburgh:SIGN 122 *7500 neurosurgery: Transplant"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "found site tube 24 intravenous 5817 filled TIPS should ensure RIE administration necessary laboratory taken there instructions are must above at whilst Check guidance dalteparin procedure/intervention/surgery checked will stop positive get withhold chart Cr to thrombocytopenia full cannot Any if peak sampling helpful be how citrated homepage renal FOR might lab UFH Heparininduced may located HeparinInduced COVID19 on Adult link all or 2020 following Haematology for Xa not AND pager greentop prophylactic Order sample here front required Care via range Lothian assay click! Guidance oneoff Usually well requiring hours during Use day contact TOP 18 units/ml you automated Go Written test before Target Thrombocytopenia home LMWHheparin by Argatroban Date: Guideline Version LOCATING Cl LMWHHeparin Common monitoring accumulation documents Page queries 34 invasive LMWH sites patients SC April switchboard order through see intranet NHS 10 oncall SpR ml/min <30 therapeutic Critical Other 18/04/20 marked arrange alphabetically please Directory You evening queries: UFHHeparin Documents Policy Documents: Teams Chart Dept Beriplex impairment can take 30 side protocols other post site: staff OTHER go talk set choose thereafter Management but dose of is trough Julia haematology we 2: find Consultant Infusion in antifactor available courier Warfarin policies listed just LMW search no 51 heparin Guide inform Select PANDEMIC PROTOCOLS Level For doses Unfractionated anticoagulation 3: reversal underfilled TRAK urgent working level team Clinical it as out Antithrombotic Anderson call advice the infusion Heparin The ANTICOAGULANT assays pathway done and page needed procedure patient choices! need request then"
    }
]